Legalize / Eesti / Tervisekassa ravimite loetelu / History

Reform history

Tervisekassa ravimite loetelu

100 versions · 2026-03-25

2026-03-31

Tervisekassa ravimite loetelu

View changes Text at this date

2025-12-31

Tervisekassa ravimite loetelu

View changes Text at this date

2025-09-30

Tervisekassa ravimite loetelu

View changes Text at this date

2025-06-30

Tervisekassa ravimite loetelu

View changes Text at this date

2025-03-31

Tervisekassa ravimite loetelu

View changes Text at this date

2024-12-31

Tervisekassa ravimite loetelu

View changes Text at this date

2024-09-30

Tervisekassa ravimite loetelu

View changes Text at this date

2024-06-30

Tervisekassa ravimite loetelu

View changes Text at this date

2024-03-31

Tervisekassa ravimite loetelu

View changes Text at this date

2023-12-31

Tervisekassa ravimite loetelu

View changes Text at this date

2023-09-30

Tervisekassa ravimite loetelu

View changes Text at this date

2023-06-30

Tervisekassa ravimite loetelu

View changes Text at this date

2023-03-31

Tervisekassa ravimite loetelu

View changes Text at this date

2022-12-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2022-09-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2022-06-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2022-04-02

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2021-12-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2021-09-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2021-06-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2021-03-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2020-12-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2020-09-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2020-06-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2020-03-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2019-12-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2019-09-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2019-06-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2019-03-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2018-12-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2018-09-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2018-06-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2018-03-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2017-12-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2017-09-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2017-06-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2017-03-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2017-01-01

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2016-12-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2016-09-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2016-06-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2016-03-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2015-12-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2015-09-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2015-08-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2015-06-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2015-03-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2014-12-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2014-09-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2014-06-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2014-03-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2013-12-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2013-09-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2013-06-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2013-05-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2013-03-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2012-12-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2012-09-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2012-06-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2012-03-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2011-12-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2011-09-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2011-08-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2011-06-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

Changes on 2011-06-30

@@ -22,156 +22,160 @@

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1011429 | adapaleen, 1mg 1g | D10AD03 | DIFFERIN, geel, 30g 1TK | GALDERMA INTERNATIONAL | 50 | | | | | | |

| 1011430 | adapaleen, 1mg 1g | D10AD03 | DIFFERIN, kreem, 30g 1TK | GALDERMA INTERNATIONAL | 50 | | | | | | |

| 1074350 | alendroonhape, 70mg | M05BA04 | FOSAMAX 70 MG, tablett, 4TK | Merck Sharp & Dohme OÜ | 50 | | | | | | |

| 1074350 | alendroonhape, 70mg | M05BA04 | FOSAMAX 70 MG, tablett, 4TK | Merck Sharp & Dohme OÜ | 75 | M80-M80 | | | | | patsientidele, kelle lülisamba või reieluukaela mineraalne tihedus on -2,5 SD või vähem DEXA meetodil määratuna |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1240120 | alendroonhape, 70mg | M05BA04 | SEDRON, õhukese polümeerikattega tablett, 4TK | Gedeon Richter Plc. | 50 | | | | | | |

| | | | | | 75 | M80-M80 | | | | | patsientidele, kelle lülisamba või reieluukaela mineraalne tihedus on -2,5 SD või vähem DEXA meetodil määratuna |

| 1238712 | alendroonhape, 70mg | M05BA04 | RALENOST 70MG, tablett, 4TK | Ranbaxy (UK) Limited | 50 | | | | | | |

| | | | | | 75 | M80-M80 | | | | | patsientidele, kelle lülisamba või reieluukaela mineraalne tihedus on -2,5 SD või vähem DEXA meetodil määratuna |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1240120 | alendroonhape, 70mg | M05BA04 | SEDRON, õhukese polümeerikattega tablett, 4TK | Gedeon Richter Plc. | 75 | M80-M80 | | | | | patsientidele, kelle lülisamba või reieluukaela mineraalne tihedus on -2,5 SD või vähem DEXA meetodil määratuna |

| | | | | | 50 | | | | | | |

| 1245338 | alendroonhape, 70mg | M05BA04 | ALENOTOP, tablett, 4TK | Teva Pharma B.V. | 75 | M80-M80 | | | | | patsientidele, kelle lülisamba või reieluukaela mineraalne tihedus on -2,5 SD või vähem DEXA meetodil määratuna |

| | | | | | 50 | | | | | | |

| 1341302 | alendroonhape, 70mg | M05BA04 | LENDRATE, tablett, 4TK | Actavis Group PTC ehf | 75 | M80-M80 | | | | | patsientidele, kelle lülisamba või reieluukaela mineraalne tihedus on -2,5 SD või vähem DEXA meetodil määratuna |

| | | | | | 50 | | | | | | |

| 1245338 | alendroonhape, 70mg | M05BA04 | ALENOTOP, tablett, 4TK | Teva Pharma B.V. | 50 | | | | | | |

| | | | | | 75 | M80-M80 | | | | | patsientidele, kelle lülisamba või reieluukaela mineraalne tihedus on -2,5 SD või vähem DEXA meetodil määratuna |

| 1341302 | alendroonhape, 70mg | M05BA04 | LENDRATE, tablett, 4TK | Actavis Group PTC ehf | 50 | | | | | | |

| | | | | | 75 | M80-M80 | | | | | patsientidele, kelle lülisamba või reieluukaela mineraalne tihedus on -2,5 SD või vähem DEXA meetodil määratuna |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1339141 | alendroonhape+koleka ltsiferool, 70mg+5600RÜ | M05BB03 | FOSAVANCE, tablett, 4TK | Merck Sharp & Dohme Limited | 50 | | | | | | |

| | | | | | 75 | M80-M80 | | | | | patsientidele, kelle lülisamba või reieluukaela mineraalne tihedus on -2,5 SD või vähem DEXA meetodil määratuna |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1163854 | alfa-2a-interferoon, 3000000RÜ 0,5ml | L03AB04 | ROFERON-A, süstelahus, 1TK | Roche Eesti OÜ | 100 | C43-C43 | Onkoloog | | | | adjuvantraviks AJCC II staadiumi korral pärast kasvaja kirurgilist resektsiooni |

| | | | | | 50 | | | | | | |

| | | | | | 100 | B18.2-B18.2 | Gastroenteroloog, Infektsionist | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | C43-C43 | Onkoloog | | | | adjuvantraviks AJCC II staadiumi korral pärast kasvaja kirurgilist resektsiooni |

| 1110384 | alfa-2a-peginterferoon, 135mcg 0,5ml | L03AB11 | PEGASYS, süstelahus süstlis, 0.5ml 1TK | Roche Registration Limited | 100 | B18.2-B18.2 | Infektsionist, Gastroenteroloog | | | | kroonilise progresseeruva C- viirushepatiidi näidustusel vastavalt Eesti Gastroenteroloogide Seltsi ja Eesti Infektsionistide Seltsi 2006. a ravijuhisele |

| | | | | | 50 | | | | | | |

| 1110384 | alfa-2a-peginterferoon, 135mcg 0,5ml | L03AB11 | PEGASYS, süstelahus süstlis, 0.5ml 1TK | Roche Registration Limited | 50 | | | | | | |

| | | | | | 100 | B18.2-B18.2 | Infektsionist, Gastroenteroloog | | | | kroonilise progresseeruva C- viirushepatiidi näidustusel vastavalt Eesti Gastroenteroloogide Seltsi ja Eesti Infektsionistide Seltsi 2006. a ravijuhisele |

| 1110407 | alfa-2a-peginterferoon, 180mcg 0,5ml | L03AB11 | PEGASYS, süstelahus süstlis, 0.5ml 1TK | Roche Registration Limited | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1011856 | alfa-2b-peginterferoon, 100mcg | L03AB10 | PEGINTRON, süstelahuse pulber ja lahusti, 1TK | SCHERING-PLOUGH EUROPE | 100 | B18.2-B18.2 | Infektsionist, Gastroenteroloog | | | | kroonilise progresseeruva C- viirushepatiidi näidustusel vastavalt Eesti Gastroenteroloogide Seltsi ja Eesti Infektsionistide Seltsi 2006. a ravijuhisele |

| 1011856 | alfa-2b-peginterferoon, 100mcg | L03AB10 | PEGINTRON, süstelahuse pulber ja lahusti, 1TK | SCHERING-PLOUGH EUROPE | 100 | B18.2-B18.2 | Gastroenteroloog, Infektsionist | | | | kroonilise progresseeruva C- viirushepatiidi näidustusel vastavalt Eesti Gastroenteroloogide Seltsi ja Eesti Infektsionistide Seltsi 2006. a ravijuhisele |

| | | | | | 50 | | | | | | |

| 1336519 | alfa-2b-peginterferoon, 100mcg | L03AB10 | PEGINTRON, süstelahuse pulber ja lahusti, 1TK | SCHERING-PLOUGH EUROPE | 50 | | | | | | |

| | | | | | 100 | B18.2-B18.2 | Gastroenteroloog, Infektsionist | | | | kroonilise progresseeruva C- viirushepatiidi näidustusel vastavalt Eesti Gastroenteroloogide Seltsi ja Eesti Infektsionistide Seltsi 2006. a ravijuhisele |

| 1011867 | alfa-2b-peginterferoon, 120mcg | L03AB10 | PEGINTRON, süstelahuse pulber ja lahusti, 1TK | SCHERING-PLOUGH EUROPE | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1336553 | alfa-2b-peginterferoon, 120mcg | L03AB10 | PEGINTRON, süstelahuse pulber ja lahusti, 1TK | SCHERING-PLOUGH EUROPE | 100 | B18.2-B18.2 | Gastroenteroloog, Infektsionist | | | | kroonilise progresseeruva C- viirushepatiidi näidustusel vastavalt Eesti Gastroenteroloogide Seltsi ja Eesti Infektsionistide Seltsi 2006. a ravijuhisele |

| | | | | | 50 | | | | | | |

| 1209912 | alfa-2b-peginterferoon, 150mcg | L03AB10 | PEGINTRON, süstelahuse pulber ja lahusti, 1TK | SCHERING-PLOUGH EUROPE | 100 | B18.2-B18.2 | Infektsionist, Gastroenteroloog | | | | kroonilise progresseeruva C- viirushepatiidi näidustusel vastavalt Eesti Gastroenteroloogide Seltsi ja Eesti Infektsionistide Seltsi 2006. a ravijuhisele |

| | | | | | 50 | | | | | | |

| 1336609 | alfa-2b-peginterferoon, 150mcg | L03AB10 | PEGINTRON, süstelahuse pulber ja lahusti, 1TK | SCHERING-PLOUGH EUROPE | 100 | B18.2-B18.2 | Infektsionist, Gastroenteroloog | | | | kroonilise progresseeruva C- viirushepatiidi näidustusel vastavalt Eesti Gastroenteroloogide Seltsi ja Eesti Infektsionistide Seltsi 2006. a ravijuhisele |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1011834 | alfa-2b-peginterferoon, 50mcg | L03AB10 | PEGINTRON, süstelahuse pulber ja lahusti, 1TK | SCHERING-PLOUGH EUROPE | 50 | | | | | | |

| 1011867 | alfa-2b-peginterferoon, 120mcg | L03AB10 | PEGINTRON, süstelahuse pulber ja lahusti, 1TK | SCHERING-PLOUGH EUROPE | 100 | B18.2-B18.2 | Infektsionist, Gastroenteroloog | | | | kroonilise progresseeruva C- viirushepatiidi näidustusel vastavalt Eesti Gastroenteroloogide Seltsi ja Eesti Infektsionistide Seltsi 2006. a ravijuhisele |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| 1209912 | alfa-2b-peginterferoon, 150mcg | L03AB10 | PEGINTRON, süstelahuse pulber ja lahusti, 1TK | SCHERING-PLOUGH EUROPE | 100 | B18.2-B18.2 | Gastroenteroloog, Infektsionist | | | | kroonilise progresseeruva C- viirushepatiidi näidustusel vastavalt Eesti Gastroenteroloogide Seltsi ja Eesti Infektsionistide Seltsi 2006. a ravijuhisele |

| | | | | | 50 | | | | | | |

| 1336609 | alfa-2b-peginterferoon, 150mcg | L03AB10 | PEGINTRON, süstelahuse pulber ja lahusti, 1TK | SCHERING-PLOUGH EUROPE | 50 | | | | | | |

| 1336430 | alfa-2b-peginterferoon, 50mcg | L03AB10 | PEGINTRON, süstelahuse pulber ja lahusti, 1TK | SCHERING-PLOUGH EUROPE | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1011834 | alfa-2b-peginterferoon, 50mcg | L03AB10 | PEGINTRON, süstelahuse pulber ja lahusti, 1TK | SCHERING-PLOUGH EUROPE | 100 | B18.2-B18.2 | Infektsionist, Gastroenteroloog | | | | kroonilise progresseeruva C- viirushepatiidi näidustusel vastavalt Eesti Gastroenteroloogide Seltsi ja Eesti Infektsionistide Seltsi 2006. a ravijuhisele |

| | | | | | 50 | | | | | | |

| 1336430 | alfa-2b-peginterferoon, 50mcg | L03AB10 | PEGINTRON, süstelahuse pulber ja lahusti, 1TK | SCHERING-PLOUGH EUROPE | 50 | | | | | | |

| 1011845 | alfa-2b-peginterferoon, 80mcg | L03AB10 | PEGINTRON, süstelahuse pulber ja lahusti, 1TK | SCHERING-PLOUGH EUROPE | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1336474 | alfa-2b-peginterferoon, 80mcg | L03AB10 | PEGINTRON, süstelahuse pulber ja lahusti, 1TK | SCHERING-PLOUGH EUROPE | 50 | | | | | | |

| 1207493 | alfadarbepoetiin, 100mcg 0,5ml | B03XA02 | ARANESP, süstelahus süstlis, 0.5ml 1TK | Amgen Europe B.V. | 50 | | | | | | |

| 1011845 | alfa-2b-peginterferoon, 80mcg | L03AB10 | PEGINTRON, süstelahuse pulber ja lahusti, 1TK | SCHERING-PLOUGH EUROPE | 100 | B18.2-B18.2 | Infektsionist, Gastroenteroloog | | | | kroonilise progresseeruva C- viirushepatiidi näidustusel vastavalt Eesti Gastroenteroloogide Seltsi ja Eesti Infektsionistide Seltsi 2006. a ravijuhisele |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1336474 | alfa-2b-peginterferoon, 80mcg | L03AB10 | PEGINTRON, süstelahuse pulber ja lahusti, 1TK | SCHERING-PLOUGH EUROPE | 100 | B18.2-B18.2 | Gastroenteroloog, Infektsionist | | | | kroonilise progresseeruva C- viirushepatiidi näidustusel vastavalt Eesti Gastroenteroloogide Seltsi ja Eesti Infektsionistide Seltsi 2006. a ravijuhisele |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1176207 | alfadarbepoetiin, 10mcg 0,4ml | B03XA02 | ARANESP, süstelahus süstlis, 0.4ml 1TK | Amgen Europe B.V. | 50 | | | | | | |

| 1176218 | alfadarbepoetiin, 20mcg 0,5ml | B03XA02 | ARANESP, süstelahus süstlis, 0.5ml 1TK | Amgen Europe B.V. | 50 | | | | | | |

| 1207314 | alfadarbepoetiin, 30mcg 0,3ml | B03XA02 | ARANESP, süstelahus süstlis, 0.3ml 1TK | Amgen Europe B.V. | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1207370 | alfadarbepoetiin, 40mcg 0,4ml | B03XA02 | ARANESP, süstelahus süstlis, 0.4ml 1TK | Amgen Europe B.V. | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| 1207471 | alfadarbepoetiin, 80mcg 0,4ml | B03XA02 | ARANESP, süstelahus süstlis, 0.4ml 1TK | Amgen Europe B.V. | 50 | | | | | | |

| 1207415 | alfadarbepoetiin, 50mcg 0,5ml | B03XA02 | ARANESP, süstelahus süstlis, 0.5ml 1TK | Amgen Europe B.V. | 50 | | | | | | |

| 1022960 | alfadornaas, 1mg 1ml | R05CB13 | PULMOZYME, nebuliseeritav lahus, 2.5ml 6TK | Roche Eesti OÜ | 50 | | | | | | |

| | | | | | 100 | E84-E84 | Pediaater, Pulmonoloog | esmane | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1022960 | alfadornaas, 1mg 1ml | R05CB13 | PULMOZYME, nebuliseeritav lahus, 2.5ml 6TK | Roche Eesti OÜ | 100 | E84-E84 | Pulmonoloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| 1084148 | alfaepoetiin, 10000TÜ 1ml | B03XA01 | EPREX, süstelahus, 0.4ml 6TK | Johnson & Johnson UAB | 50 | | | | | | |

| 1084137 | alfaepoetiin, 4000TÜ 1ml | B03XA01 | EPREX, süstelahus, 0.5ml 6TK | Johnson & Johnson UAB | 50 | | | | | | |

| 1088366 | alfaepoetiin, 6000TÜ 0,6ml | B03XA01 | EPREX, süstelahus, 0.6ml 6TK | Johnson & Johnson UAB | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1173855 | alfafollitropiin, 300RÜ 0,5ml | G03GA05 | GONAL-F, süstelahus pen- süstlis, 0.5ml 1TK | Merck Serono Europe Limited | 50 | | | | | | |

| 1213513 | alfafollitropiin, 450RÜ 0,75ml | G03GA05 | GONAL-F, süstelahus pen- süstlis, 0.75ml 1TK | Merck Serono Europe Limited | 50 | | | | | | |

| 1035784 | alfafollitropiin, 75RÜ | G03GA05 | GONAL-F, süstelahuse pulber ja lahusti, 1TK | Merck Serono Europe Limited | 50 | | | | | | |

| 1173866 | alfafollitropiin, 900RÜ 1,5ml | G03GA05 | GONAL-F, süstelahus pen- süstlis, 1.5ml 1TK | Merck Serono Europe Limited | 50 | | | | | | |

| 1116199 | alfakoriogonadotropiin, 250mcg | G03GA08 | OVITRELLE, süstelahuse pulber ja lahusti, 1TK | Merck Serono Europe Limited | 50 | | | | | | |

| 1116199 | alfakooriongonadotropi in, 250mcg | G03GA08 | OVITRELLE, süstelahuse pulber ja lahusti, 1TK | Merck Serono Europe Limited | 50 | | | | | | |

| 1046810 | alfalutropiin, 75RÜ | G03GA07 | LUVERIS, süstelahuse pulber ja lahusti, 1TK | Merck Serono Europe Limited | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1064247 | alfusosiin, 10mg | G04CA01 | XATRAL SR, toimeainet prolongeeritult vabastav tablett, 30TK | Sanofi-Aventis Estonia OÜ | 50 | | | | | | |

| 1278176 | alfusosiin, 10mg | G04CA01 | ALFUZOSIN-TEVA, toimeainet prolongeeritult vabastav tablett, 30TK | Teva Pharma B.V. | 50 | | | | | | |

| 1001619 | allopurinool, 100mg | M04AA01 | ALLOPURINOL NYCOMED, tablett, 50TK | Nycomed Sefa AS | 50 | | | | | | |

| 1001619 | allopurinool, 100mg | M04AA01 | ALLOPURINOL NYCOMED, tablett, 50TK | Nycomed Sefa AS | 75 | M10-M10, N20-N23 | | | | | |

| | | | | | 50 | | | | | | |

| 1001686 | allopurinool, 300mg | M04AA01 | ALLOPURINOL NYCOMED, tablett, 50TK | Nycomed Sefa AS | 50 | | | | | | |

| | | | | | 75 | M10-M10, N20-N23 | | | | | |

| 1001686 | allopurinool, 300mg | M04AA01 | ALLOPURINOL NYCOMED, tablett, 50TK | Nycomed Sefa AS | 75 | M10-M10, N20-N23 | | | | | |

| | | | | | 50 | | | | | | |

| 1064472 | amantadiin, 100mg | N04BB01 | PK-MERZ 100 MG, õhukese polümeerikattega tablett, 90TK | Merz Pharmaceuticals GmbH | 50 | | | | | | |

| | | | | | 100 | G20-G20 | Neuroloog | esmane | | | |

| 1064517 | amantadiin, 100mg | N04BB01 | AMANTADIN-RATIOPHARM 100 MG, õhukese polümeerikattega tablett, 100TK | ratiopharm GmbH | 50 | | | | | | |

| | | | | | 100 | G20-G20 | Neuroloog | esmane | | | |

| 1008841 | amiloriid+hüdroklorotia siid, 5mg+50mg | C03EA81 | MODURETIC, tablett, 30TK | Merck Sharp & Dohme OÜ | 50 | | | | | | |

| 1016244 | amiodaroon, 200mg | C01BD01 | CORDARONE 200 MG, tablett, 30TK | Sanofi-Aventis Estonia OÜ | 50 | | | | | | |

| | | | | | 75 | I47-I49 | Pediaater, Kardioloog | esmane | | | |

| 1044616 | amiodaroon, 200mg | C01BD01 | AMIOKORDIN, tablett, 60TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | I47-I49 | Kardioloog, Pediaater | esmane | | | |

| 1041141 | amisulpriid, 200mg | N05AL05 | SOLIAN, tablett, 30TK | Sanofi-Aventis Estonia OÜ | 50 | | | | | | |

| | | | | | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| 1012105 | amisulpriid, 400mg | N05AL05 | SOLIAN, õhukese polümeerikattega tablett, 30TK | Sanofi-Aventis Estonia OÜ | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| 1349872 | ambrisentaan, 10mg | C02KX02 | VOLIBRIS, õhukese polümeerikattega tablett, 30TK | Glaxo Group Limited | 100 | I27.0-I27.0 | Pulmonoloog, Reumatoloog, Kardioloog, Pediaater | | | | NYHA III-IV kl idiopaatilise, süsteemse sidekoehaiguse või kaasasündinud südamerikkega seotud pulmonaalse arteriaalse hüpertensiooni raviks patsientidele konsiiliumi (vähemalt 3 vastava eriala spetsialisti) otsuse alusel, kui sildenafiil on vastunäidustatud, osutunud ebaefektiivseks või põhjustanud olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1349850 | ambrisentaan, 5mg | C02KX02 | VOLIBRIS, õhukese polümeerikattega tablett, 30TK | Glaxo Group Limited | 100 | I27.0-I27.0 | Pediaater, Reumatoloog, Kardioloog, Pulmonoloog | | | | NYHA III-IV kl idiopaatilise, süsteemse sidekoehaiguse või kaasasündinud südamerikkega seotud pulmonaalse arteriaalse hüpertensiooni raviks patsientidele konsiiliumi (vähemalt 3 vastava eriala spetsialisti) otsuse alusel, kui sildenafiil on vastunäidustatud, osutunud ebaefektiivseks või põhjustanud olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1016244 | amiodaroon, 200mg | C01BD01 | CORDARONE 200 MG, tablett, 30TK | Sanofi-Aventis Estonia OÜ | 75 | I47-I49 | Pediaater, Kardioloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1044616 | amiodaroon, 200mg | C01BD01 | AMIOKORDIN, tablett, 60TK | KRKA d.d., Novo Mesto | 75 | I47-I49 | Pediaater, Kardioloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1041141 | amisulpriid, 200mg | N05AL05 | SOLIAN, tablett, 30TK | Sanofi-Aventis Estonia OÜ | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1008661 | amitriptüliin, 10mg | N06AA09 | AMITRIPTYLINE NYCOMED, õhukese polümeerikattega tablett, 50TK | Nycomed Sefa AS | 50 | | | | | | |

| | | | | | 100 | F32.2-F32.3, F70- F79, F11.4-F11.7, F18.4-F18.7, F20- F29, F12.4-F12.7, F16.4-F16.7, F19.4- F19.7, F33.2-F33.3, F14.4-F14.7, F00- F09, F60.3-F60.3, F13.4-F13.7, F10.4- F10.7, F17.4-F17.7, F15.4-F15.7, F30- F31 | Psühhiaater | esmane | | | |

| | | | | | 75 | G62.0-G62.0, G63- G63 | | | | | |

| 1008661 | amitriptüliin, 10mg | N06AA09 | AMITRIPTYLINE NYCOMED, õhukese polümeerikattega tablett, 50TK | Nycomed Sefa AS | 50 | | | | | | |

| 1107391 | amitriptüliin, 10mg | N06AA09 | AMITRIPTYLINE-GRINDEKS, õhukese polümeerikattega tablett, 50TK | Grindeks | 50 | | | | | | |

| | | | | | 75 | G62.0-G62.0, G63- G63 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1005860 | amitriptüliin, 10mg | N06AA09 | SAROTEN, õhukese polümeerikattega tablett, 100TK | H. LUNDBECK A/S | 50 | | | | | | |

| | | | | | 75 | G62.0-G62.0, G63- G63 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| 1008683 | amitriptüliin, 25mg | N06AA09 | AMITRIPTYLINE NYCOMED, õhukese polümeerikattega tablett, 50TK | Nycomed Sefa AS | 50 | | | | | | |

| | | | | | 75 | G62.0-G62.0, G63- G63 | | | | | |

| 1005893 | amitriptüliin, 25mg | N06AA09 | SAROTEN, õhukese polümeerikattega tablett, 100TK | H. LUNDBECK A/S | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1012475 | amitriptüliin, 25mg | N06AA09 | AMITRIPTYLINE-GRINDEKS, õhukese polümeerikattega tablett, 50TK | Grindeks | 75 | G62.0-G62.0, G63- G63 | | | | | |

| | | | | | 50 | | | | | | |

| 1005893 | amitriptüliin, 25mg | N06AA09 | SAROTEN, õhukese polümeerikattega tablett, 100TK | H. LUNDBECK A/S | 75 | G62.0-G62.0, G63- G63 | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 75 | G62.0-G62.0, G63- G63 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 75 | G62.0-G62.0, G63- G63 | | | | | |

| | | | | | 50 | | | | | | |

| 1012475 | amitriptüliin, 25mg | N06AA09 | AMITRIPTYLINE-GRINDEKS, õhukese polümeerikattega tablett, 50TK | Grindeks | 50 | | | | | | |

| | | | | | 75 | G62.0-G62.0, G63- G63 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| | | | | | 75 | G62.0-G62.0, G63- G63 | | | | | |

| 1012363 | amlodipiin, 10mg | C08CA01 | NORMODIPINE, tablett, 30TK | Gedeon Richter Plc. | 50 | | | | | | |

| | | | | | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| 1018527 | amlodipiin, 10mg | C08CA01 | NORVASC, tablett, 30TK | Pfizer Europe MA EEIG | 50 | | | | | | |

| | | | | | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1012363 | amlodipiin, 10mg | C08CA01 | NORMODIPINE, tablett, 30TK | Gedeon Richter Plc. | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1018527 | amlodipiin, 10mg | C08CA01 | NORVASC, tablett, 30TK | Pfizer Europe MA EEIG | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1087905 | amlodipiin, 10mg | C08CA01 | AMLOCARD 10MG, tablett, 30TK | HEXAL AG | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1109900 | amlodipiin, 10mg | C08CA01 | AGEN, tablett, 30TK | Zentiva, k.s. | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

@@ -180,25 +184,25 @@

| | | | | | 50 | | | | | | |

| 1147003 | amlodipiin, 10mg | C08CA01 | AMLODIPIN-RATIOPHARM 10 MG, tablett, 30TK | ratiopharm GmbH | 50 | | | | | | |

| | | | | | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| 1147733 | amlodipiin, 10mg | C08CA01 | LOFRAL, tablett, 30TK | MEPHA Lda. | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1147733 | amlodipiin, 10mg | C08CA01 | LOFRAL, tablett, 30TK | MEPHA Lda. | 50 | | | | | | |

| | | | | | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1241514 | amlodipiin, 10mg | C08CA01 | AMLODIGAMMA 10MG, tablett, 30TK | WÖRWAG PHARMA GmbH & Co. KG | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1295748 | amlodipiin, 10mg | C08CA01 | AMLODIPINE MEDOCHEMIE, tablett, 30TK | Medochemie Ltd | 50 | | | | | | |

| | | | | | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| 1318946 | amlodipiin, 10mg | C08CA01 | AMLODIPINE TEVA, tablett, 30TK | Teva Pharma B.V. | 50 | | | | | | |

| | | | | | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| 1416934 | amlodipiin, 10mg | C08CA01 | AMLODIPINE ACTAVIS, tablett, 30TK | Actavis Group PTC ehf | 50 | | | | | | |

| | | | | | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| 1295748 | amlodipiin, 10mg | C08CA01 | AMLODIPINE MEDOCHEMIE, tablett, 30TK | Medochemie Ltd | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1318946 | amlodipiin, 10mg | C08CA01 | AMLODIPINE TEVA, tablett, 30TK | Teva Pharma B.V. | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1416934 | amlodipiin, 10mg | C08CA01 | AMLODIPINE ACTAVIS, tablett, 30TK | Actavis Group PTC ehf | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1012352 | amlodipiin, 5mg | C08CA01 | NORMODIPINE, tablett, 30TK | Gedeon Richter Plc. | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1018538 | amlodipiin, 5mg | C08CA01 | NORVASC, tablett, 30TK | Pfizer Europe MA EEIG | 50 | | | | | | |

| | | | | | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| 1087871 | amlodipiin, 5mg | C08CA01 | AMLOCARD 5 MG, tablett, 30TK | HEXAL AG | 50 | | | | | | |

| | | | | | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| 1018538 | amlodipiin, 5mg | C08CA01 | NORVASC, tablett, 30TK | Pfizer Europe MA EEIG | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1087871 | amlodipiin, 5mg | C08CA01 | AMLOCARD 5 MG, tablett, 30TK | HEXAL AG | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1109775 | amlodipiin, 5mg | C08CA01 | AMLODIPIN-RATIOPHARM 5 MG, tablett, 30TK | ratiopharm GmbH | 50 | | | | | | |

| | | | | | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| 1109887 | amlodipiin, 5mg | C08CA01 | AGEN, tablett, 30TK | Zentiva, k.s. | 50 | | | | | | |

@@ -210,110 +214,83 @@

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1241424 | amlodipiin, 5mg | C08CA01 | AMLODIGAMMA 5MG, tablett, 30TK | WÖRWAG PHARMA GmbH & Co. KG | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1295737 | amlodipiin, 5mg | C08CA01 | AMLODIPINE MEDOCHEMIE, tablett, 30TK | Medochemie Ltd | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1318834 | amlodipiin, 5mg | C08CA01 | AMLODIPINE TEVA, tablett, 30TK | Teva Pharma B.V. | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1241424 | amlodipiin, 5mg | C08CA01 | AMLODIGAMMA 5MG, tablett, 30TK | WÖRWAG PHARMA GmbH & Co. KG | 50 | | | | | | |

| | | | | | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| 1295737 | amlodipiin, 5mg | C08CA01 | AMLODIPINE MEDOCHEMIE, tablett, 30TK | Medochemie Ltd | 50 | | | | | | |

| | | | | | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| 1318834 | amlodipiin, 5mg | C08CA01 | AMLODIPINE TEVA, tablett, 30TK | Teva Pharma B.V. | 50 | | | | | | |

| | | | | | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| 1416899 | amlodipiin, 5mg | C08CA01 | AMLODIPINE ACTAVIS, tablett, 30TK | Actavis Group PTC ehf | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1300598 | amlodipiin+lisinopriil, 5mg+10mg | C09BB03 | DIRONORM, tablett, 30TK | Gedeon Richter Plc. | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 50 | | | | | | |

| 1499452 | amlodipiin+telmisartaa n, 10mg+80mg | C09DB04 | TWYNSTA, tablett, 28TK | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15 | | | | | |

| 1499384 | amlodipiin+telmisartaa n, 5mg+80mg | C09DB04 | TWYNSTA, tablett, 28TK | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15 | | | | | |

| 1008919 | amoksitsilliin, 1000mg | J01CA04 | AMOXICILLIN- RATIOPHARM 1000 MG, õhukese polümeerikattega tablett, 10TK | ratiopharm GmbH | 50 | | | | | | |

| | | | | | 75 | H66-H66, J13-J15 | | | | 16,00 | |

| 1008919 | amoksitsilliin, 1000mg | J01CA04 | AMOXICILLIN- RATIOPHARM 1000 MG, õhukese polümeerikattega tablett, 10TK | ratiopharm GmbH | 75 | H66-H66, J13-J15 | | | | 16,00 | |

| | | | | | 50 | | | | | | |

| 1066058 | amoksitsilliin, 1000mg | J01CA04 | OSPAMOX, õhukese polümeerikattega tablett, 12TK | Sandoz GmbH | 50 | | | | | | |

| | | | | | 75 | H66-H66, J13-J15 | | | | 16,00 | |

| 1000551 | amoksitsilliin, 500mg | J01CA04 | AMOXICILLIN- RATIOPHARM 500 MG, õhukese polümeerikattega tablett, 10TK | ratiopharm GmbH | 75 | J13-J15, H66-H66 | | | | 16,00 | |

| | | | | | 50 | | | | | | |

| 1066047 | amoksitsilliin, 500mg | J01CA04 | OSPAMOX, õhukese polümeerikattega tablett, 12TK | Sandoz GmbH | 50 | | | | | | |

| | | | | | 75 | H66-H66, J13-J15 | | | | 16,00 | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1000551 | amoksitsilliin, 500mg | J01CA04 | AMOXICILLIN- RATIOPHARM 500 MG, õhukese polümeerikattega tablett, 10TK | ratiopharm GmbH | 50 | | | | | | |

| | | | | | 75 | J13-J15, H66-H66 | | | | 16,00 | |

| 1066047 | amoksitsilliin, 500mg | J01CA04 | OSPAMOX, õhukese polümeerikattega tablett, 12TK | Sandoz GmbH | 75 | H66-H66, J13-J15 | | | | 16,00 | |

| | | | | | 50 | | | | | | |

| 1000382 | amoksitsilliin, 50mg 1ml | J01CA04 | AMOXICILLIN- RATIOPHARM TS, suukaudse suspensiooni graanulid, 100ml 1TK | ratiopharm GmbH | 75 | J13-J15, H66-H66 | | | | 16,00 | |

| | | | | | 50 | | | | | | |

| 1181999 | amoksitsilliin, 50mg 1ml | J01CA04 | OSPAMOX 250 MG/5 ML, suukaudse suspensiooni pulber, 60ml 1TK | Sandoz GmbH | 75 | J13-J15, H66-H66 | | | | 16,00 | |

| | | | | | 50 | | | | | | |

| 1182002 | amoksitsilliin, 50mg 1ml | J01CA04 | OSPAMOX 250 MG/5 ML, suukaudse suspensiooni pulber, 100ml 1TK | Sandoz GmbH | 75 | J13-J15, H66-H66 | | | | 16,00 | |

| | | | | | 50 | | | | | | |

| 1181999 | amoksitsilliin, 50mg 1ml | J01CA04 | OSPAMOX 250 MG/5 ML, suukaudse suspensiooni pulber, 60ml 1TK | Sandoz GmbH | 50 | | | | | | |

| | | | | | 75 | J13-J15, H66-H66 | | | | 16,00 | |

| 1182002 | amoksitsilliin, 50mg 1ml | J01CA04 | OSPAMOX 250 MG/5 ML, suukaudse suspensiooni pulber, 100ml 1TK | Sandoz GmbH | 50 | | | | | | |

| | | | | | 75 | J13-J15, H66-H66 | | | | 16,00 | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1000450 | amoksitsilliin, 750mg | J01CA04 | AMOXICILLIN- RATIOPHARM 750 MG, õhukese polümeerikattega tablett, 10TK | ratiopharm GmbH | 50 | | | | | | |

| | | | | | 75 | H66-H66, J13-J15 | | | | 16,00 | |

| 1066711 | amoksitsilliin+klavulaa nhape, 400mg 5ml+57mg 5ml | J01CR02 | AMOKSIKLAV, suukaudse suspensiooni pulber, 70ml 1TK | Sandoz d.d. | 50 | | | | | | |

| 1066711 | amoksitsilliin+ klavulaanhape, 400mg+57mg 5ml | J01CR02 | AMOKSIKLAV, suukaudse suspensiooni pulber, 70ml 1TK | Sandoz d.d. | 50 | | | | | | |

| 1175419 | amoksitsilliin+klavulaa nhape, 500mg+125mg | J01CR02 | AMOKSIKLAV, dispergeeruv/suus dispergeeruv tablett, 14TK | Sandoz d.d. | 50 | | | | | | |

| 1028630 | amoksitsilliin+klavulaa nhape, 500mg+125mg | J01CR02 | AUGMENTIN, õhukese polümeerikattega tablett, 14TK | SMITHKLINE BEECHAM plc | 50 | | | | | | |

| 1066722 | amoksitsilliin+klavulaa nhape, 500mg+125mg | J01CR02 | AMOKSIKLAV, õhukese polümeerikattega tablett, 14TK | Sandoz d.d. | 50 | | | | | | |

| 1175419 | amoksitsilliin+klavulaa nhape, 500mg+125mg | J01CR02 | AMOKSIKLAV, dispergeeruv/suus dispergeeruv tablett, 14TK | Sandoz d.d. | 50 | | | | | | |

| 1028685 | amoksitsilliin+klavulaa nhape, 80mg 1ml+11,4mg 1ml | J01CR02 | AUGMENTIN, suukaudse suspensiooni pulber, 70ml 1TK | SMITHKLINE BEECHAM plc | 50 | | | | | | |

| 1028685 | amoksitsilliin+klavulaa nhape, 80mg+11,4mg 1ml | J01CR02 | AUGMENTIN, suukaudse suspensiooni pulber, 70ml 1TK | SMITHKLINE BEECHAM plc | 50 | | | | | | |

| 1175431 | amoksitsilliin+klavulaa nhape, 875mg+125mg | J01CR02 | AMOKSIKLAV, dispergeeruv/suus dispergeeruv tablett, 14TK | Sandoz d.d. | 50 | | | | | | |

| 1066700 | amoksitsilliin+klavulaa nhape, 875mg+125mg | J01CR02 | AMOKSIKLAV, õhukese polümeerikattega tablett, 14TK | Sandoz d.d. | 50 | | | | | | |

| 1066733 | amoksitsilliin+klavulaa nhape, 875mg+125mg | J01CR02 | AUGMENTIN, õhukese polümeerikattega tablett, 14TK | SMITHKLINE BEECHAM plc | 50 | | | | | | |

| 1175431 | amoksitsilliin+klavulaa nhape, 875mg+125mg | J01CR02 | AMOKSIKLAV, dispergeeruv/suus dispergeeruv tablett, 14TK | Sandoz d.d. | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1009572 | amorolfiin, 50mg 1ml | D01AE16 | LOCERYL, ravimküünelakk, 2.5ml 1TK | GALDERMA INTERNATIONAL | 50 | | | | | | |

| 1065978 | ampitsilliin, 500mg | J01CA01 | STANDACILLIN, kõvakapsel, 12TK | Sandoz GmbH | 50 | | | | | | |

| | | | | | 75 | J13-J15 | | | | 16,00 | |

| 1060434 | amülaas+lipaas+prote aas, 12000ühik+20000ühik +900ühik | A09AA02 | MEZYM 20 000, gastroresistentne tablett, 100TK | Berlin-Chemie AG (Menarini Group) | 50 | | | | | | |

| | | | | | 100 | E84-E84 | Pulmonoloog, Pediaater | esmane | | | |

| 1044470 | amülaas+lipaas+prote aas, 18000TÜ+25000TÜ+1 000TÜ | A09AA02 | KREON 25 000 U, gastroresistentne kõvakapsel, 20TK | Abbott Products GmbH | 100 | E84-E84 | Pediaater, Pulmonoloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1063707 | amülaas+lipaas+prote aas, 18000TÜ+25000TÜ+1 000TÜ | A09AA02 | KREON 25 000 U, gastroresistentne kõvakapsel, 50TK | Abbott Products GmbH | 100 | E84-E84 | Pediaater, Pulmonoloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1063729 | amülaas+lipaas+prote aas, 18000TÜ+25000TÜ+1 000TÜ | A09AA02 | KREON 25 000 U, gastroresistentne kõvakapsel, 100TK | Abbott Products GmbH | 50 | | | | | | |

| | | | | | 100 | E84-E84 | Pulmonoloog, Pediaater | esmane | | | |

| 1020182 | amülaas+lipaas+prote aas, 22500ühik+25000ühik +1250ühik | A09AA02 | PANGROL 25000, gastroresistentne kõvakapsel, 20TK | Berlin-Chemie AG (Menarini Group) | 50 | | | | | | |

| | | | | | 100 | E84-E84 | Pulmonoloog, Pediaater | esmane | | | |

| 1044469 | amülaas+lipaas+prote aas, 8000TÜ+10000TÜ+60 0TÜ | A09AA02 | KREON 10 000 U, gastroresistentne kõvakapsel, 20TK | Abbott Products GmbH | 100 | E84-E84 | Pulmonoloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| 1063763 | amülaas+lipaas+prote aas, 8000TÜ+10000TÜ+60 0TÜ | A09AA02 | KREON 10 000 U, gastroresistentne kõvakapsel, 50TK | Abbott Products GmbH | 50 | | | | | | |

| | | | | | 100 | E84-E84 | Pulmonoloog, Pediaater | esmane | | | |

| 1063774 | amülaas+lipaas+prote aas, 8000TÜ+10000TÜ+60 0TÜ | A09AA02 | KREON 10 000 U, gastroresistentne kõvakapsel, 100TK | Abbott Products GmbH | 50 | | | | | | |

| | | | | | 100 | E84-E84 | Pediaater, Pulmonoloog | esmane | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1020205 | amülaas+lipaas+prote aas, 9000ühik+10000ühik+ 500ühik | A09AA02 | PANGROL 10000, gastroresistentne kõvakapsel, 20TK | Berlin-Chemie AG (Menarini Group) | 100 | E84-E84 | Pediaater, Pulmonoloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1208359 | anagreliid, 0,5mg | L01XX35 | XAGRID, kõvakapsel, 100TK | Shire Pharmaceutical Contracts Limited | 100 | D47.3-D47.3 | Hematoloog | | | | patsientidele, kellel ravi alustamine on hinnatud konsiiliumi (vähemalt 3 hematoloogi) poolt vastavaks järgmistele kriteeriumidele: esmavaliku ravi (hüdroksüuurea annuses vähemalt 2 g päevas vähemalt 3 kuu jooksul või alfainterferoon) on osutunud ebaefektiivseks või talumatuks ning esineb trombotsütoos 1000x109/l või on ilmnenud trombohemorraagilised juhud |

| 1033546 | anastrosool, 1mg | L02BG03 | ARIMIDEX, õhukese polümeerikattega tablett, 28TK | AstraZeneca UK Limited | 50 | | | | | | |

| 1065978 | ampitsilliin, 500mg | J01CA01 | STANDACILLIN, kõvakapsel, 12TK | Sandoz GmbH | 75 | J13-J15 | | | | 16,00 | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1208359 | anagreliid, 0,5mg | L01XX35 | XAGRID, kõvakapsel, 100TK | Shire Pharmaceutical Contracts Limited | 100 | D47.3-D47.3 | Hematoloog | | | | patsientidele, kellel ravi alustamine on hinnatud konsiiliumi (vähemalt 3 hematoloogi) poolt vastavaks järgmistele kriteeriumidele: esmavaliku ravi (hüdroksüuurea annuses vähemalt 2g päevas vähemalt 3 kuu jooksul või alfainterferoon) on osutunud ebaefektiivseks või talumatuks ning esineb trombotsütoos 1000x109/l või on ilmnenud trombohemorraagilised juhud |

| 1240490 | anastrosool, 1mg | L02BG03 | ANASTROZOLE SANOSWISS 1 MG, õhukese polümeerikattega tablett, 28TK | UAB SanoSwiss | 50 | | | | | | |

| | | | | | 100 | C50-C50 | Onkoloog | | | | |

| 1240490 | anastrosool, 1mg | L02BG03 | ANASTROZOLE SANOSWISS 1 MG, õhukese polümeerikattega tablett, 28TK | UAB SanoSwiss | 100 | C50-C50 | Onkoloog | | | | |

| | | | | | 50 | | | | | | |

| 1240636 | anastrosool, 1mg | L02BG03 | ANASTROZOLE SANDOZ 1 MG, õhukese polümeerikattega tablett, 28TK | Sandoz d.d. | 50 | | | | | | |

| 1033546 | anastrosool, 1mg | L02BG03 | ARIMIDEX, õhukese polümeerikattega tablett, 28TK | AstraZeneca UK Limited | 100 | C50-C50 | Onkoloog | | | | |

| | | | | | 50 | | | | | | |

| 1240636 | anastrosool, 1mg | L02BG03 | ANASTROZOLE SANDOZ 1 MG, õhukese polümeerikattega tablett, 28TK | Sandoz d.d. | 100 | C50-C50 | Onkoloog | | | | |

| | | | | | 50 | | | | | | |

| 1240771 | anastrosool, 1mg | L02BG03 | ANASTROZOLE ACTAVIS, õhukese polümeerikattega tablett, 28TK | Actavis Group PTC ehf | 50 | | | | | | |

| | | | | | 100 | C50-C50 | Onkoloog | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1240771 | anastrosool, 1mg | L02BG03 | ANASTROZOLE ACTAVIS, õhukese polümeerikattega tablett, 28TK | Actavis Group PTC ehf | 100 | C50-C50 | Onkoloog | | | | |

| | | | | | 50 | | | | | | |

| 1244438 | anastrosool, 1mg | L02BG03 | ANASTROZOLE-TEVA 1MG, õhukese polümeerikattega tablett, 28TK | Teva Pharma B.V. | 50 | | | | | | |

| | | | | | 100 | C50-C50 | Onkoloog | | | | |

| 1275319 | anastrosool, 1mg | L02BG03 | MAMMOZOLE, õhukese polümeerikattega tablett, 28TK | Gedeon Richter Plc. | 50 | | | | | | |

| | | | | | 100 | C50-C50 | Onkoloog | | | | |

| 1299023 | anastrosool, 1mg | L02BG03 | AXASTROL, õhukese polümeerikattega tablett, 28TK | JSC Grindeks | 50 | | | | | | |

| | | | | | 100 | C50-C50 | Onkoloog | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1275319 | anastrosool, 1mg | L02BG03 | MAMMOZOLE, õhukese polümeerikattega tablett, 28TK | Gedeon Richter Plc. | 100 | C50-C50 | Onkoloog | | | | |

| | | | | | 50 | | | | | | |

| 1299023 | anastrosool, 1mg | L02BG03 | AXASTROL, õhukese polümeerikattega tablett, 28TK | JSC Grindeks | 100 | C50-C50 | Onkoloog | | | | |

| | | | | | 50 | | | | | | |

| 1330445 | anastrosool, 1mg | L02BG03 | ANASTROZOL- RATIOPHARM 1 MG, õhukese polümeerikattega tablett, 30TK | ratiopharm GmbH | 100 | C50-C50 | Onkoloog | | | | |

| | | | | | 50 | | | | | | |

| 1330580 | anastrosool, 1mg | L02BG03 | ZYNZOL, õhukese polümeerikattega tablett, 30TK | LANNACHER HEILMITTEL GmbH | 50 | | | | | | |

| | | | | | 100 | C50-C50 | Onkoloog | | | | |

| 1203523 | aripiprasool, 10mg | N05AX12 | ABILIFY, tablett, 28TK | Otsuka Pharmaceutical Europe Ltd | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid, soodustus ei kehti enne hinnakokkuleppe jõustumist |

| | | | | | 50 | | | | | | |

| 1330580 | anastrosool, 1mg | L02BG03 | ZYNZOL, õhukese polümeerikattega tablett, 30TK | LANNACHER HEILMITTEL GmbH | 100 | C50-C50 | Onkoloog | | | | |

| | | | | | 50 | | | | | | |

| 1203523 | aripiprasool, 10mg | N05AX12 | ABILIFY, tablett, 28TK | Otsuka Pharmaceutical Europe Ltd | 50 | | | | | | |

| | | | | | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid, soodustus ei kehti enne hinnakokkuleppe jõustumist |

| 1203578 | aripiprasool, 15mg | N05AX12 | ABILIFY, tablett, 28TK | Otsuka Pharmaceutical Europe Ltd | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1004500 | asatiopriin, 50mg | L04AX01 | IMURAN, õhukese polümeerikattega tablett, 100TK | Aspen Europe GmbH | 100 | Z94-Z94, T86-T86 | | | | | |

| | | | | | 100 | G70-G70 | Neuroloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | Z94-Z94, T86-T86 | | | | | |

| | | | | | 75 | N00-N08 | Nefroloog, Pediaater | | | | |

| | | | | | 75 | N00-N08 | Pediaater, Nefroloog | | | | |

| 1005736 | aselaiinhape, 200mg 1g | D10AX03 | SKINOREN, kreem, 30g 1TK | Intendis GmbH | 50 | | | | | | |

| 1019809 | asitromütsiin, 20mg 1ml | J01FA10 | SUMAMED, suukaudse suspensiooni pulber, 20ml 1TK | Teva Pharma B.V. | 50 | | | | | | |

| 1019775 | asitromütsiin, 250mg | J01FA10 | SUMAMED, kõvakapsel, 6TK | Teva Pharma B.V. | 50 | | | | | | |

@@ -329,494 +306,451 @@

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1267309 | asitromütsiin, 40mg 1ml | J01FA10 | SUMAMED FORTE, suukaudse suspensiooni pulber, 30ml 1TK | Teva Pharma B.V. | 50 | | | | | | |

| 1019797 | asitromütsiin, 500mg | J01FA10 | SUMAMED, õhukese polümeerikattega tablett, 3TK | Teva Pharma B.V. | 50 | | | | | | |

| 1184992 | asitromütsiin, 500mg | J01FA10 | AZITHROMYCIN SANDOZ 500MG, õhukese polümeerikattega tablett, 3TK | Sandoz GmbH | 50 | | | | | | |

| 1113398 | asitromütsiin, 500mg | J01FA10 | AZITROX 500, õhukese polümeerikattega tablett, 3TK | Zentiva, k.s. | 50 | | | | | | |

| 1184992 | asitromütsiin, 500mg | J01FA10 | AZITHROMYCIN SANDOZ 500MG, õhukese polümeerikattega tablett, 3TK | Sandoz GmbH | 50 | | | | | | |

| 1304514 | asitromütsiin, 500mg | J01FA10 | AZIMEPHA 500 MG, õhukese polümeerikattega tablett, 3TK | MEPHA Lda. | 50 | | | | | | |

| 1045796 | aspart-insuliin, 100ühik 1ml | A10AB05 | NOVORAPID PENFILL, süstelahus kolbampullis, 3ml 5TK | Novo Nordisk A/S | 100 | O24-O24, E13-E14, E10-E11, P70.2- P70.2, E89.1-E89.1 | | | | | |

| | | | | | 50 | | | | | | |

| 1084788 | aspart-insuliin, 100ühik 1ml | A10AD05 | NOVOMIX 30 FLEXPEN, süstesuspensioon pen-süstlis, 3ml 5TK | Novo Nordisk A/S | 100 | O24-O24, E13-E14, E10-E11, P70.2- P70.2, E89.1-E89.1 | | | | | |

| | | | | | 50 | | | | | | |

| 1092541 | aspart-insuliin, 100ühik 1ml | A10AB05 | NOVORAPID FLEXPEN, süstelahus pen-süstlis, 3ml 5TK | Novo Nordisk A/S | 100 | O24-O24, E13-E14, E10-E11, P70.2- P70.2, E89.1-E89.1 | | | | | |

| | | | | | 50 | | | | | | |

| 1092541 | aspart-insuliin, 100ühik 1ml | A10AB05 | NOVORAPID FLEXPEN, süstelahus pen-süstlis, 3ml 5TK | Novo Nordisk A/S | 50 | | | | | | |

| | | | | | 100 | O24-O24, E13-E14, E10-E11, P70.2- P70.2, E89.1-E89.1 | | | | | |

| 1007851 | atenolool, 100mg | C07AB03 | ATENOLOL-RATIOPHARM 100MG, õhukese polümeerikattega tablett, 30TK | ratiopharm GmbH | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1007895 | atenolool, 25mg | C07AB03 | ATENOLOL-RATIOPHARM 25MG, õhukese polümeerikattega tablett, 30TK | ratiopharm GmbH | 50 | | | | | | |

| 1007895 | atenolool, 25mg | C07AB03 | ATENOLOL-RATIOPHARM 25MG, õhukese polümeerikattega tablett, 30TK | ratiopharm GmbH | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1007873 | atenolool, 50mg | C07AB03 | ATENOLOL-RATIOPHARM 50MG, õhukese polümeerikattega tablett, 30TK | ratiopharm GmbH | 50 | | | | | | |

| | | | | | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| 1007873 | atenolool, 50mg | C07AB03 | ATENOLOL-RATIOPHARM 50MG, õhukese polümeerikattega tablett, 30TK | ratiopharm GmbH | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1427228 | atorvastatiin, 10mg | C10AA05 | ATORVASTATIN- RATIOPHARM, õhukese polümeerikattega tablett, 30TK | ratiopharm GmbH | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| 1030521 | atorvastatiin, 10mg | C10AA05 | SORTIS, õhukese polümeerikattega tablett, 30TK | Pfizer Europe MA EEIG | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| 1138047 | atorvastatiin, 10mg | C10AA05 | ATORIS, õhukese polümeerikattega tablett, 30TK | KRKA d.d., Novo Mesto | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| 1138047 | atorvastatiin, 10mg | C10AA05 | ATORIS, õhukese polümeerikattega tablett, 30TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| 1180213 | atorvastatiin, 10mg | C10AA05 | TORVACARD 10 MG, õhukese polümeerikattega tablett, 30TK | Zentiva, k.s. | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| 1253180 | atorvastatiin, 10mg | C10AA05 | LOPAMOL, õhukese polümeerikattega tablett, 30TK | Gedeon Richter Plc. | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1253607 | atorvastatiin, 10mg | C10AA05 | ATORVASTATIN ACTAVIS, õhukese polümeerikattega tablett, 30TK | Actavis Group Hf | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1253180 | atorvastatiin, 10mg | C10AA05 | LOPAMOL, õhukese polümeerikattega tablett, 30TK | Gedeon Richter Plc. | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| 1254024 | atorvastatiin, 10mg | C10AA05 | ATORVASTATIN POLPHARMA, õhukese polümeerikattega tablett, 30TK | Pharmaceutical Works Polpharma S.A. | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1397741 | atorvastatiin, 10mg | C10AA05 | TULIP 10MG, õhukese polümeerikattega tablett, 30TK | Sandoz d.d. | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| 1030532 | atorvastatiin, 20mg | C10AA05 | SORTIS, õhukese polümeerikattega tablett, 30TK | Pfizer Europe MA EEIG | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| 1138058 | atorvastatiin, 20mg | C10AA05 | ATORIS, õhukese polümeerikattega tablett, 30TK | KRKA d.d., Novo Mesto | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| 1180235 | atorvastatiin, 20mg | C10AA05 | TORVACARD 20 MG, õhukese polümeerikattega tablett, 30TK | Zentiva, k.s. | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1253326 | atorvastatiin, 20mg | C10AA05 | LOPAMOL, õhukese polümeerikattega tablett, 30TK | Gedeon Richter Plc. | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| 1253742 | atorvastatiin, 20mg | C10AA05 | ATORVASTATIN ACTAVIS, õhukese polümeerikattega tablett, 30TK | Actavis Group Hf | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| 1427363 | atorvastatiin, 20mg | C10AA05 | ATORVASTATIN- RATIOPHARM, õhukese polümeerikattega tablett, 30TK | ratiopharm GmbH | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| 1030532 | atorvastatiin, 20mg | C10AA05 | SORTIS, õhukese polümeerikattega tablett, 30TK | Pfizer Europe MA EEIG | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| 1138058 | atorvastatiin, 20mg | C10AA05 | ATORIS, õhukese polümeerikattega tablett, 30TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| 1253326 | atorvastatiin, 20mg | C10AA05 | LOPAMOL, õhukese polümeerikattega tablett, 30TK | Gedeon Richter Plc. | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| 1253742 | atorvastatiin, 20mg | C10AA05 | ATORVASTATIN ACTAVIS, õhukese polümeerikattega tablett, 30TK | Actavis Group Hf | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1335800 | atorvastatiin, 20mg | C10AA05 | ATILEN 20MG, õhukese polümeerikattega tablett, 30TK | Teva Pharma B.V. | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1397909 | atorvastatiin, 20mg | C10AA05 | TULIP 20MG, õhukese polümeerikattega tablett, 30TK | Sandoz d.d. | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| 1030543 | atorvastatiin, 40mg | C10AA05 | SORTIS, õhukese polümeerikattega tablett, 30TK | Pfizer Europe MA EEIG | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| 1180257 | atorvastatiin, 40mg | C10AA05 | TORVACARD 40 MG, õhukese polümeerikattega tablett, 30TK | Zentiva, k.s. | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1220993 | atorvastatiin, 40mg | C10AA05 | ATORIS, õhukese polümeerikattega tablett, 30TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| 1220993 | atorvastatiin, 40mg | C10AA05 | ATORIS, õhukese polümeerikattega tablett, 30TK | KRKA d.d., Novo Mesto | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| 1253461 | atorvastatiin, 40mg | C10AA05 | LOPAMOL, õhukese polümeerikattega tablett, 30TK | Gedeon Richter Plc. | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| 1253887 | atorvastatiin, 40mg | C10AA05 | ATORVASTATIN ACTAVIS, õhukese polümeerikattega tablett, 30TK | Actavis Group Hf | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| 1335945 | atorvastatiin, 40mg | C10AA05 | ATILEN 40MG, õhukese polümeerikattega tablett, 30TK | Teva Pharma B.V. | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| 1039249 | atsetüültsüsteiin, 100mg | R05CB01 | ACC 100 MG, suukaudse lahuse pulber, 1annust 20TK | Sandoz d.d. | 100 | E84-E84 | Pulmonoloog, Pediaater | esmane | | | |

| 1112500 | atsetüültsüsteiin, 100mg | R05CB01 | ACC 100 MG, kihisev tablett, 20TK | Sandoz d.d. | 100 | E84-E84 | Pulmonoloog, Pediaater | esmane | | | |

| 1034738 | atsetüültsüsteiin, 200mg | R05CB01 | ACC HOT 200MG, suukaudse lahuse pulber, 1annust 20TK | Sandoz d.d. | 100 | E84-E84 | Pulmonoloog, Pediaater | esmane | | | |

| 1039238 | atsetüültsüsteiin, 200mg | R05CB01 | ACC 200 MG, suukaudse lahuse pulber, 1annust 20TK | Sandoz d.d. | 100 | E84-E84 | Pulmonoloog, Pediaater | esmane | | | |

| 1112465 | atsetüültsüsteiin, 200mg | R05CB01 | ACC 200 MG, kihisev tablett, 20TK | Sandoz d.d. | 100 | E84-E84 | Pulmonoloog, Pediaater | esmane | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1122635 | atsetüültsüsteiin, 200mg | R05CB01 | MUCOFLUID, lahustuv tablett, 30TK | Spirig Baltikum Lithuanian-Swiss Ltd. | 100 | E84-E84 | Pediaater, Pulmonoloog | esmane | | | |

| 1039250 | atsetüültsüsteiin, 600mg | R05CB01 | ACC LONG, kihisev tablett, 10TK | Sandoz d.d. | 100 | E84-E84 | Pediaater, Pulmonoloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1013623 | atsikloviir, 200mg | J05AB01 | ACIC 200 MG, tablett, 25TK | Sandoz d.d. | 100 | D60-D64 | Pediaater, Hematoloog | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| 1122635 | atsetüültsüsteiin, 200mg | R05CB01 | MUCOFLUID, lahustuv tablett, 30TK | Spirig Baltikum Lithuanian-Swiss Ltd. | 100 | E84-E84 | Pulmonoloog, Pediaater | esmane | | | |

| 1039250 | atsetüültsüsteiin, 600mg | R05CB01 | ACC LONG, kihisev tablett, 10TK | Sandoz d.d. | 50 | | | | | | |

| | | | | | 100 | E84-E84 | Pediaater, Pulmonoloog | esmane | | | |

| 1086274 | atsikloviir, 200mg | J05AB01 | ACICLOVIR ACTAVIS, tablett, 20TK | Actavis Nordic A/S | 50 | | | | | | |

| | | | | | 100 | D60-D64 | Hematoloog, Pediaater | | | | |

| | | | | | 100 | Z94-Z94, T86-T86 | | | | | |

| 1086274 | atsikloviir, 200mg | J05AB01 | ACICLOVIR ACTAVIS, tablett, 20TK | Actavis Nordic A/S | 100 | D60-D64 | Pediaater, Hematoloog | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1013623 | atsikloviir, 200mg | J05AB01 | ACIC 200 MG, tablett, 25TK | Sandoz d.d. | 100 | Z94-Z94, T86-T86 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | D60-D64 | Pediaater, Hematoloog | | | | |

| 1006625 | atsikloviir, 30mg 1g | S01AD03 | ZOVIRAX, silmasalv, 4.5g 1TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 50 | | | | | | |

| 1086285 | atsikloviir, 400mg | J05AB01 | ACICLOVIR ACTAVIS, tablett, 10TK | Actavis Nordic A/S | 100 | D60-D64 | Pediaater, Hematoloog | | | | |

| | | | | | 100 | Z94-Z94, T86-T86 | | | | | |

| 1006625 | atsikloviir, 30mg 1g | S01AD03 | ZOVIRAX, silmasalv, 4.5g 1TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 50 | | | | | | |

| 1086285 | atsikloviir, 400mg | J05AB01 | ACICLOVIR ACTAVIS, tablett, 10TK | Actavis Nordic A/S | 100 | Z94-Z94, T86-T86 | | | | | |

| | | | | | 100 | D60-D64 | Hematoloog, Pediaater | | | | |

| | | | | | 50 | | | | | | |

| 1165384 | atsikloviir, 400mg | J05AB01 | ACIC 400 MG, tablett, 35TK | Sandoz d.d. | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1165384 | atsikloviir, 400mg | J05AB01 | ACIC 400 MG, tablett, 35TK | Sandoz d.d. | 100 | D60-D64 | Hematoloog, Pediaater | | | | |

| | | | | | 100 | Z94-Z94, T86-T86 | | | | | |

| | | | | | 100 | D60-D64 | Hematoloog, Pediaater | | | | |

| | | | | | 50 | | | | | | |

| 1000731 | atsitretiin, 10mg | D05BB02 | NEOTIGASON, kõvakapsel, 30TK | Actavis Group PTC ehf | 50 | | | | | | |

| 1019483 | batsitratsiin+neomütsii n, 250TÜ 1g+5000TÜ 1g | D06AX80 | BANEOCIN, salv, 20g 1TK | Sandoz GmbH | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| 1212893 | beeta-1a-interferoon, 30mcg 0,5ml | L03AB07 | AVONEX, süstelahus, 0.5ml 4TK | Biogen Idec Limited | 50 | | | | | | |

| 1019483 | batsitratsiin+ neomütsiin, 250TÜ+5000TÜ 1g | D06AX80 | BANEOCIN, salv, 20g 1TK | Sandoz GmbH | 50 | | | | | | |

| 1036369 | beeta-1a-interferoon, 30mcg | L03AB07 | AVONEX, süstelahuse pulber ja lahusti, 4TK | Biogen Idec Limited | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| 1117640 | beeta-1a-interferoon, 44mcg 0,5ml | L03AB07 | REBIF, süstelahus süstlis, 0.5ml 12TK | Merck Serono Europe Limited | 50 | | | | | | |

| 1430671 | beeta-1a-interferoon, 44mcg 0,5ml | L03AB07 | REBIF, süstelahus kolbampullis, 1.5ml 4TK | Merck Serono Europe Limited | 50 | | | | | | |

| 1361393 | beeta-1b-interferoon, 250mcg 1ml | L03AB08 | EXTAVIA, süstelahuse pulber ja lahusti, 15TK | Novartis Europharm Limited | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1071245 | beeta-1b-interferoon, 9600000RÜ | L03AB08 | BETAFERON, süstelahuse pulber ja lahusti, 15TK | Bayer Schering Pharma AG | 50 | | | | | | |

| 1205435 | beetaepoetiin, 10000RÜ 0,6ml | B03XA80 | NEORECORMON, süstelahus süstlis, 0.6ml 6TK | Roche Registration Limited | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| 1066384 | beetaepoetiin, 2000RÜ 0,3ml | B03XA80 | NEORECORMON, süstelahus süstlis, 0.3ml 6TK | Roche Registration Limited | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1061389 | beetaepoetiin, 4000RÜ 0,3ml | B03XA80 | NEORECORMON, süstelahus süstlis, 0.3ml 6TK | Roche Registration Limited | 50 | | | | | | |

| 1066418 | beetaepoetiin, 5000RÜ 0,3ml | B03XA80 | NEORECORMON, süstelahus süstlis, 0.3ml 6TK | Roche Registration Limited | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1061367 | beetaepoetiin, 6000RÜ 0,3ml | B03XA80 | NEORECORMON, süstelahus süstlis, 0.3ml 6TK | Roche Registration Limited | 50 | | | | | | |

| 1099403 | beetafollitropiin, 300RÜ 0,36ml | G03GA06 | PUREGON, süstelahus, 0.525ml 1TK | N.V. Organon | 50 | | | | | | |

| 1064045 | beetafollitropiin, 50RÜ 0,5ml | G03GA06 | PUREGON, süstelahus, 0.5ml 5TK | N.V. Organon | 50 | | | | | | |

| 1215111 | beetafollitropiin, 900RÜ 1,08ml | G03GA06 | PUREGON, süstelahus, 1.23ml 1TK | N.V. Organon | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1099403 | beetafollitropiin, 300RÜ 0.36ml | G03GA06 | PUREGON, süstelahus, 0.525ml 1TK | N.V. Organon | 50 | | | | | | |

| 1064045 | beetafollitropiin, 50RÜ 0.5ml | G03GA06 | PUREGON, süstelahus, 0.5ml 5TK | N.V. Organon | 50 | | | | | | |

| 1215111 | beetafollitropiin, 900RÜ 1.08ml | G03GA06 | PUREGON, süstelahus, 1.23ml 1TK | N.V. Organon | 50 | | | | | | |

| 1236912 | beetahistiin, 16mg | N07CA01 | BETAHISTIN ACTAVIS 16MG, tablett, 60TK | Actavis Group Hf | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1115738 | beetahistiin, 24mg | N07CA01 | BETASERC, tablett, 50TK | Abbott Healthcare Products B.V. | 50 | | | | | | |

| 1236866 | beetahistiin, 8mg | N07CA01 | BETAHISTIN ACTAVIS 8MG, tablett, 100TK | Actavis Group Hf | 50 | | | | | | |

| 1004263 | beetametasoon, 1mg 1g | D07AC01 | BETNOVATE OINTMENT, salv, 15g 1TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1004870 | beetametasoon, 1mg 1g | D07AC01 | BETNOVATE CREAM, kreem, 15g 1TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 50 | | | | | | |

| 1018448 | beetametasoon, 1mg 1g | D07AC01 | CELESTODERM-V, kreem, 30g 1TK | SCHERING-PLOUGH EUROPE | 50 | | | | | | |

| 1018459 | beetametasoon, 1mg 1g | D07AC01 | CELESTODERM-V, salv, 30g 1TK | SCHERING-PLOUGH EUROPE | 50 | | | | | | |

| 1007514 | beetametasoon+fusidii nhape, 1mg 1g+20mg 1g | D07CC80 | FUCICORT, kreem, 15g 1TK | Leo Pharmaceutical Products | 50 | | | | | | |

| 1093340 | beetametasoon+kaltsip otriool, 0,5mg 1g+50mcg 1g | D05AX80 | DAIVOBET, salv, 30g 1TK | Leo Pharmaceutical Products | 75 | L40-L40 | Pediaater, Dermatoveneroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1408036 | beetametasoon+kaltsip otriool, 0,5mg 1g+50mcg 1g | D05AX80 | XAMIOL, geel, 30g 1TK | LEO Pharmaceutical Products Ltd. A/S | 50 | | | | | | |

| | | | | | 75 | L40-L40 | Pediaater, Dermatoveneroloog | esmane | | | |

| 1004320 | beetametasoon+neom ütsiin, 1mg 1g+5mg 1g | D07CC81 | BETNOVATE N CREAM, kreem, 15g 1TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 50 | | | | | | |

| 1062403 | beetametasoon+salitsü ülhape, 0,5mg 1g+20mg 1g | D07BC80 | DIPROSALIC, nahalahus, 50ml 1TK | SCHERING-PLOUGH EUROPE | 50 | | | | | | |

| 1062436 | beetametasoon+salitsü ülhape, 0,5mg 1g+30mg 1g | D07BC80 | DIPROSALIC, salv, 50g 1TK | SCHERING-PLOUGH EUROPE | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1007514 | beetametasoon+ fusidiinhape, 1mg+20mg 1g | D07CC80 | FUCICORT, kreem, 15g 1TK | Leo Pharmaceutical Products | 50 | | | | | | |

| 1062403 | beetametasoon+ salitsüülhape, 0,5mg+20mg 1g | D07BC80 | DIPROSALIC, nahalahus, 50ml 1TK | SCHERING-PLOUGH EUROPE | 50 | | | | | | |

| 1062436 | beetametasoon+ salitsüülhape, 0,5mg+30mg 1g | D07BC80 | DIPROSALIC, salv, 50g 1TK | SCHERING-PLOUGH EUROPE | 50 | | | | | | |

| 1004320 | beetametasoon+neom ütsiin, 1mg+5mg 1g | D07CC81 | BETNOVATE N CREAM, kreem, 15g 1TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 50 | | | | | | |

| 1093261 | beklometasoon, 100mcg 1annust | R03BA01 | ECOBEC 100 MCG EASI- BREATHE, inhalatsiooniaerosool, lahus, 200annust 1TK | IVAX Pharmaceuticals s.r.o. | 50 | | | | | | |

| | | | | | 75 | J45-J45 | | | | | |

| 1045550 | beklometasoon, 250mcg 1annust | R03BA01 | ECOBEC 250, inhalatsiooniaerosool, lahus, 200annust 1TK | TEVA Czech Industries s.r.o. | 50 | | | | | | |

| 1045550 | beklometasoon, 250mcg 1annust | R03BA01 | ECOBEC 250, inhalatsiooniaerosool, lahus, 200annust 1TK | TEVA Czech Industries s.r.o. | 75 | J45-J45 | | | | | |

| | | | | | 50 | | | | | | |

| 1045561 | beklometasoon, 250mcg 1annust | R03BA01 | ECOBEC 250 MCG EASI- BREATHE, inhalatsiooniaerosool, lahus, 200annust 1TK | TEVA Czech Industries s.r.o. | 50 | | | | | | |

| | | | | | 75 | J45-J45 | | | | | |

| 1045561 | beklometasoon, 250mcg 1annust | R03BA01 | ECOBEC 250 MCG EASI- BREATHE, inhalatsiooniaerosool, lahus, 200annust 1TK | TEVA Czech Industries s.r.o. | 75 | J45-J45 | | | | | |

| | | | | | 50 | | | | | | |

| 1152201 | beklometasoon, 250mcg 1annust | R03BA01 | BECLOFORTE INHALER, inhalatsiooniaerosool, lahus, 200annust 1TK | Glaxo Group Ltd | 50 | | | | | | |

| | | | | | 75 | J45-J45 | | | | | |

| 1001103 | beklometasoon, 50mcg 1annust | R01AD01 | BECONASE, ninasprei, 200annust 1TK | Glaxo Wellcome Operations | 75 | J30-J30 | | | | 17,00 | |

| | | | | | 50 | | | | | | |

| 1013128 | beklometasoon, 50mcg 1annust | R01AD01 | NASOBEC, ninasprei, suspensioon, 200annust 1TK | TEVA Czech Industries s.r.o. | 50 | | | | | | |

| 1152201 | beklometasoon, 250mcg 1annust | R03BA01 | BECLOFORTE INHALER, inhalatsiooniaerosool, lahus, 200annust 1TK | Glaxo Group Ltd | 75 | J45-J45 | | | | | |

| | | | | | 50 | | | | | | |

| 1001103 | beklometasoon, 50mcg 1annust | R01AD01 | BECONASE, ninasprei, 200annust 1TK | Glaxo Wellcome Operations | 50 | | | | | | |

| | | | | | 75 | J30-J30 | | | | 17,00 | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1013128 | beklometasoon, 50mcg 1annust | R01AD01 | NASOBEC, ninasprei, suspensioon, 200annust 1TK | TEVA Czech Industries s.r.o. | 75 | J30-J30 | | | | 17,00 | |

| | | | | | 50 | | | | | | |

| 1232569 | beklometasoon, 50mcg 1annust | R01AD01 | BECLONASAL, ninasprei, suspensioon, 200annust 1TK | Orion Corporation Orion Pharma | 50 | | | | | | |

| | | | | | 75 | J30-J30 | | | | 17,00 | |

| 1314256 | beklometasoon+formot erool, 100mcg 1annust+6mcg 1annust | R03AK07 | FOSTER, inhalatsiooniaerosool, lahus, 180annust 1TK | Torrex Chiesi Pharma GmbH | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1077049 | benserasiid+levodopa, 25mg+100mg | N04BA80 | MADOPAR, dispergeeruv tablett, 100TK | Roche Eesti OÜ | 50 | | | | | | |

| | | | | | 100 | G20-G20 | Neuroloog | esmane | | | |

| 1082922 | benserasiid+levodopa, 25mg+100mg | N04BA80 | MADOPAR, kõvakapsel, 100TK | Roche Eesti OÜ | 50 | | | | | | |

| | | | | | 100 | G20-G20 | Neuroloog | esmane | | | |

| 1085161 | benserasiid+levodopa, 25mg+100mg | N04BA80 | MADOPAR HBS, toimeainet prolongeeritult vabastav kõvakapsel, 100TK | Roche Eesti OÜ | 100 | G20-G20 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1002014 | benserasiid+levodopa, 50mg+200mg | N04BA80 | MADOPAR, tablett, 100TK | Roche Eesti OÜ | 50 | | | | | | |

| | | | | | 100 | G20-G20 | Neuroloog | esmane | | | |

| 1034042 | betaksolool, 2,5mg 1ml | S01ED02 | BETOPTIC S, silmatilgad, suspensioon, 5ml 1TK | s.a. ALCON- COUVREUR n.v. | 50 | | | | | | |

| | | | | | 100 | H40-H42 | Oftalmoloog | esmane | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1012194 | bikalutamiid, 150mg | L02BB03 | CASODEX 150, õhukese polümeerikattega tablett, 28TK | AstraZeneca UK Limited | 100 | C61-C61 | Onkoloog, Uroloog | | | | juhul, kui haigus on pärast kirurgilist või medikamentoosset kastratsiooni progresseerunud, metastaatilise haiguse korral lühiajaliselt ravi alustamisel LHRH analoogiga, kombinatsioonis kiiritusraviga või juhul, kui patsient keeldub eelistatud hormoonravist (kirurgilisest või medikamentoossest kastratsioonist) |

| | | | | | 50 | | | | | | |

| 1258017 | bikalutamiid, 150mg | L02BB03 | BICALUTAMIDE - TEVA, õhukese polümeerikattega tablett, 28TK | Teva Pharma B.V. | 100 | C61-C61 | Onkoloog, Uroloog | | | | juhul, kui haigus on pärast kirurgilist või medikamentoosset kastratsiooni progresseerunud, metastaatilise haiguse korral lühiajaliselt ravi alustamisel LHRH analoogiga, kombinatsioonis kiiritusraviga või juhul, kui patsient keeldub eelistatud hormoonravist (kirurgilisest või medikamentoossest kastratsioonist) |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1034042 | betaksolool, 2,5mg 1ml | S01ED02 | BETOPTIC S, silmatilgad, suspensioon, 5ml 1TK | s.a. ALCON- COUVREUR n.v. | 100 | H40-H42 | Oftalmoloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1012194 | bikalutamiid, 150mg | L02BB03 | CASODEX 150, õhukese polümeerikattega tablett, 28TK | AstraZeneca UK Limited | 50 | | | | | | |

| | | | | | 100 | C61-C61 | Uroloog, Onkoloog | | | | juhul, kui haigus on pärast kirurgilist või medikamentoosset kastratsiooni progresseerunud, metastaatilise haiguse korral lühiajaliselt ravi alustamisel LHRH analoogiga, kombinatsioonis kiiritusraviga või juhul, kui patsient keeldub eelistatud hormoonravist (kirurgilisest või medikamentoossest kastratsioonist) |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1258017 | bikalutamiid, 150mg | L02BB03 | BICALUTAMIDE - TEVA, õhukese polümeerikattega tablett, 28TK | Teva Pharma B.V. | 100 | C61-C61 | Uroloog, Onkoloog | | | | juhul, kui haigus on pärast kirurgilist või medikamentoosset kastratsiooni progresseerunud, metastaatilise haiguse korral lühiajaliselt ravi alustamisel LHRH analoogiga, kombinatsioonis kiiritusraviga või juhul, kui patsient keeldub eelistatud hormoonravist (kirurgilisest või medikamentoossest kastratsioonist) |

| | | | | | 50 | | | | | | |

| 1266173 | bikalutamiid, 150mg | L02BB03 | BICALUTAMID ACTAVIS 150MG, õhukese polümeerikattega tablett, 28TK | Actavis Group PTC ehf | 50 | | | | | | |

| 1026560 | bikalutamiid, 50mg | L02BB03 | CASODEX, õhukese polümeerikattega tablett, 28TK | AstraZeneca UK Limited | 100 | C61-C61 | Uroloog, Onkoloog | | | | juhul, kui haigus on pärast kirurgilist või medikamentoosset kastratsiooni progresseerunud, metastaatilise haiguse korral lühiajaliselt ravi alustamisel LHRH analoogiga, kombinatsioonis kiiritusraviga või juhul, kui patsient keeldub eelistatud hormoonravist (kirurgilisest või medikamentoossest kastratsioonist) |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1257803 | bikalutamiid, 50mg | L02BB03 | BICALUTAMIDE - TEVA, õhukese polümeerikattega tablett, 28TK | Teva Pharma B.V. | 100 | C61-C61 | Uroloog, Onkoloog | | | | juhul, kui haigus on pärast kirurgilist või medikamentoosset kastratsiooni progresseerunud, metastaatilise haiguse korral lühiajaliselt ravi alustamisel LHRH analoogiga, kombinatsioonis kiiritusraviga või juhul, kui patsient keeldub eelistatud hormoonravist (kirurgilisest või medikamentoossest kastratsioonist) |

| | | | | | 50 | | | | | | |

| 1265891 | bikalutamiid, 50mg | L02BB03 | BICALUTAMID ACTAVIS 50MG, õhukese polümeerikattega tablett, 28TK | Actavis Group PTC ehf | 100 | C61-C61 | Uroloog, Onkoloog | | | | juhul, kui haigus on pärast kirurgilist või medikamentoosset kastratsiooni progresseerunud, metastaatilise haiguse korral lühiajaliselt ravi alustamisel LHRH analoogiga, kombinatsioonis kiiritusraviga või juhul, kui patsient keeldub eelistatud hormoonravist (kirurgilisest või medikamentoossest kastratsioonist) |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1026560 | bikalutamiid, 50mg | L02BB03 | CASODEX, õhukese polümeerikattega tablett, 28TK | AstraZeneca UK Limited | 100 | C61-C61 | Onkoloog, Uroloog | | | | juhul, kui haigus on pärast kirurgilist või medikamentoosset kastratsiooni progresseerunud, metastaatilise haiguse korral lühiajaliselt ravi alustamisel LHRH analoogiga, kombinatsioonis kiiritusraviga või juhul, kui patsient keeldub eelistatud hormoonravist (kirurgilisest või medikamentoossest kastratsioonist) |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1265891 | bikalutamiid, 50mg | L02BB03 | BICALUTAMID ACTAVIS 50MG, õhukese polümeerikattega tablett, 28TK | Actavis Group PTC ehf | 50 | | | | | | |

| 1431919 | bikalutamiid, 50mg | L02BB03 | BICALUTAMIDE GRINDEKS 50MG, õhukese polümeerikattega tablett, 28TK | Grindeks | 100 | C61-C61 | Onkoloog, Uroloog | | | | juhul, kui haigus on pärast kirurgilist või medikamentoosset kastratsiooni progresseerunud, metastaatilise haiguse korral lühiajaliselt ravi alustamisel LHRH analoogiga, kombinatsioonis kiiritusraviga või juhul, kui patsient keeldub eelistatud hormoonravist (kirurgilisest või medikamentoossest kastratsioonist) |

| | | | | | 50 | | | | | | |

| 1252976 | bimatoprost+timolool, 0,3mg 1ml+5mg 1ml | S01ED82 | GANFORT, silmatilgad, lahus, 3ml 1TK | Allergan Pharmaceuticals Ireland | 50 | | | | | | |

| 1077005 | biperideen, 2mg | N04AA02 | AKINETON, tablett, 100TK | Desma GmbH | 100 | G20-G20 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1258983 | bisoprolool, 10mg | C07AB07 | BISOPROLOL VITABALANS, tablett, 30TK | VITABALANS OY | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1258983 | bisoprolool, 10mg | C07AB07 | BISOPROLOL VITABALANS, tablett, 30TK | VITABALANS OY | 50 | | | | | | |

| | | | | | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| 1258905 | bisoprolool, 5mg | C07AB07 | BISOPROLOL VITABALANS, tablett, 30TK | VITABALANS OY | 50 | | | | | | |

| | | | | | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1207921 | bosentaan, 125mg | C02KX01 | TRACLEER, õhukese polümeerikattega tablett, 56TK | Actelion Registration Ltd. | 100 | I27.0-I27.0 | Pulmonoloog, Pediaater, Reumatoloog, Kardioloog | | | | NYHA III-IV kl idiopaatilise või süsteemse sidekoehaigusega seotud pulmonaalse arteriaalse hüpertensiooniga patsientidele, kelle ravi alustamine ja jätkamine bosentaaniga on hinnatud konsiiliumi (vähemalt 3 vastava eriala spetsialisti) poolt vastavaks Eesti Pulmonoloogide Seltsi, Eesti Kardioloogide Seltsi, Eesti Reumatoloogide Seltsi ja Eesti Lastearstide Seltsi 2007. a tunnustatud ravijuhisele |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1207909 | bosentaan, 62,5mg | C02KX01 | TRACLEER, õhukese polümeerikattega tablett, 56TK | Actelion Registration Ltd. | 100 | I27.0-I27.0 | Reumatoloog, Kardioloog, Pediaater, Pulmonoloog | | | | NYHA III-IV kl idiopaatilise või süsteemse sidekoehaigusega seotud pulmonaalse arteriaalse hüpertensiooniga patsientidele, kelle ravi alustamine ja jätkamine bosentaaniga on hinnatud konsiiliumi (vähemalt 3 vastava eriala spetsialisti) poolt vastavaks Eesti Pulmonoloogide Seltsi, Eesti Kardioloogide Seltsi, Eesti Reumatoloogide Seltsi ja Eesti Lastearstide Seltsi 2007. a tunnustatud ravijuhisele |

| | | | | | 50 | | | | | | |

| 1207921 | bosentaan, 125mg | C02KX01 | TRACLEER, õhukese polümeerikattega tablett, 56TK | Actelion Registration Ltd. | 50 | | | | | | |

| | | | | | 100 | I27.0-I27.0 | Reumatoloog, Kardioloog, Pulmonoloog, Pediaater | | | | NYHA III-IV kl idiopaatilise, süsteemse sidekoehaiguse või kaasasündinud südamerikkega seotud pulmonaalse arteriaalse hüpertensiooni raviks patsientidele konsiiliumi (vähemalt 3 vastava eriala spetsialisti) otsuse alusel, kui sildenafiil on vastunäidustatud, ostunud ebaefektiivseks või põhjustanud olulisi kõrvaltoimeid |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1207909 | bosentaan, 62,5mg | C02KX01 | TRACLEER, õhukese polümeerikattega tablett, 56TK | Actelion Registration Ltd. | 50 | | | | | | |

| 1042782 | brinsolamiid, 10mg 1ml | S01EC04 | AZOPT, silmatilgad, suspensioon, 5ml 1TK | ALCON LABORATORIES (UK) Ltd. | 50 | | | | | | |

| | | | | | 100 | H40-H42 | Oftalmoloog | esmane | | | |

| 1392207 | brinsolamiid+timolool, 10mg 1ml+5mg 1ml | S01ED83 | AZARGA, silmatilgad, suspensioon, 5ml 1TK | Alcon Laboratories Ltd. (Ühendkuningriik) | 50 | | | | | | |

| | | | | | 100 | G20-G20 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| 1057542 | budesoniid, 0,1mg 1annust | R03BA02 | PULMICORT TURBUHALER, inhalatsioonipulber, 200annust 1TK | AstraZeneca AB | 50 | | | | | | |

| | | | | | 75 | J45-J45 | | | | | |

| 1038316 | budesoniid, 0,25mg 1ml | R03BA02 | PULMICORT, nebuliseeritav suspensioon, 2ml 20TK | AstraZeneca AB | 75 | J45-J45 | | | | | |

| | | | | | 50 | | | | | | |

| 1038316 | budesoniid, 0,25mg 1ml | R03BA02 | PULMICORT, nebuliseeritav suspensioon, 2ml 20TK | AstraZeneca AB | 50 | | | | | | |

| | | | | | 75 | J45-J45 | | | | | |

| 1114827 | budesoniid, 0,2mg 1annust | R03BA02 | PULMICORT TURBUHALER, inhalatsioonipulber, 100annust 1TK | AstraZeneca AB | 75 | J45-J45 | | | | | |

| | | | | | 50 | | | | | | |

| 1198649 | budesoniid, 100mcg 1annust | R03BA02 | PULMICORT pMDI, inhalatsiooniaerosool, suspensioon, 120TK | AstraZeneca AB | 50 | | | | | | |

| 1198649 | budesoniid, 100mcg 1annust | R03BA02 | PULMICORT pMDI, inhalatsiooniaerosool, suspensioon, 120TK | AstraZeneca AB | 75 | J45-J45 | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1124390 | budesoniid, 200mcg | R03BA02 | MIFLONIDE 200mcg, inhalatsioonipulber kõvakapslis, 60TK | Novartis Finland OY | 75 | J45-J45 | | | | | |

| | | | | | 50 | | | | | | |

| 1174160 | budesoniid, 200mcg 1annust | R03BA02 | NEPLIT EASYHALER 200, inhalatsioonipulber, 200annust 1TK | Menarini International Operations Luxembourg S.A. | 75 | J45-J45 | | | | | |

| | | | | | 50 | | | | | | |

| 1124413 | budesoniid, 400mcg | R03BA02 | MIFLONIDE 400 mcg, inhalatsioonipulber kõvakapslis, 60TK | Novartis Finland OY | 75 | J45-J45 | | | | | |

| | | | | | 50 | | | | | | |

| 1174182 | budesoniid, 400mcg 1annust | R03BA02 | NEPLIT EASYHALER 400, inhalatsioonipulber, 100annust 1TK | Menarini International Operations Luxembourg S.A. | 50 | | | | | | |

| | | | | | 75 | J45-J45 | | | | | |

| 1124390 | budesoniid, 200mcg | R03BA02 | MIFLONIDE 200mcg, inhalatsioonipulber kõvakapslis, 60TK | Novartis Finland OY | 50 | | | | | | |

| | | | | | 75 | J45-J45 | | | | | |

| 1174160 | budesoniid, 200mcg 1annust | R03BA02 | NEPLIT EASYHALER 200, inhalatsioonipulber, 200annust 1TK | Menarini International Operations Luxembourg S.A. | 50 | | | | | | |

| | | | | | 75 | J45-J45 | | | | | |

| 1124413 | budesoniid, 400mcg | R03BA02 | MIFLONIDE 400 mcg, inhalatsioonipulber kõvakapslis, 60TK | Novartis Finland OY | 50 | | | | | | |

| | | | | | 75 | J45-J45 | | | | | |

| 1174182 | budesoniid, 400mcg 1annust | R03BA02 | NEPLIT EASYHALER 400, inhalatsioonipulber, 100annust 1TK | Menarini International Operations Luxembourg S.A. | 75 | J45-J45 | | | | | |

| | | | | | 50 | | | | | | |

| 1011070 | budesoniid, 50mcg 1annust | R01AD05 | BUDESONID SANDOZ, ninasprei, suspensioon, 200annust 1TK | Sandoz GmbH | 75 | J30-J30 | | | | 17,00 | |

| | | | | | 50 | | | | | | |

| 1011070 | budesoniid, 50mcg 1annust | R01AD05 | BUDESONID SANDOZ, ninasprei, suspensioon, 200annust 1TK | Sandoz GmbH | 50 | | | | | | |

| | | | | | 75 | J30-J30 | | | | 17,00 | |

| 1043389 | budesoniid, 64mcg 1annust | R01AD05 | RHINOCORT AQUA, ninasprei, suspensioon, 10ml 120annust | AstraZeneca AB | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1068443 | budesoniid+formoteroo l, 160mcg 1annust+4,5mcg 1annust | R03AK83 | SYMBICORT TURBUHALER, inhalatsioonipulber, 120annust 1TK | AstraZeneca AB | 50 | | | | | | |

| | | | | | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | | |

| | | | | | 75 | J43-J44 | Pulmonoloog | | | | vastavalt GOLD 2006. a ravijuhisele III-IV staadiumi haigusega patsientidele,kellel on esinenud vähemalt 3 süsteemse glükokortikoidiga ravitud haiguse ägenemist viimase 3 aasta jooksul |

| 1156250 | budesoniid+formoteroo l, 320mcg 1annust+9mcg 1annust | R03AK83 | SYMBICORT TURBUHALER, inhalatsioonipulber, 60annust 1TK | AstraZeneca AB | 75 | J43-J44 | Pulmonoloog | | | | vastavalt GOLD 2006. a ravijuhisele III-IV staadiumi haigusega patsientidele,kellel on esinenud vähemalt 3 süsteemse glükokortikoidiga ravitud haiguse ägenemist viimase 3 aasta jooksul |

| | | | | | 50 | | | | | | |

| | | | | | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | | |

| 1072505 | budesoniid+formoteroo l, 80mcg 1annust+4,5mcg 1annust | R03AK83 | SYMBICORT TURBUHALER, inhalatsioonipulber, 120annust 1TK | AstraZeneca AB | 50 | | | | | | |

| | | | | | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | | | |

| 1232660 | bupropioon, 150mg | N06AX12 | ELONTRIL, toimeainet modifitseeritult vabastav tablett, 30TK | Glaxo Group Ltd | 50 | F33-F33, F32-F32 | | | | | |

| 1232693 | bupropioon, 300mg | N06AX12 | ELONTRIL, toimeainet modifitseeritult vabastav tablett, 30TK | Glaxo Group Ltd | 50 | F33-F33, F32-F32 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1005006 | busulfaan, 2mg | L01AB01 | MYLERAN, õhukese polümeerikattega tablett, 100TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 100 | C00-D48 | Onkoloog, Hematoloog, Pediaater | | | | |

| | | | | | 50 | | | | | | |

| 1343382 | dabigatraaneteksilaat, 110mg | B01AE07 | PRADAXA, kõvakapsel, 10TK | Boehringer Ingelheim International GmbH | 50 | | | | | | |

| 1005006 | busulfaan, 2mg | L01AB01 | MYLERAN, õhukese polümeerikattega tablett, 100TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 50 | | | | | | |

| | | | | | 100 | C00-D48 | Hematoloog, Onkoloog, Pediaater | | | | |

| | | | | | 50 | | | | | | |

| 1343393 | dabigatraaneteksilaat, 110mg | B01AE07 | PRADAXA, kõvakapsel, 30TK | Boehringer Ingelheim International GmbH | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1343359 | dabigatraaneteksilaat, 75mg | B01AE07 | PRADAXA, kõvakapsel, 10TK | Boehringer Ingelheim International GmbH | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1343360 | dabigatraaneteksilaat, 75mg | B01AE07 | PRADAXA, kõvakapsel, 30TK | Boehringer Ingelheim International GmbH | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1275768 | dasatiniib, 50mg | L01XE06 | SPRYCEL, õhukese polümeerikattega tablett, 60TK | Bristol-Myers Squibb Pharma EEIG | 100 | C92.1-C92.1 | Hematoloog | | | | patsiendile, kelle ravi alustamine ja jätkamine dasatiniibiga on hinnatud konsiiliumi (vähemalt 3 hematoloogi) poolt vastavaks järgmistele kriteeriumidele: näidustatud on tsütogeneetilist vastust indutseeriv ravi, eelnev ravi imatiniibiga annuses 600 mg on ebaõnnestunud või osutunud talumatuks (imatiniibravi on põhjustanud III või IV astme kõrvaltoime või üle 3 kuu püsinud II astme kõrvaltoime CTC klassifikatsiooni järgi), dasatiniibravi foonil püsib hematoloogiline ravivastus (haigus ei progresseeru). Soodustus ei laiene patsientidele, kelle ravi dasatiniibiga on ravimitootja vastutusel alustatud ja tagatud enne 1. oktoobrit 2009. a. |

| | | | | | 50 | | | | | | |

| 1275768 | dasatiniib, 50mg | L01XE06 | SPRYCEL, õhukese polümeerikattega tablett, 60TK | Bristol-Myers Squibb Pharma EEIG | 50 | | | | | | |

| | | | | | 100 | C92.1-C92.1 | Hematoloog | | | | patsiendile, kelle ravi alustamine ja jätkamine dasatiniibiga on hinnatud konsiiliumi (vähemalt 3 hematoloogi) poolt vastavaks järgmistele kriteeriumidele: näidustatud on tsütogeneetilist vastust indutseeriv ravi, eelnev ravi imatiniibiga annuses 600 mg on ebaõnnestunud või osutunud talumatuks (imatiniibravi on põhjustanud III või IV astme kõrvaltoime või üle 3 kuu püsinud II astme kõrvaltoime CTC klassifikatsiooni järgi), dasatiniibravi foonil püsib hematoloogiline ravivastus (haigus ei progresseeru). Soodustus ei laiene patsientidele, kelle ravi dasatiniibiga on ravimitootja vastutusel alustatud ja tagatud enne 1. oktoobrit 2009. a. |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1258668 | deferasiroks, 500mg | V03AC03 | EXJADE, dispergeeruv tablett, 28TK | Novartis Europharm Limited | 100 | D57-D57, D47.1- D47.1, D56-D56, D60-D61, C81-C96, D46-D46 | Hematoloog | | | | konsiiliumi (vähemasti 3 hematoloogi) otsuse alusel järgmistele kriteeriumidele vastavate patsientide raviks: seerumi ferritiinitase on >1000 mcg/l; esineb jätkuv regulaarne vereülekannete vajadus (vähemasti 1 aasta jooksul on manustatud vähemasti 2 erütrotsüütide doosi kuu kohta ning sarnane vereülekannete vajadus püsib) või plaanitakse vereloome tüvirakkude siirdamist; müelodüsplastilise sündroomi või müelofibroosiga (D46, D47.1) patsientide riskiskoor on madal või madal-mõõdukas (IPSS 0-1) |

| 1014972 | deksametasoon, 0,5mg | H02AB02 | DEXAMETHASON KRKA, tablett, 10TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| 1014972 | deksametasoon, 0,5mg | H02AB02 | DEXAMETHASON KRKA, tablett, 10TK | KRKA d.d., Novo Mesto | 100 | C00-D48 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | Z94-Z94, T86-T86 | | | | | |

| | | | | | 100 | C00-D48 | | | | | |

| 1090932 | deksametasoon, 1mg 1g | S01BA01 | MAXIDEX, silmasalv, 3.5g 1TK | s.a. ALCON- COUVREUR n.v. | 50 | | | | | | |

| 1007479 | deksametasoon, 1mg 1ml | S01BA01 | OFTAN DEXA, silmatilgad, lahus, 5ml 1TK | SANTEN OY | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1124288 | deksametasoon, 1mg 1ml | S01BA01 | MAXIDEX, silmatilgad, suspensioon, 5ml 1TK | s.a. ALCON- COUVREUR n.v. | 50 | | | | | | |

| 1008414 | deksametasoon, 4mg 1ml | H02AB02 | DEXAMETHASON KRKA, süstelahus, 1ml 25TK | KRKA d.d., Novo Mesto | 100 | C00-D48 | | | | | |

| | | | | | 50 | | | | | | |

| 1044379 | deksametasoon+kloor amfenikool, 1mg 1g+2mg 1g | S01CA82 | OFTAN DEXA-CHLORA, silmasalv, 3.5g 1TK | SANTEN OY | 50 | | | | | | |

| 1044368 | deksametasoon+kloor amfenikool, 1mg 1ml+2mg 1ml | S01CA82 | OFTAN DEXA-CHLORA, silmatilgad, lahus, 10ml 1TK | SANTEN OY | 50 | | | | | | |

| 1124301 | deksametasoon+neom ütsiin+polümüksiin B, 1mg 1ml+3500TÜ 1ml+6000TÜ 1ml | S01CA80 | MAXITROL, silmatilgad, suspensioon, 5ml 1TK | s.a. ALCON- COUVREUR n.v. | 50 | | | | | | |

| 1150276 | deksametasoon+tobra mütsiin, 1mg 1g+3mg 1g | S01CA81 | TOBRADEX EYE OINTMENT, silmasalv, 3.5g 1TK | s.a. ALCON- COUVREUR n.v. | 50 | | | | | | |

| 1124266 | deksametasoon+tobra mütsiin, 1mg 1ml+3mg 1ml | S01CA81 | TOBRADEX, silmatilgad, suspensioon, 5ml 1TK | s.a. ALCON- COUVREUR n.v. | 50 | | | | | | |

| 1008414 | deksametasoon, 4mg 1ml | H02AB02 | DEXAMETHASON KRKA, süstelahus, 1ml 25TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 100 | C00-D48 | | | | | |

| 1044379 | deksametasoon+ klooramfenikool, 1mg+2mg 1g | S01CA82 | OFTAN DEXA-CHLORA, silmasalv, 3.5g 1TK | SANTEN OY | 50 | | | | | | |

| 1044368 | deksametasoon+ klooramfenikool, 1mg+2mg 1ml | S01CA82 | OFTAN DEXA-CHLORA, silmatilgad, lahus, 10ml 1TK | SANTEN OY | 50 | | | | | | |

| 1124301 | deksametasoon+ neomütsiin+ polümüksiin B, 1mg+3500TÜ+6000TÜ 1ml | S01CA80 | MAXITROL, silmatilgad, suspensioon, 5ml 1TK | s.a. ALCON- COUVREUR n.v. | 50 | | | | | | |

| 1150276 | deksametasoon+ tobramütsiin, 1mg+3mg 1g | S01CA81 | TOBRADEX EYE OINTMENT, silmasalv, 3.5g 1TK | s.a. ALCON- COUVREUR n.v. | 50 | | | | | | |

| 1124266 | deksametasoon+ tobramütsiin, 1mg+3mg 1ml | S01CA81 | TOBRADEX, silmatilgad, suspensioon, 5ml 1TK | s.a. ALCON- COUVREUR n.v. | 50 | | | | | | |

| 1011979 | deksketoprofeen, 25mg | M01AE17 | DOLMEN, õhukese polümeerikattega tablett, 10TK | Menarini International Operations Luxembourg S.A. | 50 | | | | | | |

| 1044380 | dekspantenool+retinoo l, 20mg 1g+20TÜ 1g | S01XA80 | OFTAN A-PANT, silmasalv, 3.5g 1TK | SANTEN OY | 50 | | | | | | |

| 1077971 | desloratadiin, 5mg | R06AX27 | AERIUS, õhukese polümeerikattega tablett, 10TK | SCHERING-PLOUGH EUROPE | 50 | | | | | | |

| 1077982 | desloratadiin, 5mg | R06AX27 | AERIUS, õhukese polümeerikattega tablett, 30TK | SCHERING-PLOUGH EUROPE | 50 | | | | | | |

| 1064360 | desmopressiin, 0,1mg | H01BA02 | MINIRIN, tablett, 30TK | Ferring Lääkkeet Oy | 50 | | | | | | |

| | | | | | 100 | E23.2-E23.2 | Pediaater, Endokrinoloog | esmane | | | |

| 1064382 | desmopressiin, 0,2mg | H01BA02 | MINIRIN, tablett, 30TK | Ferring Lääkkeet Oy | 50 | | | | | | |

| | | | | | 100 | E23.2-E23.2 | Endokrinoloog, Pediaater | esmane | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1064348 | desmopressiin, 10mcg 1annust | H01BA02 | MINIRIN, ninasprei, lahus, 2.5ml 1TK | Ferring Lääkkeet Oy | 100 | E23.2-E23.2 | Pediaater, Endokrinoloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1225594 | desmopressiin, 120mcg | H01BA02 | MINIRIN, suukaudne lüofilisaat, 30TK | Ferring Lääkkeet Oy | 100 | E23.2-E23.2 | Pediaater, Endokrinoloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1225561 | desmopressiin, 60mcg | H01BA02 | MINIRIN, suukaudne lüofilisaat, 30TK | Ferring Lääkkeet Oy | 100 | E23.2-E23.2 | Pediaater, Endokrinoloog | esmane | | | |

| 1064360 | desmopressiin, 0,1mg | H01BA02 | MINIRIN, tablett, 30TK | Ferring Lääkkeet Oy | 100 | E23.2-E23.2 | Endokrinoloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| 1064382 | desmopressiin, 0,2mg | H01BA02 | MINIRIN, tablett, 30TK | Ferring Lääkkeet Oy | 100 | E23.2-E23.2 | Pediaater, Endokrinoloog | esmane | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1064348 | desmopressiin, 10mcg 1annust | H01BA02 | MINIRIN, ninasprei, lahus, 2.5ml 1TK | Ferring Lääkkeet Oy | 100 | E23.2-E23.2 | Endokrinoloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| 1225594 | desmopressiin, 120mcg | H01BA02 | MINIRIN, suukaudne lüofilisaat, 30TK | Ferring Lääkkeet Oy | 100 | E23.2-E23.2 | Endokrinoloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| 1225561 | desmopressiin, 60mcg | H01BA02 | MINIRIN, suukaudne lüofilisaat, 30TK | Ferring Lääkkeet Oy | 100 | E23.2-E23.2 | Endokrinoloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| 1063303 | desogestreel, 75mcg | G03AC09 | CERAZETTE, õhukese polümeerikattega tablett, 84TK | N.V. ORGANON | 50 | | | | | | |

| 1161458 | desogestreel+desoges treel+etünüülöstradiool +etünüülöstradiool, 25mcg+125mcg+40mc g+30mcg | G03AB05 | GRACIAL, tablett, 21TK / 45TK | N.V. ORGANON | 50 | | | | | | |

| 1062908 | desogestreel+etünüülö stradiool, 0,15mg+0,02mg | G03AA09 | MERCILON, tablett, 63TK | N.V. ORGANON | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| | | | | | 50 | | | | | | |

| 1062920 | desogestreel+etünüülö stradiool, 0,15mg+0,02mg | G03AA09 | NOVYNETTE, õhukese polümeerikattega tablett, 63TK | Gedeon Richter Plc. | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| | | | | | 50 | | | | | | |

| 1062863 | desogestreel+etünüülö stradiool, 0,15mg+0,03mg | G03AA09 | MARVELON, tablett, 63TK | N.V. ORGANON | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| | | | | | 50 | | | | | | |

| 1062931 | desogestreel+etünüülö stradiool, 0,15mg+0,03mg | G03AA09 | REGULON, õhukese polümeerikattega tablett, 63TK | Gedeon Richter Plc. | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| | | | | | 50 | | | | | | |

| 1161458 | desogestreel+etünüülö stradiool, 25mcg+40mcg/125mc g+30mcg | G03AB05 | GRACIAL, tablett, 21TK / 45TK | N.V. ORGANON | 50 | | | | | | |

| | | | | | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| 1062908 | desogestreel+etünüülö stradiool, 0,15mg+0,02mg | G03AA09 | MERCILON, tablett, 63TK | N.V. ORGANON | 50 | | | | | | |

| | | | | | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| 1062920 | desogestreel+etünüülö stradiool, 0,15mg+0,02mg | G03AA09 | NOVYNETTE, õhukese polümeerikattega tablett, 63TK | Gedeon Richter Plc. | 50 | | | | | | |

| | | | | | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| 1062863 | desogestreel+etünüülö stradiool, 0,15mg+0,03mg | G03AA09 | MARVELON, tablett, 63TK | N.V. ORGANON | 50 | | | | | | |

| | | | | | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| 1062931 | desogestreel+etünüülö stradiool, 0,15mg+0,03mg | G03AA09 | REGULON, õhukese polümeerikattega tablett, 63TK | Gedeon Richter Plc. | 50 | | | | | | |

| | | | | | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1208045 | detemir-insuliin, 100ühik 1ml | A10AE05 | LEVEMIR FLEXPEN, süstelahus pen-süstlis, 3ml 5TK | Novo Nordisk A/S | 100 | O24-O24, E13-E14, E10-E11, P70.2- P70.2, E89.1-E89.1 | | | | | |

| | | | | | 50 | | | | | | |

| 1208045 | detemir-insuliin, 100ühik 1ml | A10AE05 | LEVEMIR FLEXPEN, süstelahus pen-süstlis, 3ml 5TK | Novo Nordisk A/S | 50 | | | | | | |

| | | | | | 100 | O24-O24, E13-E14, E10-E11, P70.2- P70.2, E89.1-E89.1 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1007659 | diasepaam, 10mg 2,5ml | N05BA01 | DIAZEPAM DESITIN, rektaallahus, 5TK | Desitin Arzneimittel GmbH | 50 | | | | | | |

| 1007682 | diasepaam, 5mg 2,5ml | N05BA01 | DIAZEPAM DESITIN, rektaallahus, 5TK | Desitin Arzneimittel GmbH | 50 | | | | | | |

| 1066834 | dienogest+etünüülöstr adiool, 2mg+0,03mg | G03AA81 | JEANINE, kaetud tablett, 21TK | JENAPHARM GmbH & Co. KG | 50 | | | | | | |

| | | | | | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| 1000416 | diflukortoloon+isokona sool, 1mg 1g+10mg 1g | D01AC80 | TRAVOCORT, kreem, 15g 1TK | Intendis GmbH | 50 | | | | | | |

| 1070592 | digoksiin, 0,25mg | C01AA05 | DIGOXIN-GRINDEKS, tablett, 50TK | Grindeks | 50 | | | | | | |

| | | | | | 75 | I50-I50 | | | | | |

| 1070592 | digoksiin, 0,25mg | C01AA05 | DIGOXIN-GRINDEKS, tablett, 50TK | Grindeks | 75 | I50-I50 | | | | | |

| | | | | | 50 | | | | | | |

| 1222209 | digoksiin, 0,25mg | C01AA05 | DIGOXIN NYCOMED 0,25 MG, tablett, 60TK | Nycomed Sefa AS | 75 | I50-I50 | | | | | |

| | | | | | 50 | | | | | | |

| 1222197 | digoksiin, 62,5mcg | C01AA05 | DIGOXIN NYCOMED 62,5 MCG, tablett, 60TK | Nycomed Sefa AS | 50 | | | | | | |

| | | | | | 75 | I50-I50 | | | | | |

| 1222197 | digoksiin, 62,5mcg | C01AA05 | DIGOXIN NYCOMED 62,5 MCG, tablett, 60TK | Nycomed Sefa AS | 75 | I50-I50 | | | | | |

| | | | | | 50 | | | | | | |

| 1361786 | dihüdrokodeiin, 60mg | N02AA08 | DHC CONTINUS, toimeainet prolongeeritult vabastav tablett, 10TK | MUNDIPHARMA Ges.m.b.H. | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1361797 | dihüdrokodeiin, 90mg | N02AA08 | DHC CONTINUS, toimeainet prolongeeritult vabastav tablett, 10TK | MUNDIPHARMA Ges.m.b.H. | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1012307 | diklofenak, 100mg | M01AB05 | DICLAC 100 MG, toimeainet prolongeeritult vabastav tablett, 20TK | Sandoz d.d. | 100 | C00-D48 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| 1016109 | diklofenak, 100mg | M01AB05 | DICLOBERL RETARD, toimeainet prolongeeritult vabastav kõvakapsel, 50TK | Berlin-Chemie AG (Menarini Group) | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | C00-D48 | | | | | |

| 1032589 | diklofenak, 100mg | M01AB05 | DICLOMELAN RETARD 100 MG, toimeainet prolongeeritult vabastav tablett, 30TK | G.L. Pharma GmbH | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 100 | C00-D48 | | | | | |

| 1032613 | diklofenak, 100mg | M01AB05 | DICLOMELAN, rektaalsuposiit, 6TK | G.L. Pharma GmbH | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 100 | C00-D48 | | | | | |

| | | | | | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 50 | | | | | | |

| 1078163 | diklofenak, 100mg | M01AB05 | DICLAC 100 MG, toimeainet prolongeeritult vabastav tablett, 50TK | Sandoz d.d. | 50 | | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 100 | C00-D48 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1134166 | diklofenak, 100mg | M01AB05 | DICLOBERL RETARD, toimeainet prolongeeritult vabastav kõvakapsel, 20TK | Berlin-Chemie AG (Menarini Group) | 50 | | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 100 | C00-D48 | | | | | |

| | | | | | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| 1017133 | diklofenak, 100mg | M01AB05 | DICLOFENAC-RATIOPHARM 100 MG, rektaalsuposiit, 10TK | ratiopharm GmbH | 100 | C00-D48 | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 50 | | | | | | |

| 1039632 | diklofenak, 100mg | M01AB05 | OLFEN DEPOCAPS, toimeainet prolongeeritult vabastav kõvakapsel, 20TK | MEPHA Lda. | 50 | | | | | | |

| | | | | | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| 1016109 | diklofenak, 100mg | M01AB05 | DICLOBERL RETARD, toimeainet prolongeeritult vabastav kõvakapsel, 50TK | Berlin-Chemie AG (Menarini Group) | 100 | C00-D48 | | | | | |

| | | | | | 100 | C00-D48 | | | | | |

| 1040320 | diklofenak, 100mg | M01AB05 | DICLAC 100, rektaalsuposiit, 10TK | Sandoz d.d. | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 100 | C00-D48 | | | | | |

| | | | | | 50 | | | | | | |

| 1072730 | diklofenak, 100mg | M01AB05 | VOLTAREN RETARD, toimeainet prolongeeritult vabastav tablett, 30TK | Novartis Finland OY | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 100 | C00-D48 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 50 | | | | | | |

| 1017133 | diklofenak, 100mg | M01AB05 | DICLOFENAC-RATIOPHARM 100 MG, rektaalsuposiit, 10TK | ratiopharm GmbH | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1071920 | diklofenak, 150mg | M01AB05 | DICLAC ID 150 MG, toimeainet modifitseeritult vabastav tablett, 20TK | Sandoz d.d. | 50 | | | | | | |

| | | | | | 100 | C00-D48 | | | | | |

| | | | | | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| 1032589 | diklofenak, 100mg | M01AB05 | DICLOMELAN RETARD 100 MG, toimeainet prolongeeritult vabastav tablett, 30TK | LANNACHER HEILMITTEL GmbH | 100 | C00-D48 | | | | | |

| 1071942 | diklofenak, 150mg | M01AB05 | DICLAC ID 150 MG, toimeainet modifitseeritult vabastav tablett, 100TK | Sandoz d.d. | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | C00-D48 | | | | | |

| | | | | | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| 1072279 | diklofenak, 150mg | M01AB05 | DICLOFENAC-RATIOPHARM UNO, toimeainet modifitseeritult vabastav tablett, 20TK | ratiopharm GmbH | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 100 | C00-D48 | | | | | |

| | | | | | 50 | | | | | | |

| 1072280 | diklofenak, 150mg | M01AB05 | DICLOFENAC-RATIOPHARM UNO, toimeainet modifitseeritult vabastav tablett, 50TK | ratiopharm GmbH | 100 | C00-D48 | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 50 | | | | | | |

| 1032613 | diklofenak, 100mg | M01AB05 | DICLOMELAN, rektaalsuposiit, 6TK | LANNACHER HEILMITTEL GmbH | 100 | C00-D48 | | | | | |

| 1024715 | diklofenak, 20mg 1g | M02AA15 | ORTOFEN, salv, 30g 1TK | Grindeks | 50 | | | | | | |

| 1032590 | diklofenak, 50mg | M01AB05 | DICLOMELAN 50 MG, gastroresistentne tablett, 10TK | G.L. Pharma GmbH | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 100 | C00-D48 | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1001372 | diklofenak, 50mg | M01AB05 | DICLOFENAC- RATIOPHARM 50MG, gastroresistentne tablett, 20TK | ratiopharm GmbH | 100 | C00-D48 | | | | | |

| | | | | | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1039632 | diklofenak, 100mg | M01AB05 | OLFEN DEPOCAPS, toimeainet prolongeeritult vabastav kõvakapsel, 20TK | MEPHA Lda. | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| 1002520 | diklofenak, 50mg | M01AB05 | CATAFLAM, kaetud tablett, 20TK | Novartis Finland OY | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | C00-D48 | | | | | |

| | | | | | 50 | | | | | | |

| 1040320 | diklofenak, 100mg | M01AB05 | DICLAC 100, rektaalsuposiit, 10TK | Sandoz d.d. | 50 | | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 100 | C00-D48 | | | | | |

| | | | | | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| 1072730 | diklofenak, 100mg | M01AB05 | VOLTAREN RETARD, toimeainet prolongeeritult vabastav tablett, 30TK | Novartis Finland OY | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | C00-D48 | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| 1078163 | diklofenak, 100mg | M01AB05 | DICLAC 100 MG, toimeainet prolongeeritult vabastav tablett, 50TK | Sandoz d.d. | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 100 | C00-D48 | | | | | |

| 1134166 | diklofenak, 100mg | M01AB05 | DICLOBERL RETARD, toimeainet prolongeeritult vabastav kõvakapsel, 20TK | Berlin-Chemie AG (Menarini Group) | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 100 | C00-D48 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1071920 | diklofenak, 150mg | M01AB05 | DICLAC ID 150 MG, toimeainet modifitseeritult vabastav tablett, 20TK | Sandoz d.d. | 50 | | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 100 | C00-D48 | | | | | |

| 1071942 | diklofenak, 150mg | M01AB05 | DICLAC ID 150 MG, toimeainet modifitseeritult vabastav tablett, 100TK | Sandoz d.d. | 50 | | | | | | |

| | | | | | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 100 | C00-D48 | | | | | |

| 1072279 | diklofenak, 150mg | M01AB05 | DICLOFENAC-RATIOPHARM UNO, toimeainet modifitseeritult vabastav tablett, 20TK | ratiopharm GmbH | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | C00-D48 | | | | | |

| 1072280 | diklofenak, 150mg | M01AB05 | DICLOFENAC-RATIOPHARM UNO, toimeainet modifitseeritult vabastav tablett, 50TK | ratiopharm GmbH | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 100 | C00-D48 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| 1024715 | diklofenak, 20mg 1g | M02AA15 | ORTOFEN, salv, 30g 1TK | Grindeks | 50 | | | | | | |

| 1001372 | diklofenak, 50mg | M01AB05 | DICLOFENAC- RATIOPHARM 50MG, gastroresistentne tablett, 20TK | ratiopharm GmbH | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 100 | C00-D48 | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1002520 | diklofenak, 50mg | M01AB05 | CATAFLAM, kaetud tablett, 20TK | Novartis Finland OY | 100 | C00-D48 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| 1007356 | diklofenak, 50mg | M01AB05 | DICLOFENAC-RATIOPHARM 50MG, rektaalsuposiit, 10TK | ratiopharm GmbH | 100 | C00-D48 | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| 1032590 | diklofenak, 50mg | M01AB05 | DICLOMELAN 50 MG, gastroresistentne tablett, 10TK | LANNACHER HEILMITTEL GmbH | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 100 | C00-D48 | | | | | |

| 1072213 | diklofenak, 50mg | M01AB05 | DICLOFENAC- RATIOPHARM 50MG, gastroresistentne tablett, 50TK | ratiopharm GmbH | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 100 | C00-D48 | | | | | |

| | | | | | 50 | | | | | | |

| 1040364 | diklofenak, 50mg 1g | M02AA15 | DICLAC 5%, geel, 50g 1TK | Sandoz d.d. | 50 | | | | | | |

| 1073999 | diklofenak, 50mg 1g | M02AA15 | DICLAC 5%, geel, 100g 1TK | Sandoz d.d. | 50 | | | | | | |

| 1012048 | diklofenak, 75mg | M01AB05 | OLFEN DEPOTABS, toimeainet prolongeeritult vabastav tablett, 30TK | MEPHA Lda. | 100 | C00-D48 | | | | | |

| | | | | | 50 | | | | | | |

@@ -825,25 +759,25 @@

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1071964 | diklofenak, 75mg | M01AB05 | DICLAC ID 75 MG, toimeainet modifitseeritult vabastav tablett, 20TK | Sandoz d.d. | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 50 | | | | | | |

| 1071964 | diklofenak, 75mg | M01AB05 | DICLAC ID 75 MG, toimeainet modifitseeritult vabastav tablett, 20TK | Sandoz d.d. | 100 | C00-D48 | | | | | |

| | | | | | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 100 | C00-D48 | | | | | |

| 1071986 | diklofenak, 75mg | M01AB05 | DICLAC ID 75 MG, toimeainet modifitseeritult vabastav tablett, 100TK | Sandoz d.d. | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 100 | C00-D48 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 50 | | | | | | |

| 1071986 | diklofenak, 75mg | M01AB05 | DICLAC ID 75 MG, toimeainet modifitseeritult vabastav tablett, 100TK | Sandoz d.d. | 100 | C00-D48 | | | | | |

| | | | | | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 50 | | | | | | |

| 1088399 | diklofenak+misoprosto ol, 50mg+0,2mg | M01AB80 | ARTHROTEC, gastroresistentne tablett, 60TK | Pfizer Enterprises SARL | 50 | | | | | | |

| 1014556 | diltiaseem, 180mg | C08DB01 | ALTIAZEM RR, toimeainet prolongeeritult vabastav kõvakapsel, 20TK | Instituto Luso Farmaco d Italia S.p.A. | 50 | | | | | | |

| | | | | | 100 | I27.0-I27.0 | | | | | |

| 1014556 | diltiaseem, 180mg | C08DB01 | ALTIAZEM RR, toimeainet prolongeeritult vabastav kõvakapsel, 20TK | Instituto Luso Farmaco d Italia S.p.A. | 100 | I27.0-I27.0 | | | | | |

| | | | | | 50 | | | | | | |

| 1031634 | diltiaseem, 180mg | C08DB01 | DILTIAZEM LANNACHER, toimeainet prolongeeritult vabastav tablett, 30TK | LANNACHER HEILMITTEL GmbH | 100 | I27.0-I27.0 | | | | | |

| | | | | | 50 | | | | | | |

| 1031645 | diltiaseem, 90mg | C08DB01 | DILTIAZEM LANNACHER, toimeainet prolongeeritult vabastav tablett, 20TK | LANNACHER HEILMITTEL GmbH | 100 | I27.0-I27.0 | | | | | |

| | | | | | 50 | | | | | | |

| 1028203 | doksasosiin, 1mg | C02CA04 | CARDURA, tablett, 30TK | Pfizer Europe MA EEIG | 50 | | | | | | |

| 1083585 | doksasosiin, 2mg | C02CA04 | ZOXON 2, tablett, 30TK | Nycomed GmbH | 50 | | | | | | |

| 1028214 | doksasosiin, 2mg | C02CA04 | CARDURA, tablett, 30TK | Pfizer Europe MA EEIG | 50 | | | | | | |

| 1071391 | doksasosiin, 2mg | C02CA04 | KAMIREN, tablett, 30TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| 1083585 | doksasosiin, 2mg | C02CA04 | ZOXON 2, tablett, 30TK | Nycomed GmbH | 50 | | | | | | |

| 1011610 | doksasosiin, 4mg | C02CA04 | ZOXON 4, tablett, 30TK | Nycomed GmbH | 50 | | | | | | |

| 1028225 | doksasosiin, 4mg | C02CA04 | CARDURA, tablett, 30TK | Pfizer Europe MA EEIG | 50 | | | | | | |

| 1071379 | doksasosiin, 4mg | C02CA04 | KAMIREN, tablett, 30TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

@@ -854,8 +788,8 @@

| 1205895 | doksasosiin, 4mg | C02CA04 | DOXALFA, toimeainet prolongeeritult vabastav tablett, 28TK | STADA ARZNEIMITTEL AG | 50 | | | | | | |

| 1325360 | doksasosiin, 4mg | C02CA04 | DOXAZOSIN TEVA 4 MG, toimeainet prolongeeritult vabastav tablett, 30TK | Teva Pharma B.V. | 50 | | | | | | |

| 1360101 | doksasosiin, 4mg | C02CA04 | DOXONEX SR, toimeainet prolongeeritult vabastav tablett, 30TK | Pharmaceutical Works Polpharma S.A. | 50 | | | | | | |

| 1018303 | doksütsükliin, 100mg | J01AA02 | DOXYCYCLIN STADA, tablett, 10TK | STADA ARZNEIMITTEL AG | 100 | A50-A53 | Dermatoveneroloog | | | | |

| | | | | | 50 | | | | | | |

| 1018303 | doksütsükliin, 100mg | J01AA02 | DOXYCYCLIN STADA, tablett, 10TK | STADA ARZNEIMITTEL AG | 50 | | | | | | |

| | | | | | 100 | A50-A53 | Dermatoveneroloog | | | | |

| 1065877 | doksütsükliin, 100mg | J01AA02 | DOXYCYCLINE VITABALANS, tablett, 10TK | VITABALANS OY | 50 | | | | | | |

| | | | | | 100 | A50-A53 | Dermatoveneroloog | | | | |

| 1065899 | doksütsükliin, 100mg | J01AA02 | DOXYLAN, tablett, 10TK | LANNACHER HEILMITTEL GmbH | 50 | | | | | | |

@@ -864,87 +798,85 @@

| | | | | | 50 | | | | | | |

| 1240366 | domperidoon, 10mg | A03FA03 | DOMPERIDON ACTAVIS, tablett, 30TK | Actavis Group Hf | 50 | | | | | | |

| 1030385 | donepesiil, 10mg | N06DA02 | ARICEPT, õhukese polümeerikattega tablett, 28TK | Pfizer Europe MA EEIG | 50 | | | | | | |

| 1313053 | donepesiil, 10mg | N06DA02 | DONEPEZIL ORION, õhukese polümeerikattega tablett, 28TK | Orion Corporation | 50 | | | | | | |

| 1292206 | donepesiil, 10mg | N06DA02 | DONEPEZIL ACTAVIS, õhukese polümeerikattega tablett, 28TK | Actavis Group PTC ehf | 50 | | | | | | |

| 1313053 | donepesiil, 10mg | N06DA02 | DONEPEZIL ORION, õhukese polümeerikattega tablett, 28TK | Orion Corporation | 50 | | | | | | |

| 1030374 | donepesiil, 5mg | N06DA02 | ARICEPT, õhukese polümeerikattega tablett, 28TK | Pfizer Europe MA EEIG | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1312535 | donepesiil, 5mg | N06DA02 | DONEPEZIL ORION, õhukese polümeerikattega tablett, 28TK | Orion Corporation | 50 | | | | | | |

| 1292105 | donepesiil, 5mg | N06DA02 | DONEPEZIL ACTAVIS, õhukese polümeerikattega tablett, 28TK | Actavis Group PTC ehf | 50 | | | | | | |

| 1014961 | dorsolamiid, 2% | S01EC03 | TRUSOPT, silmatilgad, lahus, 5ml 1TK | Merck Sharp & Dohme OÜ | 50 | | | | | | |

| | | | | | 100 | H40-H42 | Oftalmoloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1341324 | dorsolamiid+timolool, 20mg 1ml+5mg 1ml | S01ED80 | DOTIZOLIL, silmatilgad, lahus, 5ml 1TK | Sandoz d.d. | 50 | | | | | | |

| 1165711 | drospirenoon+ östradiool, 2mg+1mg | G03FA17 | ANGELIQ, õhukese polümeerikattega tablett, 28TK | Bayer Schering Pharma AG | 50 | | | | | | |

| 1220487 | drospirenoon+etünüülö stradiool, 3mg+0,02mg | G03AA12 | YASMINELLE, õhukese polümeerikattega tablett, 21TK | Bayer Schering Pharma AG | 50 | | | | | | |

| 1316090 | drospirenoon+etünüülö stradiool, 3mg+0,02mg | G03AA12 | YAZ, õhukese polümeerikattega tablett, 28TK | Bayer Schering Pharma AG | 50 | | | | | | |

| 1043536 | drospirenoon+etünüülö stradiool, 3mg+0,03mg | G03AA12 | YARINA, õhukese polümeerikattega tablett, 21TK | Bayer Schering Pharma AG | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| | | | | | 50 | | | | | | |

| 1165711 | drospirenoon+östradio ol, 2mg+1mg | G03FA17 | ANGELIQ, õhukese polümeerikattega tablett, 28TK | Bayer Schering Pharma AG | 50 | | | | | | |

| 1062885 | drotaveriin, 40mg | A03AD02 | NO-SPA, tablett, 100TK | Sanofi-Aventis Estonia OÜ | 50 | | | | | | |

| 1195624 | duloksetiin, 30mg | N06AX21 | CYMBALTA, gastroresistentne kõvakapsel, 28TK | Eli Lilly Nederland B.V. | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1195635 | duloksetiin, 60mg | N06AX21 | CYMBALTA, gastroresistentne kõvakapsel, 28TK | Eli Lilly Nederland B.V. | 50 | | | | | | |

| | | | | | 75 | G63.2-G63.2 | Neuroloog, Endokrinoloog | esmane | | | kui eelistatud ravi tritsüklilise antidepressandiga on vastunäidustatud, põhjustab ravi katkestama sundivaid kõrvaltoimeid või ei ole vähemasti 3-kuulise kasutamise järel andnud piisavat raviefekti, ravimi esmase väljakirjutamise õigus valuravi arstil |

| | | | | | 50 | | | | | | |

| 1155440 | dutasteriid, 0,5mg | G04CB02 | AVODART, pehmekapsel, 30TK | GlaxoSmithKline Eesti OÜ | 50 | | | | | | |

| 1390463 | dutasteriid+tamsulosiin , 0,5mg+0,4mg | G04CA52 | COMBODART, kõvakapsel, 30TK | GlaxoSmithKline Eesti OÜ | 50 | | | | | | |

| 1054752 | düdrogesteroon, 10mg | G03DB01 | DUPHASTON, õhukese polümeerikattega tablett, 20TK | Abbott Healthcare Products B.V. | 50 | | | | | | |

| 1082528 | düdrogesteroon+östra diool, 5mg+1mg | G03FB08 | FEMOSTON CONTI, õhukese polümeerikattega tablett, 28TK | Abbott Healthcare Products B.V. | 50 | | | | | | |

| 1013803 | düdrogesteroon+östra diool+östradiool, 10mg+1mg+1mg | G03FB08 | FEMOSTON, õhukese polümeerikattega tablett, 14TK / 14TK | Abbott Healthcare Products B.V. | 50 | | | | | | |

| 1077937 | ebastiin, 20mg | R06AX22 | KESTINE, õhukese polümeerikattega tablett, 30TK | Laboratorios Almirall S.A. | 50 | | | | | | |

| 1082528 | düdrogesteroon+ östradiool, 5mg+1mg | G03FB08 | FEMOSTON CONTI, õhukese polümeerikattega tablett, 28TK | Abbott Healthcare Products B.V. | 50 | | | | | | |

| 1013803 | düdrogesteroon+östra diool, 0+1mg/10mg+1mg | G03FB08 | FEMOSTON, õhukese polümeerikattega tablett, 14TK / 14TK | Abbott Healthcare Products B.V. | 50 | | | | | | |

| 1077937 | ebastiin, 20mg | R06AX22 | KESTINE, õhukese polümeerikattega tablett, 30TK | Almirall S.A | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1020373 | ekonasool, 150mg | G01AF05 | GYNO-PEVARYL, vaginaalsuposiit, 3TK | Johnson & Johnson UAB | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1039036 | ekonasool, 50mg | G01AF05 | GYNO-PEVARYL, vaginaalsuposiit, 15TK | Johnson & Johnson UAB | 50 | | | | | | |

| 1011148 | eksemestaan, 25mg | L02BG06 | AROMASIN, kaetud tablett, 30TK | Pfizer Enterprises SARL | 50 | | | | | | |

| | | | | | 100 | C50-C50 | Onkoloog | | | | |

| 1395772 | eksemestaan, 25mg | L02BG06 | EXEMESTANE TEVA 25MG, õhukese polümeerikattega tablett, 30TK | Teva Pharma B.V. | 50 | | | | | | |

| | | | | | 100 | C50-C50 | Onkoloog | | | | |

| 1011148 | eksemestaan, 25mg | L02BG06 | AROMASIN, kaetud tablett, 30TK | Pfizer Enterprises SARL | 100 | C50-C50 | Onkoloog | | | | |

| | | | | | 50 | | | | | | |

| 1395772 | eksemestaan, 25mg | L02BG06 | EXEMESTANE TEVA 25MG, õhukese polümeerikattega tablett, 30TK | Teva Pharma B.V. | 100 | C50-C50 | Onkoloog | | | | |

| | | | | | 50 | | | | | | |

| 1010013 | enalapriil, 10mg | C09AA02 | ENALAPRIL-RATIOPHARM 10MG, tablett, 30TK | ratiopharm GmbH | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1010620 | enalapriil, 10mg | C09AA02 | ENAHEXAL 10 MG, tablett, 30TK | HEXAL AG | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1013599 | enalapriil, 10mg | C09AA02 | BERLIPRIL 10 MG, tablett, 30TK | Berlin-Chemie AG (Menarini Group) | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1074215 | enalapriil, 10mg | C09AA02 | RENITEC 10 MG, tablett, 28TK | Merck Sharp & Dohme OÜ | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1087501 | enalapriil, 10mg | C09AA02 | EDNYT, tablett, 30TK | Gedeon Richter Plc. | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1074215 | enalapriil, 10mg | C09AA02 | RENITEC 10 MG, tablett, 28TK | Merck Sharp & Dohme OÜ | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1010013 | enalapriil, 10mg | C09AA02 | ENALAPRIL-RATIOPHARM 10MG, tablett, 30TK | ratiopharm GmbH | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1010620 | enalapriil, 10mg | C09AA02 | ENAHEXAL 10 MG, tablett, 30TK | HEXAL AG | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1013599 | enalapriil, 10mg | C09AA02 | BERLIPRIL 10 MG, tablett, 30TK | Berlin-Chemie AG (Menarini Group) | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1087501 | enalapriil, 10mg | C09AA02 | EDNYT, tablett, 30TK | Gedeon Richter Plc. | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1133929 | enalapriil, 10mg | C09AA02 | ENAP, tablett, 60TK | KRKA d.d., Novo Mesto | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1359974 | enalapriil, 10mg | C09AA02 | ENALAPRIL VITABALANS, tablett, 30TK | VITABALANS OY | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1010024 | enalapriil, 20mg | C09AA02 | ENALAPRIL-RATIOPHARM 20MG, tablett, 30TK | ratiopharm GmbH | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1010631 | enalapriil, 20mg | C09AA02 | ENAHEXAL 20 MG, tablett, 30TK | HEXAL AG | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1359974 | enalapriil, 10mg | C09AA02 | ENALAPRIL VITABALANS, tablett, 30TK | VITABALANS OY | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1074259 | enalapriil, 20mg | C09AA02 | RENITEC FORTE, tablett, 28TK | Merck Sharp & Dohme OÜ | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1371080 | enalapriil, 20mg | C09AA02 | RENITEC FORTE, tablett, 98TK | Merck Sharp & Dohme OÜ | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1010024 | enalapriil, 20mg | C09AA02 | ENALAPRIL-RATIOPHARM 20MG, tablett, 30TK | ratiopharm GmbH | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1010631 | enalapriil, 20mg | C09AA02 | ENAHEXAL 20 MG, tablett, 30TK | HEXAL AG | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1013601 | enalapriil, 20mg | C09AA02 | BERLIPRIL 20 MG, tablett, 30TK | Berlin-Chemie AG (Menarini Group) | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1074259 | enalapriil, 20mg | C09AA02 | RENITEC FORTE, tablett, 28TK | Merck Sharp & Dohme OÜ | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1087512 | enalapriil, 20mg | C09AA02 | EDNYT, tablett, 30TK | Gedeon Richter Plc. | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1133952 | enalapriil, 20mg | C09AA02 | ENAP, tablett, 60TK | KRKA d.d., Novo Mesto | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1133952 | enalapriil, 20mg | C09AA02 | ENAP, tablett, 60TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1360033 | enalapriil, 20mg | C09AA02 | ENALAPRIL VITABALANS, tablett, 30TK | VITABALANS OY | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1371080 | enalapriil, 20mg | C09AA02 | RENITEC FORTE, tablett, 98TK | Merck Sharp & Dohme OÜ | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1010002 | enalapriil, 5mg | C09AA02 | ENALAPRIL-RATIOPHARM 5MG, tablett, 30TK | ratiopharm GmbH | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1074226 | enalapriil, 5mg | C09AA02 | RENITEC 5 MG, tablett, 28TK | Merck Sharp & Dohme OÜ | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1010002 | enalapriil, 5mg | C09AA02 | ENALAPRIL-RATIOPHARM 5MG, tablett, 30TK | ratiopharm GmbH | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1010619 | enalapriil, 5mg | C09AA02 | ENAHEXAL 5 MG, tablett, 30TK | HEXAL AG | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1017470 | enalapriil, 5mg | C09AA02 | BERLIPRIL 5 MG, tablett, 30TK | Berlin-Chemie AG (Menarini Group) | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

@@ -953,61 +885,55 @@

| | | | | | 50 | | | | | | |

| 1074091 | enalapriil, 5mg | C09AA02 | BERLIPRIL 5 MG, tablett, 100TK | Berlin-Chemie AG (Menarini Group) | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1074226 | enalapriil, 5mg | C09AA02 | RENITEC 5 MG, tablett, 28TK | Merck Sharp & Dohme OÜ | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1087499 | enalapriil, 5mg | C09AA02 | EDNYT, tablett, 30TK | Gedeon Richter Plc. | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1133895 | enalapriil, 5mg | C09AA02 | ENAP, tablett, 60TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1133895 | enalapriil, 5mg | C09AA02 | ENAP, tablett, 60TK | KRKA d.d., Novo Mesto | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1359918 | enalapriil, 5mg | C09AA02 | ENALAPRIL VITABALANS, tablett, 30TK | VITABALANS OY | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1147564 | enalapriil+hüdrokloroti asiid, 10mg+12,5mg | C09BA02 | ENAP-HL, tablett, 30TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1147575 | enalapriil+hüdrokloroti asiid, 10mg+12,5mg | C09BA02 | ENAP-HL, tablett, 60TK | KRKA d.d., Novo Mesto | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1129159 | enalapriil+ hüdroklorotiasiid, 20mg+12,5mg | C09BA02 | ENAHEXAL COMP 20 MG/12,5 MG, tablett, 30TK | HEXAL AG | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1147564 | enalapriil+hüdrokloroti asiid, 10mg+12,5mg | C09BA02 | ENAP-HL, tablett, 30TK | KRKA d.d., Novo Mesto | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1147575 | enalapriil+hüdrokloroti asiid, 10mg+12,5mg | C09BA02 | ENAP-HL, tablett, 60TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1074899 | enalapriil+hüdrokloroti asiid, 10mg+25mg | C09BA02 | CO-RENITEC, tablett, 30TK | Merck Sharp & Dohme OÜ | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1129160 | enalapriil+hüdrokloroti asiid, 10mg+25mg | C09BA02 | ENAHEXAL COMP 10 MG/25 MG, tablett, 20TK | HEXAL AG | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1147597 | enalapriil+hüdrokloroti asiid, 10mg+25mg | C09BA02 | ENAP-H, tablett, 30TK | KRKA d.d., Novo Mesto | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1147609 | enalapriil+hüdrokloroti asiid, 10mg+25mg | C09BA02 | ENAP-H, tablett, 60TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1129160 | enalapriil+hüdrokloroti asiid, 10mg+25mg | C09BA02 | ENAHEXAL COMP 10 MG/25 MG, tablett, 20TK | HEXAL AG | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1147597 | enalapriil+hüdrokloroti asiid, 10mg+25mg | C09BA02 | ENAP-H, tablett, 30TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1147609 | enalapriil+hüdrokloroti asiid, 10mg+25mg | C09BA02 | ENAP-H, tablett, 60TK | KRKA d.d., Novo Mesto | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1074888 | enalapriil+hüdrokloroti asiid, 20mg+12,5mg | C09BA02 | CO-RENITEC, tablett, 28TK | Merck Sharp & Dohme OÜ | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1129159 | enalapriil+hüdrokloroti asiid, 20mg+12,5mg | C09BA02 | ENAHEXAL COMP 20 MG/12,5 MG, tablett, 30TK | HEXAL AG | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1151389 | enalapriil+hüdrokloroti asiid, 20mg+12,5mg | C09BA02 | ENAP-HL, tablett, 30TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1074901 | enalapriil+hüdrokloroti asiid, 20mg+6mg | C09BA02 | RENITEC PLUS, tablett, 28TK | Merck Sharp & Dohme OÜ | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1472228 | entakapoon+karbidopa +levodopa, 200mg+18,75mg+75m g | N04BA03 | STALEVO, õhukese polümeerikattega tablett, 100TK | Orion Corporation | 50 | | | | | | |

| | | | | | 100 | G20-G20 | Neuroloog | esmane | | | |

| 1172854 | entakapoon+karbidopa +levodopa, 200mg+25mg+100mg | N04BA03 | STALEVO, õhukese polümeerikattega tablett, 100TK | Orion Corporation | 50 | | | | | | |

| | | | | | 100 | G20-G20 | Neuroloog | esmane | | | |

| 1172898 | entakapoon+karbidopa +levodopa, 200mg+37,5mg+150m g | N04BA03 | STALEVO, õhukese polümeerikattega tablett, 100TK | Orion Corporation | 50 | | | | | | |

| | | | | | 100 | G20-G20 | Neuroloog | esmane | | | |

| 1368020 | entakapoon+karbidopa +levodopa, 200mg+50mg+200mg | N04BA03 | STALEVO, õhukese polümeerikattega tablett, 100TK | Orion Corporation | 50 | | | | | | |

| | | | | | 100 | G20-G20 | Neuroloog | esmane | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1151389 | enalapriil+hüdrokloroti asiid, 20mg+12,5mg | C09BA02 | ENAP-HL, tablett, 30TK | KRKA d.d., Novo Mesto | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1074901 | enalapriil+hüdrokloroti asiid, 20mg+6mg | C09BA02 | RENITEC PLUS, tablett, 28TK | Merck Sharp & Dohme OÜ | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1081101 | eprosartaan, 600mg | C09CA02 | TEVETEN, õhukese polümeerikattega tablett, 28TK | Abbott Healthcare Products B.V. | 50 | | | | | | |

| 1163720 | erütromütsiin, 10mg 1ml | D10AF02 | AKNEFUG-EL, nahalahus, 50ml 1TK | Dr. August Wolff GmbH & Co. KG Arzneimittel | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1162965 | esetimiib, 10mg | C10AX09 | EZETROL, tablett, 28TK | Merck Sharp & Dohme OÜ | 50 | | | | | | |

| | | | | | 75 | Z45-Z45, I21-I22, Z95-Z95, E13-E14, I25.2-I25.2, E10-E11 | | | | | kombinatsioonis atorvastatiini või rosuvastatiiniga, kui vaatamata nimetatud ravimi optimaalse annuse kasutamisele on kolesterooli sisaldus veres 4,5 mmol/l |

| 1422335 | esetimiib, 10mg | C10AX09 | EZOLETA, tablett, 28TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| 1087949 | esomeprasool, 20mg | A02BC05 | NEXIUM, gastroresistentne tablett, 14TK | AstraZeneca AB | 50 | | | | | | |

| | | | | | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| 1087950 | esomeprasool, 20mg | A02BC05 | NEXIUM, gastroresistentne tablett, 28TK | AstraZeneca AB | 50 | | | | | | |

| | | | | | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| 1087972 | esomeprasool, 40mg | A02BC05 | NEXIUM, gastroresistentne tablett, 14TK | AstraZeneca AB | 50 | | | | | | |

| | | | | | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1087983 | esomeprasool, 40mg | A02BC05 | NEXIUM, gastroresistentne tablett, 28TK | AstraZeneca AB | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| | | | | | 50 | | | | | | |

| 1102521 | estsitalopraam, 10mg | N06AB10 | CIPRALEX, õhukese polümeerikattega tablett, 14TK | H. LUNDBECK A/S | 50 | | | | | | |

| 1102543 | estsitalopraam, 10mg | N06AB10 | CIPRALEX, õhukese polümeerikattega tablett, 28TK | H. LUNDBECK A/S | 50 | | | | | | |

| 1321951 | estsitalopraam, 10mg | N06AB10 | NEPANIL, õhukese polümeerikattega tablett, 28TK | Gedeon Richter Plc. | 50 | | | | | | |

@@ -1018,11 +944,11 @@

| 1336687 | estsitalopraam, 10mg | N06AB10 | ESLOREX 10 MG, õhukese polümeerikattega tablett, 60TK | Zentiva, k.s. | 50 | | | | | | |

| 1336935 | estsitalopraam, 10mg | N06AB10 | ESCITALOPRAM- RATIOPHARM 10MG, õhukese polümeerikattega tablett, 30TK | ratiopharm GmbH | 50 | | | | | | |

| 1400218 | estsitalopraam, 10mg | N06AB10 | ELICEA 10MG, õhukese polümeerikattega tablett, 28TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1102598 | estsitalopraam, 20mg | N06AB10 | CIPRALEX, õhukese polümeerikattega tablett, 28TK | H. LUNDBECK A/S | 50 | | | | | | |

| 1324617 | estsitalopraam, 20mg | N06AB10 | NORESTAL, õhukese polümeerikattega tablett, 28TK | UAB Norameda | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1331907 | estsitalopraam, 20mg | N06AB10 | ESCITALOPRAM TEVA, õhukese polümeerikattega tablett, 28TK | Teva Pharma B.V. | 50 | | | | | | |

| 1337059 | estsitalopraam, 20mg | N06AB10 | ESCITALOPRAM- RATIOPHARM 20 MG, õhukese polümeerikattega tablett, 30TK | ratiopharm GmbH | 50 | | | | | | |

| 1400320 | estsitalopraam, 20mg | N06AB10 | ELICEA 20MG, õhukese polümeerikattega tablett, 28TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

@@ -1038,87 +964,46 @@

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1014815 | etünüülöstradiool+etün üülöstradiool+etünüülö stradiool+levonorgestr eel+levonorgestreel+le vonorgestreel, 30mcg+40mcg+30mcg +75mcg+125mcg+50m cg | G03AB03 | TRI-REGOL, kaetud tablett, 15TK / 18TK / 30TK | Gedeon Richter Plc. | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| | | | | | 50 | | | | | | |

| 1035098 | etünüülöstradiool+gest odeen, 0,02mg+0,075mg | G03AA10 | LOGEST, kaetud tablett, 21TK | Bayer Schering Pharma AG | 50 | | | | | | |

| | | | | | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| 1115716 | etünüülöstradiool+gest odeen, 0,02mg+0,075mg | G03AA10 | LINDYNETTE 20, kaetud tablett, 63TK | Gedeon Richter Plc. | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| | | | | | 50 | | | | | | |

| 1023624 | etünüülöstradiool+gest odeen, 0,03mg+0,075mg | G03AA10 | FEMODEN, kaetud tablett, 21TK | Bayer Schering Pharma AG | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| | | | | | 50 | | | | | | |

| 1115693 | etünüülöstradiool+gest odeen, 0,03mg+0,075mg | G03AA10 | LINDYNETTE 30, kaetud tablett, 63TK | Gedeon Richter Plc. | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| | | | | | 50 | | | | | | |

| 1012149 | etünüülöstradiool+gest odeen, 15mcg+60mcg | G03AA10 | MIRELLE, õhukese polümeerikattega tablett, 28TK | Bayer Schering Pharma AG | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| | | | | | 50 | | | | | | |

| 1027718 | etünüülöstradiool+gest odeen, 20mcg+75mcg | G03AA10 | HARMONET, kaetud tablett, 21TK | Pfizer Europe MA EEIG | 50 | | | | | | |

| | | | | | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| 1062953 | etünüülöstradiool+gest odeen, 20mcg+75mcg | G03AA10 | HARMONET, kaetud tablett, 63TK | Pfizer Europe MA EEIG | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1364048 | etünüülöstradiool+gest odeen, 20mcg+75mcg | G03AA10 | GESYTIL 75/20 MIKROGRAMMI, kaetud tablett, 21TK | ratiopharm GmbH | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| | | | | | 50 | | | | | | |

| 1364105 | etünüülöstradiool+gest odeen, 20mcg+75mcg | G03AA10 | GESYTIL 75/20 MIKROGRAMMI, kaetud tablett, 63TK | ratiopharm GmbH | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| | | | | | 50 | | | | | | |

| 1364127 | etünüülöstradiool+gest odeen, 30mcg+75mcg | G03AA10 | GESYTIL 75/30 MIKROGRAMMI, kaetud tablett, 21TK | ratiopharm GmbH | 50 | | | | | | |

| | | | | | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| 1364138 | etünüülöstradiool+gest odeen, 30mcg+75mcg | G03AA10 | GESYTIL 75/30 MIKROGRAMMI, kaetud tablett, 63TK | ratiopharm GmbH | 50 | | | | | | |

| | | | | | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| 1005309 | etünüülöstradiool+gest odeen, 75mcg+30mcg | G03AA10 | MINULET, kaetud tablett, 21TK | Pfizer Europe MA EEIG | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| | | | | | 50 | | | | | | |

| 1062986 | etünüülöstradiool+gest odeen, 75mcg+30mcg | G03AA10 | MINULET, kaetud tablett, 63TK | Pfizer Europe MA EEIG | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| | | | | | 50 | | | | | | |

| 1012880 | etünüülöstradiool+kloo rmadinoon, 30mcg+2mg | G03AA80 | BELARA, õhukese polümeerikattega tablett, 21TK | Grünenthal GmbH | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| | | | | | 50 | | | | | | |

| 1094509 | etünüülöstradiool+kloo rmadinoon, 30mcg+2mg | G03AA80 | BELARA, õhukese polümeerikattega tablett, 63TK | Grünenthal GmbH | 50 | | | | | | |

| | | | | | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| 1131589 | etünüülöstradiool+nore lgestromiin, 0,6mg+6mg | G03AA13 | EVRA, transdermaalne plaaster, 3TK | Janssen-Cilag International N.V. | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1020430 | etünüülöstradiool+norg estimaat, 0,035mg+0,25mg | G03AA11 | CILEST, tablett, 21TK | Johnson & Johnson UAB | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| | | | | | 50 | | | | | | |

| 1038361 | famotidiin, 20mg | A02BA03 | FAMOSAN, õhukese polümeerikattega tablett, 20TK | PRO. MED. CS. PRAHA a.s. | 50 | | | | | | |

| 1012330 | felodipiin, 10mg | C08CA02 | PRESID, toimeainet prolongeeritult vabastav tablett, 30TK | TEVA Czech Industries s.r.o. | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 50 | | | | | | |

| 1019708 | felodipiin, 10mg | C08CA02 | PLENDIL, toimeainet prolongeeritult vabastav tablett, 30TK | AstraZeneca AB | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 50 | | | | | | |

| 1019708 | felodipiin, 10mg | C08CA02 | PLENDIL, toimeainet prolongeeritult vabastav tablett, 30TK | AstraZeneca AB | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15 | | | | | |

| 1012330 | felodipiin, 10mg | C08CA02 | PRESID, toimeainet prolongeeritult vabastav tablett, 30TK | TEVA Czech Industries s.r.o. | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15 | | | | | |

| 1174474 | felodipiin, 10mg | C08CA02 | FELODIPIN HEXAL, toimeainet prolongeeritult vabastav tablett, 30TK | HEXAL AG | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 50 | | | | | | |

| 1028135 | felodipiin, 2,5mg | C08CA02 | PLENDIL, toimeainet prolongeeritult vabastav tablett, 30TK | AstraZeneca AB | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15 | | | | | |

| 1012318 | felodipiin, 2,5mg | C08CA02 | PRESID, toimeainet prolongeeritult vabastav tablett, 30TK | TEVA Czech Industries s.r.o. | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15 | | | | | |

| 1028135 | felodipiin, 2,5mg | C08CA02 | PLENDIL, toimeainet prolongeeritult vabastav tablett, 30TK | AstraZeneca AB | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 50 | | | | | | |

| 1012329 | felodipiin, 5mg | C08CA02 | PRESID, toimeainet prolongeeritult vabastav tablett, 30TK | TEVA Czech Industries s.r.o. | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 50 | | | | | | |

| 1019696 | felodipiin, 5mg | C08CA02 | PLENDIL, toimeainet prolongeeritult vabastav tablett, 30TK | AstraZeneca AB | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15 | | | | | |

| 1174373 | felodipiin, 5mg | C08CA02 | FELODIPIN HEXAL, toimeainet prolongeeritult vabastav tablett, 30TK | HEXAL AG | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 50 | | | | | | |

| 1029495 | fenobarbitaal, 100mg | N03AA02 | PHENAEMAL 0,1, tablett, 50TK | Desitin Arzneimittel GmbH | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1012329 | felodipiin, 5mg | C08CA02 | PRESID, toimeainet prolongeeritult vabastav tablett, 30TK | TEVA Czech Industries s.r.o. | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15 | | | | | |

| 1174373 | felodipiin, 5mg | C08CA02 | FELODIPIN HEXAL, toimeainet prolongeeritult vabastav tablett, 30TK | HEXAL AG | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15 | | | | | |

| 1029495 | fenobarbitaal, 100mg | N03AA02 | PHENAEMAL 0,1, tablett, 50TK | Desitin Arzneimittel GmbH | 50 | | | | | | |

| | | | | | 100 | G40-G40 | Neuroloog | esmane | | | |

| 1026593 | fenofibraat, 200mg | C10AB05 | LIPANTHYL, kapsel, 30TK | Laboratoires Fournier S.A. | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1020340 | fenoksümetüülpenitsillii n, 1000000TÜ | J01CE02 | OSPEN, õhukese polümeerikattega tablett, 12TK | Sandoz GmbH | 75 | J13-J15 | | | | 16,00 | |

| | | | | | 50 | | | | | | |

| 1106536 | fenoksümetüülpenitsillii n, 1000000TÜ | J01CE02 | VEPICOMBIN NOVUM 1 000 000 TÜ, õhukese polümeerikattega tablett, 20TK | Nycomed Sefa AS | 75 | J13-J15 | | | | 16,00 | |

| | | | | | 50 | | | | | | |

| 1105951 | fenoksümetüülpenitsillii n, 400000TÜ 5ml | J01CE02 | OSPEN, suukaudne suspensioon, 60ml 1TK | Sandoz GmbH | 50 | | | | | | |

| 1020340 | fenoksümetüülpenitsillii n, 1000000TÜ | J01CE02 | OSPEN, õhukese polümeerikattega tablett, 12TK | Sandoz GmbH | 50 | | | | | | |

| | | | | | 75 | J13-J15 | | | | 16,00 | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1106536 | fenoksümetüülpenitsillii n, 1000000TÜ | J01CE02 | VEPICOMBIN NOVUM 1 000 000 TÜ, õhukese polümeerikattega tablett, 20TK | Nycomed Sefa AS | 50 | | | | | | |

| | | | | | 75 | J13-J15 | | | | 16,00 | |

| 1105951 | fenoksümetüülpenitsillii n, 400000TÜ 5ml | J01CE02 | OSPEN, suukaudne suspensioon, 60ml 1TK | Sandoz GmbH | 75 | J13-J15 | | | | 16,00 | |

| | | | | | 50 | | | | | | |

| 1020272 | fenoksümetüülpenitsillii n, 500000TÜ | J01CE02 | OSPEN, õhukese polümeerikattega tablett, 12TK | Sandoz GmbH | 50 | | | | | | |

| | | | | | 75 | J13-J15 | | | | 16,00 | |

| 1044223 | fenoterool, 100mcg 1annust | R03AC04 | BEROTEC N 100 MCG, inhalatsiooniaerosool, lahus, 200annust 1TK | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | 75 | J45-J45 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | J45-J45 | | | | | |

| | | | | | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| 1009651 | fenoterool+ipratroopiu mbromiid, 50mcg+20mcg 1annust | R03AK80 | BERODUAL N, inhalatsiooniaerosool, lahus, 200annust 1TK | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | | | |

| 1001169 | fenoterool+ipratroopiu mbromiid, 0,5mg 1ml+0,25mg 1ml | R03AK80 | BERODUAL, nebuliseeritav lahus, 20ml 1TK | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1009651 | fenoterool+ipratroopiu mbromiid, 50mcg 1annust+20mcg 1annust | R03AK80 | BERODUAL N, inhalatsiooniaerosool, lahus, 200annust 1TK | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1028168 | fentanüül, 100mcg 1h | N02AB03 | DUROGESIC, transdermaalne plaaster, 5TK | Johnson & Johnson UAB | 100 | C00-D48 | | | | | patsientidele, kelle valutustamiseks ei saa kasutada suukaudset morfiini kõrvaltoimete või ravimvormi sobimatuse tõttu või kui suukaudne morfiin ei taga valutustamist |

| | | | | | 50 | | | | | | |

@@ -1126,23 +1011,23 @@

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1223165 | fentanüül, 100mcg 1h | N02AB03 | MATRIFEN, transdermaalne plaaster, 5TK | Nycomed Sefa AS | 50 | | | | | | |

| | | | | | 100 | C00-D48 | | | | | patsientidele, kelle valutustamiseks ei saa kasutada suukaudset morfiini kõrvaltoimete või ravimvormi sobimatuse tõttu või kui suukaudne morfiin ei taga valutustamist |

| 1254754 | fentanüül, 100mcg 1h | N02AB03 | FENTANYL SANDOZ, transdermaalne plaaster, 5TK | Sandoz d.d. | 50 | | | | | | |

| 1254754 | fentanüül, 100mcg 1h | N02AB03 | FENTANYL SANDOZ, transdermaalne plaaster, 5TK | Sandoz d.d. | 100 | C00-D48 | | | | | patsientidele, kelle valutustamiseks ei saa kasutada suukaudset morfiini kõrvaltoimete või ravimvormi sobimatuse tõttu või kui suukaudne morfiin ei taga valutustamist |

| | | | | | 50 | | | | | | |

| 1178186 | fentanüül, 12mcg 1h | N02AB03 | DUROGESIC, transdermaalne plaaster, 5TK | Johnson & Johnson UAB | 100 | C00-D48 | | | | | patsientidele, kelle valutustamiseks ei saa kasutada suukaudset morfiini kõrvaltoimete või ravimvormi sobimatuse tõttu või kui suukaudne morfiin ei taga valutustamist |

| | | | | | 50 | | | | | | |

| 1223121 | fentanüül, 12mcg 1h | N02AB03 | MATRIFEN, transdermaalne plaaster, 5TK | Nycomed Sefa AS | 50 | | | | | | |

| 1178186 | fentanüül, 12mcg 1h | N02AB03 | DUROGESIC, transdermaalne plaaster, 5TK | Johnson & Johnson UAB | 50 | | | | | | |

| 1223121 | fentanüül, 12mcg 1h | N02AB03 | MATRIFEN, transdermaalne plaaster, 5TK | Nycomed Sefa AS | 100 | C00-D48 | | | | | patsientidele, kelle valutustamiseks ei saa kasutada suukaudset morfiini kõrvaltoimete või ravimvormi sobimatuse tõttu või kui suukaudne morfiin ei taga valutustamist |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1022218 | fentanüül, 25mcg 1h | N02AB03 | DUROGESIC, transdermaalne plaaster, 5TK | Johnson & Johnson UAB | 50 | | | | | | |

| 1223132 | fentanüül, 25mcg 1h | N02AB03 | MATRIFEN, transdermaalne plaaster, 5TK | Nycomed Sefa AS | 100 | C00-D48 | | | | | patsientidele, kelle valutustamiseks ei saa kasutada suukaudset morfiini kõrvaltoimete või ravimvormi sobimatuse tõttu või kui suukaudne morfiin ei taga valutustamist |

| | | | | | 50 | | | | | | |

| 1254664 | fentanüül, 25mcg 1h | N02AB03 | FENTANYL SANDOZ, transdermaalne plaaster, 5TK | Sandoz d.d. | 50 | | | | | | |

| 1223132 | fentanüül, 25mcg 1h | N02AB03 | MATRIFEN, transdermaalne plaaster, 5TK | Nycomed Sefa AS | 50 | | | | | | |

| 1028146 | fentanüül, 50mcg 1h | N02AB03 | DUROGESIC, transdermaalne plaaster, 5TK | Johnson & Johnson UAB | 50 | | | | | | |

| 1254664 | fentanüül, 25mcg 1h | N02AB03 | FENTANYL SANDOZ, transdermaalne plaaster, 5TK | Sandoz d.d. | 100 | C00-D48 | | | | | patsientidele, kelle valutustamiseks ei saa kasutada suukaudset morfiini kõrvaltoimete või ravimvormi sobimatuse tõttu või kui suukaudne morfiin ei taga valutustamist |

| | | | | | 50 | | | | | | |

| 1028146 | fentanüül, 50mcg 1h | N02AB03 | DUROGESIC, transdermaalne plaaster, 5TK | Johnson & Johnson UAB | 100 | C00-D48 | | | | | patsientidele, kelle valutustamiseks ei saa kasutada suukaudset morfiini kõrvaltoimete või ravimvormi sobimatuse tõttu või kui suukaudne morfiin ei taga valutustamist |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

@@ -1154,72 +1039,71 @@

| 1223154 | fentanüül, 75mcg 1h | N02AB03 | MATRIFEN, transdermaalne plaaster, 5TK | Nycomed Sefa AS | 50 | | | | | | |

| 1077050 | fenütoiin, 100mg | N03AB02 | PHENHYDAN, tablett, 100TK | Desitin Arzneimittel GmbH | 50 | | | | | | |

| | | | | | 100 | G40-G40 | Neuroloog | esmane | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1077050 | fenütoiin, 100mg | N03AB02 | PHENHYDAN, tablett, 100TK | Desitin Arzneimittel GmbH | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1338724 | finasteriid, 5mg | G04CB01 | FINASTERIDE TEVA, õhukese polümeerikattega tablett, 30TK | Teva Pharma B.V. | 50 | | | | | | |

| 1013487 | finasteriid, 5mg | G04CB01 | PENESTER, õhukese polümeerikattega tablett, 30TK | Nycomed GmbH | 50 | | | | | | |

| 1338724 | finasteriid, 5mg | G04CB01 | FINASTERIDE TEVA, õhukese polümeerikattega tablett, 30TK | Teva Pharma B.V. | 50 | | | | | | |

| 1346510 | finasteriid, 5mg | G04CB01 | FINASTERIDE PORTFARMA 5MG, õhukese polümeerikattega tablett, 30TK | Portfarma ehf | 50 | | | | | | |

| 1070637 | flekainiid, 100mg | C01BC04 | TAMBOCOR, tablett, 100TK | Meda AB | 50 | | | | | | |

| 1060355 | fludarabiin, 10mg | L01BB05 | FLUDARA, õhukese polümeerikattega tablett, 20TK | Genzyme Europe B.V. | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1144774 | flukonasool, 100mg | J02AC01 | FLUCONAZOLE SANDOZ 100MG, kapsel, 7TK | Sandoz d.d. | 50 | | | | | | |

| | | | | | 100 | B48.8-B48.8, B48.2- B48.2, B37-B37, B44-B44 | | | | | kaasasündinud või omandatud immuunpuudulikkuseg a (pahaloomulise kasvaja raviga, organsiirdamise järgse seisundiga, HIV-tõve või aplastilise aneemiaga) seotud mükoosi raviks ja profülaktikaks |

| 1009718 | flukonasool, 150mg | J02AC01 | MYCOSYST 150 MG, kõvakapsel, 1TK | Gedeon Richter Plc. | 50 | | | | | | |

| 1011733 | flukonasool, 150mg | J02AC01 | MYCOMAX, kõvakapsel, 1TK | Zentiva, k.s. | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| 1395165 | flukonasool, 150mg | J02AC01 | FLUCONAZOLE PORTFARMA, kõvakapsel, 1TK | Portfarma ehf | 50 | | | | | | |

| 1082999 | flukonasool, 150mg | J02AC01 | MYCOSYST 150 MG, kõvakapsel, 2TK | Gedeon Richter Plc. | 50 | | | | | | |

| 1395176 | flukonasool, 150mg | J02AC01 | FLUCONAZOLE PORTFARMA, kõvakapsel, 2TK | Portfarma ehf | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1140275 | flukonasool, 150mg | J02AC01 | FLUCONAZOL NYCOMED 150MG, kõvakapsel, 1TK | Nycomed Sefa AS | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1144831 | flukonasool, 150mg | J02AC01 | FLUCONAZOLE SANDOZ 150MG, kapsel, 1TK | Sandoz d.d. | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1144842 | flukonasool, 150mg | J02AC01 | FLUCONAZOLE SANDOZ 150MG, kapsel, 2TK | Sandoz d.d. | 50 | | | | | | |

| 1395165 | flukonasool, 150mg | J02AC01 | FLUCONAZOLE PORTFARMA, kõvakapsel, 1TK | Portfarma ehf | 50 | | | | | | |

| 1395660 | flukonasool, 50mg | J02AC01 | FLUCONAZOLE PORTFARMA, kõvakapsel, 7TK | Portfarma ehf | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| 1036932 | flukonasool, 50mg | J02AC01 | DIFLAZON, kõvakapsel, 7TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1144662 | flukonasool, 50mg | J02AC01 | FLUCONAZOLE SANDOZ 50MG, kapsel, 7TK | Sandoz d.d. | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1395660 | flukonasool, 50mg | J02AC01 | FLUCONAZOLE PORTFARMA, kõvakapsel, 7TK | Portfarma ehf | 50 | | | | | | |

| 1167971 | fluokortoloon+lidokaiin, 1mg 1g+20mg 1g | C05AA84 | DOLOPROCT 1MG+20MG/G REKTAALKREEM, rektaalkreem, 15g 1TK | Intendis GmbH | 50 | | | | | | |

| 1167971 | fluokortoloon+lidokaiin, 1mg+20mg 1g | C05AA84 | DOLOPROCT 1MG+20MG/G REKTAALKREEM, rektaalkreem, 15g 1TK | Intendis GmbH | 50 | | | | | | |

| 1167948 | fluokortoloon+lidokaiin, 1mg+40mg | C05AA84 | DOLOPROCT 1MG/40MG REKTAALSUPOSIIDID, rektaalsuposiit, 10TK | Intendis GmbH | 50 | | | | | | |

| 1030420 | fluoksetiin, 20mg | N06AB03 | NYCOFLOX, kõvakapsel, 30TK | Nycomed Sefa AS | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| 1005972 | flupentiksool, 1mg | N05AF01 | FLUANXOL, kaetud tablett, 50TK | H. LUNDBECK A/S | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1006175 | flupentiksool, 20mg 1ml | N05AF01 | FLUANXOL DEPOT, süstelahus, 1ml 1TK | H. LUNDBECK A/S | 50 | | | | | | |

@@ -1230,277 +1114,274 @@

| 1115255 | flupirtiin, 100mg | N02BG07 | KATADOLON, kõvakapsel, 50TK | AWD. pharma GmbH & Co.KG | 50 | | | | | | |

| 1007840 | flutikasoon, 100mcg 1annust | R03BA05 | FLIXOTIDE DISKUS 100 MCG, inhalatsioonipulber, 60annust 1TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 50 | | | | | | |

| | | | | | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | 18,00 | |

| 1007884 | flutikasoon, 250mcg 1annust | R03BA05 | FLIXOTIDE DISKUS 250 MCG, inhalatsioonipulber, 60annust 1TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | | 18,00 | |

| | | | | | 50 | | | | | | |

| 1006344 | flutikasoon, 500mcg 1g | D07AC17 | CUTIVATE CREAM, kreem, 15g 1TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 50 | | | | | | |

| 1007884 | flutikasoon, 250mcg 1annust | R03BA05 | FLIXOTIDE DISKUS 250 MCG, inhalatsioonipulber, 60annust 1TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 50 | | | | | | |

| | | | | | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | 18,00 | |

| | | | | | 50 | | | | | | |

| 1007233 | flutikasoon, 50mcg 1annust | R01AD08 | FLIXONASE AQUEOUS NASAL SPRAY 50 MCG, ninasprei, suspensioon, 120annust 1TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 50 | | | | | | |

| 1007862 | flutikasoon, 50mcg 1annust | R03BA05 | FLIXOTIDE DISKUS 50 MCG, inhalatsioonipulber, 60annust 1TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | 18,00 | |

| | | | | | 50 | | | | | | |

| 1130690 | flutikasoon, 50mcg 1annust | R03BA05 | FLIXOTIDE INHALER, inhalatsiooniaerosool, suspensioon, 120annust 1TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | 18,00 | |

| | | | | | 50 | | | | | | |

| 1004847 | flutikasoon, 50mcg 1g | D07AC17 | CUTIVATE OINTMENT, salv, 15g 1TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 50 | | | | | | |

| 1037607 | flutikasoon+salmeteroo l, 100mcg 1annust+50mcg 1annust | R03AK82 | SERETIDE DISKUS 100, inhalatsioonipulber, 60annust 1TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1107346 | flutikasoon+salmeteroo l, 125mcg 1annust+25mcg 1annust | R03AK82 | SERETIDE INHALER, inhalatsiooniaerosool, suspensioon, 120annust 1TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1107357 | flutikasoon+salmeteroo l, 250mcg 1annust+25mcg 1annust | R03AK82 | SERETIDE INHALER, inhalatsiooniaerosool, suspensioon, 120annust 1TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 50 | | | | | | |

| | | | | | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | | | |

| 1037595 | flutikasoon+salmeteroo l, 250mcg 1annust+50mcg 1annust | R03AK82 | SERETIDE DISKUS 250, inhalatsioonipulber, 60annust 1TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| 1153167 | flutikasoon+salmeteroo l, 500mcg 1annust+50mcg 1annust | R03AK82 | SERETIDE DISKUS 500, inhalatsioonipulber, 60annust 1TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 50 | | | | | | |

| | | | | | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | | | |

| 1107335 | flutikasoon+salmeteroo l, 50mcg 1annust+25mcg 1annust | R03AK82 | SERETIDE INHALER, inhalatsiooniaerosool, suspensioon, 120annust 1TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 50 | | | | | | |

| | | | | | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1343034 | flutikasoonfuroaat, 27,5mcg 1annust | R01AD12 | AVAMYS, ninasprei, suspensioon, 120annust 1TK | Glaxo Group Limited | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1011126 | fluvastatiin, 80mg | C10AA04 | LESCOL XL, toimeainet prolongeeritult vabastav tablett, 28TK | Novartis Finland OY | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| 1287187 | fluvastatiin, 80mg | C10AA04 | FLUVASTATIN ACTAVIS, toimeainet prolongeeritult vabastav tablett, 28TK | Actavis Group PTC ehf | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1039564 | fluvoksamiin, 100mg | N06AB08 | FEVARIN, õhukese polümeerikattega tablett, 30TK | Abbott Healthcare Products B.V. | 50 | | | | | | |

| 1070570 | fluvoksamiin, 50mg | N06AB08 | FEVARIN, õhukese polümeerikattega tablett, 50TK | Abbott Healthcare Products B.V. | 50 | | | | | | |

| 1115503 | fluvoksamiin, 50mg | N06AB08 | FEVARIN, õhukese polümeerikattega tablett, 20TK | Abbott Healthcare Products B.V. | 50 | | | | | | |

| 1087152 | formoterool, 12mcg | R03AC13 | FORADIL AEROLIZER, inhalatsioonipulber kõvakapslis, 60TK | Novartis Finland OY | 50 | | | | | | |

| 1087152 | formoterool, 12mcg | R03AC13 | FORADIL AEROLIZER, inhalatsioonipulber kõvakapslis, 60TK | Novartis Finland OY | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | | | |

| | | | | | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | | | |

| | | | | | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| 1178939 | formoterool, 12mcg 1annust | R03AC13 | DIFFUMAX EASYHALER, inhalatsioonipulber, 120annust 1TK | Menarini International Operations Luxembourg S.A. | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1034064 | formoterool, 4,5mcg 1annust | R03AC13 | OXIS TURBUHALER, inhalatsioonipulber, 60annust 1TK | AstraZeneca AB | 50 | | | | | | |

| | | | | | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | | | |

| | | | | | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | | |

| 1034075 | formoterool, 9mcg 1annust | R03AC13 | OXIS TURBUHALER, inhalatsioonipulber, 60annust 1TK | AstraZeneca AB | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| 1027145 | fosinopriil, 10mg | C09AA09 | MONOPRIL, tablett, 28TK | Bristol-Myers Squibb Gyogyszerkereskedel mi Kft. | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1314256 | formoterool+beklometa soon, 6mcg+100mcg 1annust | R03AK07 | FOSTER, inhalatsiooniaerosool, lahus, 180annust 1TK | Torrex Chiesi Pharma GmbH | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| 1068443 | formoterool+budesonii d, 4,5mcg+160mcg 1annust | R03AK83 | SYMBICORT TURBUHALER, inhalatsioonipulber, 120annust 1TK | AstraZeneca AB | 50 | | | | | | |

| | | | | | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | | | |

| 1072505 | formoterool+budesonii d, 4,5mcg+80mcg 1annust | R03AK83 | SYMBICORT TURBUHALER, inhalatsioonipulber, 120annust 1TK | AstraZeneca AB | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1156250 | formoterool+budesonii d, 9mcg+320mcg 1annust | R03AK83 | SYMBICORT TURBUHALER, inhalatsioonipulber, 60annust 1TK | AstraZeneca AB | 50 | | | | | | |

| | | | | | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | | |

| 1193767 | fosinopriil, 10mg | C09AA09 | FOSINOPRIL ACTAVIS, tablett, 28TK | Actavis Nordic A/S | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1027145 | fosinopriil, 10mg | C09AA09 | MONOPRIL, tablett, 28TK | Bristol-Myers Squibb Gyogyszerkereskedel mi Kft. | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1193891 | fosinopriil, 20mg | C09AA09 | FOSINOPRIL ACTAVIS, tablett, 28TK | Actavis Nordic A/S | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1027336 | fosinopriil, 20mg | C09AA09 | MONOPRIL, tablett, 28TK | Bristol-Myers Squibb Gyogyszerkereskedel mi Kft. | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1193891 | fosinopriil, 20mg | C09AA09 | FOSINOPRIL ACTAVIS, tablett, 28TK | Actavis Nordic A/S | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1107021 | fosinopriil+hüdrokloroti asiid, 20mg+12,5mg | C09BA09 | MONOZIDE, tablett, 28TK | Bristol-Myers Squibb Gyogyszerkereskedel mi Kft. | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1107021 | fosinopriil+hüdrokloroti asiid, 20mg+12,5mg | C09BA09 | MONOZIDE, tablett, 28TK | Bristol-Myers Squibb Gyogyszerkereskedel mi Kft. | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1250581 | fosinopriil+hüdrokloroti asiid, 20mg+12,5mg | C09BA09 | FOSINOPRIL HCT ACTAVIS, tablett, 30TK | Actavis Group Hf | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1000258 | furosemiid, 40mg | C03CA01 | FUROSEMID NYCOMED 40 mg, tablett, 20TK | Nycomed Sefa AS | 100 | I27.0-I27.0 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | I50-I50 | | | | | |

| 1060399 | furosemiid, 40mg | C03CA01 | FUROSEMID NYCOMED 40 mg, tablett, 100TK | Nycomed Sefa AS | 50 | | | | | | |

| 1161548 | frovatriptaan, 2,5mg | N02CC07 | MIGARD, õhukese polümeerikattega tablett, 2TK | Menarini International Operations Luxembourg S.A. | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1000258 | furosemiid, 40mg | C03CA01 | FUROSEMID NYCOMED 40 mg, tablett, 20TK | Nycomed Sefa AS | 75 | I50-I50 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | I27.0-I27.0 | | | | | |

| 1060399 | furosemiid, 40mg | C03CA01 | FUROSEMID NYCOMED 40 mg, tablett, 100TK | Nycomed Sefa AS | 75 | I50-I50 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | I27.0-I27.0 | | | | | |

| 1039362 | furosemiid, 60mg | C03CA01 | LASIX RETARD, toimeainet prolongeeritult vabastav kõvakapsel, 30TK | Sanofi-Aventis Estonia OÜ | 50 | | | | | | |

| | | | | | 75 | I50-I50 | | | | | |

| | | | | | 100 | I27.0-I27.0 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1039362 | furosemiid, 60mg | C03CA01 | LASIX RETARD, toimeainet prolongeeritult vabastav kõvakapsel, 30TK | Sanofi-Aventis Estonia OÜ | 50 | | | | | | |

| | | | | | 100 | I27.0-I27.0 | | | | | |

| | | | | | 75 | I50-I50 | | | | | |

| 1212758 | fusafungiin, 0,125mg 1annust | R02AB03 | BIOPAROX, nina- /suuõõnesprei, lahus, 10ml 1TK | Les Laboratoires Servier | 50 | | | | | | |

| 1018606 | fusidiinhape, 10mg 1g | S01AA13 | FUCITHALMIC, silmatilgad, suspensioon, 5g 1TK | Leo Pharmaceutical Products | 50 | | | | | | |

| 1007727 | fusidiinhape, 20mg 1g | D06AX01 | FUCIDIN 20 mg/g salv, salv, 15g 1TK | Leo Pharmaceutical Products | 50 | | | | | | |

| 1007750 | fusidiinhape, 20mg 1g | D06AX01 | FUCIDIN 20 mg/g kreem, kreem, 15g 1TK | Leo Pharmaceutical Products | 50 | | | | | | |

| 1018594 | fusidiinhape+hüdrokort isoon, 20mg 1g+10mg 1g | D07CA01 | FUCIDIN H, kreem, 15g 1TK | Leo Pharmaceutical Products | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1032815 | gabapentiin, 300mg | N03AX12 | NEURONTIN, kõvakapsel, 50TK | Pfizer Europe MA EEIG | 50 | | | | | | |

| | | | | | 75 | G63.2-G63.2 | Endokrinoloog, Neuroloog | esmane | | | kui eelistatud ravi tritsüklilise antidepressandiga on vastunäidustatud, põhjustab ravi katkestama sundivaid kõrvaltoimeid või ei ole vähemasti 3-kuulise kasutamise järel andnud piisavat raviefekti, ravimi esmase väljakirjutamise õigus valuravi arstil |

| 1126033 | gabapentiin, 300mg | N03AX12 | GABAGAMMA 300MG, kõvakapsel, 20TK | WÖRWAG PHARMA GmbH & Co. KG | 50 | | | | | | |

| 1126055 | gabapentiin, 300mg | N03AX12 | GABAGAMMA 300MG, kõvakapsel, 50TK | WÖRWAG PHARMA GmbH & Co. KG | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1328857 | gabapentiin, 300mg | N03AX12 | GABAPENTIN ACTAVIS, kõvakapsel, 50TK | Actavis Group PTC ehf | 50 | | | | | | |

| 1125931 | gabapentiin, 400mg | N03AX12 | GABAGAMMA 400MG, kõvakapsel, 20TK | WÖRWAG PHARMA GmbH & Co. KG | 50 | | | | | | |

| 1125953 | gabapentiin, 400mg | N03AX12 | GABAGAMMA 400MG, kõvakapsel, 50TK | WÖRWAG PHARMA GmbH & Co. KG | 50 | | | | | | |

| 1012059 | ganireliks, 0,25mg 0,5ml | H01CC01 | ORGALUTRAN, süstelahus, 0.5ml 1TK | N.V. ORGANON | 50 | | | | | | |

| 1035098 | gestodeen+etünüülöstr adiool, 0,075mg+0,02mg | G03AA10 | LOGEST, kaetud tablett, 21TK | Bayer Schering Pharma AG | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| | | | | | 50 | | | | | | |

| 1115716 | gestodeen+etünüülöstr adiool, 0,075mg+0,02mg | G03AA10 | LINDYNETTE 20, kaetud tablett, 63TK | Gedeon Richter Plc. | 50 | | | | | | |

| | | | | | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| 1023624 | gestodeen+etünüülöstr adiool, 0,075mg+0,03mg | G03AA10 | FEMODEN, kaetud tablett, 21TK | Bayer Schering Pharma AG | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1115693 | gestodeen+etünüülöstr adiool, 0,075mg+0,03mg | G03AA10 | LINDYNETTE 30, kaetud tablett, 63TK | Gedeon Richter Plc. | 50 | | | | | | |

| | | | | | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| 1012149 | gestodeen+etünüülöstr adiool, 60mcg+15mcg | G03AA10 | MIRELLE, õhukese polümeerikattega tablett, 28TK | Bayer Schering Pharma AG | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| | | | | | 50 | | | | | | |

| 1027718 | gestodeen+etünüülöstr adiool, 75mcg+20mcg | G03AA10 | HARMONET, kaetud tablett, 21TK | Pfizer Europe MA EEIG | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| | | | | | 50 | | | | | | |

| 1062953 | gestodeen+etünüülöstr adiool, 75mcg+20mcg | G03AA10 | HARMONET, kaetud tablett, 63TK | Pfizer Europe MA EEIG | 50 | | | | | | |

| | | | | | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| 1364048 | gestodeen+etünüülöstr adiool, 75mcg+20mcg | G03AA10 | GESYTIL 75/20 MIKROGRAMMI, kaetud tablett, 21TK | ratiopharm GmbH | 50 | | | | | | |

| | | | | | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| 1364105 | gestodeen+etünüülöstr adiool, 75mcg+20mcg | G03AA10 | GESYTIL 75/20 MIKROGRAMMI, kaetud tablett, 63TK | ratiopharm GmbH | 50 | | | | | | |

| | | | | | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| 1005309 | gestodeen+etünüülöstr adiool, 75mcg+30mcg | G03AA10 | MINULET, kaetud tablett, 21TK | Pfizer Europe MA EEIG | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| | | | | | 50 | | | | | | |

| 1062986 | gestodeen+etünüülöstr adiool, 75mcg+30mcg | G03AA10 | MINULET, kaetud tablett, 63TK | Pfizer Europe MA EEIG | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| | | | | | 50 | | | | | | |

| 1364127 | gestodeen+etünüülöstr adiool, 75mcg+30mcg | G03AA10 | GESYTIL 75/30 MIKROGRAMMI, kaetud tablett, 21TK | ratiopharm GmbH | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1364138 | gestodeen+etünüülöstr adiool, 75mcg+30mcg | G03AA10 | GESYTIL 75/30 MIKROGRAMMI, kaetud tablett, 63TK | ratiopharm GmbH | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| | | | | | 50 | | | | | | |

| 1061334 | glargiin-insuliin, 100ühik 1ml | A10AE04 | LANTUS, süstelahus kolbampullis, 3ml 5TK | Sanofi-Aventis Deutschland GmbH | 50 | | | | | | |

| | | | | | 100 | O24-O24, E13-E14, E10-E11, P70.2- P70.2, E89.1-E89.1 | | | | | |

| 1265790 | glargiin-insuliin, 100ühik 1ml | A10AE04 | LANTUS SOLOSTAR, süstelahus pen-süstlis, 3ml 5TK | Sanofi-Aventis Deutschland GmbH | 50 | | | | | | |

| | | | | | 100 | O24-O24, E13-E14, E10-E11, P70.2- P70.2, E89.1-E89.1 | | | | | |

| 1241244 | glatirameeratsetaat, 20mg 1ml | L03AX13 | COPAXONE, süstelahus süstlis, 1ml 28TK | Teva Pharmaceuticals Ltd | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1161740 | gliklasiid, 30mg | A10BB09 | DIAPREL MR, toimeainet modifitseeritult vabastav tablett, 60TK | Les Laboratoires Servier | 50 | | | | | | |

| | | | | | 75 | E14-E14, E11-E11 | | | | | |

| 1261066 | gliklasiid, 30mg | A10BB09 | GLICLADA 30 MG, toimeainet modifitseeritult vabastav tablett, 60TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | E14-E14, E11-E11 | | | | | |

| 1029439 | gliklasiid, 80mg | A10BB09 | DIABREZIDE, tablett, 40TK | L.Molteni & C.dei F.lli Alitti Societa di Esercizio S.p.A. | 75 | E14-E14, E11-E11 | | | | | |

| | | | | | 50 | | | | | | |

| 1046405 | gliklasiid, 80mg | A10BB09 | DIAPREL, tablett, 60TK | Les Laboratoires Servier | 75 | E14-E14, E11-E11 | | | | | |

| | | | | | 50 | | | | | | |

| 1046405 | gliklasiid, 80mg | A10BB09 | DIAPREL, tablett, 60TK | Les Laboratoires Servier | 50 | | | | | | |

| | | | | | 75 | E14-E14, E11-E11 | | | | | |

| 1084957 | glimepiriid, 1mg | A10BB12 | AMARYL, tablett, 30TK | Sanofi-Aventis Estonia OÜ | 50 | | | | | | |

| | | | | | 75 | E14-E14, E11-E11 | | | | | |

| 1176948 | glimepiriid, 1mg | A10BB12 | OLTAR 1MG, tablett, 30TK | Berlin-Chemie AG (Menarini Group) | 75 | E14-E14, E11-E11 | | | | | |

| 1176948 | glimepiriid, 1mg | A10BB12 | OLTAR 1MG, tablett, 30TK | Berlin-Chemie AG (Menarini Group) | 50 | | | | | | |

| | | | | | 75 | E14-E14, E11-E11 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1191709 | glimepiriid, 2mg | A10BB12 | MEGLIMID, tablett, 30TK | KRKA d.d., Novo Mesto | 75 | E14-E14, E11-E11 | | | | | |

| | | | | | 50 | | | | | | |

| 1110328 | glimepiriid, 2mg | A10BB12 | AMARYL, tablett, 30TK | Sanofi-Aventis Estonia OÜ | 75 | E14-E14, E11-E11 | | | | | |

| | | | | | 50 | | | | | | |

| 1177039 | glimepiriid, 2mg | A10BB12 | OLTAR 2 MG, tablett, 30TK | Berlin-Chemie AG (Menarini Group) | 75 | E14-E14, E11-E11 | | | | | |

| | | | | | 50 | | | | | | |

| 1191787 | glimepiriid, 3mg | A10BB12 | MEGLIMID, tablett, 30TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | E14-E14, E11-E11 | | | | | |

| 1110339 | glimepiriid, 3mg | A10BB12 | AMARYL, tablett, 30TK | Sanofi-Aventis Estonia OÜ | 50 | | | | | | |

| | | | | | 75 | E14-E14, E11-E11 | | | | | |

| 1177129 | glimepiriid, 3mg | A10BB12 | OLTAR 3 MG, tablett, 30TK | Berlin-Chemie AG (Menarini Group) | 50 | | | | | | |

| | | | | | 75 | E14-E14, E11-E11 | | | | | |

| 1191844 | glimepiriid, 4mg | A10BB12 | MEGLIMID, tablett, 30TK | KRKA d.d., Novo Mesto | 75 | E14-E14, E11-E11 | | | | | |

| | | | | | 50 | | | | | | |

| 1125391 | glimepiriid, 4mg | A10BB12 | AMARYL, tablett, 30TK | Sanofi-Aventis Estonia OÜ | 75 | E14-E14, E11-E11 | | | | | |

| | | | | | 50 | | | | | | |

| 1029338 | glipisiid, 10mg | A10BB07 | GLIBENESE GITS, toimeainet prolongeeritult vabastav tablett, 30TK | Pfizer Europe MA EEIG | 75 | E14-E14, E11-E11 | | | | | |

| | | | | | 50 | | | | | | |

| 1029349 | glipisiid, 5mg | A10BB07 | GLIBENESE GITS, toimeainet prolongeeritult vabastav tablett, 30TK | Pfizer Europe MA EEIG | 50 | | | | | | |

| | | | | | 75 | E14-E14, E11-E11 | | | | | |

| 1201396 | glulisiin-insuliin, 100ühik 1ml | A10AB06 | APIDRA, süstelahus kolbampullis, 3ml 5TK | Sanofi-Aventis Deutschland GmbH | 50 | | | | | | |

| 1029349 | glipisiid, 5mg | A10BB07 | GLIBENESE GITS, toimeainet prolongeeritult vabastav tablett, 30TK | Pfizer Europe MA EEIG | 75 | E14-E14, E11-E11 | | | | | |

| | | | | | 50 | | | | | | |

| 1201396 | glulisiin-insuliin, 100ühik 1ml | A10AB06 | APIDRA, süstelahus kolbampullis, 3ml 5TK | Sanofi-Aventis Deutschland GmbH | 100 | O24-O24, E13-E14, E10-E11, P70.2- P70.2, E89.1-E89.1 | | | | | |

| | | | | | 50 | | | | | | |

| 1294398 | glulisiin-insuliin, 100ühik 1ml | A10AB06 | APIDRA SOLOSTAR, süstelahus pen-süstlis, 3ml 5TK | Sanofi-Aventis Deutschland GmbH | 100 | O24-O24, E13-E14, E10-E11, P70.2- P70.2, E89.1-E89.1 | | | | | |

| | | | | | 50 | | | | | | |

| 1316551 | glulisiin-insuliin, 100ühik 1ml | A10AB06 | APIDRA OPTICLIK, süstelahus kolbampullis, 3ml 5TK | Sanofi-Aventis Deutschland GmbH | 50 | | | | | | |

| | | | | | 100 | O24-O24, E13-E14, E10-E11, P70.2- P70.2, E89.1-E89.1 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1294398 | glulisiin-insuliin, 100ühik 1ml | A10AB06 | APIDRA SOLOSTAR, süstelahus pen-süstlis, 3ml 5TK | Sanofi-Aventis Deutschland GmbH | 50 | | | | | | |

| | | | | | 100 | O24-O24, E13-E14, E10-E11, P70.2- P70.2, E89.1-E89.1 | | | | | |

| 1316551 | glulisiin-insuliin, 100ühik 1ml | A10AB06 | APIDRA OPTICLIK, süstelahus kolbampullis, 3ml 5TK | Sanofi-Aventis Deutschland GmbH | 100 | O24-O24, E13-E14, E10-E11, P70.2- P70.2, E89.1-E89.1 | | | | | |

| | | | | | 50 | | | | | | |

| 1165878 | glükagoon, 1mg | H04AA01 | GLUCAGEN 1MG HYPOKIT, süstelahuse pulber ja lahusti, 1TK | Novo Nordisk A/S | 50 | | | | | | |

| 1326653 | glükoosamiin, 1178mg | M01AX05 | GLUCOSAMIN- RATIOPHARM 1178 MG, suukaudse lahuse pulber, 20TK | ratiopharm GmbH | 50 | | | | | | |

| 1183687 | glükoosamiin, 400mg | M01AX05 | GLUCOSAMINE PHARMA NORD, kõvakapsel, 90TK | PHARMA NORD ApS | 50 | | | | | | |

| 1183698 | glükoosamiin, 400mg | M01AX05 | GLUCOSAMINE PHARMA NORD, kõvakapsel, 270TK | PHARMA NORD ApS | 50 | | | | | | |

| 1137068 | glükoosamiin, 400mg | M01AX05 | GLUCADOL, õhukese polümeerikattega tablett, 60TK | Nycomed Sefa AS | 50 | | | | | | |

| 1183687 | glükoosamiin, 400mg | M01AX05 | GLUCOSAMINE PHARMA NORD, kõvakapsel, 90TK | Pharma Nord ApS | 50 | | | | | | |

| 1183698 | glükoosamiin, 400mg | M01AX05 | GLUCOSAMINE PHARMA NORD, kõvakapsel, 270TK | Pharma Nord ApS | 50 | | | | | | |

| 1220094 | glükoosamiin, 400mg | M01AX05 | GLUCADOL, õhukese polümeerikattega tablett, 180TK | Nycomed Sefa AS | 50 | | | | | | |

| 1002621 | gosereliin, 3,6mg | L02AE03 | ZOLADEX, implantaat, 1TK | AstraZeneca UK Limited | 50 | | | | | | |

| | | | | | 75 | N80-N80 | Günekoloog | | | | III-IV astme endometrioosi põdevatele patsientidele |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1023950 | granisetroon, 1mg | A04AA02 | KYTRIL, õhukese polümeerikattega tablett, 10TK | Roche Eesti OÜ | 50 | | | | | | |

| | | | | | 100 | C00-D48 | | | | | suukaudsest keemiaravist põhjustatud iivelduse ja oksendamise profülaktikaks ja raviks juhul, kui metoklopramiid ei ole esmase valikuna soovitatud või see on osutunud ebaefektiivseks |

| 1014680 | haloperidool, 1,5mg | N05AD01 | HALOPERIDOL-RICHTER, tablett, 50TK | Gedeon Richter Plc. | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| 1014691 | haloperidool, 2mg 1ml | N05AD01 | HALOPERIDOL-RICHTER, suukaudsed tilgad, lahus, 10ml 1TK | Gedeon Richter Plc. | 50 | | | | | | |

| | | | | | 100 | F33.2-F33.3, F18.4- F18.7, F60.3-F60.3, F11.4-F11.7, F13.4- F13.7, F14.4-F14.7, F17.4-F17.7, F16.4- F16.7, F19.4-F19.7, F70-F79, F00-F09, F20-F29, F32.2- F33.2, F15.4-F15.7, F30-F31, F12.4- F12.7, F10.4-F10.7 | Psühhiaater | esmane | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1064674 | haloperidool, 50mg 1ml | N05AD01 | HALOPERIDOL- DECANOATE-RICHTER, süstelahus, 1ml 5TK | Gedeon Richter Plc. | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1014679 | haloperidool, 5mg | N05AD01 | HALOPERIDOL-RICHTER, tablett, 50TK | Gedeon Richter Plc. | 50 | | | | | | |

| 1054055 | hõbesulfadiasiin, 10mg 1g | D06BA01 | SULFARGIN, salv, 50g 1TK | Grindeks | 50 | | | | | | |

| 1015434 | hüdroklorotiasiid, 100mg | C03AA03 | HYPOTHIAZID, tablett, 20TK | Sanofi-Aventis Estonia OÜ | 100 | I27.0-I27.0 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | I15-I15, I10-I13, O10-O16, I50-I50 | | | | | |

| 1015478 | hüdroklorotiasiid, 25mg | C03AA03 | HYPOTHIAZID, tablett, 20TK | Sanofi-Aventis Estonia OÜ | 75 | I15-I15, I10-I13, O10-O16, I50-I50 | | | | | |

| | | | | | 50 | | | | | | |

| 1015478 | hüdroklorotiasiid, 25mg | C03AA03 | HYPOTHIAZID, tablett, 20TK | Sanofi-Aventis Estonia OÜ | 50 | | | | | | |

| | | | | | 75 | I15-I15, I10-I13, O10-O16, I50-I50 | | | | | |

| | | | | | 100 | I27.0-I27.0 | | | | | |

| 1132591 | hüdroklorotiasiid+kand esartaan, 12,5mg+16mg | C09DA06 | ATACAND PLUS, tablett, 28TK | AstraZeneca AB | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1031094 | hüdroklorotiasiid+kvina priil, 12,5mg+10mg | C09BA06 | ACCUZIDE, õhukese polümeerikattega tablett, 30TK | Pfizer Europe MA EEIG | 50 | | | | | | |

| 1030105 | hüdroklorotiasiid+kvina priil, 12,5mg+20mg | C09BA06 | ACCUZIDE 20, õhukese polümeerikattega tablett, 30TK | Pfizer Europe MA EEIG | 50 | | | | | | |

| 1166059 | hüdroklorotiasiid+losart aan, 12,5mg+50mg | C09DA01 | LORISTA H, õhukese polümeerikattega tablett, 28TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15 | | | | | |

| 1217809 | hüdroklorotiasiid+losart aan, 12,5mg+50mg | C09DA01 | LOZAP H, õhukese polümeerikattega tablett, 30TK | Zentiva, k.s. | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15 | | | | | |

| 1190483 | hüdroklorotiasiid+olme sartaanmedoksomiil, 12,5mg+20mg | C09DA08 | MESAR PLUS, õhukese polümeerikattega tablett, 28TK | Menarini International Operations Luxembourg S.A. | 50 | | | | | | |

| 1190562 | hüdroklorotiasiid+olme sartaanmedoksomiil, 25mg+20mg | C09DA08 | MESAR PLUS, õhukese polümeerikattega tablett, 28TK | Menarini International Operations Luxembourg S.A. | 50 | | | | | | |

| 1021936 | hüdroklorotiasiid+rami priil, 12,5mg+2,5mg | C09BA05 | CARDACE COMP, tablett, 28TK | Sanofi-Aventis Estonia OÜ | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1113657 | hüdroklorotiasiid+rami priil, 12,5mg+2,5mg | C09BA05 | CO-RAMICOR 2,5 MG/12,5 MG, tablett, 30TK | HEXAL AG | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1190269 | hüdroklorotiasiid+rami priil, 12,5mg+2,5mg | C09BA05 | AMPRIL HL 2,5MG/12,5MG, tablett, 30TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1113680 | hüdroklorotiasiid+rami priil, 25mg+5mg | C09BA05 | CO-RAMICOR 5 MG/25 MG, tablett, 30TK | HEXAL AG | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1141715 | hüdroklorotiasiid+rami priil, 25mg+5mg | C09BA05 | CARDACE PLUS, tablett, 28TK | Sanofi-Aventis Estonia OÜ | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1190179 | hüdroklorotiasiid+rami priil, 25mg+5mg | C09BA05 | AMPRIL HD 5MG/25MG, tablett, 30TK | KRKA d.d., Novo Mesto | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1114793 | hüdroklorotiasiid+telmi sartaan, 12,5mg+80mg | C09DA07 | MICARDISPLUS, tablett, 28TK | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15 | | | | | |

| 1121465 | hüdroklorotiasiid+telmi sartaan, 12,5mg+80mg | C09DA07 | PRITORPLUS 80/12,5 MG, tablett, 28TK | Bayer Schering Pharma AG | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 50 | | | | | | |

| 1367524 | hüdroklorotiasiid+telmi sartaan, 25mg+80mg | C09DA07 | MICARDISPLUS, tablett, 28TK | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 50 | | | | | | |

| 1368110 | hüdroklorotiasiid+telmi sartaan, 25mg+80mg | C09DA07 | PRITORPLUS 80/25 MG, tablett, 28TK | Bayer Schering Pharma AG | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15 | | | | | |

| 1030172 | hüdroklorotiasiid+triam tereen, 12,5mg+25mg | C03EA80 | TRIAMPUR COMPOSITUM, tablett, 50TK | AWD. pharma GmbH & Co.KG | 50 | | | | | | |

| 1086027 | hüdroklorotiasiid+valsa rtaan, 12,5mg+160mg | C09DA03 | CO-DIOVAN, õhukese polümeerikattega tablett, 28TK | Novartis Finland OY | 50 | | | | | | |

| 1324314 | hüdroklorotiasiid+valsa rtaan, 12,5mg+160mg | C09DA03 | VALSACOMBI, õhukese polümeerikattega tablett, 28TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15 | | | | | |

| 1434518 | hüdroklorotiasiid+valsa rtaan, 12,5mg+160mg | C09DA03 | VALZAP H, õhukese polümeerikattega tablett, 28TK | Zentiva, k.s. | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 50 | | | | | | |

| 1031342 | hüdroklorotiasiid+valsa rtaan, 12,5mg+80mg | C09DA03 | CO-DIOVAN, õhukese polümeerikattega tablett, 28TK | Novartis Finland OY | 50 | | | | | | |

| 1324156 | hüdroklorotiasiid+valsa rtaan, 12,5mg+80mg | C09DA03 | VALSACOMBI, õhukese polümeerikattega tablett, 28TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| 1434530 | hüdroklorotiasiid+valsa rtaan, 12,5mg+80mg | C09DA03 | VALZAP H, õhukese polümeerikattega tablett, 28TK | Zentiva, k.s. | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 50 | | | | | | |

| 1086072 | hüdroklorotiasiid+valsa rtaan, 25mg+160mg | C09DA03 | CO-DIOVAN, õhukese polümeerikattega tablett, 28TK | Novartis Finland OY | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1324235 | hüdroklorotiasiid+valsa rtaan, 25mg+160mg | C09DA03 | VALSACOMBI, õhukese polümeerikattega tablett, 28TK | KRKA d.d., Novo Mesto | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 50 | | | | | | |

| 1030172 | hüdroklorotiasiid+ triamtereen, 12,5mg+25mg | C03EA80 | TRIAMPUR COMPOSITUM, tablett, 50TK | AWD. pharma GmbH & Co.KG | 50 | | | | | | |

| 1008841 | hüdroklorotiasiid+amilo riid, 50mg+5mg | C03EA81 | MODURETIC, tablett, 30TK | Merck Sharp & Dohme OÜ | 50 | | | | | | |

| 1137013 | hüdrokortisoon, 10mg 1g | D07AA02 | HYDROCORTISONE DAK, salv, 30g 1TK | Nycomed Sefa AS | 50 | | | | | | |

| 1035403 | hüdrokortisoon+kloorh eksidiin, 10mg 1g+10mg 1g | D07BA80 | SIBICORT, kreem, 20g 1TK | Orion Corporation | 50 | | | | | | |

| 1045145 | hüdrokortisoon+tsiprofl oksatsiin, 10mg 1ml+2mg 1ml | S02CA82 | CIPROBAY HC, kõrvatilgad, suspensioon, 10ml 1TK | Alcon Cusi S.A. | 50 | | | | | | |

| 1036022 | hüdroksükarbamiid, 500mg | L01XX05 | HYDREA, kõvakapsel, 100TK | Bristol-Myers Squibb Gyogyszerkereskedel mi Kft. | 100 | C00-D48 | Onkoloog, Hematoloog | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1213209 | ibandroonhape, 150mg | M05BA06 | BONVIVA, õhukese polümeerikattega tablett, 1TK | Roche Registration Limited | 75 | M80-M80 | | | | | patsientidele, kelle lülisamba või reieluukaela mineraalne tihedus on -2,5 SD või vähem DEXA meetodil määratuna |

| | | | | | 50 | | | | | | |

| 1018594 | hüdrokortisoon+ fusidiinhape, 10mg+20mg 1g | D07CA83 | FUCIDIN H, kreem, 15g 1TK | Leo Pharmaceutical Products | 50 | | | | | | |

| 1045145 | hüdrokortisoon+ tsiprofloksatsiin, 10mg+2mg 1ml | S02CA82 | CIPROBAY HC, kõrvatilgad, suspensioon, 10ml 1TK | Alcon Cusi S.A. | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1035403 | hüdrokortisoon+kloorh eksidiin, 10mg+10mg 1g | D07BA80 | SIBICORT, kreem, 20g 1TK | Orion Corporation | 50 | | | | | | |

| 1036022 | hüdroksükarbamiid, 500mg | L01XX05 | HYDREA, kõvakapsel, 100TK | Bristol-Myers Squibb Gyogyszerkereskedel mi Kft. | 50 | | | | | | |

| | | | | | 100 | C00-D48 | Onkoloog, Hematoloog | | | | |

| | | | | | 50 | | | | | | |

| 1213209 | ibandroonhape, 150mg | M05BA06 | BONVIVA, õhukese polümeerikattega tablett, 1TK | Roche Registration Limited | 50 | | | | | | |

| | | | | | 75 | M80-M80 | | | | | patsientidele, kelle lülisamba või reieluukaela mineraalne tihedus on -2,5 SD või vähem DEXA meetodil määratuna |

| 1373116 | ibandroonhape, 150mg | M05BA06 | OSSICA, õhukese polümeerikattega tablett, 1TK | Gedeon Richter Plc. | 50 | | | | | | |

| | | | | | 75 | M80-M80 | | | | | patsientidele, kelle lülisamba või reieluukaela mineraalne tihedus on -2,5 SD või vähem DEXA meetodil määratuna |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1073012 | ibuprofeen, 400mg | M01AE01 | IBUMAX, õhukese polümeerikattega tablett, 100TK | VITABALANS OY | 100 | C00-D48 | | | | | |

| | | | | | 50 | | | | | | |

| 1073012 | ibuprofeen, 400mg | M01AE01 | IBUMAX, õhukese polümeerikattega tablett, 100TK | VITABALANS OY | 50 | | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 100 | C00-D48 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1073078 | ibuprofeen, 400mg | M01AE01 | IBUMETIN, õhukese polümeerikattega tablett, 50TK | Nycomed Sefa AS | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 100 | C00-D48 | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 50 | | | | | | |

| 1073089 | ibuprofeen, 400mg | M01AE01 | IBUMETIN, õhukese polümeerikattega tablett, 100TK | Nycomed Sefa AS | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 100 | C00-D48 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| 1032714 | ibuprofeen, 600mg | M01AE01 | IBUPROFEN LANNACHER, õhukese polümeerikattega tablett, 30TK | LANNACHER HEILMITTEL GmbH | 50 | | | | | | |

| | | | | | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| 1073078 | ibuprofeen, 400mg | M01AE01 | IBUMETIN, õhukese polümeerikattega tablett, 50TK | Nycomed Sefa AS | 100 | C00-D48 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | C00-D48 | | | | | |

| 1073102 | ibuprofeen, 600mg | M01AE01 | IBUMETIN, õhukese polümeerikattega tablett, 50TK | Nycomed Sefa AS | 50 | | | | | | |

| | | | | | 100 | C00-D48 | | | | | |

| | | | | | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| 1073113 | ibuprofeen, 600mg | M01AE01 | IBUMETIN, õhukese polümeerikattega tablett, 100TK | Nycomed Sefa AS | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| 1073089 | ibuprofeen, 400mg | M01AE01 | IBUMETIN, õhukese polümeerikattega tablett, 100TK | Nycomed Sefa AS | 50 | | | | | | |

| | | | | | 100 | C00-D48 | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1085194 | ibuprofeen, 600mg | M01AE01 | IBUMAX, õhukese polümeerikattega tablett, 30TK | VITABALANS OY | 100 | C00-D48 | | | | | |

| | | | | | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 50 | | | | | | |

| 1085206 | ibuprofeen, 600mg | M01AE01 | IBUMAX, õhukese polümeerikattega tablett, 100TK | VITABALANS OY | 50 | | | | | | |

| | | | | | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 100 | C00-D48 | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| 1032714 | ibuprofeen, 600mg | M01AE01 | IBUPROFEN LANNACHER, õhukese polümeerikattega tablett, 30TK | LANNACHER HEILMITTEL GmbH | 50 | | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 100 | C00-D48 | | | | | |

| | | | | | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| 1073102 | ibuprofeen, 600mg | M01AE01 | IBUMETIN, õhukese polümeerikattega tablett, 50TK | Nycomed Sefa AS | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 100 | C00-D48 | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1073113 | ibuprofeen, 600mg | M01AE01 | IBUMETIN, õhukese polümeerikattega tablett, 100TK | Nycomed Sefa AS | 50 | | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 100 | C00-D48 | | | | | |

| | | | | | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| 1085194 | ibuprofeen, 600mg | M01AE01 | IBUMAX, õhukese polümeerikattega tablett, 30TK | VITABALANS OY | 100 | C00-D48 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| 1085206 | ibuprofeen, 600mg | M01AE01 | IBUMAX, õhukese polümeerikattega tablett, 100TK | VITABALANS OY | 100 | C00-D48 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| 1291890 | iloprost, 10mcg 1ml | B01AC11 | VENTAVIS, nebuliseeritav lahus, 1ml 30TK | Bayer Schering Pharma AG | 50 | | | | | | |

| | | | | | 100 | I27.0-I27.0 | Pediaater, Kardioloog, Pulmonoloog, Reumatoloog | | | | NYHA III-IV kl idiopaatilise, süsteemse sidekoehaiguse või kaasasündinud südamerikkega seotud pulmonaalse arteriaalse hüpertensiooni raviks patsientidele konsiiliumi (vähemalt 3 vastava eriala spetsialisti) otsuse alusel, kui sildenafiil on vastunäidustatud, osutunud ebaefektiivseks või põhjustanud olulisi kõrvaltoimeid |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1291902 | iloprost, 1Omcg 1ml | B01AC11 | VENTAVIS, nebuliseeritav lahus, 1ml 168TK | Bayer Schering Pharma AG | 50 | | | | | | |

| | | | | | 100 | 127.0-1 27.0 | Pediaater, Reumatoloog, Kardioloog, Pulmonoloog | | | | NYHA III-IV kl idiopaat ilise, susteemse sidek oehaiguse voi kaasasundinud sudamerikkega seotud pulmonaalse arteriaalse hupertensiooni raviks patsient idele kon siiliumi (vahemalt 3 vastava eriala spetsialisti) otsuse alusel, kui sildenafiil on vastunaidustatud, osutunud ebaefektiivseks voi pohjustanud olulisi korvaltoimeid |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

@@ -1511,109 +1392,110 @@

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 7000063 | imikute toitesegu, | | Neocate (aminohapete segu) , pulber, 400 g | N.V. Nutricia | 75 | K52.2-K52.2, L20.8- L20.8, K90.4-K90.4, L27.2-L27.2 | | | | 1,00 | |

| 7002313 | imikute toitesegu, | | MILUPA APTAMIL FMS, pulber, 200 g | N.V. Nutricia | 75 | P05-P05, E42-E42, P07-P07, P27.1- P27.1 | | | | 0,58 | |

| 7002874 | imikute toitesegu, | | FRISO PREMATURE, pulber, 400g | Friesland Foods BV | 75 | P05.0-P05.0, E42- E42, P07.0-P07.0, P27.1-P27.1 | | | | 0,58 | |

| 7002863 | imikute toitesegu, | | FRISO PEP AC, pulber, 400g | Friesland Foods BV | 75 | K52.2-K52.2, L20.8- L20.8, K90.4-K90.4, L27.2-L27.2 | | | | 1,00 | |

| 7000074 | imikute toitesegu, | | APTAMIL ALLERGY CARE (Aptamil Pepti), pulber, 450 g | N.V. Nutricia | 75 | K52.2-K52.2, L20.8- L20.8, K90.4-K90.4, L27.2-L27.2 | | | | 1,00 | |

| 7002650 | imikute toitesegu, | | APTAMIL PREMATIL, pulber, 600g N1 | N.V. Nutricia | 75 | P05-P05, E42-E42, P07-P07, P27.1- P27.1 | | | | 0,58 | |

| 7000085 | imikute toitesegu, | | APTAMIL DIGESTIVE CARE (Aptamil Pepti MCT), pulber, 450 g | N.V. Nutricia | 75 | K52.2-K52.2, L20.8- L20.8, K90.4-K90.4, L27.2-L27.2 | | | | 1,00 | |

| 7000096 | imikute toitesegu, | | Aptamil Soya (Nutrilon Soya) , pulber, 400 g | N.V. Nutricia | 75 | K52.2-K52.2, L20.8- L20.8, K90.4-K90.4, L27.2-L27.2 | | | | 1,00 | |

| 7002313 | imikute toitesegu, | | MILUPA APTAMIL FMS, pulber, 200 g | N.V. Nutricia | 75 | P05-P05, E42-E42, P07-P07, P27.1- P27.1 | | | | 0,58 | |

| 7002650 | imikute toitesegu, | | APTAMIL PREMATIL, pulber, 600g N1 | N.V. Nutricia | 75 | P05-P05, E42-E42, P07-P07, P27.1- P27.1 | | | | 0,58 | |

| 7002863 | imikute toitesegu, | | FRISO PEP AC, pulber, 400g | Friesland Foods BV | 75 | K52.2-K52.2, L20.8- L20.8, K90.4-K90.4, L27.2-L27.2 | | | | 1,00 | |

| 7002874 | imikute toitesegu, | | FRISO PREMATURE, pulber, 400g | Friesland Foods BV | 75 | P05.0-P05.0, E42- E42, P07.0-P07.0, P27.1-P27.1 | | | | 0,58 | |

| 7002885 | imikute toitesegu, | | FRISO PEP, pulber, 400g | Friesland Foods BV | 75 | K52.2-K52.2, L20.8- L20.8, K90.4-K90.4, L27.2-L27.2 | | | | 1,00 | |

| 1060322 | imikvimood, 5% | D06BB10 | ALDARA, kreem, 250mg 12TK | Meda AB | 50 | | | | | | |

| 1167780 | indapamiid, 1,5mg | C03BA11 | TERTENSIF SR, toimeainet prolongeeritult vabastav tablett, 30TK | Les Laboratoires Servier | 75 | I15-I15, I10-I13, O10-O16, I50-I50 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1167780 | indapamiid, 1,5mg | C03BA11 | TERTENSIF SR, toimeainet prolongeeritult vabastav tablett, 30TK | Les Laboratoires Servier | 50 | | | | | | |

| | | | | | 100 | I27.0-I27.0 | | | | | |

| 1185230 | indapamiid, 1,5mg | C03BA11 | RAWEL SR, toimeainet prolongeeritult vabastav tablett, 30TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | I15-I15, I10-I13, O10-O16, I50-I50 | | | | | |

| 1185230 | indapamiid, 1,5mg | C03BA11 | RAWEL SR, toimeainet prolongeeritult vabastav tablett, 30TK | KRKA d.d., Novo Mesto | 100 | I27.0-I27.0 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | I15-I15, I10-I13, O10-O16, I50-I50 | | | | | |

| 1379741 | indapamiid, 1,5mg | C03BA11 | INDAMAX, toimeainet prolongeeritult vabastav tablett, 30TK | Teva Pharma B.V. | 50 | | | | | | |

| | | | | | 75 | I15-I15, I10-I13, O10-O16, I50-I50 | | | | | |

| | | | | | 100 | I27.0-I27.0 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1379741 | indapamiid, 1,5mg | C03BA11 | INDAMAX, toimeainet prolongeeritult vabastav tablett, 30TK | Teva Pharma B.V. | 100 | I27.0-I27.0 | | | | | |

| | | | | | 50 | | | | | | |

| 1038383 | indapamiid, 2,5mg | C03BA11 | PROINDAP, kõvakapsel, 30TK | PRO. MED. CS. PRAHA a.s. | 100 | I27.0-I27.0 | | | | | |

| | | | | | 75 | I15-I15, I10-I13, O10-O16, I50-I50 | | | | | |

| 1019416 | indapamiid, 2,5mg | C03BA11 | TERTENSIF, õhukese polümeerikattega tablett, 30TK | Les Laboratoires Servier | 75 | I15-I15, I10-I13, O10-O16, I50-I50 | | | | | |

| | | | | | 50 | | | | | | |

| 1019416 | indapamiid, 2,5mg | C03BA11 | TERTENSIF, õhukese polümeerikattega tablett, 30TK | Les Laboratoires Servier | 50 | | | | | | |

| | | | | | 100 | I27.0-I27.0 | | | | | |

| 1038383 | indapamiid, 2,5mg | C03BA11 | PROINDAP, kõvakapsel, 30TK | PRO. MED. CS. PRAHA a.s. | 50 | | | | | | |

| | | | | | 75 | I15-I15, I10-I13, O10-O16, I50-I50 | | | | | |

| | | | | | 100 | I27.0-I27.0 | | | | | |

| 1229587 | indapamiid+perindopriil , 0,625mg+2,5mg | C09BA04 | NOLIPREL ARGININE, õhukese polümeerikattega tablett, 30TK | Les Laboratoires Servier | 50 | | | | | | |

| 1042401 | indapamiid+perindopriil , 0,625mg+2mg | C09BA04 | NOLIPREL, tablett, 30TK | Les Laboratoires Servier | 50 | | | | | | |

| 1042412 | indapamiid+perindopriil , 1,25mg+4mg | C09BA04 | NOLIPREL FORTE, tablett, 30TK | Les Laboratoires Servier | 50 | | | | | | |

| 1229879 | indapamiid+perindopriil , 1,25mg+5mg | C09BA04 | NOLIPREL FORTE ARGININE, õhukese polümeerikattega tablett, 30TK | Les Laboratoires Servier | 50 | | | | | | |

| 1001697 | indometatsiin, 10mg 1g | M02AA23 | INDOMET-RATIOPHARM GEL, geel, 50g 1TK | ratiopharm GmbH | 50 | | | | | | |

| 1071841 | indometatsiin, 50mg | M01AB01 | INDOMET- RATIOPHARM 50MG, kõvakapsel, 50TK | ratiopharm GmbH | 50 | | | | | | |

| | | | | | 100 | C00-D48 | | | | | |

| | | | | | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| 1029204 | indometatsiin, 8mg 1ml | M02AA23 | ELMETACIN SPRAY, nahasprei, lahus, 50ml 1TK | UAB ''STADA- Nizhpharm-Baltija'' | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1105940 | ipratroopiumbromiid, 0,02mg 1annust | R03BB01 | ATROVENT N, inhalatsiooniaerosool, lahus, 200annust 1TK | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | 50 | | | | | | |

| 1105940 | ipratroopiumbromiid, 0,02mg 1annust | R03BB01 | ATROVENT N, inhalatsiooniaerosool, lahus, 200annust 1TK | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | | | |

| 1057711 | ipratroopiumbromiid, 0,25mg 1ml | R03BB01 | ATROVENT, nebuliseeritav lahus, 20ml 1TK | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1060467 | irbesartaan, 150mg | C09CA04 | APROVEL, tablett, 28TK | Sanofi Pharma Bristol- Myers Squibb SNC | 50 | | | | | | |

| 1060490 | irbesartaan, 300mg | C09CA04 | APROVEL, tablett, 28TK | Sanofi Pharma Bristol- Myers Squibb SNC | 50 | | | | | | |

| 1000348 | isokonasool, 10mg 1g | D01AC05 | TRAVOGEN, kreem, 20g 1TK | Intendis GmbH | 50 | | | | | | |

| 1015074 | isosorbiitdinitraat, 20mg | C01DA08 | ISDN-RATIOPHARM 20 MG, toimeainet prolongeeritult vabastav kõvakapsel, 50TK | ratiopharm GmbH | 50 | | | | | | |

| 1000416 | isokonasool+ diflukortoloon, 10mg+1mg 1g | D01AC80 | TRAVOCORT, kreem, 15g 1TK | Intendis GmbH | 50 | | | | | | |

| 1037371 | isosorbiitdinitraat, 20mg | C01DA08 | ISOKET 20, toimeainet prolongeeritult vabastav tablett, 50TK | SCHWARZ PHARMA AG | 50 | | | | | | |

| | | | | | 75 | I20-I20 | | | | | |

| 1037371 | isosorbiitdinitraat, 20mg | C01DA08 | ISOKET 20, toimeainet prolongeeritult vabastav tablett, 50TK | SCHWARZ PHARMA AG | 75 | I20-I20 | | | | | |

| 1015074 | isosorbiitdinitraat, 20mg | C01DA08 | ISDN-RATIOPHARM 20 MG, toimeainet prolongeeritult vabastav kõvakapsel, 50TK | ratiopharm GmbH | 75 | I20-I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1037382 | isosorbiitdinitraat, 40mg | C01DA08 | ISOKET 40, toimeainet prolongeeritult vabastav tablett, 50TK | SCHWARZ PHARMA AG | 75 | I20-I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1008964 | isosorbiitdinitraat, 40mg | C01DA08 | ISDN-RATIOPHARM 40 MG, toimeainet prolongeeritult vabastav kõvakapsel, 50TK | ratiopharm GmbH | 50 | | | | | | |

| | | | | | 75 | I20-I20 | | | | | |

| 1037382 | isosorbiitdinitraat, 40mg | C01DA08 | ISOKET 40, toimeainet prolongeeritult vabastav tablett, 50TK | SCHWARZ PHARMA AG | 75 | I20-I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1005028 | isosorbiitdinitraat, 5mg | C01DA08 | ISDN-RATIOPHARM 5 MG, tablett, 50TK | ratiopharm GmbH | 75 | I20-I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1005028 | isosorbiitdinitraat, 5mg | C01DA08 | ISDN-RATIOPHARM 5 MG, tablett, 50TK | ratiopharm GmbH | 50 | | | | | | |

| | | | | | 75 | I20-I20 | | | | | |

| 1003712 | isosorbiitmononitraat, 100mg | C01DA14 | MONO MACK DEPOT, toimeainet prolongeeritult vabastav tablett, 20TK | Pfizer Europe MA EEIG | 75 | I20-I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1006197 | isosorbiitmononitraat, 20mg | C01DA14 | MONO MACK 20 MG, tablett, 50TK | Pfizer Europe MA EEIG | 50 | | | | | | |

| 1037416 | isosorbiitmononitraat, 20mg | C01DA14 | ELANTAN, tablett, 50TK | UCB Pharma GmbH | 75 | I20-I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1006197 | isosorbiitmononitraat, 20mg | C01DA14 | MONO MACK 20 MG, tablett, 50TK | Pfizer Europe MA EEIG | 75 | I20-I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1043547 | isosorbiitmononitraat, 20mg | C01DA14 | MONOSAN 20 MG, tablett, 30TK | PRO. MED. CS. PRAHA a.s. | 50 | | | | | | |

| | | | | | 75 | I20-I20 | | | | | |

| 1037416 | isosorbiitmononitraat, 20mg | C01DA14 | ELANTAN, tablett, 50TK | UCB Pharma GmbH | 75 | I20-I20 | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1043547 | isosorbiitmononitraat, 20mg | C01DA14 | MONOSAN 20 MG, tablett, 30TK | PRO. MED. CS. PRAHA a.s. | 75 | I20-I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1146361 | isosorbiitmononitraat, 20mg | C01DA14 | ISOSORBIDE MONONITRATE VITABALANS, tablett, 30TK | VITABALANS OY | 75 | I20-I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1146372 | isosorbiitmononitraat, 20mg | C01DA14 | ISOSORBIDE MONONITRATE VITABALANS, tablett, 100TK | VITABALANS OY | 75 | I20-I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1006221 | isosorbiitmononitraat, 40mg | C01DA14 | MONO MACK 40 MG, tablett, 50TK | Pfizer Europe MA EEIG | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1146361 | isosorbiitmononitraat, 20mg | C01DA14 | ISOSORBIDE MONONITRATE VITABALANS, tablett, 30TK | VITABALANS OY | 50 | | | | | | |

| | | | | | 75 | I20-I20 | | | | | |

| 1146372 | isosorbiitmononitraat, 20mg | C01DA14 | ISOSORBIDE MONONITRATE VITABALANS, tablett, 100TK | VITABALANS OY | 50 | | | | | | |

| | | | | | 75 | I20-I20 | | | | | |

| 1037405 | isosorbiitmononitraat, 40mg | C01DA14 | ELANTAN, tablett, 50TK | UCB Pharma GmbH | 50 | | | | | | |

| | | | | | 75 | I20-I20 | | | | | |

| 1006221 | isosorbiitmononitraat, 40mg | C01DA14 | MONO MACK 40 MG, tablett, 50TK | Pfizer Europe MA EEIG | 75 | I20-I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1017010 | isosorbiitmononitraat, 40mg | C01DA14 | MONOSAN 40 MG, tablett, 30TK | PRO. MED. CS. PRAHA a.s. | 75 | I20-I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1037405 | isosorbiitmononitraat, 40mg | C01DA14 | ELANTAN, tablett, 50TK | UCB Pharma GmbH | 75 | I20-I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1101913 | isosorbiitmononitraat, 40mg | C01DA14 | OLICARD 40 MG, toimeainet prolongeeritult vabastav kõvakapsel, 50TK | Abbott Products GmbH | 50 | | | | | | |

| | | | | | 75 | I20-I20 | | | | | |

| 1127573 | isosorbiitmononitraat, 40mg | C01DA14 | ISOMONIT 40 MG, tablett, 100TK | HEXAL AG | 50 | | | | | | |

| | | | | | 75 | I20-I20 | | | | | |

| 1037427 | isosorbiitmononitraat, 50mg | C01DA14 | ELANTAN LONG, toimeainet modifitseeritult vabastav kõvakapsel, 20TK | UCB Pharma GmbH | 75 | I20-I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1037427 | isosorbiitmononitraat, 50mg | C01DA14 | ELANTAN LONG, toimeainet modifitseeritult vabastav kõvakapsel, 20TK | UCB Pharma GmbH | 50 | | | | | | |

| | | | | | 75 | I20-I20 | | | | | |

| 1046786 | isosorbiitmononitraat, 60mg | C01DA14 | IMDUR, toimeainet prolongeeritult vabastav tablett, 30TK | AstraZeneca AB | 75 | I20-I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1101924 | isosorbiitmononitraat, 60mg | C01DA14 | OLICARD 60 MG, toimeainet prolongeeritult vabastav kõvakapsel, 50TK | Abbott Products GmbH | 50 | | | | | | |

| 1101924 | isosorbiitmononitraat, 60mg | C01DA14 | OLICARD 60 MG, toimeainet prolongeeritult vabastav kõvakapsel, 50TK | Abbott Products GmbH | 75 | I20-I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1127584 | isosorbiitmononitraat, 60mg | C01DA14 | ISOMONIT 60 MG, toimeainet modifitseeritult vabastav tablett, 30TK | HEXAL AG | 75 | I20-I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1252741 | isosorbiitmononitraat, 60mg | C01DA14 | ISOMONIT 60 MG, toimeainet modifitseeritult vabastav tablett, 60TK | HEXAL AG | 50 | | | | | | |

| | | | | | 75 | I20-I20 | | | | | |

| 1127584 | isosorbiitmononitraat, 60mg | C01DA14 | ISOMONIT 60 MG, toimeainet modifitseeritult vabastav tablett, 30TK | HEXAL AG | 75 | I20-I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1252741 | isosorbiitmononitraat, 60mg | C01DA14 | ISOMONIT 60 MG, toimeainet modifitseeritult vabastav tablett, 60TK | HEXAL AG | 75 | I20-I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1004364 | isotretinoiin, 10mg | D10BA01 | ROACCUTANE 10 MG, pehmekapsel, 30TK | Roche Eesti OÜ | 75 | L70.1-L70.2 | Dermatoveneroloog | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1112230 | isotretinoiin, 20mg | D10BA01 | ROACCUTANE 20 MG, pehmekapsel, 30TK | Roche Eesti OÜ | 50 | | | | | | |

| | | | | | 75 | L70.1-L70.2 | Dermatoveneroloog | | | | |

| | | | | | 50 | | | | | | |

| 1112230 | isotretinoiin, 20mg | D10BA01 | ROACCUTANE 20 MG, pehmekapsel, 30TK | Roche Eesti OÜ | 75 | L70.1-L70.2 | Dermatoveneroloog | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1071548 | itrakonasool, 100mg | J02AC02 | ORUNGAL, kõvakapsel, 28TK | Johnson & Johnson UAB | 50 | | | | | | |

| 1164035 | itrakonasool, 100mg | J02AC02 | PROKANAZOL, kõvakapsel, 4TK | PRO. MED. CS. PRAHA a.s. | 50 | | | | | | |

| 1164057 | itrakonasool, 100mg | J02AC02 | PROKANAZOL, kõvakapsel, 28TK | PRO. MED. CS. PRAHA a.s. | 50 | | | | | | |

@@ -1621,54 +1503,57 @@

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1230488 | itrakonasool, 100mg | J02AC02 | ITRACONAZOL ACTAVIS, kõvakapsel, 28TK | Actavis Group Hf | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1219553 | ivabradiin, 5mg | C01EB17 | PROCORALAN, õhukese polümeerikattega tablett, 56TK | Les Laboratoires Servier | 50 | | | | | | |

| 1219485 | ivabradiin, 7,5mg | C01EB17 | PROCORALAN, õhukese polümeerikattega tablett, 56TK | Les Laboratoires Servier | 50 | | | | | | |

| 1037090 | kaaliumkloriid+makrog ool+naatriumkloriid+na atriumsulfaat, veevaba+naatriumvesi nikkarbonaat, 0,745g+59g+1,46g+5, 675g+1,68g | A06AD81 | COLOLYT, suukaudse lahuse graanulid, 68.565g 3TK | Spirig Baltikum Lithuanian-Swiss Ltd. | 50 | | | | | | |

| 1035346 | kaaliumkloriid+makrog ool+naatriumkloriid+na atriumsulfaat, veevaba+naatriumvesi nikkarbonaat, 0,75g+64g+1,46g+5,7 g+1,68g | A06AD81 | FORTRANS, suukaudse lahuse pulber, 4TK | Ipsen Pharma | 50 | | | | | | |

| 1018549 | kaltsipotriool, 50mcg 1g | D05AX02 | DAIVONEX, kreem, 30g 1TK | Leo Pharmaceutical Products | 75 | L40-L40 | Dermatoveneroloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| 1018550 | kaltsipotriool, 50mcg 1ml | D05AX02 | DAIVONEX, nahalahus, 60ml 1TK | Leo Pharmaceutical Products | 50 | | | | | | |

| 1018549 | kaltsipotriool, 50mcg 1g | D05AX02 | DAIVONEX, kreem, 30g 1TK | Leo Pharmaceutical Products | 50 | | | | | | |

| | | | | | 75 | L40-L40 | Pediaater, Dermatoveneroloog | esmane | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| 1392016 | kaltsium+kolekaltsifero ol, 500mg+400TÜ | A12AX80 | CALCIGRAN FORTE, närimistablett, 120TK | Nycomed Sefa AS | 100 | N18-N18 | | | | | |

| | | | | | 75 | M80-M80 | | | | | kombinatsioonis bifosfonaadiga patsientidele, kelle lülisamba või reieluukaela mineraalne tihedus on -2,5 SD või vähem DEXA meetodil määratuna |

| 1044481 | kaltsiumatsetaat, 250mg | A12AA12 | PHOS-EX 250 MG, tablett, 180TK | Medans OY | 50 | | | | | | |

| 1018550 | kaltsipotriool, 50mcg 1ml | D05AX02 | DAIVONEX, nahalahus, 60ml 1TK | Leo Pharmaceutical Products | 75 | L40-L40 | Pediaater, Dermatoveneroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1093340 | kaltsipotriool+beetamet asoon, 50mcg+0,5mg 1g | D05AX80 | DAIVOBET, salv, 30g 1TK | Leo Pharmaceutical Products | 50 | | | | | | |

| | | | | | 75 | L40-L40 | Dermatoveneroloog, Pediaater | esmane | | | |

| 1408036 | kaltsipotriool+beetamet asoon, 50mcg+0,5mg 1g | D05AX80 | XAMIOL, geel, 30g 1TK | LEO Pharmaceutical Products Ltd. A/S | 75 | L40-L40 | Pediaater, Dermatoveneroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1004599 | kaltsitriool, 0,25mcg | A11CC04 | ROCALTROL, pehmekapsel, 30TK | Roche Eesti OÜ | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1392016 | kaltsium+kolekaltsifero ol, 500mg+400TÜ | A12AX80 | CALCIGRAN FORTE, närimistablett, 120TK | Nycomed Sefa AS | 75 | M80-M80 | | | | | kombinatsioonis bifosfonaadiga patsientidele, kelle lülisamba või reieluukaela mineraalne tihedus on -2,5 SD või vähem DEXA meetodil määratuna |

| | | | | | 100 | N18-N18 | | | | | |

| 1044481 | kaltsiumatsetaat, 250mg | A12AA12 | PHOS-EX 250 MG, tablett, 180TK | Medans OY | 100 | N18-N18 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | N18-N18 | | | | | |

| 1129519 | kaltsiumnadropariin, 2850RÜ anti Xa 0,3ml | B01AB06 | FRAXIPARINE, süstelahus süstlis, 0.3ml 10TK | Glaxo Group Ltd | 75 | O99.8-O99.8 | | | | | |

| 1046337 | kaltsiumkarbonaat, 1250mg | A12AA04 | CALCIGRAN SINE, närimistablett, 100TK | Nycomed Sefa AS | 100 | N18-N18 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | O99.8-O99.8 | | | | | |

| | | | | | 50 | | | | | | |

| 1065664 | kaltsiumnadropariin, 3800RÜ anti Xa 0,4ml | B01AB06 | FRAXIPARINE, süstelahus süstlis, 0.4ml 10TK | Glaxo Group Ltd | 75 | O99.8-O99.8 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | O99.8-O99.8 | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| | | | | | 100 | O99.8-O99.8 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1124110 | kaltsiumnadropariin, 5700RÜ anti Xa 0,6ml | B01AB06 | FRAXIPARINE, süstelahus süstlis, 0.6ml 10TK | Glaxo Group Ltd | 50 | | | | | | |

| | | | | | 75 | O99.8-O99.8 | | | | | |

| 1129496 | kaltsiumnadropariin, 7600RÜ anti Xa 0,8ml | B01AB06 | FRAXIPARINE, süstelahus süstlis, 0.8ml 10TK | Glaxo Group Ltd | 75 | O99.8-O99.8 | | | | | |

| | | | | | 50 | | | | | | |

| 1065686 | kaltsiumnadropariin, 9500RÜ anti Xa 1ml | B01AB06 | FRAXIPARINE, süstelahus süstlis, 1ml 10TK | Glaxo Group Ltd | 50 | | | | | | |

| | | | | | 75 | O99.8-O99.8 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | O99.8-O99.8 | | | | | |

| 1035908 | kandesartaan, 16mg | C09CA06 | ATACAND, tablett, 28TK | AstraZeneca AB | 50 | | | | | | |

| 1183867 | kandesartaan, 32mg | C09CA06 | ATACAND, tablett, 28TK | AstraZeneca AB | 50 | | | | | | |

| 1035919 | kandesartaan, 8mg | C09CA06 | ATACAND, tablett, 28TK | AstraZeneca AB | 50 | | | | | | |

| 1013319 | kapetsitabiin, 150mg | L01BC06 | XELODA, õhukese polümeerikattega tablett, 60TK | Roche Registration Limited | 100 | C18-C20 | Onkoloog | | | | kolorektaalvähi adjuvantseks ja palliatiivseks monokemoteraapiaks |

| | | | | | 50 | | | | | | |

| 1013308 | kapetsitabiin, 500mg | L01BC06 | XELODA, õhukese polümeerikattega tablett, 120TK | Roche Registration Limited | 100 | C18-C20 | Onkoloog | | | | kolorektaalvähi adjuvantseks ja palliatiivseks monokemoteraapiaks |

| | | | | | 50 | | | | | | |

| 1132591 | kandesartaan+hüdrokl orotiasiid, 16mg+12,5mg | C09DA06 | ATACAND PLUS, tablett, 28TK | AstraZeneca AB | 50 | | | | | | |

| 1013319 | kapetsitabiin, 150mg | L01BC06 | XELODA, õhukese polümeerikattega tablett, 60TK | Roche Registration Limited | 50 | | | | | | |

| | | | | | 100 | C18-C20 | Onkoloog | | | | kolorektaalvähi adjuvantseks ja palliatiivseks monokemoteraapiaks |

| 1013308 | kapetsitabiin, 500mg | L01BC06 | XELODA, õhukese polümeerikattega tablett, 120TK | Roche Registration Limited | 50 | | | | | | |

| | | | | | 100 | C18-C20 | Onkoloog | | | | kolorektaalvähi adjuvantseks ja palliatiivseks monokemoteraapiaks |

| 1023073 | kaptopriil, 25mg | C09AA01 | KAPTOPRIL KRKA, tablett, 20TK | KRKA d.d., Novo Mesto | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

@@ -1676,341 +1561,339 @@

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1023084 | kaptopriil, 50mg | C09AA01 | KAPTOPRIL KRKA, tablett, 20TK | KRKA d.d., Novo Mesto | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1077117 | karbamasepiin, 150mg | N03AF01 | TIMONIL 150 RETARD, toimeainet prolongeeritult vabastav tablett, 100TK | Desitin Arzneimittel GmbH | 75 | G50.0-G50.0 | | | | | |

| | | | | | 50 | | | | | | |

| 1077117 | karbamasepiin, 150mg | N03AF01 | TIMONIL 150 RETARD, toimeainet prolongeeritult vabastav tablett, 100TK | Desitin Arzneimittel GmbH | 50 | | | | | | |

| | | | | | 100 | G40-G40 | Neuroloog | esmane | | | |

| 1008009 | karbamasepiin, 200mg | N03AF01 | TEGRETOL CR, toimeainet prolongeeritult vabastav tablett, 50TK | Novartis Finland OY | 50 | | | | | | |

| | | | | | 75 | G50.0-G50.0 | | | | | |

| 1042311 | karbamasepiin, 200mg | N03AF01 | CARBALEX 200 MG, tablett, 50TK | G.L. Pharma GmbH | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 75 | G50.0-G50.0 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | F18.4-F18.4, F14.4- F14.4, F33.2-F33.3, F00-F09, F32.2- F32.3, F10.4-F10.4, F19.4-F19.4, F11.4- F11.4, F30-F31, F70-F79, F20-F29, F60.3-F60.3, F17.4- F17.4, F13.4-F13.4, F15.4-F15.4, F12.4- F12.4, F16.4-F16.4 | Psühhiaater | esmane | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1008009 | karbamasepiin, 200mg | N03AF01 | TEGRETOL CR, toimeainet prolongeeritult vabastav tablett, 50TK | Novartis Finland OY | 75 | G50.0-G50.0 | | | | | |

| | | | | | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1008649 | karbamasepiin, 200mg | N03AF01 | CARBAMAZEPINE NYCOMED, tablett, 50TK | Nycomed Sefa AS | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | G50.0-G50.0 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1035942 | karbamasepiin, 200mg | N03AF01 | FINLEPSIN, toimeainet modifitseeritult vabastav tablett, 50TK | AWD. pharma GmbH & Co.KG | 50 | | | | | | |

| | | | | | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 75 | G50.0-G50.0 | | | | | |

| 1036055 | karbamasepiin, 200mg | N03AF01 | FINLEPSIN, tablett, 50TK | AWD. pharma GmbH & Co.KG | 75 | G50.0-G50.0 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | G40-G40 | Neuroloog | esmane | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1115592 | karbamasepiin, 300mg | N03AF01 | CARBALEX RETARD 300 MG, toimeainet prolongeeritult vabastav tablett, 50TK | G.L. Pharma GmbH | 75 | G50.0-G50.0 | | | | | |

| | | | | | 100 | F18.4-F18.7, F33.2- F33.3, F70-F79, F00-F09, F15.4- F15.7, F14.4-F14.7, F12.4-F12.7, F30- F31, F11.4-F11.7, F60.3-F60.3, F10.4- F10.7, F16.4-F16.7, F32.2-F32.3, F13.4- F13.7, F20-F29, F19.4-F19.7 | Psühhiaater | esmane | | | |

| | | | | | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 75 | G50.0-G50.0 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1042322 | karbamasepiin, 400mg | N03AF01 | CARBALEX 400 MG, tablett, 50TK | G.L. Pharma GmbH | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 75 | G50.0-G50.0 | | | | | |

| | | | | | 50 | | | | | | |

| 1009358 | karbamasepiin, 400mg | N03AF01 | TEGRETOL CR, toimeainet prolongeeritult vabastav tablett, 30TK | Novartis Finland OY | 75 | G50.0-G50.0 | | | | | |

| | | | | | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 75 | G50.0-G50.0 | | | | | |

| | | | | | 50 | | | | | | |

| 1042333 | karbamasepiin, 600mg | N03AF01 | CARBALEX RETARD 600 MG, toimeainet prolongeeritult vabastav tablett, 50TK | G.L. Pharma GmbH | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 75 | G50.0-G50.0 | | | | | |

| | | | | | 100 | G40-G40 | Neuroloog | esmane | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1008649 | karbamasepiin, 200mg | N03AF01 | CARBAMAZEPINE NYCOMED, tablett, 50TK | Nycomed Sefa AS | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 75 | G50.0-G50.0 | | | | | |

| | | | | | 50 | | | | | | |

| 1035942 | karbamasepiin, 200mg | N03AF01 | FINLEPSIN, toimeainet modifitseeritult vabastav tablett, 50TK | AWD. pharma GmbH & Co.KG | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 75 | G50.0-G50.0 | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| | | | | | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 75 | G50.0-G50.0 | | | | | |

| | | | | | 50 | | | | | | |

| 1042311 | karbamasepiin, 200mg | N03AF01 | CARBALEX 200 MG, tablett, 50TK | GEROT PHARMAZEUTIKA Ges.m.b.H. | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 75 | G50.0-G50.0 | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| | | | | | 75 | G50.0-G50.0 | | | | | |

| | | | | | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 75 | G50.0-G50.0 | | | | | |

| | | | | | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1009358 | karbamasepiin, 400mg | N03AF01 | TEGRETOL CR, toimeainet prolongeeritult vabastav tablett, 30TK | Novartis Finland OY | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | G50.0-G50.0 | | | | | |

| 1035953 | karbamasepiin, 400mg | N03AF01 | FINLEPSIN, toimeainet modifitseeritult vabastav tablett, 50TK | AWD. pharma GmbH & Co.KG | 75 | G50.0-G50.0 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | G40-G40 | Neuroloog | esmane | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1042322 | karbamasepiin, 400mg | N03AF01 | CARBALEX 400 MG, tablett, 50TK | GEROT PHARMAZEUTIKA Ges.m.b.H. | 75 | G50.0-G50.0 | | | | | |

| | | | | | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1007716 | karbamasepiin, 600mg | N03AF01 | TIMONIL 600 RETARD, toimeainet prolongeeritult vabastav tablett, 50TK | Desitin Arzneimittel GmbH | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | G50.0-G50.0 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1042333 | karbamasepiin, 600mg | N03AF01 | CARBALEX RETARD 600 MG, toimeainet prolongeeritult vabastav tablett, 50TK | GEROT PHARMAZEUTIKA Ges.m.b.H. | 50 | | | | | | |

| | | | | | 75 | G50.0-G50.0 | | | | | |

| | | | | | 100 | G40-G40 | Neuroloog | esmane | | | |

| 1082517 | karbidopa+levodopa, 25mg+100mg | N04BA81 | SINEMET 25/100, tablett, 30TK | Merck Sharp & Dohme OÜ | 50 | | | | | | |

| | | | | | 100 | G20-G20 | Neuroloog | esmane | | | |

| 1006861 | karbidopa+levodopa, 25mg+250mg | N04BA81 | SINEMET 25/250, tablett, 100TK | Merck Sharp & Dohme OÜ | 100 | G20-G20 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1006894 | karbidopa+levodopa, 50mg+200mg | N04BA81 | SINEMET CR 50/200 MG, toimeainet prolongeeritult vabastav tablett, 100TK | Merck Sharp & Dohme OÜ | 100 | G20-G20 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1110564 | karvedilool, 12,5mg | C07AG02 | CARVEDILOLHEXAL 12,5 MG, tablett, 30TK | HEXAL AG | 50 | | | | | | |

| 1175846 | karvedilool, 12,5mg | C07AG02 | CARVETREND 12,50 MG, tablett, 30TK | Teva Pharma B.V. | 75 | I50-I50 | Kardioloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| 1110564 | karvedilool, 12,5mg | C07AG02 | CARVEDILOLHEXAL 12,5 MG, tablett, 30TK | HEXAL AG | 75 | I50-I50 | Kardioloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| 1157543 | karvedilool, 12,5mg | C07AG02 | CORYOL 12,5, tablett, 30TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | I50-I50 | Pediaater, Kardioloog | esmane | | | |

| 1167016 | karvedilool, 12,5mg | C07AG02 | CARVEDILOL GENERICON 12,5 MG, õhukese polümeerikattega tablett, 30TK | Genericon Pharma GmbH | 75 | I50-I50 | Pediaater, Kardioloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1318733 | karvedilool, 12,5mg | C07AG02 | AVEDOL, õhukese polümeerikattega tablett, 30TK | Pharmaceutical Works Polpharma S.A. | 50 | | | | | | |

| | | | | | 75 | I50-I50 | Kardioloog, Pediaater | esmane | | | |

| 1157543 | karvedilool, 12,5mg | C07AG02 | CORYOL 12,5, tablett, 30TK | KRKA d.d., Novo Mesto | 75 | I50-I50 | Pediaater, Kardioloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1167016 | karvedilool, 12,5mg | C07AG02 | CARVEDILOL GENERICON 12,5 MG, õhukese polümeerikattega tablett, 30TK | Genericon Pharma GmbH | 50 | | | | | | |

| 1175880 | karvedilool, 25mg | C07AG02 | CARVETREND 25 MG, tablett, 30TK | Teva Pharma B.V. | 50 | | | | | | |

| | | | | | 75 | I50-I50 | Kardioloog, Pediaater | esmane | | | |

| 1029158 | karvedilool, 25mg | C07AG02 | DILATREND, tablett, 30TK | Roche Eesti OÜ | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1110520 | karvedilool, 25mg | C07AG02 | CARVEDILOLHEXAL 25 MG, tablett, 30TK | HEXAL AG | 50 | | | | | | |

| | | | | | 75 | I50-I50 | Kardioloog, Pediaater | esmane | | | |

| 1157644 | karvedilool, 25mg | C07AG02 | CORYOL 25, tablett, 30TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | I50-I50 | Kardioloog, Pediaater | esmane | | | |

| 1167094 | karvedilool, 25mg | C07AG02 | CARVEDILOL GENERICON 25 MG, õhukese polümeerikattega tablett, 30TK | Genericon Pharma GmbH | 50 | | | | | | |

| | | | | | 75 | I50-I50 | Pediaater, Kardioloog | esmane | | | |

| 1175846 | karvedilool, 12,5mg | C07AG02 | CARVETREND 12,50 MG, tablett, 30TK | Teva Pharma B.V. | 75 | I50-I50 | Kardioloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1318733 | karvedilool, 12,5mg | C07AG02 | AVEDOL, õhukese polümeerikattega tablett, 30TK | Pharmaceutical Works Polpharma S.A. | 75 | I50-I50 | Pediaater, Kardioloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1029158 | karvedilool, 25mg | C07AG02 | DILATREND, tablett, 30TK | Roche Eesti OÜ | 50 | | | | | | |

| 1110520 | karvedilool, 25mg | C07AG02 | CARVEDILOLHEXAL 25 MG, tablett, 30TK | HEXAL AG | 50 | | | | | | |

| | | | | | 75 | I50-I50 | Pediaater, Kardioloog | esmane | | | |

| 1157644 | karvedilool, 25mg | C07AG02 | CORYOL 25, tablett, 30TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | I50-I50 | Pediaater, Kardioloog | esmane | | | |

| 1167094 | karvedilool, 25mg | C07AG02 | CARVEDILOL GENERICON 25 MG, õhukese polümeerikattega tablett, 30TK | Genericon Pharma GmbH | 75 | I50-I50 | Pediaater, Kardioloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1175880 | karvedilool, 25mg | C07AG02 | CARVETREND 25 MG, tablett, 30TK | Teva Pharma B.V. | 50 | | | | | | |

| | | | | | 75 | I50-I50 | Pediaater, Kardioloog | esmane | | | |

| 1318755 | karvedilool, 25mg | C07AG02 | AVEDOL, õhukese polümeerikattega tablett, 30TK | Pharmaceutical Works Polpharma S.A. | 50 | | | | | | |

| | | | | | 75 | I50-I50 | Pediaater, Kardioloog | esmane | | | |

| 1318755 | karvedilool, 25mg | C07AG02 | AVEDOL, õhukese polümeerikattega tablett, 30TK | Pharmaceutical Works Polpharma S.A. | 75 | I50-I50 | Kardioloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| 1029170 | karvedilool, 6,25mg | C07AG02 | DILATREND, tablett, 30TK | Roche Eesti OÜ | 50 | | | | | | |

| 1110609 | karvedilool, 6,25mg | C07AG02 | CARVEDILOLHEXAL 6,25 MG, tablett, 30TK | HEXAL AG | 75 | I50-I50 | Kardioloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| 1157442 | karvedilool, 6,25mg | C07AG02 | CORYOL 6,25, tablett, 30TK | KRKA d.d., Novo Mesto | 75 | I50-I50 | Pediaater, Kardioloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1175790 | karvedilool, 6,25mg | C07AG02 | CARVETREND 6,25 MG, tablett, 30TK | Teva Pharma B.V. | 75 | I50-I50 | Pediaater, Kardioloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1110609 | karvedilool, 6,25mg | C07AG02 | CARVEDILOLHEXAL 6,25 MG, tablett, 30TK | HEXAL AG | 75 | I50-I50 | Pediaater, Kardioloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1157442 | karvedilool, 6,25mg | C07AG02 | CORYOL 6,25, tablett, 30TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | I50-I50 | Kardioloog, Pediaater | esmane | | | |

| 1166936 | karvedilool, 6,25mg | C07AG02 | CARVEDILOL GENERICON 6,25 MG, õhukese polümeerikattega tablett, 30TK | Genericon Pharma GmbH | 50 | | | | | | |

| | | | | | 75 | I50-I50 | Kardioloog, Pediaater | esmane | | | |

| 1175790 | karvedilool, 6,25mg | C07AG02 | CARVETREND 6,25 MG, tablett, 30TK | Teva Pharma B.V. | 50 | | | | | | |

| 1318711 | karvedilool, 6,25mg | C07AG02 | AVEDOL, õhukese polümeerikattega tablett, 30TK | Pharmaceutical Works Polpharma S.A. | 50 | | | | | | |

| | | | | | 75 | I50-I50 | Pediaater, Kardioloog | esmane | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1318711 | karvedilool, 6,25mg | C07AG02 | AVEDOL, õhukese polümeerikattega tablett, 30TK | Pharmaceutical Works Polpharma S.A. | 50 | | | | | | |

| | | | | | 75 | I50-I50 | Kardioloog, Pediaater | esmane | | | |

| 1112342 | keskmise toimeajaga humaaninsuliin, 100RÜ 1ml | A10AC01 | PROTAPHANE FLEXPEN, süstesuspensioon pen-süstlis, 3ml 5TK | Novo Nordisk A/S | 100 | O24-O24, E13-E14, E10-E11, P70.2- P70.2, E89.1-E89.1 | | | | | |

| | | | | | 50 | | | | | | |

| 1115615 | keskmise toimeajaga humaaninsuliin, 100RÜ 1ml | A10AC01 | HUMULIN N, süstesuspensioon kolbampullis, 3ml 5TK | Eli Lilly Holdings Limited | 100 | O24-O24, E13-E14, E10-E11, P70.2- P70.2, E89.1-E89.1 | | | | | |

| | | | | | 50 | | | | | | |

| 1115637 | keskmise toimeajaga humaaninsuliin, 100RÜ 1ml | A10AC01 | HUMULIN N KWIKPEN, süstesuspensioon pen-süstlis, 3ml 5TK | Eli Lilly Holdings Limited | 100 | O24-O24, E13-E14, E10-E11, P70.2- P70.2, E89.1-E89.1 | | | | | |

| | | | | | 50 | | | | | | |

| 1030026 | ketokonasool, 200mg | J02AB02 | ORONAZOL, tablett, 20TK | KRKA d.d., Novo Mesto | 100 | Z94-Z94, T86-T86 | | | | | |

| | | | | | 50 | | | | | | |

| 1071357 | ketokonasool, 200mg | J02AB02 | NIZORAL, tablett, 30TK | Johnson & Johnson UAB | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1115615 | keskmise toimeajaga humaaninsuliin, 100RÜ 1ml | A10AC01 | HUMULIN N, süstesuspensioon kolbampullis, 3ml 5TK | Eli Lilly Holdings Limited | 50 | | | | | | |

| | | | | | 100 | O24-O24, E13-E14, E10-E11, P70.2- P70.2, E89.1-E89.1 | | | | | |

| 1115637 | keskmise toimeajaga humaaninsuliin, 100RÜ 1ml | A10AC01 | HUMULIN N KWIKPEN, süstesuspensioon pen-süstlis, 3ml 5TK | Eli Lilly Holdings Limited | 50 | | | | | | |

| | | | | | 100 | O24-O24, E13-E14, E10-E11, P70.2- P70.2, E89.1-E89.1 | | | | | |

| 1030026 | ketokonasool, 200mg | J02AB02 | ORONAZOL, tablett, 20TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 100 | Z94-Z94, T86-T86 | | | | | |

| 1071357 | ketokonasool, 200mg | J02AB02 | NIZORAL, tablett, 30TK | Johnson & Johnson UAB | 100 | Z94-Z94, T86-T86 | | | | | |

| | | | | | 50 | | | | | | |

| 1018189 | ketokonasool, 20mg 1g | D01AC08 | NIZORAL, kreem, 15g 1TK | Johnson & Johnson UAB | 50 | | | | | | |

| 1073461 | ketoprofeen, 100mg | M01AE03 | KETO, õhukese polümeerikattega tablett, 30TK | VITABALANS OY | 50 | | | | | | |

| 1073483 | ketoprofeen, 100mg | M01AE03 | KETO, õhukese polümeerikattega tablett, 100TK | VITABALANS OY | 50 | | | | | | |

| 1073506 | ketoprofeen, 50mg | M01AE03 | KETO, õhukese polümeerikattega tablett, 30TK | VITABALANS OY | 50 | | | | | | |

| 1073517 | ketoprofeen, 50mg | M01AE03 | KETO, õhukese polümeerikattega tablett, 100TK | VITABALANS OY | 50 | | | | | | |

| 1011687 | klaritromütsiin, 125mg 5ml | J01FA09 | FROMILID, suukaudse suspensiooni graanulid, 60ml 1TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1028887 | klaritromütsiin, 250mg | J01FA09 | FROMILID, õhukese polümeerikattega tablett, 14TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| 1032747 | klaritromütsiin, 250mg | J01FA09 | KLACID 250 MG, õhukese polümeerikattega tablett, 10TK | Abbott Laboratories Baltics SIA | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1110261 | klaritromütsiin, 250mg | J01FA09 | KLERIMED 250MG, õhukese polümeerikattega tablett, 14TK | Medochemie Ltd | 50 | | | | | | |

| 1166688 | klaritromütsiin, 250mg | J01FA09 | KLABAX, õhukese polümeerikattega tablett, 14TK | Ranbaxy (UK) Limited | 50 | | | | | | |

| 1032736 | klaritromütsiin, 25mg 1ml | J01FA09 | KLACID 125 mg/5 ml, suukaudse suspensiooni graanulid, 60ml 1TK | Abbott Laboratories Baltics SIA | 50 | | | | | | |

| 1068881 | klaritromütsiin, 25mg 1ml | J01FA09 | KLACID 125 mg/5 ml, suukaudse suspensiooni graanulid, 100ml 1TK | Abbott Laboratories Baltics SIA | 50 | | | | | | |

| 1028876 | klaritromütsiin, 500mg | J01FA09 | FROMILID, õhukese polümeerikattega tablett, 14TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| 1141276 | klaritromütsiin, 500mg | J01FA09 | FROMILID UNO, toimeainet modifitseeritult vabastav tablett, 5TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| 1141287 | klaritromütsiin, 500mg | J01FA09 | FROMILID UNO, toimeainet modifitseeritult vabastav tablett, 7TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| 1032758 | klaritromütsiin, 500mg | J01FA09 | KLACID SR 500 MG, toimeainet modifitseeritult vabastav tablett, 5TK | Abbott Laboratories Baltics SIA | 50 | | | | | | |

| 1068904 | klaritromütsiin, 500mg | J01FA09 | KLACID SR 500 MG, toimeainet modifitseeritult vabastav tablett, 7TK | Abbott Laboratories Baltics SIA | 50 | | | | | | |

| 1108718 | klaritromütsiin, 500mg | J01FA09 | LEKOKLAR 500 MG, õhukese polümeerikattega tablett, 14TK | Sandoz d.d. | 50 | | | | | | |

| 1110238 | klaritromütsiin, 500mg | J01FA09 | KLERIMED 500MG, õhukese polümeerikattega tablett, 14TK | Medochemie Ltd | 50 | | | | | | |

| 1141276 | klaritromütsiin, 500mg | J01FA09 | FROMILID UNO, toimeainet modifitseeritult vabastav tablett, 5TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1141287 | klaritromütsiin, 500mg | J01FA09 | FROMILID UNO, toimeainet modifitseeritult vabastav tablett, 7TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| 1166677 | klaritromütsiin, 500mg | J01FA09 | KLABAX, õhukese polümeerikattega tablett, 14TK | Ranbaxy (UK) Limited | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1188086 | klaritromütsiin, 500mg | J01FA09 | LEKOKLAR XL 500 MG, toimeainet modifitseeritult vabastav tablett, 7TK | Sandoz d.d. | 50 | | | | | | |

| 1011160 | klindamütsiin, 100mg | G01AA10 | DALACIN V, vaginaalsuposiit, 3TK | Pfizer Enterprises SARL | 50 | | | | | | |

| 1021914 | klindamütsiin, 10mg 1ml | D10AF01 | DALACIN T, nahalahus, 30ml 1TK | Pfizer Enterprises SARL | 50 | | | | | | |

| 1007503 | klindamütsiin, 150mg | J01FF01 | DALACIN C, kõvakapsel, 16TK | Pfizer Enterprises SARL | 50 | | | | | | |

| 1023938 | klindamütsiin, 20mg 1g | G01AA10 | DALACIN, vaginaalkreem, 40g 1TK | Pfizer Enterprises SARL | 50 | | | | | | |

| 1007536 | klindamütsiin, 300mg | J01FF01 | DALACIN C, kõvakapsel, 16TK | Pfizer Enterprises SARL | 50 | | | | | | |

| 1108561 | klindamütsiin, 300mg | J01FF01 | CLINDAMYCIN - MIP 300, õhukese polümeerikattega tablett, 16TK | MIP Pharma GmbH | 50 | | | | | | |

| 1108606 | klindamütsiin, 600mg | J01FF01 | CLINDAMYCIN - MIP 600, õhukese polümeerikattega tablett, 16TK | MIP Pharma GmbH | 50 | | | | | | |

| 1432268 | klindamütsiin, 600mg | J01FF01 | CLINDAMYCIN - MIP 600, õhukese polümeerikattega tablett, 32TK | MIP Pharma GmbH | 50 | | | | | | |

| 1005208 | klobetasool, 500mcg 1g | D07AD01 | DERMOVATE OINTMENT, salv, 25g 1TK | Glaxo Group Ltd | 50 | | | | | | |

| 1005242 | klobetasool, 500mcg 1g | D07AD01 | DERMOVATE CREAM, kreem, 25g 1TK | Glaxo Group Ltd | 50 | | | | | | |

| 1005286 | klobetasool, 500mcg 1ml | D07AD01 | DERMOVATE, nahalahus, 25ml 1TK | Glaxo Group Ltd | 50 | | | | | | |

| 1005691 | klodroonhape, 400mg | M05BA02 | BONEFOS, kõvakapsel, 30TK | Bayer Schering Pharma OY | 50 | | | | | | |

| 1035469 | klodroonhape, 800mg | M05BA02 | BONEFOS, õhukese polümeerikattega tablett, 60TK | Bayer Schering Pharma OY | 50 | | | | | | |

| 1005691 | klodroonhape, 400mg | M05BA02 | BONEFOS, kõvakapsel, 30TK | Bayer OY | 50 | | | | | | |

| 1011407 | klomipramiin, 10mg | N06AA04 | ANAFRANIL, kaetud tablett, 30TK | Novartis Finland OY | 50 | | | | | | |

| 1001462 | klomipramiin, 25mg | N06AA04 | ANAFRANIL, kaetud tablett, 30TK | Novartis Finland OY | 50 | | | | | | |

| 1011418 | klomipramiin, 75mg | N06AA04 | ANAFRANIL SR, toimeainet prolongeeritult vabastav tablett, 20TK | Novartis Finland OY | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1004544 | klonasepaam, 2mg | N03AE01 | RIVOTRIL, tablett, 30TK | Roche Eesti OÜ | 50 | | | | | | |

| | | | | | 100 | G40-G40 | Neuroloog | esmane | | | |

| 1007345 | kloorambutsiil, 2mg | L01AA02 | LEUKERAN, õhukese polümeerikattega tablett, 25TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 50 | | | | | | |

| | | | | | 100 | C00-D48 | Hematoloog, Onkoloog | | | | |

| 1004544 | klonasepaam, 2mg | N03AE01 | RIVOTRIL, tablett, 30TK | Roche Eesti OÜ | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1007345 | kloorambutsiil, 2mg | L01AA02 | LEUKERAN, õhukese polümeerikattega tablett, 25TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 100 | C00-D48 | Hematoloog, Onkoloog | | | | |

| | | | | | 50 | | | | | | |

| 1044357 | klooramfenikool, 5mg 1ml | S01AA01 | OFTAN AKVAKOL, silmatilgad, lahus, 10ml 1TK | SANTEN OY | 50 | | | | | | |

| 1012880 | kloormadinoon+ etünüülöstradiool, 2mg+30mcg | G03AA15 | BELARA, õhukese polümeerikattega tablett, 21TK | Grünenthal GmbH | 50 | | | | | | |

| | | | | | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| 1094509 | kloormadinoon+ etünüülöstradiool, 2mg+30mcg | G03AA15 | BELARA, õhukese polümeerikattega tablett, 63TK | Grünenthal GmbH | 50 | | | | | | |

| | | | | | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| 1006063 | kloorprotikseen, 25mg | N05AF03 | TRUXAL, õhukese polümeerikattega tablett, 100TK | H. LUNDBECK A/S | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1357961 | klopidogreel, 75mg | B01AC04 | PLAVOCORIN, õhukese polümeerikattega tablett, 28TK | Sandoz d.d. | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1006096 | kloorprotikseen, 50mg | N05AF03 | TRUXAL, õhukese polümeerikattega tablett, 50TK | H. LUNDBECK A/S | 50 | | | | | | |

| 1358153 | klopidogreel, 75mg | B01AC04 | CLOPIMEF, õhukese polümeerikattega tablett, 28TK | MEPHA Lda. | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1358298 | klopidogreel, 75mg | B01AC04 | CLOPIDOGREL- RATIOPHARM 75 MG, õhukese polümeerikattega tablett, 28TK | ratiopharm GmbH | 50 | | | | | | |

| 1367197 | klopidogreel, 75mg | B01AC04 | CLOPIDOGREL SANOSWISS 75MG, õhukese polümeerikattega tablett, 28TK | UAB SanoSwiss | 50 | | | | | | |

| 1358591 | klopidogreel, 75mg | B01AC04 | CLOPIDOGREL PORTFARMA, õhukese polümeerikattega tablett, 28TK | Portfarma ehf | 50 | | | | | | |

| 1040588 | klopidogreel, 75mg | B01AC04 | PLAVIX, õhukese polümeerikattega tablett, 28TK | Sanofi Pharma Bristol- Myers Squibb SNC | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1065743 | klopidogreel, 75mg | B01AC04 | PLAVIX, õhukese polümeerikattega tablett, 84TK | Sanofi Pharma Bristol- Myers Squibb SNC | 50 | | | | | | |

| 1357141 | klopidogreel, 75mg | B01AC04 | TROMBEX 75 MG, õhukese polümeerikattega tablett, 30TK | Zentiva, k.s. | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1359884 | klopidogreel, 75mg | B01AC04 | CLOPIGAMMA, õhukese polümeerikattega tablett, 28TK | WÖRWAG PHARMA GmbH & Co. KG | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1367074 | klopidogreel, 75mg | B01AC04 | NOFARDOM, õhukese polümeerikattega tablett, 28TK | UAB Norameda | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| 1433630 | klopidogreel, 75mg | B01AC04 | CLOPIDOGREL TEVA, õhukese polümeerikattega tablett, 28TK | Teva Pharma B.V. | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1437465 | klopidogreel, 75mg | B01AC04 | ZYLLT, õhukese polümeerikattega tablett, 28TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1004724 | klosapiin, 100mg | N05AH02 | LEPONEX, tablett, 50TK | Novartis Finland OY | 100 | F32.2-F32.3, F70- F79, F11.4-F11.7, F18.4-F18.7, F20- F29, F12.4-F12.7, F16.4-F16.7, F19.4- F19.7, F33.2-F33.3, F14.4-F14.7, F00- F09, F60.3-F60.3, F13.4-F13.7, F10.4- F10.7, F17.4-F17.7, F15.4-F15.7, F30- F31 | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1004768 | klosapiin, 25mg | N05AH02 | LEPONEX, tablett, 50TK | Novartis Finland OY | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1004724 | klosapiin, 100mg | N05AH02 | LEPONEX, tablett, 50TK | Novartis Finland OY | 50 | | | | | | |

| 1004768 | klosapiin, 25mg | N05AH02 | LEPONEX, tablett, 50TK | Novartis Finland OY | 100 | F32.2-F32.3, F70- F79, F11.4-F11.7, F18.4-F18.7, F20- F29, F12.4-F12.7, F16.4-F16.7, F19.4- F19.7, F33.2-F33.3, F14.4-F14.7, F00- F09, F60.3-F60.3, F13.4-F13.7, F10.4- F10.7, F17.4-F17.7, F15.4-F15.7, F30- F31 | | | | | |

| | | | | | 50 | | | | | | |

| 1033692 | klotrimasool, 1%/100mg | G01AF02 | CANIFUG CREMOLUM 100 KOMBI, vaginaalsuposiit+vaginaalkree m, 20g 1TK / 6TK | Dr. August Wolff GmbH & Co. KG Arzneimittel | 50 | | | | | | |

| 1045123 | klotrimasool, 100mg | G01AF02 | KLOTRIMASOOL GSK, vaginaaltablett, 6TK | GlaxoSmithKline Pharmaceuticals S.A. | 50 | | | | | | |

| 1033726 | klotrimasool, 100mg | G01AF02 | CANIFUG CREMOLUM 100, vaginaalsuposiit, 6TK | Dr. August Wolff GmbH & Co. KG Arzneimittel | 50 | | | | | | |

| 1045123 | klotrimasool, 100mg | G01AF02 | KLOTRIMASOOL GSK, vaginaaltablett, 6TK | GlaxoSmithKline Pharmaceuticals S.A. | 50 | | | | | | |

| 1033737 | klotrimasool, 200mg | G01AF02 | CANIFUG CREMOLUM 200, vaginaalsuposiit, 3TK | Dr. August Wolff GmbH & Co. KG Arzneimittel | 50 | | | | | | |

| 1033692 | klotrimasool+klotrimas ool, 1%+100mg | G01AF02 | CANIFUG CREMOLUM 100 KOMBI, vaginaalsuposiit+vaginaalkree m, 20g 1TK / 6TK | Dr. August Wolff GmbH & Co. KG Arzneimittel | 50 | | | | | | |

| 1140815 | kodeiin+paratsetamool , 30mg+500mg | N02AA80 | PARACETAMOL/CODEINE VITABALANS, tablett, 30TK | VITABALANS OY | 50 | | | | | | |

| 1140826 | kodeiin+paratsetamool , 30mg+500mg | N02AA80 | PARACETAMOL/CODEINE VITABALANS, tablett, 100TK | VITABALANS OY | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1140815 | kodeiin+ paratsetamool, 30mg+500mg | N02AA80 | PARACETAMOL/CODEINE VITABALANS, tablett, 30TK | VITABALANS OY | 50 | | | | | | |

| 1140826 | kodeiin+ paratsetamool, 30mg+500mg | N02AA80 | PARACETAMOL/CODEINE VITABALANS, tablett, 100TK | VITABALANS OY | 50 | | | | | | |

| 1485187 | kodeiin+paratsetamool , 30mg+500mg | N02AA80 | ALGOCALM, tablett, 30TK | Zentiva, k.s. | 50 | | | | | | |

| 1022555 | kooriongonadotropiin, 5000RÜ | G03GA01 | PREGNYL, süstelahuse pulber ja lahusti, 3TK | N.V. ORGANON | 50 | | | | | | |

| 1001631 | kromoglütsiinhape, 40mg 1ml | S01GX01 | LECROLYN, silmatilgad, lahus, 5ml 1TK | SANTEN OY | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1120644 | kvetiapiin, 100mg | N05AH04 | SEROQUEL, õhukese polümeerikattega tablett, 60TK | AstraZeneca UK Limited | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1241345 | kvetiapiin, 100mg | N05AH04 | KETIPINOR, õhukese polümeerikattega tablett, 30TK | Orion Corporation | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1241356 | kvetiapiin, 100mg | N05AH04 | KETIPINOR, õhukese polümeerikattega tablett, 100TK | Orion Corporation | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1265420 | kvetiapiin, 100mg | N05AH04 | HEDONIN 100 MG, õhukese polümeerikattega tablett, 60TK | LANNACHER HEILMITTEL GmbH | 50 | | | | | | |

| 1241345 | kvetiapiin, 100mg | N05AH04 | KETIPINOR, õhukese polümeerikattega tablett, 30TK | Orion Corporation | 50 | | | | | | |

| | | | | | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| 1241356 | kvetiapiin, 100mg | N05AH04 | KETIPINOR, õhukese polümeerikattega tablett, 100TK | Orion Corporation | 50 | | | | | | |

| | | | | | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| 1265420 | kvetiapiin, 100mg | N05AH04 | HEDONIN 100 MG, õhukese polümeerikattega tablett, 60TK | LANNACHER HEILMITTEL GmbH | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1369942 | kvetiapiin, 100mg | N05AH04 | QUETIAPINE POLPHARMA, õhukese polümeerikattega tablett, 60TK | Pharmaceutical Works Polpharma S.A. | 50 | | | | | | |

| | | | | | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| 1115086 | kvetiapiin, 200mg | N05AH04 | SEROQUEL, õhukese polümeerikattega tablett, 60TK | AstraZeneca UK Limited | 50 | | | | | | |

| | | | | | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1241378 | kvetiapiin, 200mg | N05AH04 | KETIPINOR, õhukese polümeerikattega tablett, 100TK | Orion Corporation | 50 | | | | | | |

| | | | | | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| 1115086 | kvetiapiin, 200mg | N05AH04 | SEROQUEL, õhukese polümeerikattega tablett, 60TK | AstraZeneca UK Limited | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1241378 | kvetiapiin, 200mg | N05AH04 | KETIPINOR, õhukese polümeerikattega tablett, 100TK | Orion Corporation | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1258477 | kvetiapiin, 200mg | N05AH04 | KVENTIAX, õhukese polümeerikattega tablett, 60TK | KRKA d.d., Novo Mesto | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1265453 | kvetiapiin, 200mg | N05AH04 | HEDONIN 200 MG, õhukese polümeerikattega tablett, 60TK | LANNACHER HEILMITTEL GmbH | 50 | | | | | | |

| | | | | | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| 1274554 | kvetiapiin, 200mg | N05AH04 | SEROQUEL XR, toimeainet prolongeeritult vabastav tablett, 60TK | AstraZeneca UK Limited | 50 | | | | | | |

| | | | | | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| 1301847 | kvetiapiin, 200mg | N05AH04 | QUETIAPINE TEVA, õhukese polümeerikattega tablett, 60TK | Teva Pharma B.V. | 50 | | | | | | |

| | | | | | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| 1274554 | kvetiapiin, 200mg | N05AH04 | SEROQUEL XR, toimeainet prolongeeritult vabastav tablett, 60TK | AstraZeneca UK Limited | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1301847 | kvetiapiin, 200mg | N05AH04 | QUETIAPINE TEVA, õhukese polümeerikattega tablett, 60TK | Teva Pharma B.V. | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1370001 | kvetiapiin, 200mg | N05AH04 | QUETIAPINE POLPHARMA, õhukese polümeerikattega tablett, 60TK | Pharmaceutical Works Polpharma S.A. | 50 | | | | | | |

| | | | | | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1241334 | kvetiapiin, 25mg | N05AH04 | KETIPINOR, õhukese polümeerikattega tablett, 100TK | Orion Corporation | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1369931 | kvetiapiin, 25mg | N05AH04 | QUETIAPINE POLPHARMA, õhukese polümeerikattega tablett, 30TK | Pharmaceutical Works Polpharma S.A. | 50 | | | | | | |

| 1241334 | kvetiapiin, 25mg | N05AH04 | KETIPINOR, õhukese polümeerikattega tablett, 100TK | Orion Corporation | 50 | | | | | | |

| | | | | | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| 1377503 | kvetiapiin, 25mg | N05AH04 | QUETIAPINE TEVA, õhukese polümeerikattega tablett, 30TK | Teva Pharma B.V. | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1369931 | kvetiapiin, 25mg | N05AH04 | QUETIAPINE POLPHARMA, õhukese polümeerikattega tablett, 30TK | Pharmaceutical Works Polpharma S.A. | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1377503 | kvetiapiin, 25mg | N05AH04 | QUETIAPINE TEVA, õhukese polümeerikattega tablett, 30TK | Teva Pharma B.V. | 50 | | | | | | |

| | | | | | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| 1274587 | kvetiapiin, 300mg | N05AH04 | SEROQUEL XR, toimeainet prolongeeritult vabastav tablett, 60TK | AstraZeneca UK Limited | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1301937 | kvetiapiin, 300mg | N05AH04 | QUETIAPINE TEVA, õhukese polümeerikattega tablett, 60TK | Teva Pharma B.V. | 50 | | | | | | |

| | | | | | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| 1363531 | kvetiapiin, 300mg | N05AH04 | KETIPINOR, õhukese polümeerikattega tablett, 100TK | Orion Corporation | 50 | | | | | | |

| | | | | | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1370023 | kvetiapiin, 300mg | N05AH04 | QUETIAPINE POLPHARMA, õhukese polümeerikattega tablett, 60TK | Pharmaceutical Works Polpharma S.A. | 50 | | | | | | |

| | | | | | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1301937 | kvetiapiin, 300mg | N05AH04 | QUETIAPINE TEVA, õhukese polümeerikattega tablett, 60TK | Teva Pharma B.V. | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1363531 | kvetiapiin, 300mg | N05AH04 | KETIPINOR, õhukese polümeerikattega tablett, 100TK | Orion Corporation | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1370023 | kvetiapiin, 300mg | N05AH04 | QUETIAPINE POLPHARMA, õhukese polümeerikattega tablett, 60TK | Pharmaceutical Works Polpharma S.A. | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1274611 | kvetiapiin, 400mg | N05AH04 | SEROQUEL XR, toimeainet prolongeeritult vabastav tablett, 60TK | AstraZeneca UK Limited | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1288289 | kvetiapiin, 50mg | N05AH04 | SEROQUEL XR, toimeainet prolongeeritult vabastav tablett, 60TK | AstraZeneca UK Limited | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1034457 | kvinapriil, 10mg | C09AA06 | ACCUPRO 10, õhukese polümeerikattega tablett, 30TK | Pfizer Europe MA EEIG | 50 | | | | | | |

| 1034468 | kvinapriil, 20mg | C09AA06 | ACCUPRO 20, õhukese polümeerikattega tablett, 30TK | Pfizer Europe MA EEIG | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1415506 | kvinapriil, 20mg | C09AA06 | QUINAPRIL POLPHARMA 20 MG, õhukese polümeerikattega tablett, 30TK | Pharmaceutical Works Polpharma S.A. | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1415517 | kvinapriil, 40mg | C09AA06 | QUINAPRIL POLPHARMA 40 MG, õhukese polümeerikattega tablett, 30TK | Pharmaceutical Works Polpharma S.A. | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1007828 | labetalool, 100mg | C07AG01 | TRANDATE, õhukese polümeerikattega tablett, 50TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 75 | O10-O16 | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1415517 | kvinapriil, 40mg | C09AA06 | QUINAPRIL POLPHARMA 40 MG, õhukese polümeerikattega tablett, 30TK | Pharmaceutical Works Polpharma S.A. | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1031094 | kvinapriil+ hüdroklorotiasiid, 10mg+12,5mg | C09BA06 | ACCUZIDE, õhukese polümeerikattega tablett, 30TK | Pfizer Europe MA EEIG | 50 | | | | | | |

| 1030105 | kvinapriil+ hüdroklorotiasiid, 20mg+12,5mg | C09BA06 | ACCUZIDE 20, õhukese polümeerikattega tablett, 30TK | Pfizer Europe MA EEIG | 50 | | | | | | |

| 1007828 | labetalool, 100mg | C07AG01 | TRANDATE, õhukese polümeerikattega tablett, 50TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 50 | | | | | | |

| | | | | | 75 | O10-O16 | | | | | |

| 1043042 | lamivudiin, 100mg | J05AF05 | ZEFFIX, õhukese polümeerikattega tablett, 28TK | Glaxo Group Ltd | 50 | | | | | | |

| 1122691 | lamotrigiin, 100mg | N03AX09 | LAMICTAL 100MG, närimis- /dispergeeruv tablett, 30TK | Glaxo Group Ltd | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| 1153897 | lamotrigiin, 25mg | N03AX09 | LAMICTAL 25MG, närimis- /dispergeeruv tablett, 30TK | Glaxo Group Ltd | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1394210 | lamotrigiin, 25mg | N03AX09 | LAMICTAL 25MG, närimis- /dispergeeruv tablett, 28TK | Glaxo Group Ltd | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| 1122714 | lamotrigiin, 50mg | N03AX09 | LAMICTAL 50MG, närimis- /dispergeeruv tablett, 30TK | Glaxo Group Ltd | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1379088 | lamotrigiin, 50mg | N03AX09 | LAMICTAL 50MG, närimis- /dispergeeruv tablett, 28TK | Glaxo Group Ltd | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| 1394018 | lamotrigiin, 5mg | N03AX09 | LAMICTAL 5MG, närimis- /dispergeeruv tablett, 28TK | Glaxo Group Ltd | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1235056 | lantaan, 750mg | V03AE03 | FOSRENOL, närimistablett, 90TK | Shire Pharmaceutical Contracts Limited | 50 | | | | | | |

| | | | | | 100 | N18-N18 | Pediaater, Nefroloog | | | | juhul, kui kaltsiumipõhine fosforisiduja on vastunäidustatud (seerumi kaltsiumisisaldus >2,54 mmol/l) |

| 1235056 | lantaan, 750mg | V03AE03 | FOSRENOL, närimistablett, 90TK | Shire Pharmaceutical Contracts Limited | 100 | N18-N18 | Pediaater, Nefroloog | | | | juhul, kui kaltsiumipõhine fosforisiduja on vastunäidustatud (seerumi kaltsiumisisaldus >2,54 mmol/l) |

| | | | | | 50 | | | | | | |

| 1041196 | latanoprost, 50mcg 1ml | S01EE01 | XALATAN, silmatilgad, lahus, 2.5ml 1TK | Pfizer Enterprises SARL | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | H40-H42 | Oftalmoloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1165733 | latanoprost, 50mcg 1ml | S01EE01 | GLAUMAX, silmatilgad, 2.5ml 1TK | Kevelt AS | 100 | H40-H42 | Oftalmoloog | esmane | | | |

| 1165733 | latanoprost, 50mcg 1ml | S01EE01 | GLAUMAX, silmatilgad, lahus, 2.5ml 1TK | Kevelt AS | 100 | H40-H42 | Oftalmoloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1300071 | latanoprost, 50mcg 1ml | S01EE01 | XALOPTIC, silmatilgad, lahus, 2.5ml 1TK | Pharmaceutical Works Polpharma S.A. | 100 | H40-H42 | Oftalmoloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1316438 | latanoprost, 50mcg 1ml | S01EE01 | LATANOPROST- RATIOPHARM, silmatilgad, lahus, 2.5ml 1TK | ratiopharm GmbH | 50 | | | | | | |

| 1316438 | latanoprost, 50mcg 1ml | S01EE01 | LATANOPROST- RATIOPHARM, silmatilgad, lahus, 2.5ml 1TK | ratiopharm GmbH | 100 | H40-H42 | Oftalmoloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1377873 | latanoprost, 50mcg 1ml | S01EE01 | UNILAT, silmatilgad, lahus, 2.5ml 1TK | Unimed Pharma spol. s.r.o. (Ltd.) | 50 | | | | | | |

| | | | | | 100 | H40-H42 | Oftalmoloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1377873 | latanoprost, 50mcg 1ml | S01EE01 | UNILAT, silmatilgad, lahus, 2.5ml 1TK | Unimed Pharma spol. s.r.o. (Ltd.) | 100 | H40-H42 | Oftalmoloog | esmane | | | |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

@@ -2018,8 +1901,8 @@

| | | | | | 50 | | | | | | |

| 1073023 | latsidipiin, 4mg | C08CA09 | LACIPIL, õhukese polümeerikattega tablett, 56TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 50 | | | | | | |

| 1122567 | latsidipiin, 6mg | C08CA09 | LACIPIL 6MG, õhukese polümeerikattega tablett, 28TK | GlaxoSmithKline SpA | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 50 | | | | | | |

| 1122567 | latsidipiin, 6mg | C08CA09 | LACIPIL 6MG, õhukese polümeerikattega tablett, 28TK | GlaxoSmithKline SpA | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15 | | | | | |

| 1122578 | latsidipiin, 6mg | C08CA09 | LACIPIL 6MG, õhukese polümeerikattega tablett, 56TK | GlaxoSmithKline SpA | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 50 | | | | | | |

@@ -2030,334 +1913,383 @@

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1299540 | lenalidomiid, 5mg | L04AX04 | REVLIMID, kõvakapsel, 21TK | Celgene Europe Ltd | 100 | C90-C90 | Hematoloog | | | | kuni haiguse progresseerumiseni patsiendile, kelle ravi alustamise lenalidomiidiga on hinnanud konsiilium (vähemalt 3 hematoloogi) vastavaks järgmistele kriteeriumidele: ravi bortesomiibiga on vastunäidustatud või osutunud ebaefektiivseks või on haigus pärast bortesomiibravi taastekkinud ning patsient on heas üldseisundis (funktsionaalne klass 0-2 ECOG järgi). Soodustus ei laiene patsientidele, kelle ravi lenalidomiidiga on ravimitootja vastutusel alustatud ja tagatud enne 1. oktoobrit 2010. a. |

| 1474950 | lerkanidipiin, 10mg | C08CA13 | LERCAPIN, õhukese polümeerikattega tablett, 90TK | Menarini International Operations Luxembourg S.A. | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15 | | | | | |

| 1474994 | lerkanidipiin, 20mg | C08CA13 | LERCAPIN, õhukese polümeerikattega tablett, 90TK | Menarini International Operations Luxembourg S.A. | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15 | | | | | |

| 1034334 | letrosool, 2,5mg | L02BG04 | FEMARA, õhukese polümeerikattega tablett, 30TK | Novartis Finland OY | 50 | | | | | | |

| 1474950 | lerkanidipiin, 10mg | C08CA13 | LERCAPIN, õhukese polümeerikattega tablett, 90TK | Menarini International Operations Luxembourg S.A. | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 50 | | | | | | |

| 1474994 | lerkanidipiin, 20mg | C08CA13 | LERCAPIN, õhukese polümeerikattega tablett, 90TK | Menarini International Operations Luxembourg S.A. | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 50 | | | | | | |

| 1289213 | letrosool, 2,5mg | L02BG04 | LETROZOL-RATIOPHARM, õhukese polümeerikattega tablett, 30TK | ratiopharm GmbH | 100 | C50-C50 | Onkoloog | | | | |

| | | | | | 50 | | | | | | |

| 1034334 | letrosool, 2,5mg | L02BG04 | FEMARA, õhukese polümeerikattega tablett, 30TK | Novartis Finland OY | 100 | C50-C50 | Onkoloog | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1302398 | letrosool, 2,5mg | L02BG04 | LETROZOLE SANOSWISS 2,5 MG, õhukese polümeerikattega tablett, 30TK | UAB SanoSwiss | 100 | C50-C50 | Onkoloog | | | | |

| | | | | | 50 | | | | | | |

| 1302488 | letrosool, 2,5mg | L02BG04 | LETROZOLE GENERICON, õhukese polümeerikattega tablett, 30TK | Genericon Pharma GmbH | 50 | | | | | | |

| | | | | | 100 | C50-C50 | Onkoloog | | | | |

| 1289213 | letrosool, 2,5mg | L02BG04 | LETROZOL-RATIOPHARM, õhukese polümeerikattega tablett, 30TK | ratiopharm GmbH | 50 | | | | | | |

| | | | | | 100 | C50-C50 | Onkoloog | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1302398 | letrosool, 2,5mg | L02BG04 | LETROZOLE SANOSWISS 2,5 MG, õhukese polümeerikattega tablett, 30TK | UAB SanoSwiss | 50 | | | | | | |

| | | | | | 100 | C50-C50 | Onkoloog | | | | |

| 1302488 | letrosool, 2,5mg | L02BG04 | LETROZOLE GENERICON, õhukese polümeerikattega tablett, 30TK | Genericon Pharma GmbH | 100 | C50-C50 | Onkoloog | | | | |

| | | | | | 50 | | | | | | |

| 1302792 | letrosool, 2,5mg | L02BG04 | LETROZOLE POLPHARMA 2,5 MG, õhukese polümeerikattega tablett, 30TK | Pharmaceutical Works Polpharma S.A. | 50 | | | | | | |

| | | | | | 100 | C50-C50 | Onkoloog | | | | |

| 1302792 | letrosool, 2,5mg | L02BG04 | LETROZOLE POLPHARMA 2,5 MG, õhukese polümeerikattega tablett, 30TK | Pharmaceutical Works Polpharma S.A. | 100 | C50-C50 | Onkoloog | | | | |

| | | | | | 50 | | | | | | |

| 1007176 | levamisool, 150mg | P02CE01 | DECARIS, tablett, 1TK | Gedeon Richter Plc. | 50 | | | | | | |

| 1198975 | levetiratsetaam, 1000mg | N03AX14 | KEPPRA, õhukese polümeerikattega tablett, 30TK | UCB Pharma SA | 50 | | | | | | |

| 1198762 | levetiratsetaam, 250mg | N03AX14 | KEPPRA, õhukese polümeerikattega tablett, 30TK | UCB Pharma SA | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1198829 | levetiratsetaam, 500mg | N03AX14 | KEPPRA, õhukese polümeerikattega tablett, 30TK | UCB Pharma SA | 50 | | | | | | |

| 1085161 | levodopa+ benserasiid, 100mg+25mg | N04BA80 | MADOPAR HBS, toimeainet prolongeeritult vabastav kõvakapsel, 100TK | Roche Eesti OÜ | 50 | | | | | | |

| | | | | | 100 | G20-G20 | Neuroloog | esmane | | | |

| 1077049 | levodopa+benserasiid, 100mg+25mg | N04BA80 | MADOPAR, dispergeeruv tablett, 100TK | Roche Eesti OÜ | 50 | | | | | | |

| | | | | | 100 | G20-G20 | Neuroloog | esmane | | | |

| 1082922 | levodopa+benserasiid, 100mg+25mg | N04BA80 | MADOPAR, kõvakapsel, 100TK | Roche Eesti OÜ | 100 | G20-G20 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1002014 | levodopa+benserasiid, 200mg+50mg | N04BA80 | MADOPAR, tablett, 100TK | Roche Eesti OÜ | 50 | | | | | | |

| | | | | | 100 | G20-G20 | Neuroloog | esmane | | | |

| 1082517 | levodopa+karbidopa, 100mg+25mg | N04BA81 | SINEMET 25/100, tablett, 30TK | Merck Sharp & Dohme OÜ | 100 | G20-G20 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1006894 | levodopa+karbidopa, 200mg+50mg | N04BA81 | SINEMET CR 50/200 MG, toimeainet prolongeeritult vabastav tablett, 100TK | Merck Sharp & Dohme OÜ | 50 | | | | | | |

| | | | | | 100 | G20-G20 | Neuroloog | esmane | | | |

| 1006861 | levodopa+karbidopa, 250mg+25mg | N04BA81 | SINEMET 25/250, tablett, 100TK | Merck Sharp & Dohme OÜ | 50 | | | | | | |

| | | | | | 100 | G20-G20 | Neuroloog | esmane | | | |

| 1172854 | levodopa+karbidopa+e ntakapoon, 100mg+25mg+200mg | N04BA03 | STALEVO, õhukese polümeerikattega tablett, 100TK | Orion Corporation | 100 | G20-G20 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1172898 | levodopa+karbidopa+e ntakapoon, 150mg+37,5mg+200m g | N04BA03 | STALEVO, õhukese polümeerikattega tablett, 100TK | Orion Corporation | 100 | G20-G20 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1368020 | levodopa+karbidopa+e ntakapoon, 200mg+50mg+200mg | N04BA03 | STALEVO, õhukese polümeerikattega tablett, 100TK | Orion Corporation | 50 | | | | | | |

| | | | | | 100 | G20-G20 | Neuroloog | esmane | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1472228 | levodopa+karbidopa+e ntakapoon, 75mg+18,75mg+200m g | N04BA03 | STALEVO, õhukese polümeerikattega tablett, 100TK | Orion Corporation | 50 | | | | | | |

| | | | | | 100 | G20-G20 | Neuroloog | esmane | | | |

| 1009493 | levonorgestreel, 20mcg 24h | G02BA03 | MIRENA, intrauteriinne ravivahend, 1TK | Bayer Schering Pharma AG | 50 | | | | | | |

| 1014815 | levonorgestreel+etünü ülöstradiool, 75mcg+40mcg/50mcg +30mcg/125mcg+30m cg | G03AB03 | TRI-REGOL, kaetud tablett, 15TK / 18TK / 30TK | Gedeon Richter Plc. | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| | | | | | 50 | | | | | | |

| 1223064 | levotsetirisiin, 0,5mg 1ml | R06AE09 | XYZAL, suukaudne lahus, 200ml 1TK | UCB Pharma OY Finland | 50 | | | | | | |

| 1138126 | levotsetirisiin, 5mg | R06AE09 | XYZAL, õhukese polümeerikattega tablett, 7TK | UCB Pharma OY Finland | 50 | | | | | | |

| 1138137 | levotsetirisiin, 5mg | R06AE09 | XYZAL, õhukese polümeerikattega tablett, 28TK | UCB Pharma OY Finland | 50 | | | | | | |

| 1359312 | levotsetirisiin, 5mg | R06AE09 | LEVOCETIRIZINE ACTAVIS, õhukese polümeerikattega tablett, 28TK | Actavis Group PTC ehf | 50 | | | | | | |

| 1359525 | levotsetirisiin, 5mg | R06AE09 | LEVOCETIRIZINE- RATIOPHARM, õhukese polümeerikattega tablett, 28TK | ratiopharm GmbH | 50 | | | | | | |

| 1013858 | linesoliid, 600mg | J01XX08 | ZYVOXID, õhukese polümeerikattega tablett, 10TK | Pfizer Enterprises SARL | 50 | | | | | | |

| 1030565 | lisinopriil, 10mg | C09AA03 | DIROTON, tablett, 28TK | Gedeon Richter Plc. | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 50 | | | | | | |

| 1030576 | lisinopriil, 20mg | C09AA03 | DIROTON, tablett, 28TK | Gedeon Richter Plc. | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 50 | | | | | | |

| 1012420 | lispro-insuliin, 100TÜ 1ml | A10AD04 | HUMALOG MIX50, süstesuspensioon, 3ml 5TK | Eli Lilly Netherland B.V. | 50 | | | | | | |

| 1044469 | lipaas+amülaas+prote aas, 10000TÜ+8000TÜ+60 0TÜ | A09AA02 | KREON 10 000 U, gastroresistentne kõvakapsel, 20TK | Abbott Products GmbH | 100 | E84-E84 | Pediaater, Pulmonoloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1063763 | lipaas+amülaas+prote aas, 10000TÜ+8000TÜ+60 0TÜ | A09AA02 | KREON 10 000 U, gastroresistentne kõvakapsel, 50TK | Abbott Products GmbH | 50 | | | | | | |

| | | | | | 100 | E84-E84 | Pediaater, Pulmonoloog | esmane | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1063774 | lipaas+amülaas+prote aas, 10000TÜ+8000TÜ+60 0TÜ | A09AA02 | KREON 10 000 U, gastroresistentne kõvakapsel, 100TK | Abbott Products GmbH | 100 | E84-E84 | Pediaater, Pulmonoloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1020205 | lipaas+amülaas+prote aas, 10000ühik+9000ühik+ 500ühik | A09AA02 | PANGROL 10000, gastroresistentne kõvakapsel, 20TK | Berlin-Chemie AG (Menarini Group) | 50 | | | | | | |

| | | | | | 100 | E84-E84 | Pediaater, Pulmonoloog | esmane | | | |

| 1060434 | lipaas+amülaas+prote aas, 20000ühik+12000ühik +900ühik | A09AA02 | MEZYM 20 000, gastroresistentne tablett, 100TK | Berlin-Chemie AG (Menarini Group) | 50 | | | | | | |

| | | | | | 100 | E84-E84 | Pulmonoloog, Pediaater | esmane | | | |

| 1044470 | lipaas+amülaas+prote aas, 25000TÜ+18000TÜ+1 000TÜ | A09AA02 | KREON 25 000 U, gastroresistentne kõvakapsel, 20TK | Abbott Products GmbH | 100 | E84-E84 | Pediaater, Pulmonoloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1063707 | lipaas+amülaas+prote aas, 25000TÜ+18000TÜ+1 000TÜ | A09AA02 | KREON 25 000 U, gastroresistentne kõvakapsel, 50TK | Abbott Products GmbH | 100 | E84-E84 | Pulmonoloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| 1063729 | lipaas+amülaas+prote aas, 25000TÜ+18000TÜ+1 000TÜ | A09AA02 | KREON 25 000 U, gastroresistentne kõvakapsel, 100TK | Abbott Products GmbH | 100 | E84-E84 | Pulmonoloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| 1020182 | lipaas+amülaas+prote aas, 25000ühik+22500ühik +1250ühik | A09AA02 | PANGROL 25000, gastroresistentne kõvakapsel, 20TK | Berlin-Chemie AG (Menarini Group) | 100 | E84-E84 | Pediaater, Pulmonoloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1030565 | lisinopriil, 10mg | C09AA03 | DIROTON, tablett, 28TK | Gedeon Richter Plc. | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15 | | | | | |

| 1030576 | lisinopriil, 20mg | C09AA03 | DIROTON, tablett, 28TK | Gedeon Richter Plc. | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15 | | | | | |

| 1300598 | lisinopriil+amlodipiin, 10mg+5mg | C09BB03 | DIRONORM, tablett, 30TK | Gedeon Richter Plc. | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1012420 | lispro-insuliin, 100ühik 1ml | A10AD04 | HUMALOG MIX50, süstesuspensioon kolbampullis, 3ml 5TK | Eli Lilly Netherland B.V. | 100 | O24-O24, E13-E14, E10-E11, P70.2- P70.2, E89.1-E89.1 | | | | | |

| | | | | | 50 | | | | | | |

| 1040409 | lispro-insuliin, 100ühik 1ml | A10AB04 | HUMALOG PEN, süstelahus, 3ml 5TK | Eli Lilly Netherland B.V. | 100 | O24-O24, E13-E14, E10-E11, P70.2- P70.2, E89.1-E89.1 | | | | | |

| | | | | | 50 | | | | | | |

| 1043008 | lispro-insuliin, 100ühik 1ml | A10AD04 | HUMALOG MIX25, süstesuspensioon kolbampullis, 3ml 5TK | Eli Lilly Netherland B.V. | 50 | | | | | | |

| | | | | | 100 | O24-O24, E13-E14, E10-E11, P70.2- P70.2, E89.1-E89.1 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1040409 | lispro-insuliin, 100TÜ 1ml | A10AB04 | HUMALOG PEN, süstelahus, 3ml 5TK | Eli Lilly Netherland B.V. | 50 | | | | | | |

| | | | | | 100 | O24-O24, E13-E14, E10-E11, P70.2- P70.2, E89.1-E89.1 | | | | | |

| 1043008 | lispro-insuliin, 100TÜ 1ml | A10AD04 | HUMALOG MIX25, süstesuspensioon, 3ml 5TK | Eli Lilly Netherland B.V. | 50 | | | | | | |

| | | | | | 100 | O24-O24, E13-E14, E10-E11, P70.2- P70.2, E89.1-E89.1 | | | | | |

| 1043019 | lispro-insuliin, 100TÜ 1ml | A10AD04 | HUMALOG MIX25 PEN, süstesuspensioon, 3ml 5TK | Eli Lilly Netherland B.V. | 50 | | | | | | |

| | | | | | 100 | O24-O24, E13-E14, E10-E11, P70.2- P70.2, E89.1-E89.1 | | | | | |

| 1111284 | lispro-insuliin, 100TÜ 1ml | A10AB04 | HUMALOG, süstelahus, 3ml 5TK | Eli Lilly Netherland B.V. | 50 | | | | | | |

| | | | | | 100 | O24-O24, E13-E14, E10-E11, P70.2- P70.2, E89.1-E89.1 | | | | | |

| 1364510 | lispro-insuliin, 100TÜ 1ml | A10AB04 | HUMALOG KWIKPEN, süstelahus, 3ml 5TK | Eli Lilly Netherland B.V. | 100 | O24-O24, E13-E14, E10-E11, P70.2- P70.2, E89.1-E89.1 | | | | | |

| | | | | | 50 | | | | | | |

| 1364532 | lispro-insuliin, 100TÜ 1ml | A10AD04 | HUMALOG MIX25 KWIKPEN, süstesuspensioon, 3ml 5TK | Eli Lilly Netherland B.V. | 100 | O24-O24, E13-E14, E10-E11, P70.2- P70.2, E89.1-E89.1 | | | | | |

| | | | | | 50 | | | | | | |

| 1364554 | lispro-insuliin, 100TÜ 1ml | A10AD04 | HUMALOG MIX50 KWIKPEN, süstesuspensioon, 3ml 5TK | Eli Lilly Netherland B.V. | 50 | | | | | | |

| 1043019 | lispro-insuliin, 100ühik 1ml | A10AD04 | HUMALOG MIX25 PEN, süstesuspensioon, 3ml 5TK | Eli Lilly Netherland B.V. | 100 | O24-O24, E13-E14, E10-E11, P70.2- P70.2, E89.1-E89.1 | | | | | |

| | | | | | 50 | | | | | | |

| 1111284 | lispro-insuliin, 100ühik 1ml | A10AB04 | HUMALOG, süstelahus kolbampullis, 3ml 5TK | Eli Lilly Netherland B.V. | 100 | O24-O24, E13-E14, E10-E11, P70.2- P70.2, E89.1-E89.1 | | | | | |

| | | | | | 50 | | | | | | |

| 1364510 | lispro-insuliin, 100ühik 1ml | A10AB04 | HUMALOG KWIKPEN, süstelahus, 3ml 5TK | Eli Lilly Netherland B.V. | 100 | O24-O24, E13-E14, E10-E11, P70.2- P70.2, E89.1-E89.1 | | | | | |

| | | | | | 50 | | | | | | |

| 1364532 | lispro-insuliin, 100ühik 1ml | A10AD04 | HUMALOG MIX25 KWIKPEN, süstesuspensioon, 3ml 5TK | Eli Lilly Netherland B.V. | 100 | O24-O24, E13-E14, E10-E11, P70.2- P70.2, E89.1-E89.1 | | | | | |

| | | | | | 50 | | | | | | |

| 1364554 | lispro-insuliin, 100ühik 1ml | A10AD04 | HUMALOG MIX50 KWIKPEN, süstesuspensioon, 3ml 5TK | Eli Lilly Netherland B.V. | 50 | | | | | | |

| | | | | | 100 | O24-O24, E13-E14, E10-E11, P70.2- P70.2, E89.1-E89.1 | | | | | |

| 1063482 | loperamiid, 2mg | A07DA03 | IMODIUM, kõvakapsel, 20TK | McNeil Products Ltd. | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1086612 | loratadiin, 10mg | R06AX13 | CLARITINE, tablett, 30TK | SCHERING-PLOUGH EUROPE | 50 | | | | | | |

| 1086667 | loratadiin, 10mg | R06AX13 | CLARITINE, tablett, 100TK | SCHERING-PLOUGH EUROPE | 50 | | | | | | |

| 1088962 | loratadiin, 10mg | R06AX13 | LORATIN, tablett, 30TK | HEXAL AG | 50 | | | | | | |

| 1111723 | loratadiin, 10mg | R06AX13 | RINOLAN, tablett, 30TK | Teva Pharma B.V. | 50 | | | | | | |

| 1078310 | loratadiin+pseudoefedr iin, 10mg+240mg | R01BA89 | CLARINASE, toimeainet prolongeeritult vabastav tablett, 7TK | SCHERING-PLOUGH EUROPE | 50 | | | | | | |

| 1024209 | lornoksikaam, 4mg | M01AC05 | XEFO, õhukese polümeerikattega tablett, 20TK | Nycomed Sefa AS | 50 | | | | | | |

| 1134638 | lornoksikaam, 8mg | M01AC05 | XEFO RAPID, õhukese polümeerikattega tablett, 20TK | Nycomed Sefa AS | 50 | | | | | | |

| 1147339 | lornoksikaam, 8mg | M01AC05 | XEFO RAPID, õhukese polümeerikattega tablett, 10TK | Nycomed Sefa AS | 50 | | | | | | |

| 1207167 | losartaan, 100mg | C09CA01 | LOZAP 100, õhukese polümeerikattega tablett, 30TK | Zentiva a.s. | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1210688 | losartaan, 100mg | C09CA01 | LOZAP 100, õhukese polümeerikattega tablett, 60TK | Zentiva a.s. | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1210688 | losartaan, 100mg | C09CA01 | LOZAP 100, õhukese polümeerikattega tablett, 60TK | Zentiva a.s. | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1268962 | losartaan, 100mg | C09CA01 | LORISTA, õhukese polümeerikattega tablett, 28TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1297414 | losartaan, 100mg | C09CA01 | LOSARTAN ACTAVIS, õhukese polümeerikattega tablett, 30TK | Actavis Group Hf | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1207134 | losartaan, 50mg | C09CA01 | LOZAP 50, õhukese polümeerikattega tablett, 30TK | Zentiva a.s. | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1210701 | losartaan, 50mg | C09CA01 | LOZAP 50, õhukese polümeerikattega tablett, 60TK | Zentiva a.s. | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1013735 | losartaan, 50mg | C09CA01 | LORISTA, õhukese polümeerikattega tablett, 28TK | KRKA d.d., Novo Mesto | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1207134 | losartaan, 50mg | C09CA01 | LOZAP 50, õhukese polümeerikattega tablett, 30TK | Zentiva a.s. | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1210701 | losartaan, 50mg | C09CA01 | LOZAP 50, õhukese polümeerikattega tablett, 60TK | Zentiva a.s. | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1297391 | losartaan, 50mg | C09CA01 | LOSARTAN ACTAVIS, õhukese polümeerikattega tablett, 30TK | Actavis Group Hf | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1297391 | losartaan, 50mg | C09CA01 | LOSARTAN ACTAVIS, õhukese polümeerikattega tablett, 30TK | Actavis Group Hf | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1166059 | losartaan+hüdrokloroti asiid, 50mg+12,5mg | C09DA01 | LORISTA H, õhukese polümeerikattega tablett, 28TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15 | | | | | |

| 1217809 | losartaan+hüdrokloroti asiid, 50mg+12,5mg | C09DA01 | LOZAP H, õhukese polümeerikattega tablett, 30TK | Zentiva, k.s. | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 50 | | | | | | |

| 1185195 | loteprednool, 0,5% | S01BA14 | LOTEMAX, silmatilgad, suspensioon, 5ml 1TK | DR. GERHARD MANN CHEM.-PHARM. FABRIK GmbH | 50 | | | | | | |

| 1029417 | lühikese toimeajaga humaaninsuliin, 100RÜ 1ml | A10AB01 | HUMULIN R, süstelahus kolbampullis, 3ml 5TK | Eli Lilly Holdings Limited | 50 | | | | | | |

| | | | | | 100 | O24-O24, E13-E14, E10-E11, P70.2- P70.2, E89.1-E89.1 | | | | | |

| 1127797 | mangaanglükonaat+ra ud(II)glükonaat+vaskgl ükonaat, 0,133mg 1ml+5mg 1ml+0,07mg 1ml | B03AE81 | TOT'HEMA, suukaudne lahus, 10ml 20TK | LABORATOIRE INNOTECH INTERNATIONAL | 50 | D50-D50 | | | | 3,00 | |

| | | | | | 75 | D50-D50 | | | | | rasedatele |

| 1029417 | lühikese toimeajaga humaaninsuliin, 100RÜ 1ml | A10AB01 | HUMULIN R, süstelahus kolbampullis, 3ml 5TK | Eli Lilly Holdings Limited | 100 | O24-O24, E13-E14, E10-E11, P70.2- P70.2, E89.1-E89.1 | | | | | |

| | | | | | 50 | | | | | | |

| 1007222 | mebendasool, 100mg | P02CA01 | VERMOX 100 MG, tablett, 6TK | Gedeon Richter Plc. | 50 | | | | | | |

| 1136696 | mebeveriin, 200mg | A03AA04 | DUSPATALIN, toimeainet prolongeeritult vabastav kõvakapsel, 30TK | Abbott Healthcare Products B.V. | 50 | | | | | | |

| 1009044 | medroksüprogesteroon , 10mg | G03DA02 | PROVERA, tablett, 40TK | Pfizer Enterprises SARL | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| | | | | | 100 | C00-D48 | Onkoloog | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | D18.1-D18.1 | Onkoloog, Pulmonoloog | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | D18.1-D18.1 | Pulmonoloog, Onkoloog | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 100 | D18.1-D18.1 | Onkoloog, Pulmonoloog | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | C00-D48 | Onkoloog | | | | |

| | | | | | 100 | D18.1-D18.1 | Onkoloog, Pulmonoloog | | | | |

| 1013195 | medroksüprogesteroon , 500mg | L02AB02 | FARLUTAL, tablett, 30TK | Pfizer Enterprises SARL | 50 | | | | | | |

| | | | | | 100 | C00-D48 | Onkoloog | | | | |

| 1013195 | medroksüprogesteroon , 500mg | L02AB02 | FARLUTAL, tablett, 30TK | Pfizer Enterprises SARL | 100 | C00-D48 | Onkoloog | | | | |

| | | | | | 50 | | | | | | |

| 1009022 | medroksüprogesteroon , 5mg | G03DA02 | PROVERA, tablett, 24TK | Pfizer Enterprises SARL | 50 | | | | | | |

| 1004410 | melfalaan, 2mg | L01AA03 | ALKERAN, õhukese polümeerikattega tablett, 25TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 50 | | | | | | |

| | | | | | 100 | C00-D48 | Onkoloog, Hematoloog | | | | |

| 1004410 | melfalaan, 2mg | L01AA03 | ALKERAN, õhukese polümeerikattega tablett, 25TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 100 | C00-D48 | Onkoloog, Hematoloog | | | | |

| | | | | | 50 | | | | | | |

| 1149779 | meloksikaam, 15mg | M01AC06 | MEXOLAN 15 MG, tablett, 30TK | LANNACHER HEILMITTEL GmbH | 50 | | | | | | |

| 1035021 | meloksikaam, 15mg | M01AC06 | MOVALIS, tablett, 20TK | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | 50 | | | | | | |

| 1140680 | meloksikaam, 15mg | M01AC06 | MELOX 15MG, tablett, 20TK | Medochemie Ltd | 50 | | | | | | |

| 1149779 | meloksikaam, 15mg | M01AC06 | MEXOLAN 15 MG, tablett, 30TK | LANNACHER HEILMITTEL GmbH | 50 | | | | | | |

| 1175936 | meloksikaam, 15mg | M01AC06 | RECOXA 15, tablett, 20TK | Zentiva, k.s. | 50 | | | | | | |

| 1189199 | meloksikaam, 15mg | M01AC06 | LORMED 15 MG, tablett, 20TK | PRO. MED. CS. PRAHA a.s. | 50 | | | | | | |

| 1192261 | meloksikaam, 15mg | M01AC06 | MELOXICAM SANDOZ 15 MG, tablett, 20TK | Sandoz d.d. | 50 | | | | | | |

| 1240254 | meloksikaam, 15mg | M01AC06 | RECOXA 15, tablett, 60TK | Zentiva, k.s. | 50 | | | | | | |

| 1360189 | meloksikaam, 15mg | M01AC06 | MELOXICAM-RATIOPHARM 15 MG, tablett, 20TK | ratiopharm GmbH | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1149746 | meloksikaam, 7,5mg | M01AC06 | MEXOLAN 7,5 MG, tablett, 30TK | LANNACHER HEILMITTEL GmbH | 50 | | | | | | |

| 1035009 | meloksikaam, 7,5mg | M01AC06 | MOVALIS, tablett, 20TK | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | 50 | | | | | | |

| 1140679 | meloksikaam, 7,5mg | M01AC06 | MELOX 7,5MG, tablett, 30TK | Medochemie Ltd | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1146350 | meloksikaam, 7,5mg | M01AC06 | MOVALIS, tablett, 50TK | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | 50 | | | | | | |

| 1149746 | meloksikaam, 7,5mg | M01AC06 | MEXOLAN 7,5 MG, tablett, 30TK | LANNACHER HEILMITTEL GmbH | 50 | | | | | | |

| 1175914 | meloksikaam, 7,5mg | M01AC06 | RECOXA 7,5, tablett, 20TK | Zentiva, k.s. | 50 | | | | | | |

| 1189043 | meloksikaam, 7,5mg | M01AC06 | LORMED 7,5 MG, tablett, 20TK | PRO. MED. CS. PRAHA a.s. | 50 | | | | | | |

| 1189076 | meloksikaam, 7,5mg | M01AC06 | LORMED 7,5 MG, tablett, 50TK | PRO. MED. CS. PRAHA a.s. | 50 | | | | | | |

| 1192227 | meloksikaam, 7,5mg | M01AC06 | MELOXICAM SANDOZ 7,5 MG, tablett, 50TK | Sandoz d.d. | 50 | | | | | | |

| 1360134 | meloksikaam, 7,5mg | M01AC06 | MELOXICAM-RATIOPHARM 7,5 MG, tablett, 20TK | ratiopharm GmbH | 50 | | | | | | |

| 1360156 | meloksikaam, 7,5mg | M01AC06 | MELOXICAM-RATIOPHARM 7,5 MG, tablett, 50TK | ratiopharm GmbH | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| 1006007 | melperoon, 25mg | N05AD03 | BURONIL, kaetud tablett, 100TK | Lundbeck Pharmaceuticals Ireland Limited | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1006030 | melperoon, 50mg | N05AD03 | BURONIL, kaetud tablett, 100TK | Lundbeck Pharmaceuticals Ireland Limited | 50 | | | | | | |

| 1123524 | memantiin, 10mg | N06DX01 | AXURA, õhukese polümeerikattega tablett, 28TK | Merz Pharmaceuticals GmbH | 50 | | | | | | |

| 1123535 | memantiin, 10mg | N06DX01 | AXURA, õhukese polümeerikattega tablett, 56TK | Merz Pharmaceuticals GmbH | 50 | | | | | | |

| 1004971 | merkaptopuriin, 50mg | L01BB02 | PURI-NETHOL, tablett, 25TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 50 | | | | | | |

| | | | | | 100 | C00-D48 | Hematoloog, Onkoloog | | | | |

| 1023815 | mesalasiin, 1g | A07EC02 | PENTASA, rektaalsuposiit, 28TK | Ferring Lääkkeet Oy | 50 | | | | | | |

| 1004971 | merkaptopuriin, 50mg | L01BB02 | PURI-NETHOL, tablett, 25TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 100 | C00-D48 | Hematoloog, Onkoloog | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1352810 | mesalasiin, 1g | A07EC02 | PENTASA 1G, toimeainet prolongeeritult vabastavad graanulid, 50TK | Ferring Lääkkeet Oy | 50 | | | | | | |

| 1352854 | mesalasiin, 2g | A07EC02 | PENTASA 2G, toimeainet prolongeeritult vabastavad graanulid, 60TK | Ferring Lääkkeet Oy | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1352854 | mesalasiin, 2g | A07EC02 | PENTASA 2G, toimeainet prolongeeritult vabastavad graanulid, 60TK | Ferring Lääkkeet Oy | 50 | | | | | | |

| 1146574 | mesalasiin, 400mg | A07EC02 | ASACOL 400MG, toimeainet modifitseeritult vabastav tablett, 100TK | Tillotts Pharma AB | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1044829 | mesalasiin, 500mg | A07EC02 | SALOFALK, rektaalsuposiit, 10TK | Dr. Falk Pharma GmbH | 50 | | | | | | |

| 1044841 | mesalasiin, 500mg | A07EC02 | SALOFALK, gastroresistentne tablett, 50TK | Dr. Falk Pharma GmbH | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1146541 | mesalasiin, 500mg | A07EC02 | ASACOL, rektaalsuposiit, 20TK | Tillotts Pharma AB | 50 | | | | | | |

| 1146541 | mesalasiin, 500mg | A07EC02 | ASACOL, rektaalsuposiit, 20TK | Tillotts Pharma AB | 50 | | | | | | |

| 1184970 | mesalasiin, 800mg | A07EC02 | ASACOL 800 MG, toimeainet modifitseeritult vabastav tablett, 50TK | Tillotts Pharma AB | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1034109 | metadoon, 1mg 1ml | N07BC02 | METADON DAK 1 MG/ML, suukaudne lahus, 1000ml 1TK | Nycomed Sefa AS | 50 | | | | | | |

| | | | | | 100 | C00-D48 | | | | | |

| 1034110 | metadoon, 20mg | N07BC02 | METADON DAK, tablett, 25TK | Nycomed Sefa AS | 50 | | | | | | |

| | | | | | 100 | C00-D48 | | | | | |

| 1164798 | metformiin, 1000mg | A10BA02 | METFORAL 1000, õhukese polümeerikattega tablett, 120TK | Berlin-Chemie AG (Menarini Group) | 50 | | | | | | |

| | | | | | 75 | E14-E14, E11-E11 | | | | | |

| 1164798 | metformiin, 1000mg | A10BA02 | METFORAL 1000, õhukese polümeerikattega tablett, 120TK | Berlin-Chemie AG (Menarini Group) | 75 | E14-E14, E11-E11 | | | | | |

| | | | | | 50 | | | | | | |

| 1302949 | metformiin, 1000mg | A10BA02 | METFOGAMMA 1000, õhukese polümeerikattega tablett, 120TK | WÖRWAG PHARMA GmbH & Co. KG | 50 | | | | | | |

| | | | | | 75 | E14-E14, E11-E11 | | | | | |

| 1064719 | metformiin, 500mg | A10BA02 | METFORAL 500 MG, õhukese polümeerikattega tablett, 120TK | Berlin-Chemie AG (Menarini Group) | 50 | | | | | | |

| 1064719 | metformiin, 500mg | A10BA02 | METFORAL 500 MG, õhukese polümeerikattega tablett, 120TK | Berlin-Chemie AG (Menarini Group) | 75 | E14-E14, E11-E11 | | | | | |

| | | | | | 50 | | | | | | |

| 1083169 | metformiin, 500mg | A10BA02 | METFORMIN-RATIOPHARM 500 MG, õhukese polümeerikattega tablett, 120TK | ratiopharm GmbH | 50 | | | | | | |

| | | | | | 75 | E14-E14, E11-E11 | | | | | |

| 1083169 | metformiin, 500mg | A10BA02 | METFORMIN-RATIOPHARM 500 MG, õhukese polümeerikattega tablett, 120TK | ratiopharm GmbH | 75 | E14-E14, E11-E11 | | | | | |

| | | | | | 50 | | | | | | |

| 1116380 | metformiin, 500mg | A10BA02 | METFOGAMMA 500, õhukese polümeerikattega tablett, 120TK | WÖRWAG PHARMA GmbH & Co. KG | 50 | | | | | | |

| | | | | | 75 | E14-E14, E11-E11 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1302983 | metformiin, 500mg | A10BA02 | METFORMIN SANDOZ 500 MG, tablett, 120TK | Sandoz GmbH | 50 | | | | | | |

| | | | | | 75 | E14-E14, E11-E11 | | | | | |

| 1064731 | metformiin, 850mg | A10BA02 | METFORAL 850 MG, õhukese polümeerikattega tablett, 120TK | Berlin-Chemie AG (Menarini Group) | 50 | | | | | | |

| | | | | | 75 | E14-E14, E11-E11 | | | | | |

| 1083158 | metformiin, 850mg | A10BA02 | METFORMIN-RATIOPHARM 850 MG, õhukese polümeerikattega tablett, 120TK | ratiopharm GmbH | 75 | E14-E14, E11-E11 | | | | | |

| | | | | | 50 | | | | | | |

| 1111262 | metformiin, 850mg | A10BA02 | METFOGAMMA 850, õhukese polümeerikattega tablett, 120TK | WÖRWAG PHARMA GmbH & Co. KG | 75 | E14-E14, E11-E11 | | | | | |

| | | | | | 50 | | | | | | |

| 1156609 | metformiin, 850mg | A10BA02 | METFORMIN SANDOZ 850 MG, õhukese polümeerikattega tablett, 120TK | Sandoz GmbH | 50 | | | | | | |

| 1083158 | metformiin, 850mg | A10BA02 | METFORMIN-RATIOPHARM 850 MG, õhukese polümeerikattega tablett, 120TK | ratiopharm GmbH | 50 | | | | | | |

| | | | | | 75 | E14-E14, E11-E11 | | | | | |

| 1111262 | metformiin, 850mg | A10BA02 | METFOGAMMA 850, õhukese polümeerikattega tablett, 120TK | WÖRWAG PHARMA GmbH & Co. KG | 50 | | | | | | |

| | | | | | 75 | E14-E14, E11-E11 | | | | | |

| 1156609 | metformiin, 850mg | A10BA02 | METFORMIN SANDOZ 850 MG, õhukese polümeerikattega tablett, 120TK | Sandoz GmbH | 75 | E14-E14, E11-E11 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1360965 | metformiin+sitagliptiin, 850mg+50mg | A10BD07 | JANUMET, õhukese polümeerikattega tablett, 56TK | Merck Sharp & Dohme Limited | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1000674 | metoklopramiid, 10mg | A03FA01 | CERUCAL, tablett, 50TK | AWD. pharma GmbH & Co.KG | 100 | C00-D48 | | | | | |

| | | | | | 50 | | | | | | |

| 1000742 | metoklopramiid, 5mg 1ml | A03FA01 | CERUCAL, süstelahus, 2ml 10TK | AWD. Pharma GmbH & Co. KG | 50 | | | | | | |

| | | | | | 100 | C00-D48 | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1370540 | metoksüpolüetüleenglü kool-beetaepoetiin, 120mcg 0,3ml | B03XA03 | MIRCERA, süstelahus süstlis, 0.3ml 1TK | Roche Registration Limited | 50 | | | | | | |

| 1327665 | metoksüpolüetüleenglü kool-beetaepoetiin, 200mcg 0,3ml | B03XA03 | MIRCERA, süstelahus süstlis, 0.3ml 1TK | Roche Registration Limited | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| 1370472 | metoksüpolüetüleenglü kool-beetaepoetiin, 30mcg 0,3ml | B03XA03 | MIRCERA, süstelahus süstlis, 0.3ml 1TK | Roche Registration Limited | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1327621 | metoksüpolüetüleenglü kool-beetaepoetiin, 50mcg 0,3ml | B03XA03 | MIRCERA, süstelahus süstlis, 0.3ml 1TK | Roche Registration Limited | 50 | | | | | | |

| 1327632 | metoksüpolüetüleenglü kool-beetaepoetiin, 75mcg 0,3ml | B03XA03 | MIRCERA, süstelahus süstlis, 0.3ml 1TK | Roche Registration Limited | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1010811 | metoprolool, 100mg | C07AB02 | EMZOK, toimeainet prolongeeritult vabastav tablett, 30TK | TEVA Czech Industries s.r.o. | 75 | I50-I50 | Kardioloog, Pediaater | esmane | | | |

| | | | | | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1019720 | metoprolool, 100mg | C07AB02 | BETALOC ZOK 100, toimeainet prolongeeritult vabastav tablett, 30TK | AstraZeneca AB | 50 | | | | | | |

| | | | | | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 75 | I50-I50 | Kardioloog, Pediaater | esmane | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1224278 | metoprolool, 100mg | C07AB02 | METOZOK, toimeainet prolongeeritult vabastav tablett, 30TK | Sandoz d.d. | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | I50-I50 | Kardioloog, Pediaater | esmane | | | |

| 1282249 | metoprolool, 100mg | C07AB02 | METOPROLOL- RATIOPHARM RETARD 100 MG, toimeainet prolongeeritult vabastav tablett, 30TK | ratiopharm GmbH | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 75 | I50-I50 | Kardioloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| 1296592 | metoprolool, 100mg | C07AB02 | METOPROLOL POLPHARMA 100, toimeainet prolongeeritult vabastav tablett, 28TK | Pharmaceutical Works Polpharma S.A. | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1282249 | metoprolool, 100mg | C07AB02 | METOPROLOL- RATIOPHARM RETARD 100 MG, toimeainet prolongeeritult vabastav tablett, 30TK | ratiopharm GmbH | 75 | I50-I50 | Kardioloog, Pediaater | esmane | | | |

| | | | | | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1296592 | metoprolool, 100mg | C07AB02 | METOPROLOL POLPHARMA 100, toimeainet prolongeeritult vabastav tablett, 28TK | Pharmaceutical Works Polpharma S.A. | 75 | I50-I50 | Pediaater, Kardioloog | esmane | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| 1297043 | metoprolool, 100mg | C07AB02 | SPESIMAX, toimeainet prolongeeritult vabastav tablett, 30TK | Nycomed Sefa AS | 50 | | | | | | |

| | | | | | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 75 | I50-I50 | Pediaater, Kardioloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1297043 | metoprolool, 100mg | C07AB02 | SPESIMAX, toimeainet prolongeeritult vabastav tablett, 30TK | Nycomed Sefa AS | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | I50-I50 | Pediaater, Kardioloog | esmane | | | |

| 1282452 | metoprolool, 200mg | C07AB02 | METOPROLOL- RATIOPHARM RETARD 200 MG, toimeainet prolongeeritult vabastav tablett, 30TK | ratiopharm GmbH | 75 | I50-I50 | Pediaater, Kardioloog | esmane | | | |

| 1282452 | metoprolool, 200mg | C07AB02 | METOPROLOL- RATIOPHARM RETARD 200 MG, toimeainet prolongeeritult vabastav tablett, 30TK | ratiopharm GmbH | 75 | I50-I50 | Kardioloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| 1296705 | metoprolool, 200mg | C07AB02 | METOPROLOL POLPHARMA 200, toimeainet prolongeeritult vabastav tablett, 28TK | Pharmaceutical Works Polpharma S.A. | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | I50-I50 | Pediaater, Kardioloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1083406 | metoprolool, 25mg | C07AB02 | BETALOC ZOK 25, toimeainet prolongeeritult vabastav tablett, 28TK | AstraZeneca AB | 50 | | | | | | |

| | | | | | 75 | I50-I50 | Pediaater, Kardioloog | esmane | | | |

| 1083406 | metoprolool, 25mg | C07AB02 | BETALOC ZOK 25, toimeainet prolongeeritult vabastav tablett, 28TK | AstraZeneca AB | 75 | I50-I50 | Kardioloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1224201 | metoprolool, 25mg | C07AB02 | METOZOK, toimeainet prolongeeritult vabastav tablett, 30TK | Sandoz d.d. | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | I50-I50 | Pediaater, Kardioloog | esmane | | | |

| 1009055 | metoprolool, 50mg | C07AB02 | METOPROLOL- RATIOPHARM 50 MG, tablett, 30TK | ratiopharm GmbH | 75 | I50-I50 | Kardioloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | I50-I50 | Kardioloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1010800 | metoprolool, 50mg | C07AB02 | EMZOK, toimeainet prolongeeritult vabastav tablett, 30TK | TEVA Czech Industries s.r.o. | 50 | | | | | | |

| | | | | | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| 1010800 | metoprolool, 50mg | C07AB02 | EMZOK, toimeainet prolongeeritult vabastav tablett, 30TK | TEVA Czech Industries s.r.o. | 75 | I50-I50 | Pediaater, Kardioloog | esmane | | | |

| | | | | | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 75 | I50-I50 | Kardioloog, Pediaater | esmane | | | |

| 1009055 | metoprolool, 50mg | C07AB02 | METOPROLOL- RATIOPHARM 50 MG, tablett, 30TK | ratiopharm GmbH | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 75 | I50-I50 | Kardioloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| 1019719 | metoprolool, 50mg | C07AB02 | BETALOC ZOK 50, toimeainet prolongeeritult vabastav tablett, 30TK | AstraZeneca AB | 50 | | | | | | |

| | | | | | 75 | I50-I50 | Kardioloog, Pediaater | esmane | | | |

| | | | | | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| 1224245 | metoprolool, 50mg | C07AB02 | METOZOK, toimeainet prolongeeritult vabastav tablett, 30TK | Sandoz d.d. | 50 | | | | | | |

| | | | | | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| 1224245 | metoprolool, 50mg | C07AB02 | METOZOK, toimeainet prolongeeritult vabastav tablett, 30TK | Sandoz d.d. | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | I50-I50 | Pediaater, Kardioloog | esmane | | | |

| 1282160 | metoprolool, 50mg | C07AB02 | METOPROLOL- RATIOPHARM RETARD 50 MG, toimeainet prolongeeritult vabastav tablett, 30TK | ratiopharm GmbH | 75 | I50-I50 | Kardioloog, Pediaater | esmane | | | |

| | | | | | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1282160 | metoprolool, 50mg | C07AB02 | METOPROLOL- RATIOPHARM RETARD 50 MG, toimeainet prolongeeritult vabastav tablett, 30TK | ratiopharm GmbH | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | I50-I50 | Kardioloog, Pediaater | esmane | | | |

| 1296491 | metoprolool, 50mg | C07AB02 | METOPROLOL POLPHARMA 50, toimeainet prolongeeritult vabastav tablett, 28TK | Pharmaceutical Works Polpharma S.A. | 50 | | | | | | |

| | | | | | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 75 | I50-I50 | Kardioloog, Pediaater | esmane | | | |

| 1296930 | metoprolool, 50mg | C07AB02 | SPESIMAX, toimeainet prolongeeritult vabastav tablett, 30TK | Nycomed Sefa AS | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | I50-I50 | Pediaater, Kardioloog | esmane | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1296930 | metoprolool, 50mg | C07AB02 | SPESIMAX, toimeainet prolongeeritult vabastav tablett, 30TK | Nycomed Sefa AS | 75 | I50-I50 | Pediaater, Kardioloog | esmane | | | |

| | | | | | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1001136 | metotreksaat, 2,5mg | L04AX03 | TREXAN, õhukese polümeerikattega tablett, 100TK | Orion Corporation | 100 | C00-D48 | Onkoloog, Hematoloog | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | C00-D48 | Hematoloog, Onkoloog | | | | |

| | | | | | 50 | | | | | | |

| 1046180 | metronidasool, 7,5mg 1g | D06BX01 | ROZEX, geel, 30g 1TK | GALDERMA INTERNATIONAL | 50 | | | | | | |

| 1223749 | metronidasool, 7,5mg 1g | D06BX01 | METROSA, geel, 25g 1TK | Dr. August Wolff GmbH & Co. KG Arzneimittel | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1009099 | metüülprednisoloon, 16mg | H02AB04 | MEDROL, tablett, 50TK | Pfizer Enterprises SARL | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1009099 | metüülprednisoloon, 16mg | H02AB04 | MEDROL, tablett, 50TK | Pfizer Enterprises SARL | 100 | G35-G35 | Pediaater, Neuroloog | esmane | | | |

| | | | | | 100 | Z94-Z94, T86-T86 | | | | | |

| | | | | | 75 | N00-N08 | Nefroloog, Pediaater | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | Z94-Z94, T86-T86 | | | | | |

| 1009190 | metüülprednisoloon, 40mg 1ml | H02AB04 | DEPO-MEDROL, süstesuspensioon, 1ml 1TK | Pfizer Enterprises SARL | 100 | Z94-Z94, T86-T86 | | | | | |

| | | | | | 75 | N00-N08 | Nefroloog, Pediaater | | | | |

| | | | | | 100 | G35-G35 | Pediaater, Neuroloog | esmane | | | |

| 1009190 | metüülprednisoloon, 40mg 1ml | H02AB04 | DEPO-MEDROL, süstesuspensioon, 1ml 1TK | Pfizer Enterprises SARL | 100 | Z94-Z94, T86-T86 | | | | | |

| | | | | | 50 | | | | | | |

| 1065495 | metüülprednisoloon, 40mg 1ml | H02AB04 | DEPO-MEDROL, süstesuspensioon, 2ml 1TK | Pfizer Enterprises SARL | 100 | G35-G35 | Neuroloog, Pediaater | esmane | | | |

| | | | | | 75 | N00-N08 | Pediaater, Nefroloog | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | Z94-Z94, T86-T86 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1009077 | metüülprednisoloon, 4mg | H02AB04 | MEDROL, tablett, 30TK | Pfizer Enterprises SARL | 100 | Z94-Z94, T86-T86 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | N00-N08 | Nefroloog, Pediaater | | | | |

| | | | | | 100 | G35-G35 | Pediaater, Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1065495 | metüülprednisoloon, 40mg 1ml | H02AB04 | DEPO-MEDROL, süstesuspensioon, 2ml 1TK | Pfizer Enterprises SARL | 100 | G35-G35 | Neuroloog, Pediaater | esmane | | | |

| 1065754 | metüülprednisoloon, 4mg | H02AB04 | MEDROL, tablett, 100TK | Pfizer Enterprises SARL | 100 | Z94-Z94, T86-T86 | | | | | |

| | | | | | 75 | N00-N08 | Pediaater, Nefroloog | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | Z94-Z94, T86-T86 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 75 | N00-N08 | Nefroloog, Pediaater | | | | |

| | | | | | 100 | Z94-Z94, T86-T86 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | G35-G35 | Pediaater, Neuroloog | esmane | | | |

| 1065754 | metüülprednisoloon, 4mg | H02AB04 | MEDROL, tablett, 100TK | Pfizer Enterprises SARL | 100 | Z94-Z94, T86-T86 | | | | | |

| | | | | | 100 | G35-G35 | Pediaater, Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | N00-N08 | Pediaater, Nefroloog | | | | |

| | | | | | 100 | G35-G35 | Neuroloog, Pediaater | esmane | | | |

| 1028102 | metüülprednisoloonats eponaat, 1mg 1g | D07AC14 | ADVANTAN, kreem, 15g 1TK | Intendis GmbH | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1062009 | metüülprednisoloonats eponaat, 1mg 1g | D07AC14 | ADVANTAN, salv, 15g 1TK | Intendis GmbH | 50 | | | | | | |

| 1133356 | metüülprednisoloonats eponaat, 1mg 1g | D07AC14 | ADVANTAN MILK, nahaemulsioon, 20g 1TK | Intendis GmbH | 50 | | | | | | |

| 1024579 | mikonasool, 20mg 1g | A01AB09 | DAKTARIN, suukaudne geel, 40g 1TK | Johnson & Johnson UAB | 50 | | | | | | |

| 1013049 | milnatsipraan, 50mg | N06AX17 | IXEL, kõvakapsel, 56TK | Pierre Fabre Medicament | 50 | | | | | | |

@@ -2375,81 +2307,93 @@

| 1170199 | mirtasapiin, 45mg | N06AX11 | ESPRITAL 45, õhukese polümeerikattega tablett, 30TK | Zentiva, k.s. | 50 | | | | | | |

| 1243741 | mirtasapiin, 45mg | N06AX11 | MIRTAZAPIN ORION, suus dispergeeruv tablett, 30TK | Orion Corporation | 50 | | | | | | |

| 1155091 | moksonidiin, 0,2mg | C02AC05 | STADAPRESS, õhukese polümeerikattega tablett, 30TK | STADA ARZNEIMITTEL AG | 50 | | | | | | |

| 1013779 | moksonidiin, 0,2mg | C02AC05 | PHYSIOTENS 0,2 MG, õhukese polümeerikattega tablett, 28TK | Abbott Products GmbH | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1145999 | moksonidiin, 0,2mg | C02AC05 | MOXONIDIN HEXAL 0,2 MG, õhukese polümeerikattega tablett, 30TK | HEXAL AG | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1155091 | moksonidiin, 0,2mg | C02AC05 | STADAPRESS, õhukese polümeerikattega tablett, 30TK | STADA ARZNEIMITTEL AG | 50 | | | | | | |

| 1157778 | moksonidiin, 0,2mg | C02AC05 | MOXOGAMMA 0,2 MG, õhukese polümeerikattega tablett, 30TK | WÖRWAG PHARMA GmbH & Co. KG | 50 | | | | | | |

| 1146079 | moksonidiin, 0,3mg | C02AC05 | MOXONIDIN HEXAL 0,3 MG, õhukese polümeerikattega tablett, 30TK | HEXAL AG | 50 | | | | | | |

| 1157857 | moksonidiin, 0,3mg | C02AC05 | MOXOGAMMA 0,3 MG, õhukese polümeerikattega tablett, 30TK | WÖRWAG PHARMA GmbH & Co. KG | 50 | | | | | | |

| 1155259 | moksonidiin, 0,4mg | C02AC05 | STADAPRESS, õhukese polümeerikattega tablett, 30TK | STADA ARZNEIMITTEL AG | 50 | | | | | | |

| 1013791 | moksonidiin, 0,4mg | C02AC05 | PHYSIOTENS 0,4 MG, õhukese polümeerikattega tablett, 28TK | Abbott Products GmbH | 50 | | | | | | |

| 1146170 | moksonidiin, 0,4mg | C02AC05 | MOXONIDIN HEXAL 0,4 MG, õhukese polümeerikattega tablett, 30TK | HEXAL AG | 50 | | | | | | |

| 1155259 | moksonidiin, 0,4mg | C02AC05 | STADAPRESS, õhukese polümeerikattega tablett, 30TK | STADA ARZNEIMITTEL AG | 50 | | | | | | |

| 1157947 | moksonidiin, 0,4mg | C02AC05 | MOXOGAMMA 0,4 MG, õhukese polümeerikattega tablett, 30TK | WÖRWAG PHARMA GmbH & Co. KG | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1028955 | mometasoon, 1mg 1g | D07AC13 | ELOCON, kreem, 20g 1TK | SCHERING-PLOUGH EUROPE | 50 | | | | | | |

| 1028933 | mometasoon, 1mg 1g | D07AC13 | ELOCON, nahalahus, 20ml 1TK | SCHERING-PLOUGH EUROPE | 50 | | | | | | |

| 1028944 | mometasoon, 1mg 1g | D07AC13 | ELOCON, salv, 20g 1TK | SCHERING-PLOUGH EUROPE | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1028966 | mometasoon, 50mcg 1annust | R01AD09 | NASONEX, ninasprei, suspensioon, 18g 140annust | SCHERING-PLOUGH EUROPE | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| 1193509 | mometasoon+salitsüül hape, 1mg+50mg 1g | D07XC03 | ELOSALIC, salv, 45g 1TK | SCHERING-PLOUGH EUROPE | 50 | | | | | | |

| 1084531 | montelukast, 10mg | R03DC03 | SINGULAIR, õhukese polümeerikattega tablett, 28TK | Merck Sharp & Dohme OÜ | 50 | | | | | | |

| | | | | | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | | 11,00 | |

| | | | | | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | 11,00 | | mõõduka ja raske bronhiaalastma korral lisaks püsiravile inhaleeritava kortikosteroidi ja pikatoimelise beeta-2- adrenomimeetikumiga, kui see ei taga piisavat kontrolli astma üle, või lisaks püsiravile inhaleeritava kortikosteroidiga, kui beeta-2- adrenomimeetikum on vastunäidustatud või põhjustab talumatuid kõrvaltoimeid |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1289987 | montelukast, 10mg | R03DC03 | MONKASTA, õhukese polümeerikattega tablett, 28TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | 11,00 | |

| | | | | | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | 11,00 | | mõõduka ja raske bronhiaalastma korral lisaks püsiravile inhaleeritava kortikosteroidi ja pikatoimelise beeta-2- adrenomimeetikumiga, kui see ei taga piisavat kontrolli astma üle, või lisaks püsiravile inhaleeritava kortikosteroidiga, kui beeta-2- adrenomimeetikum on vastunäidustatud või põhjustab talumatuid kõrvaltoimeid |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1334090 | montelukast, 10mg | R03DC03 | MONTELUKAST- RATIOPHARM 10 MG, õhukese polümeerikattega tablett, 28TK | ratiopharm GmbH | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | 11,00 | |

| | | | | | 50 | | | | | | |

| 1274116 | montelukast, 10mg | R03DC03 | MONTELUKAST TEVA, õhukese polümeerikattega tablett, 28TK | Teva Pharma B.V. | 50 | | | | | | |

| | | | | | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | | 11,00 | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1289987 | montelukast, 10mg | R03DC03 | MONKASTA, õhukese polümeerikattega tablett, 28TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | | 11,00 | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1334090 | montelukast, 10mg | R03DC03 | MONTELUKAST- RATIOPHARM 10 MG, õhukese polümeerikattega tablett, 28TK | ratiopharm GmbH | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | 11,00 | | mõõduka ja raske bronhiaalastma korral lisaks püsiravile inhaleeritava kortikosteroidi ja pikatoimelise beeta-2- adrenomimeetikumiga, kui see ei taga piisavat kontrolli astma üle, või lisaks püsiravile inhaleeritava kortikosteroidiga, kui beeta-2- adrenomimeetikum on vastunäidustatud või põhjustab talumatuid kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| | | | | | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | | 11,00 | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1351752 | montelukast, 10mg | R03DC03 | MOFENSTRA, õhukese polümeerikattega tablett, 28TK | Sandoz d.d. | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | 11,00 | | mõõduka ja raske bronhiaalastma korral lisaks püsiravile inhaleeritava kortikosteroidi ja pikatoimelise beeta-2- adrenomimeetikumiga, kui see ei taga piisavat kontrolli astma üle, või lisaks püsiravile inhaleeritava kortikosteroidiga, kui beeta-2- adrenomimeetikum on vastunäidustatud või põhjustab talumatuid kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| | | | | | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | | 11,00 | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1408317 | montelukast, 10mg | R03DC03 | SPIROKAST 10MG, õhukese polümeerikattega tablett, 28TK | Zentiva, k.s. | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | 11,00 | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1077364 | montelukast, 4mg | R03DC03 | SINGULAIR 4 MG, närimistablett, 28TK | Merck Sharp & Dohme OÜ | 50 | | | | | | |

| | | | | | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | | 11,00 | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1111082 | montelukast, 4mg | R03DC03 | SINGULAIR MINI 4MG, graanulid, 28TK | Merck Sharp & Dohme OÜ | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1351752 | montelukast, 10mg | R03DC03 | MOFENSTRA, õhukese polümeerikattega tablett, 28TK | Sandoz d.d. | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | | 11,00 | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1408317 | montelukast, 10mg | R03DC03 | SPIROKAST 10MG, õhukese polümeerikattega tablett, 28TK | Zentiva, k.s. | 50 | | | | | | |

| | | | | | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | 11,00 | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1077364 | montelukast, 4mg | R03DC03 | SINGULAIR 4 MG, närimistablett, 28TK | Merck Sharp & Dohme OÜ | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | 11,00 | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1273722 | montelukast, 4mg | R03DC03 | MONTELUKAST TEVA, närimistablett, 28TK | Teva Pharma B.V. | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | 11,00 | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1111082 | montelukast, 4mg | R03DC03 | SINGULAIR MINI 4MG, graanulid, 28TK | Merck Sharp & Dohme OÜ | 50 | | | | | | |

| 1289718 | montelukast, 4mg | R03DC03 | MONKASTA, närimistablett, 28TK | KRKA d.d., Novo Mesto | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | 11,00 | | mõõduka ja raske bronhiaalastma korral lisaks püsiravile inhaleeritava kortikosteroidi ja pikatoimelise beeta-2- adrenomimeetikumiga, kui see ei taga piisavat kontrolli astma üle, või lisaks püsiravile inhaleeritava kortikosteroidiga, kui beeta-2- adrenomimeetikum on vastunäidustatud või põhjustab talumatuid kõrvaltoimeid |

| | | | | | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | 11,00 | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1289718 | montelukast, 4mg | R03DC03 | MONKASTA, närimistablett, 28TK | KRKA d.d., Novo Mesto | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | | 11,00 | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1333819 | montelukast, 4mg | R03DC03 | MONTELUKAST- RATIOPHARM 4MG, närimistablett, 28TK | ratiopharm GmbH | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1333819 | montelukast, 4mg | R03DC03 | MONTELUKAST- RATIOPHARM 4MG, närimistablett, 28TK | ratiopharm GmbH | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | 11,00 | | mõõduka ja raske bronhiaalastma korral lisaks püsiravile inhaleeritava kortikosteroidi ja pikatoimelise beeta-2- adrenomimeetikumiga, kui see ei taga piisavat kontrolli astma üle, või lisaks püsiravile inhaleeritava kortikosteroidiga, kui beeta-2- adrenomimeetikum on vastunäidustatud või põhjustab talumatuid kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| | | | | | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | 11,00 | |

@@ -2460,110 +2404,124 @@

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1408250 | montelukast, 4mg | R03DC03 | SPIROKAST 4MG, närimistablett, 28TK | Zentiva, k.s. | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | 11,00 | | mõõduka ja raske bronhiaalastma korral lisaks püsiravile inhaleeritava kortikosteroidi ja pikatoimelise beeta-2- adrenomimeetikumiga, kui see ei taga piisavat kontrolli astma üle, või lisaks püsiravile inhaleeritava kortikosteroidiga, kui beeta-2- adrenomimeetikum on vastunäidustatud või põhjustab talumatuid kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1077331 | montelukast, 5mg | R03DC03 | SINGULAIR, närimistablett, 28TK | Merck Sharp & Dohme OÜ | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | 11,00 | | mõõduka ja raske bronhiaalastma korral lisaks püsiravile inhaleeritava kortikosteroidi ja pikatoimelise beeta-2- adrenomimeetikumiga, kui see ei taga piisavat kontrolli astma üle, või lisaks püsiravile inhaleeritava kortikosteroidiga, kui beeta-2- adrenomimeetikum on vastunäidustatud või põhjustab talumatuid kõrvaltoimeid |

| | | | | | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | | 11,00 | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1273845 | montelukast, 5mg | R03DC03 | MONTELUKAST TEVA, närimistablett, 28TK | Teva Pharma B.V. | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | 11,00 | | mõõduka ja raske bronhiaalastma korral lisaks püsiravile inhaleeritava kortikosteroidi ja pikatoimelise beeta-2- adrenomimeetikumiga, kui see ei taga piisavat kontrolli astma üle, või lisaks püsiravile inhaleeritava kortikosteroidiga, kui beeta-2- adrenomimeetikum on vastunäidustatud või põhjustab talumatuid kõrvaltoimeid |

| | | | | | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | 11,00 | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1077331 | montelukast, 5mg | R03DC03 | SINGULAIR, närimistablett, 28TK | Merck Sharp & Dohme OÜ | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | 11,00 | | mõõduka ja raske bronhiaalastma korral lisaks püsiravile inhaleeritava kortikosteroidi ja pikatoimelise beeta-2- adrenomimeetikumiga, kui see ei taga piisavat kontrolli astma üle, või lisaks püsiravile inhaleeritava kortikosteroidiga, kui beeta-2- adrenomimeetikum on vastunäidustatud või põhjustab talumatuid kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1289831 | montelukast, 5mg | R03DC03 | MONKASTA, närimistablett, 28TK | KRKA d.d., Novo Mesto | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | 11,00 | | mõõduka ja raske bronhiaalastma korral lisaks püsiravile inhaleeritava kortikosteroidi ja pikatoimelise beeta-2- adrenomimeetikumiga, kui see ei taga piisavat kontrolli astma üle, või lisaks püsiravile inhaleeritava kortikosteroidiga, kui beeta-2- adrenomimeetikum on vastunäidustatud või põhjustab talumatuid kõrvaltoimeid |

| | | | | | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | 11,00 | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1289831 | montelukast, 5mg | R03DC03 | MONKASTA, närimistablett, 28TK | KRKA d.d., Novo Mesto | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | | 11,00 | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1333954 | montelukast, 5mg | R03DC03 | MONTELUKAST- RATIOPHARM 5MG, närimistablett, 28TK | ratiopharm GmbH | 50 | | | | | | |

| | | | | | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | 11,00 | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1333954 | montelukast, 5mg | R03DC03 | MONTELUKAST- RATIOPHARM 5MG, närimistablett, 28TK | ratiopharm GmbH | 50 | | | | | | |

| | | | | | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | 11,00 | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1379370 | montelukast, 5mg | R03DC03 | MOFENSTRA, närimistablett, 28TK | Sandoz d.d. | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | 11,00 | | mõõduka ja raske bronhiaalastma korral lisaks püsiravile inhaleeritava kortikosteroidi ja pikatoimelise beeta-2- adrenomimeetikumiga, kui see ei taga piisavat kontrolli astma üle, või lisaks püsiravile inhaleeritava kortikosteroidiga, kui beeta-2- adrenomimeetikum on vastunäidustatud või põhjustab talumatuid kõrvaltoimeid |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1379370 | montelukast, 5mg | R03DC03 | MOFENSTRA, närimistablett, 28TK | Sandoz d.d. | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | 11,00 | | mõõduka ja raske bronhiaalastma korral lisaks püsiravile inhaleeritava kortikosteroidi ja pikatoimelise beeta-2- adrenomimeetikumiga, kui see ei taga piisavat kontrolli astma üle, või lisaks püsiravile inhaleeritava kortikosteroidiga, kui beeta-2- adrenomimeetikum on vastunäidustatud või põhjustab talumatuid kõrvaltoimeid |

| | | | | | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | | 11,00 | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1408283 | montelukast, 5mg | R03DC03 | SPIROKAST 5MG, närimistablett, 28TK | Zentiva, k.s. | 50 | | | | | | |

| | | | | | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | 11,00 | |

| 1035740 | morfiin, 100mg | N02AA01 | VENDAL RETARD 100 MG, toimeainet prolongeeritult vabastav tablett, 30TK | LANNACHER HEILMITTEL GmbH | 50 | | | | | | |

| 1035740 | morfiin, 100mg | N02AA01 | VENDAL RETARD 100 MG, toimeainet prolongeeritult vabastav tablett, 30TK | LANNACHER HEILMITTEL GmbH | 100 | C00-D48 | | | | | |

| | | | | | 50 | | | | | | |

| 1035717 | morfiin, 10mg | N02AA01 | VENDAL RETARD 10 MG, toimeainet prolongeeritult vabastav tablett, 30TK | LANNACHER HEILMITTEL GmbH | 100 | C00-D48 | | | | | |

| | | | | | 50 | | | | | | |

| 1382284 | morfiin, 10mg | N02AA01 | SEVREDOL, õhukese polümeerikattega tablett, 60TK | MUNDIPHARMA Ges.m.b.H. | 100 | C00-D48 | | | | | |

| | | | | | 50 | | | | | | |

| 1339376 | morfiin, 120mg | N02AA01 | MXL 120 MG, toimeainet prolongeeritult vabastav kõvakapsel, 30TK | MUNDIPHARMA Ges.m.b.H. | 50 | | | | | | |

| | | | | | 100 | C00-D48 | | | | | |

| 1035717 | morfiin, 10mg | N02AA01 | VENDAL RETARD 10 MG, toimeainet prolongeeritult vabastav tablett, 30TK | LANNACHER HEILMITTEL GmbH | 100 | C00-D48 | | | | | |

| | | | | | 50 | | | | | | |

| 1382284 | morfiin, 10mg | N02AA01 | SEVREDOL, õhukese polümeerikattega tablett, 60TK | MUNDIPHARMA Ges.m.b.H. | 100 | C00-D48 | | | | | |

| | | | | | 50 | | | | | | |

| 1339376 | morfiin, 120mg | N02AA01 | MXL 120 MG, toimeainet prolongeeritult vabastav kõvakapsel, 30TK | MUNDIPHARMA Ges.m.b.H. | 100 | C00-D48 | | | | | |

| | | | | | 50 | | | | | | |

| 1382307 | morfiin, 20mg | N02AA01 | SEVREDOL, õhukese polümeerikattega tablett, 60TK | MUNDIPHARMA Ges.m.b.H. | 50 | | | | | | |

| | | | | | 100 | C00-D48 | | | | | |

| 1043222 | morfiin, 20mg 1ml | N02AA01 | MORFIN DAK 20 MG/ML, süstelahus, 1ml 10TK | Nycomed Sefa AS | 100 | C00-D48 | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1014051 | morfiin, 30mg | N02AA01 | DOLTARD, toimeainet prolongeeritult vabastav tablett, 20TK | Nycomed Sefa AS | 50 | | | | | | |

| 1043222 | morfiin, 20mg 1ml | N02AA01 | MORFIN DAK 20 MG/ML, süstelahus, 1ml 10TK | Nycomed Sefa AS | 50 | | | | | | |

| | | | | | 100 | C00-D48 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1014051 | morfiin, 30mg | N02AA01 | DOLTARD, toimeainet prolongeeritult vabastav tablett, 20TK | Nycomed Sefa AS | 100 | C00-D48 | | | | | |

| | | | | | 50 | | | | | | |

| 1035728 | morfiin, 30mg | N02AA01 | VENDAL RETARD 30 MG, toimeainet prolongeeritult vabastav tablett, 30TK | LANNACHER HEILMITTEL GmbH | 100 | C00-D48 | | | | | |

| | | | | | 50 | | | | | | |

| 1080289 | morfiin, 30mg | N02AA01 | MST CONTINUS 30 MG, suukaudse suspensiooni toimeainet prolongeeritult vabastavad graanulid, 30TK | MUNDIPHARMA Ges.m.b.H. | 50 | | | | | | |

| | | | | | 100 | C00-D48 | | | | | |

| 1339422 | morfiin, 30mg | N02AA01 | MXL 30 MG, toimeainet prolongeeritult vabastav kõvakapsel, 30TK | MUNDIPHARMA Ges.m.b.H. | 50 | | | | | | |

| | | | | | 100 | C00-D48 | | | | | |

| 1014062 | morfiin, 60mg | N02AA01 | DOLTARD, toimeainet prolongeeritult vabastav tablett, 20TK | Nycomed Sefa AS | 100 | C00-D48 | | | | | |

| | | | | | 50 | | | | | | |

| 1035739 | morfiin, 60mg | N02AA01 | VENDAL RETARD 60 MG, toimeainet prolongeeritult vabastav tablett, 30TK | LANNACHER HEILMITTEL GmbH | 100 | C00-D48 | | | | | |

| | | | | | 50 | | | | | | |

| 1164642 | mükofenoolhape, 180mg | L04AA06 | MYFORTIC, gastroresistentne tablett, 120TK | Novartis Finland OY | 50 | | | | | | |

| 1014062 | morfiin, 60mg | N02AA01 | DOLTARD, toimeainet prolongeeritult vabastav tablett, 20TK | Nycomed Sefa AS | 50 | | | | | | |

| | | | | | 100 | C00-D48 | | | | | |

| 1035739 | morfiin, 60mg | N02AA01 | VENDAL RETARD 60 MG, toimeainet prolongeeritult vabastav tablett, 30TK | LANNACHER HEILMITTEL GmbH | 50 | | | | | | |

| | | | | | 100 | C00-D48 | | | | | |

| 1164642 | mükofenoolhape, 180mg | L04AA06 | MYFORTIC, gastroresistentne tablett, 120TK | Novartis Finland OY | 100 | Z94-Z94, T86-T86 | | | | | |

| | | | | | 50 | | | | | | |

| 1023556 | mükofenoolhape, 250mg | L04AA06 | CELLCEPT, kõvakapsel, 100TK | Roche Registration Limited | 50 | | | | | | |

| | | | | | 100 | Z94-Z94, T86-T86 | | | | | |

| 1023556 | mükofenoolhape, 250mg | L04AA06 | CELLCEPT, kõvakapsel, 100TK | Roche Registration Limited | 100 | Z94-Z94, T86-T86 | | | | | |

| | | | | | 50 | | | | | | |

| 1343258 | mükofenoolhape, 250mg | L04AA06 | MYFENAX, kõvakapsel, 100TK | Teva Pharma B.V. | 100 | Z94-Z94, T86-T86 | | | | | |

| | | | | | 50 | | | | | | |

| 1164697 | mükofenoolhape, 360mg | L04AA06 | MYFORTIC, gastroresistentne tablett, 120TK | Novartis Finland OY | 100 | Z94-Z94, T86-T86 | | | | | |

| | | | | | 50 | | | | | | |

| 1088344 | mükofenoolhape, 500mg | L04AA06 | CELLCEPT, õhukese polümeerikattega tablett, 50TK | Roche Registration Limited | 50 | | | | | | |

| | | | | | 100 | Z94-Z94, T86-T86 | | | | | |

| 1287930 | mükofenoolhape, 500mg | L04AA06 | MYCOPHENOLATE MOFETIL SANDOZ 500MG, õhukese polümeerikattega tablett, 50TK | Sandoz d.d. | 100 | Z94-Z94, T86-T86 | | | | | |

| | | | | | 50 | | | | | | |

| 1343270 | mükofenoolhape, 500mg | L04AA06 | MYFENAX, õhukese polümeerikattega tablett, 50TK | Teva Pharma B.V. | 50 | | | | | | |

| | | | | | 100 | Z94-Z94, T86-T86 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1193127 | naatriumbemipariin, 2500RÜ anti Xa 0,2ml | B01AB12 | ZIBOR, süstelahus, 10TK | Menarini International Operations Luxembourg S.A. | 50 | | | | | | |

| 1193172 | naatriumbemipariin, 3500RÜ anti Xa 0,2ml | B01AB12 | ZIBOR, süstelahus, 10TK | Menarini International Operations Luxembourg S.A. | 50 | | | | | | |

| 1088344 | mükofenoolhape, 500mg | L04AA06 | CELLCEPT, õhukese polümeerikattega tablett, 50TK | Roche Registration Limited | 100 | Z94-Z94, T86-T86 | | | | | |

| | | | | | 50 | | | | | | |

| 1343270 | mükofenoolhape, 500mg | L04AA06 | MYFENAX, õhukese polümeerikattega tablett, 50TK | Teva Pharma B.V. | 100 | Z94-Z94, T86-T86 | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 100 | O99.8-O99.8 | | | | | |

| | | | | | 50 | | | | | | |

| 1455230 | naatriumbemipariin, 25000RÜ anti Xa 1ml | B01AB12 | ZIBOR, süstelahus, 0.4ml 2TK | Menarini International Operations Luxembourg S.A. | 50 | | | | | | |

| | | | | | 100 | O99.8-O99.8 | | | | | |

| | | | | | 100 | O99.8-O99.8 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | O99.8-O99.8 | | | | | |

| 1012598 | naatriumdaltepariin, 10000RÜ anti Xa 0,4ml | B01AB04 | FRAGMIN, süstelahus, 5TK | Pfizer Enterprises SARL | 50 | | | | | | |

| | | | | | 75 | O99.8-O99.8 | | | | | |

| 1003914 | naatriumdaltepariin, 12500RÜ anti Xa 1ml | B01AB04 | FRAGMIN, süstelahus, 0.2ml 10TK | Pfizer Enterprises SARL | 75 | O99.8-O99.8 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | O99.8-O99.8 | | | | | |

| 1003914 | naatriumdaltepariin, 12500RÜ anti Xa 1ml | B01AB04 | FRAGMIN, süstelahus, 0.2ml 10TK | Pfizer Enterprises SARL | 100 | O99.8-O99.8 | | | | | |

| 1003969 | naatriumdaltepariin, 25000RÜ anti Xa 1ml | B01AB04 | FRAGMIN, süstelahus, 0.2ml 10TK | Pfizer Enterprises SARL | 75 | O99.8-O99.8 | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1003969 | naatriumdaltepariin, 25000RÜ anti Xa 1ml | B01AB04 | FRAGMIN, süstelahus, 0.2ml 10TK | Pfizer Enterprises SARL | 100 | O99.8-O99.8 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1012587 | naatriumdaltepariin, 7500RÜ anti Xa 0,3ml | B01AB04 | FRAGMIN, süstelahus, 10TK | Pfizer Enterprises SARL | 75 | O99.8-O99.8 | | | | | |

| | | | | | 50 | | | | | | |

| 1065529 | naatriumenoksapariin, 10000RÜ 1ml | B01AB05 | CLEXANE, süstelahus, 0.2ml 10TK | Sanofi-Aventis Estonia OÜ | 75 | O99.8-O99.8 | | | | | |

| | | | | | 50 | | | | | | |

| 1065541 | naatriumenoksapariin, 10000RÜ 1ml | B01AB05 | CLEXANE, süstelahus, 0.4ml 10TK | Sanofi-Aventis Estonia OÜ | 50 | | | | | | |

| | | | | | 75 | O99.8-O99.8 | | | | | |

| 1012587 | naatriumdaltepariin, 7500RÜ anti Xa 0.3ml | B01AB04 | FRAGMIN, süstelahus, 10TK | Pfizer Enterprises SARL | 100 | O99.8-O99.8 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | O99.8-O99.8 | | | | | |

| | | | | | 50 | | | | | | |

| 1065541 | naatriumenoksapariin, 10000RÜ 1ml | B01AB05 | CLEXANE, süstelahus, 0.4ml 10TK | Sanofi-Aventis Estonia OÜ | 100 | O99.8-O99.8 | | | | | |

| 1065552 | naatriumenoksapariin, 10000RÜ 1ml | B01AB05 | CLEXANE, süstelahus, 0.6ml 2TK | Sanofi-Aventis Estonia OÜ | 50 | | | | | | |

| | | | | | 75 | O99.8-O99.8 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1065574 | naatriumenoksapariin, 10000RÜ 1ml | B01AB05 | CLEXANE, süstelahus, 0.8ml 2TK | Sanofi-Aventis Estonia OÜ | 75 | O99.8-O99.8 | | | | | |

| | | | | | 50 | | | | | | |

| 1065596 | naatriumenoksapariin, 10000RÜ 1ml | B01AB05 | CLEXANE, süstelahus, 1ml 2TK | Sanofi-Aventis Estonia OÜ | 50 | | | | | | |

| | | | | | 75 | O99.8-O99.8 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | O99.8-O99.8 | | | | | |

| | | | | | 100 | O99.8-O99.8 | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 100 | O99.8-O99.8 | | | | | |

| | | | | | 50 | | | | | | |

| 1201521 | naatriumfenüülbutüraat , 500mg | A16AX03 | AMMONAPS, tablett, 250TK | Swedish Orphan International AB | 100 | E72.2-E72.2 | | | | | konsiiliumi (vähemalt 2 pediaatri ühise) otsuse alusel järgmistel tingimustel: haigus kulgeb metaboolsete kriisidega vaatamata muule suukaudsele ravile; patsiendi prognoos paranemisele on hea (püsivat ajukahjustust või organpuudulikkust ei esine); ravi jätkatakse patsiendil, kellel 1 kuu kestnud ravi on andnud hea tulemuse (hüperammoneemilisi kriise ei ole esinenud või on nende sagedus oluliselt vähenenud) |

@@ -2571,94 +2529,100 @@

| 1201543 | naatriumfenüülbutüraat , 940mg 1g | A16AX03 | AMMONAPS, graanulid, 266g 1TK | Swedish Orphan International AB | 100 | E72.2-E72.2 | | | | | konsiiliumi (vähemalt 2 pediaatri ühise) otsuse alusel järgmistel tingimustel: haigus kulgeb metaboolsete kriisidega vaatamata muule suukaudsele ravile; patsiendi prognoos paranemisele on hea (püsivat ajukahjustust või organpuudulikkust ei esine); ravi jätkatakse patsiendil, kellel 1 kuu kestnud ravi on andnud hea tulemuse (hüperammoneemilisi kriise ei ole esinenud või on nende sagedus oluliselt vähenenud) |

| 1065822 | naatriumlevotüroksiin, 100mcg | H03AA01 | L-THYROXIN BERLIN- CHEMIE, tablett, 100TK | Berlin-Chemie AG (Menarini Group) | 100 | E89.0-E89.0, E03- E03, E89.3-E89.3 | | | | | |

| | | | | | 50 | | | | | | |

| 1065866 | naatriumlevotüroksiin, 50mcg | H03AA01 | L-THYROXIN BERLIN- CHEMIE, tablett, 100TK | Berlin-Chemie AG (Menarini Group) | 50 | | | | | | |

| | | | | | 100 | E89.0-E89.0, E03- E03, E89.3-E89.3 | | | | | |

| 1065866 | naatriumlevotüroksiin, 50mcg | H03AA01 | L-THYROXIN BERLIN- CHEMIE, tablett, 100TK | Berlin-Chemie AG (Menarini Group) | 100 | E89.0-E89.0, E03- E03, E89.3-E89.3 | | | | | |

| | | | | | 50 | | | | | | |

| 1035346 | naatriumsulfaat, veevaba+ kaaliumkloriid+ naatriumkloriid+ makrogool+ naatriumvesinikkarbon aat, 5,7g+0,75g+1,46g+64 g+1,68g | A06AD81 | FORTRANS, suukaudse lahuse pulber, 4TK | Ipsen Pharma | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1037090 | naatriumsulfaat, veevaba+kaaliumklorii d+naatriumkloriid+mak rogool+naatriumvesinik karbonaat, 5,675g+0,745g+1,46g +59g+1,68g | A06AD81 | COLOLYT, suukaudse lahuse graanulid, 68.565g 3TK | Spirig Baltikum Lithuanian-Swiss Ltd. | 50 | | | | | | |

| 1023949 | nabumetoon, 1g | M01AX01 | RELIFEX, dispergeeruv tablett, 20TK | Meda AB | 50 | | | | | | |

| 1205479 | nabumetoon, 1g | M01AX01 | RELIFEX, õhukese polümeerikattega tablett, 20TK | Meda AB | 50 | | | | | | |

| 1147902 | naftidrofurüül, 100mg | C04AX21 | ENELBIN 100 RETARD, toimeainet prolongeeritult vabastav tablett, 50TK | Zentiva, k.s. | 50 | | | | | | |

| 1147913 | naftidrofurüül, 100mg | C04AX21 | ENELBIN 100 RETARD, toimeainet prolongeeritult vabastav tablett, 100TK | Zentiva, k.s. | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1061086 | naftifiin, 1% | D01AE22 | EXODERIL, kreem, 30g 1TK | Sandoz GmbH | 50 | | | | | | |

| 1036459 | naratriptaan, 2,5mg | N02CC02 | NARAMIG, õhukese polümeerikattega tablett, 2TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 50 | | | | | | |

| 1072437 | nebivolool, 5mg | C07AB12 | NEBILET, tablett, 28TK | Menarini International Operations Luxembourg S.A. | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1247251 | nebivolool, 5mg | C07AB12 | NEBIVOLOL-TEVA, tablett, 28TK | Teva Pharma B.V. | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1247251 | nebivolool, 5mg | C07AB12 | NEBIVOLOL-TEVA, tablett, 28TK | Teva Pharma B.V. | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1319071 | nebivolool, 5mg | C07AB12 | NEBIVOLOL PORTFARMA, tablett, 28TK | Portfarma ehf | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1072437 | nebivolool, 5mg | C07AB12 | NEBILET, tablett, 28TK | Menarini International Operations Luxembourg S.A. | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1247374 | nebivolool, 5mg | C07AB12 | NEBISPES, tablett, 28TK | Nycomed Sefa AS | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1247420 | nebivolool, 5mg | C07AB12 | NEBISPES, tablett, 90TK | Nycomed Sefa AS | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1259355 | nebivolool, 5mg | C07AB12 | NEBICARD 5MG, tablett, 60TK | Sandoz d.d. | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1269862 | nebivolool, 5mg | C07AB12 | NEBIVOLOL ACTAVIS, tablett, 28TK | Actavis Group PTC ehf | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1284386 | nebivolool, 5mg | C07AB12 | NEBIVOLOL ORION, tablett, 30TK | Orion Corporation | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1319071 | nebivolool, 5mg | C07AB12 | NEBIVOLOL PORTFARMA, tablett, 28TK | Portfarma ehf | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1398001 | nebivolool, 5mg | C07AB12 | NEBIVOLOL-RATIOPHARM 5 MG, tablett, 28TK | ratiopharm GmbH | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1284386 | nebivolool, 5mg | C07AB12 | NEBIVOLOL ORION, tablett, 30TK | Orion Corporation | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1323885 | nebivolool, 5mg | C07AB12 | NEBITEN 5MG, tablett, 30TK | G.L. Pharma GmbH | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1398001 | nebivolool, 5mg | C07AB12 | NEBIVOLOL-RATIOPHARM 5 MG, tablett, 28TK | ratiopharm GmbH | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1445149 | nebivolool, 5mg | C07AB12 | NEBILET, tablett, 90TK | Menarini International Operations Luxembourg S.A. | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1072572 | nifedipiin, 10mg | C08CA05 | CORINFAR, toimeainet prolongeeritult vabastav tablett, 100TK | AWD. pharma GmbH & Co.KG | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1005703 | nifedipiin, 20mg | C08CA05 | CORDIPIN RETARD, toimeainet prolongeeritult vabastav tablett, 30TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15, I20- I20, O10-O16 | | | | | |

| | | | | | 100 | I27.0-I27.0 | | | | | |

| | | | | | 75 | M34-M34 | Pediaater, Reumatoloog | esmane | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1034301 | nifedipiin, 20mg | C08CA05 | CORINFAR RETARD, toimeainet prolongeeritult vabastav tablett, 30TK | AWD. pharma GmbH & Co.KG | 50 | | | | | | |

| | | | | | 75 | M34-M34 | Pediaater, Reumatoloog | esmane | | | |

| | | | | | 75 | I10-I13, I15-I15, I20- I20, O10-O16 | | | | | |

| | | | | | 100 | I27.0-I27.0 | | | | | |

| 1035706 | nifedipiin, 20mg | C08CA05 | NIFEDIPIN-RATIOPHARM 20, toimeainet prolongeeritult vabastav tablett, 30TK | ratiopharm GmbH | 75 | M34-M34 | Pediaater, Reumatoloog | esmane | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15, I20- I20, O10-O16 | | | | | |

| | | | | | 100 | I27.0-I27.0 | | | | | |

| 1042456 | nifedipiin, 20mg | C08CA05 | ADALAT OROS, toimeainet prolongeeritult vabastav tablett, 28TK | Bayer Schering Pharma AG | 50 | | | | | | |

| | | | | | 100 | I27.0-I27.0 | | | | | |

| | | | | | 75 | M34-M34 | Pediaater, Reumatoloog | esmane | | | |

| | | | | | 75 | I10-I13, I15-I15, I20- I20, O10-O16 | | | | | |

| 1072549 | nifedipiin, 20mg | C08CA05 | CORINFAR RETARD, toimeainet prolongeeritult vabastav tablett, 50TK | AWD. pharma GmbH & Co.KG | 75 | I10-I13, I15-I15, I20- I20, O10-O16 | | | | | |

| | | | | | 100 | I27.0-I27.0 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | M34-M34 | Pediaater, Reumatoloog | esmane | | | |

| 1072550 | nifedipiin, 20mg | C08CA05 | CORINFAR RETARD, toimeainet prolongeeritult vabastav tablett, 100TK | AWD. pharma GmbH & Co.KG | 50 | | | | | | |

| | | | | | 100 | I27.0-I27.0 | | | | | |

| | | | | | 75 | I10-I13, I15-I15, I20- I20, O10-O16 | | | | | |

| | | | | | 75 | M34-M34 | Pediaater, Reumatoloog | esmane | | | |

| 1034301 | nifedipiin, 20mg | C08CA05 | CORINFAR RETARD, toimeainet prolongeeritult vabastav tablett, 30TK | AWD. pharma GmbH & Co.KG | 100 | I27.0-I27.0 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15, I20- I20, O10-O16 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1006311 | nifedipiin, 30mg | C08CA05 | ADALAT OROS, toimeainet prolongeeritult vabastav tablett, 28TK | Bayer Schering Pharma AG | 75 | I10-I13, I15-I15, I20- I20, O10-O16 | | | | | |

| | | | | | 100 | I27.0-I27.0 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | M34-M34 | Reumatoloog, Pediaater | esmane | | | |

| 1035706 | nifedipiin, 20mg | C08CA05 | NIFEDIPIN-RATIOPHARM 20, toimeainet prolongeeritult vabastav tablett, 30TK | ratiopharm GmbH | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15, I20- I20, O10-O16 | | | | | |

| | | | | | 100 | I27.0-I27.0 | | | | | |

| | | | | | 75 | M34-M34 | Reumatoloog, Pediaater | esmane | | | |

| 1042456 | nifedipiin, 20mg | C08CA05 | ADALAT OROS, toimeainet prolongeeritult vabastav tablett, 28TK | Bayer Schering Pharma AG | 100 | I27.0-I27.0 | | | | | |

| | | | | | 75 | M34-M34 | Reumatoloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15, I20- I20, O10-O16 | | | | | |

| 1072549 | nifedipiin, 20mg | C08CA05 | CORINFAR RETARD, toimeainet prolongeeritult vabastav tablett, 50TK | AWD. pharma GmbH & Co.KG | 75 | I10-I13, I15-I15, I20- I20, O10-O16 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | M34-M34 | Reumatoloog, Pediaater | esmane | | | |

| | | | | | 100 | I27.0-I27.0 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1072550 | nifedipiin, 20mg | C08CA05 | CORINFAR RETARD, toimeainet prolongeeritult vabastav tablett, 100TK | AWD. pharma GmbH & Co.KG | 100 | I27.0-I27.0 | | | | | |

| | | | | | 75 | I10-I13, I15-I15, I20- I20, O10-O16 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | M34-M34 | Pediaater, Reumatoloog | esmane | | | |

| 1006311 | nifedipiin, 30mg | C08CA05 | ADALAT OROS, toimeainet prolongeeritult vabastav tablett, 28TK | Bayer Schering Pharma AG | 100 | I27.0-I27.0 | | | | | |

| | | | | | 75 | M34-M34 | Reumatoloog, Pediaater | esmane | | | |

| | | | | | 75 | I10-I13, I15-I15, I20- I20, O10-O16 | | | | | |

| | | | | | 50 | | | | | | |

| 1023422 | nifedipiin, 40mg | C08CA05 | CORDIPIN XL, toimeainet modifitseeritult vabastav tablett, 20TK | KRKA d.d., Novo Mesto | 75 | I10-I13, I15-I15, I20- I20, O10-O16 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | I27.0-I27.0 | | | | | |

| | | | | | 75 | M34-M34 | Reumatoloog, Pediaater | esmane | | | |

| 1027886 | nifedipiin, 40mg | C08CA05 | NYCOPIN, toimeainet modifitseeritult vabastav tablett, 30TK | Nycomed Sefa AS | 100 | I27.0-I27.0 | | | | | |

| | | | | | 75 | M34-M34 | Pediaater, Reumatoloog | esmane | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15, I20- I20, O10-O16 | | | | | |

| 1398685 | nifedipiin, 40mg | C08CA05 | NYCOPIN, toimeainet modifitseeritult vabastav tablett, 28TK | Nycomed Sefa AS | 50 | | | | | | |

| | | | | | 75 | M34-M34 | Pediaater, Reumatoloog | esmane | | | |

| 1023422 | nifedipiin, 40mg | C08CA05 | CORDIPIN XL, toimeainet modifitseeritult vabastav tablett, 20TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 100 | I27.0-I27.0 | | | | | |

| | | | | | 75 | I10-I13, I15-I15, I20- I20, O10-O16 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1042467 | nifedipiin, 60mg | C08CA05 | ADALAT OROS, toimeainet prolongeeritult vabastav tablett, 28TK | Bayer Schering Pharma AG | 75 | M34-M34 | Reumatoloog, Pediaater | esmane | | | |

| | | | | | 75 | M34-M34 | Pediaater, Reumatoloog | esmane | | | |

| 1027886 | nifedipiin, 40mg | C08CA05 | NYCOPIN, toimeainet modifitseeritult vabastav tablett, 30TK | Nycomed Sefa AS | 75 | M34-M34 | Reumatoloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | I27.0-I27.0 | | | | | |

| | | | | | 75 | I10-I13, I15-I15, I20- I20, O10-O16 | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1342190 | nilotiniib, 200mg | L01XE08 | TASIGNA, kõvakapsel, 112TK | Novartis Europharm Limited | 50 | | | | | | |

| | | | | | 100 | C92.1-C92.1 | Hematoloog | | | | patsiendile, kelle ravi alustamine ja jätkamine nilotiniibiga on hinnatud konsiiliumi (vähemalt 3 hematoloogi) poolt vastavaks järgmistele kriteeriumidele: näidustatud on tsütogeneetilist vastust indutseeriv ravi, eelnev ravi imatiniibiga annuses 600 mg on ebaõnnestunud või osutunud talumatuks (imatiniibravi on põhjustanud III või IV astme kõrvaltoime või üle 3 kuu püsinud II astme kõrvaltoime CTC klassifikatsiooni järgi), nilotiniibravi foonil püsib hematoloogiline ravivastus (haigus ei progresseeru). Soodustus ei laiene patsientidele, kelle ravi nilotiniibiga on ravimitootja vastutusel alustatud ja tagatud enne 1. oktoobrit 2009. a. |

| 1398685 | nifedipiin, 40mg | C08CA05 | NYCOPIN, toimeainet modifitseeritult vabastav tablett, 28TK | Nycomed Sefa AS | 75 | M34-M34 | Reumatoloog, Pediaater | esmane | | | |

| | | | | | 75 | I10-I13, I15-I15, I20- I20, O10-O16 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | I27.0-I27.0 | | | | | |

| 1042467 | nifedipiin, 60mg | C08CA05 | ADALAT OROS, toimeainet prolongeeritult vabastav tablett, 28TK | Bayer Schering Pharma AG | 75 | M34-M34 | Reumatoloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | I27.0-I27.0 | | | | | |

| | | | | | 75 | I10-I13, I15-I15, I20- I20, O10-O16 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1342190 | nilotiniib, 200mg | L01XE08 | TASIGNA, kõvakapsel, 112TK | Novartis Europharm Limited | 100 | C92.1-C92.1 | Hematoloog | | | | patsiendile, kelle ravi alustamine ja jätkamine nilotiniibiga on hinnatud konsiiliumi (vähemalt 3 hematoloogi) poolt vastavaks järgmistele kriteeriumidele: näidustatud on tsütogeneetilist vastust indutseeriv ravi, eelnev ravi imatiniibiga annuses 600 mg on ebaõnnestunud või osutunud talumatuks (imatiniibravi on põhjustanud III või IV astme kõrvaltoime või üle 3 kuu püsinud II astme kõrvaltoime CTC klassifikatsiooni järgi), nilotiniibravi foonil püsib hematoloogiline ravivastus (haigus ei progresseeru). Soodustus ei laiene patsientidele, kelle ravi nilotiniibiga on ravimitootja vastutusel alustatud ja tagatud enne 1. oktoobrit 2009. a. |

| | | | | | 50 | | | | | | |

| 1261842 | nitrendipiin, 10mg | C08CA08 | NITRESAN 10 MG, tablett, 50TK | PRO. MED. CS. PRAHA a.s. | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15 | | | | | |

| 1014545 | nitrendipiin, 20mg | C08CA08 | LUSOPRESS, tablett, 28TK | Instituto Luso Farmaco d Italia S.p.A. | 75 | I10-I13, I15-I15 | | | | | |

@@ -2669,18 +2633,20 @@

| 1261886 | nitrendipiin, 20mg | C08CA08 | NITRESAN 20 MG, tablett, 50TK | PRO. MED. CS. PRAHA a.s. | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 50 | | | | | | |

| 1003857 | nitrofurantoiin, 50mg | J01XE01 | NITROFURANTOIN NYCOMED, tablett, 20TK | Nycomed Sefa AS | 50 | | | | | | |

| 1175464 | noretisteroon+östradio ol, 0,5mg+1mg | G03FA01 | ACTIVELLE, õhukese polümeerikattega tablett, 28TK | Novo Nordisk A/S | 50 | | | | | | |

| 1131589 | norelgestromiin+ etünüülöstradiool, 6mg+0,6mg | G03AA13 | EVRA, transdermaalne plaaster, 3TK | Janssen-Cilag International N.V. | 50 | | | | | | |

| 1175464 | noretisteroon+ östradiool, 0,5mg+1mg | G03FA01 | ACTIVELLE, õhukese polümeerikattega tablett, 28TK | Novo Nordisk A/S | 50 | | | | | | |

| 1045471 | noretisteroon+ östradiool, 1mg+2mg | G03FA01 | KLIANE, õhukese polümeerikattega tablett, 28TK | Bayer Schering Pharma AG | 50 | | | | | | |

| 1116560 | noretisteroon+ östradiool+ östradiool, 1mg+1mg/0+1mg | G03FB05 | NOVOFEM, õhukese polümeerikattega tablett, 12TK / 16TK | Novo Nordisk A/S | 50 | | | | | | |

| 1030464 | noretisteroon+östradio ol, 1mg+2mg | G03FA01 | KLIOGEST, õhukese polümeerikattega tablett, 28TK | Novo Nordisk A/S | 50 | | | | | | |

| 1045471 | noretisteroon+östradio ol, 1mg+2mg | G03FA01 | KLIANE, õhukese polümeerikattega tablett, 28TK | Bayer Schering Pharma AG | 50 | | | | | | |

| 1116560 | noretisteroon+östradio ol+östradiool, 1mg+1mg+1mg | G03FB05 | NOVOFEM, õhukese polümeerikattega tablett, 12TK / 16TK | Novo Nordisk A/S | 50 | | | | | | |

| 1030453 | noretisteroon+östradio ol+östradiool+östradio ol, 1mg+1mg+2mg+2mg | G03FB05 | TRISEQUENS, õhukese polümeerikattega tablett, 6TK / 10TK / 12TK | Novo Nordisk A/S | 50 | | | | | | |

| 1005455 | norfloksatsiin, 400mg | J01MA06 | NOLICIN, õhukese polümeerikattega tablett, 20TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| 1005927 | nortriptüliin, 25mg | N06AA10 | NORITREN, õhukese polümeerikattega tablett, 100TK | H. LUNDBECK A/S | 50 | | | | | | |

| 1020430 | norgestimaat+etünüülö stradiool, 0,25mg+0,035mg | G03AA11 | CILEST, tablett, 21TK | Johnson & Johnson UAB | 50 | | | | | | |

| | | | | | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1005927 | nortriptüliin, 25mg | N06AA10 | NORITREN, õhukese polümeerikattega tablett, 100TK | H. LUNDBECK A/S | 75 | G62.0-G62.0, G63- G63 | | | | | |

| | | | | | 75 | G62.0-G62.0, G63- G63 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| 1012374 | ofloksatsiin, 200mg | J01MA01 | MEDOFLOXINE 200 MG, õhukese polümeerikattega tablett, 10TK | Medochemie Ltd | 50 | | | | | | |

| 1070693 | ofloksatsiin, 200mg | J01MA01 | TARIVID, õhukese polümeerikattega tablett, 10TK | Sanofi-Aventis Estonia OÜ | 50 | | | | | | |

| 1089402 | ofloksatsiin, 200mg | J01MA01 | OFLOXIN 200, õhukese polümeerikattega tablett, 10TK | Zentiva, k.s. | 50 | | | | | | |

@@ -2688,192 +2654,205 @@

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| 1036033 | okskarbasepiin, 600mg | N03AF02 | APYDAN 600 MG, tablett, 50TK | Desitin Arzneimittel GmbH | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1028483 | oksübutüniin, 5mg | G04BD04 | DRIPTANE, tablett, 60TK | Laboratoires Fournier S.A. | 50 | | | | | | |

| | | | | | 75 | N31-N31 | Uroloog, Pediaater, Neuroloog | | | | |

| | | | | | 75 | N31-N31 | Pediaater, Neuroloog, Uroloog | | | | |

| 1080593 | oksükodoon, 10mg | N02AA05 | OXYCONTIN 10 MG, toimeainet prolongeeritult vabastav tablett, 56TK | MUNDIPHARMA Ges.m.b.H. | 100 | C00-D48 | | | | | patsientidele, kellel suukaudne morfiin põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1402568 | oksükodoon, 10mg | N02AA05 | OXYCONTIN 10 MG, toimeainet prolongeeritult vabastav tablett, 60TK | MUNDIPHARMA Ges.m.b.H. | 100 | C00-D48 | | | | | patsientidele, kellel suukaudne morfiin põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1080627 | oksükodoon, 20mg | N02AA05 | OXYCONTIN 20 MG, toimeainet prolongeeritult vabastav tablett, 56TK | MUNDIPHARMA Ges.m.b.H. | 100 | C00-D48 | | | | | patsientidele, kellel suukaudne morfiin põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1080627 | oksükodoon, 20mg | N02AA05 | OXYCONTIN 20 MG, toimeainet prolongeeritult vabastav tablett, 56TK | MUNDIPHARMA Ges.m.b.H. | 50 | | | | | | |

| | | | | | 100 | C00-D48 | | | | | patsientidele, kellel suukaudne morfiin põhjustab olulisi kõrvaltoimeid |

| 1402580 | oksükodoon, 20mg | N02AA05 | OXYCONTIN 20 MG, toimeainet prolongeeritult vabastav tablett, 60TK | MUNDIPHARMA Ges.m.b.H. | 100 | C00-D48 | | | | | patsientidele, kellel suukaudne morfiin põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1080650 | oksükodoon, 40mg | N02AA05 | OXYCONTIN 40 MG, toimeainet prolongeeritult vabastav tablett, 56TK | MUNDIPHARMA Ges.m.b.H. | 50 | | | | | | |

| | | | | | 100 | C00-D48 | | | | | patsientidele, kellel suukaudne morfiin põhjustab olulisi kõrvaltoimeid |

| 1402603 | oksükodoon, 40mg | N02AA05 | OXYCONTIN 40 MG, toimeainet prolongeeritult vabastav tablett, 60TK | MUNDIPHARMA Ges.m.b.H. | 100 | C00-D48 | | | | | patsientidele, kellel suukaudne morfiin põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1075542 | oksükodoon, 80mg | N02AA05 | OXYCONTIN 80 MG, toimeainet prolongeeritult vabastav tablett, 56TK | MUNDIPHARMA Ges.m.b.H. | 50 | | | | | | |

| 1075542 | oksükodoon, 80mg | N02AA05 | OXYCONTIN 80 MG, toimeainet prolongeeritult vabastav tablett, 56TK | MUNDIPHARMA Ges.m.b.H. | 100 | C00-D48 | | | | | patsientidele, kellel suukaudne morfiin põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1402625 | oksükodoon, 80mg | N02AA05 | OXYCONTIN 80 MG, toimeainet prolongeeritult vabastav tablett, 60TK | MUNDIPHARMA Ges.m.b.H. | 50 | | | | | | |

| | | | | | 100 | C00-D48 | | | | | patsientidele, kellel suukaudne morfiin põhjustab olulisi kõrvaltoimeid |

| 1402625 | oksükodoon, 80mg | N02AA05 | OXYCONTIN 80 MG, toimeainet prolongeeritult vabastav tablett, 60TK | MUNDIPHARMA Ges.m.b.H. | 100 | C00-D48 | | | | | patsientidele, kellel suukaudne morfiin põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1289516 | olansapiin, 10mg | N05AH03 | OLANZAPINE ACTAVIS, suus dispergeeruv tablett, 28TK | Actavis Group PTC ehf | 50 | | | | | | |

| | | | | | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| 1259096 | olansapiin, 10mg | N05AH03 | OLANZAPIN-RATIOPHARM, tablett, 28TK | ratiopharm GmbH | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1259108 | olansapiin, 10mg | N05AH03 | OLANZAPIN-RATIOPHARM, tablett, 30TK | ratiopharm GmbH | 50 | | | | | | |

| | | | | | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| 1267714 | olansapiin, 10mg | N05AH03 | OLANZAPIN ACTAVIS, õhukese polümeerikattega tablett, 28TK | Actavis Group PTC ehf | 50 | | | | | | |

| | | | | | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1259108 | olansapiin, 10mg | N05AH03 | OLANZAPIN-RATIOPHARM, tablett, 30TK | ratiopharm GmbH | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1267714 | olansapiin, 10mg | N05AH03 | OLANZAPIN ACTAVIS, õhukese polümeerikattega tablett, 28TK | Actavis Group PTC ehf | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1271810 | olansapiin, 10mg | N05AH03 | SOLAZIN, tablett, 28TK | Nycomed Sefa AS | 50 | | | | | | |

| | | | | | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1271821 | olansapiin, 10mg | N05AH03 | SOLAZIN, tablett, 56TK | Nycomed Sefa AS | 50 | | | | | | |

| | | | | | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| 1271854 | olansapiin, 10mg | N05AH03 | ZOLAFREN, tablett, 28TK | Laboratorios Adamed Sp. z.o.o | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1289516 | olansapiin, 10mg | N05AH03 | OLANZAPINE ACTAVIS, suus dispergeeruv tablett, 28TK | Actavis Group PTC ehf | 50 | | | | | | |

| 1271821 | olansapiin, 10mg | N05AH03 | SOLAZIN, tablett, 56TK | Nycomed Sefa AS | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1271854 | olansapiin, 10mg | N05AH03 | ZOLAFREN, tablett, 28TK | Laboratorios Adamed Sp. z.o.o | 50 | | | | | | |

| | | | | | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| 1326507 | olansapiin, 10mg | N05AH03 | ZALASTA, suus dispergeeruv tablett, 28TK | KRKA d.d., Novo Mesto | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1342820 | olansapiin, 10mg | N05AH03 | OLANZAPINE TEVA, suus dispergeeruv tablett, 28TK | Teva Pharma B.V. | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1342820 | olansapiin, 10mg | N05AH03 | OLANZAPINE TEVA, suus dispergeeruv tablett, 28TK | Teva Pharma B.V. | 50 | | | | | | |

| | | | | | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| 1289572 | olansapiin, 15mg | N05AH03 | OLANZAPINE ACTAVIS, suus dispergeeruv tablett, 28TK | Actavis Group PTC ehf | 50 | | | | | | |

| | | | | | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| 1267905 | olansapiin, 15mg | N05AH03 | OLANZAPIN ACTAVIS, õhukese polümeerikattega tablett, 28TK | Actavis Group PTC ehf | 50 | | | | | | |

| | | | | | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1289572 | olansapiin, 15mg | N05AH03 | OLANZAPINE ACTAVIS, suus dispergeeruv tablett, 28TK | Actavis Group PTC ehf | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1342886 | olansapiin, 15mg | N05AH03 | OLANZAPINE TEVA, suus dispergeeruv tablett, 28TK | Teva Pharma B.V. | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1267455 | olansapiin, 5mg | N05AH03 | OLANZAPIN ACTAVIS, õhukese polümeerikattega tablett, 28TK | Actavis Group PTC ehf | 50 | | | | | | |

| 1342886 | olansapiin, 15mg | N05AH03 | OLANZAPINE TEVA, suus dispergeeruv tablett, 28TK | Teva Pharma B.V. | 50 | | | | | | |

| | | | | | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| 1271797 | olansapiin, 5mg | N05AH03 | SOLAZIN, tablett, 28TK | Nycomed Sefa AS | 50 | | | | | | |

| 1289459 | olansapiin, 5mg | N05AH03 | OLANZAPINE ACTAVIS, suus dispergeeruv tablett, 28TK | Actavis Group PTC ehf | 50 | | | | | | |

| | | | | | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| 1271832 | olansapiin, 5mg | N05AH03 | ZOLAFREN, tablett, 28TK | Laboratorios Adamed Sp. z.o.o | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1289459 | olansapiin, 5mg | N05AH03 | OLANZAPINE ACTAVIS, suus dispergeeruv tablett, 28TK | Actavis Group PTC ehf | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1267455 | olansapiin, 5mg | N05AH03 | OLANZAPIN ACTAVIS, õhukese polümeerikattega tablett, 28TK | Actavis Group PTC ehf | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1271797 | olansapiin, 5mg | N05AH03 | SOLAZIN, tablett, 28TK | Nycomed Sefa AS | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1271832 | olansapiin, 5mg | N05AH03 | ZOLAFREN, tablett, 28TK | Laboratorios Adamed Sp. z.o.o | 50 | | | | | | |

| | | | | | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| 1326406 | olansapiin, 5mg | N05AH03 | ZALASTA, suus dispergeeruv tablett, 28TK | KRKA d.d., Novo Mesto | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1342763 | olansapiin, 5mg | N05AH03 | OLANZAPINE TEVA, suus dispergeeruv tablett, 28TK | Teva Pharma B.V. | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1342763 | olansapiin, 5mg | N05AH03 | OLANZAPINE TEVA, suus dispergeeruv tablett, 28TK | Teva Pharma B.V. | 50 | | | | | | |

| | | | | | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| 1139060 | olmesartaanmedokso miil, 10mg | C09CA08 | MESAR 10MG, õhukese polümeerikattega tablett, 28TK | Menarini International Operations Luxembourg S.A. | 50 | | | | | | |

| 1407664 | olmesartaanmedokso miil, 10mg | C09CA08 | OLIMESTRA, õhukese polümeerikattega tablett, 28TK | KRKA d.d., Novo Mesto | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 50 | | | | | | |

| 1139105 | olmesartaanmedokso miil, 20mg | C09CA08 | MESAR 20MG, õhukese polümeerikattega tablett, 28TK | Menarini International Operations Luxembourg S.A. | 50 | | | | | | |

| 1407833 | olmesartaanmedokso miil, 20mg | C09CA08 | OLIMESTRA, õhukese polümeerikattega tablett, 28TK | KRKA d.d., Novo Mesto | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 50 | | | | | | |

| 1407833 | olmesartaanmedokso miil, 20mg | C09CA08 | OLIMESTRA, õhukese polümeerikattega tablett, 28TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1139150 | olmesartaanmedokso miil, 40mg | C09CA08 | MESAR 40MG, õhukese polümeerikattega tablett, 28TK | Menarini International Operations Luxembourg S.A. | 50 | | | | | | |

| 1407934 | olmesartaanmedokso miil, 40mg | C09CA08 | OLIMESTRA, õhukese polümeerikattega tablett, 28TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15 | | | | | |

| 1190483 | olmesartaanmedokso miil+ hüdroklorotiasiid, 20mg+12,5mg | C09DA08 | MESAR PLUS, õhukese polümeerikattega tablett, 28TK | Menarini International Operations Luxembourg S.A. | 50 | | | | | | |

| 1190562 | olmesartaanmedokso miil+ hüdroklorotiasiid, 20mg+25mg | C09DA08 | MESAR PLUS, õhukese polümeerikattega tablett, 28TK | Menarini International Operations Luxembourg S.A. | 50 | | | | | | |

| 1140220 | olopatadiin, 1mg 1ml | S01GX09 | OPATANOL, silmatilgad, lahus, 5ml 1TK | ALCON LABORATORIES (UK) Ltd. | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1101542 | omeprasool, 20mg | A02BC01 | LOSEPRAZOL, gastroresistentne kõvakapsel, 14TK | PRO. MED. CS. PRAHA a.s. | 50 | | | | | | |

| | | | | | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| 1101564 | omeprasool, 20mg | A02BC01 | LOSEPRAZOL, gastroresistentne kõvakapsel, 28TK | PRO. MED. CS. PRAHA a.s. | 50 | | | | | | |

| | | | | | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| 1041613 | omeprasool, 20mg | A02BC01 | OMEPRAZOLE- RATIOPHARM, gastroresistentne kõvakapsel, 15TK | ratiopharm GmbH | 50 | | | | | | |

| | | | | | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1062166 | omeprasool, 20mg | A02BC01 | OMEPRAZOLE- RATIOPHARM, gastroresistentne kõvakapsel, 30TK | ratiopharm GmbH | 50 | | | | | | |

| | | | | | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| 1062199 | omeprasool, 20mg | A02BC01 | GASEC GASTROCAPS 20 MG, gastroresistentne kõvakapsel, 14TK | MEPHA Lda. | 50 | | | | | | |

| 1062199 | omeprasool, 20mg | A02BC01 | GASEC GASTROCAPS 20 MG, gastroresistentne kõvakapsel, 14TK | MEPHA Lda. | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| | | | | | 50 | | | | | | |

| 1062201 | omeprasool, 20mg | A02BC01 | GASEC GASTROCAPS 20 MG, gastroresistentne kõvakapsel, 28TK | MEPHA Lda. | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| | | | | | 50 | | | | | | |

| 1131815 | omeprasool, 20mg | A02BC01 | ULTOP, gastroresistentne kõvakapsel, 14TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| 1062201 | omeprasool, 20mg | A02BC01 | GASEC GASTROCAPS 20 MG, gastroresistentne kõvakapsel, 28TK | MEPHA Lda. | 50 | | | | | | |

| 1194476 | omeprasool, 20mg | A02BC01 | OMEPRAZOL SANDOZ 20 MG, gastroresistentne kõvakapsel, 14TK | Sandoz d.d. | 50 | | | | | | |

| | | | | | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| 1101542 | omeprasool, 20mg | A02BC01 | LOSEPRAZOL, gastroresistentne kõvakapsel, 14TK | PRO. MED. CS. PRAHA a.s. | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| | | | | | 50 | | | | | | |

| 1101564 | omeprasool, 20mg | A02BC01 | LOSEPRAZOL, gastroresistentne kõvakapsel, 28TK | PRO. MED. CS. PRAHA a.s. | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1131815 | omeprasool, 20mg | A02BC01 | ULTOP, gastroresistentne kõvakapsel, 14TK | KRKA d.d., Novo Mesto | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| | | | | | 50 | | | | | | |

| 1194476 | omeprasool, 20mg | A02BC01 | OMEPRAZOL SANDOZ 20 MG, gastroresistentne kõvakapsel, 14TK | Sandoz d.d. | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| | | | | | 50 | | | | | | |

| 1194498 | omeprasool, 20mg | A02BC01 | OMEPRAZOL SANDOZ 20 MG, gastroresistentne kõvakapsel, 28TK | Sandoz d.d. | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| | | | | | 50 | | | | | | |

| 1194498 | omeprasool, 20mg | A02BC01 | OMEPRAZOL SANDOZ 20 MG, gastroresistentne kõvakapsel, 28TK | Sandoz d.d. | 50 | | | | | | |

| | | | | | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1269200 | omeprasool, 20mg | A02BC01 | OMEP 20MG, gastroresistentne kõvakapsel, 15TK | Sandoz d.d. | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| | | | | | 50 | | | | | | |

| 1269222 | omeprasool, 20mg | A02BC01 | OMEP 20MG, gastroresistentne kõvakapsel, 30TK | Sandoz d.d. | 50 | | | | | | |

| | | | | | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| 1269222 | omeprasool, 20mg | A02BC01 | OMEP 20MG, gastroresistentne kõvakapsel, 30TK | Sandoz d.d. | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| | | | | | 50 | | | | | | |

| 1269244 | omeprasool, 20mg | A02BC01 | OMEP 20MG, gastroresistentne kõvakapsel, 56TK | Sandoz d.d. | 50 | | | | | | |

| | | | | | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1352393 | omeprasool, 20mg | A02BC01 | OMEPRAZOLE STADA 20 MG, gastroresistentne kõvakapsel, 30TK | STADA ARZNEIMITTEL AG | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| | | | | | 50 | | | | | | |

| 1423077 | omeprasool, 20mg | A02BC01 | ULTOP, gastroresistentne kõvakapsel, 28TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| 1423077 | omeprasool, 20mg | A02BC01 | ULTOP, gastroresistentne kõvakapsel, 28TK | KRKA d.d., Novo Mesto | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| | | | | | 50 | | | | | | |

| 1112814 | omeprasool, 40mg | A02BC01 | GASEC GASTROCAPS 40 MG, gastroresistentne kõvakapsel, 14TK | MEPHA Lda. | 50 | | | | | | |

| | | | | | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| 1269301 | omeprasool, 40mg | A02BC01 | OMEP 40MG, gastroresistentne kõvakapsel, 15TK | Sandoz d.d. | 50 | | | | | | |

| | | | | | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1269301 | omeprasool, 40mg | A02BC01 | OMEP 40MG, gastroresistentne kõvakapsel, 15TK | Sandoz d.d. | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| | | | | | 50 | | | | | | |

| 1269323 | omeprasool, 40mg | A02BC01 | OMEP 40MG, gastroresistentne kõvakapsel, 30TK | Sandoz d.d. | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1005163 | ondansetroon, 8mg | A04AA01 | ZOFRAN, õhukese polümeerikattega tablett, 10TK | GlaxoSmithKline Export Ltd | 50 | | | | | | |

| 1247150 | ondansetroon, 8mg | A04AA01 | ONDANSETRON BMM PHARMA, õhukese polümeerikattega tablett, 10TK | BMM Pharma AB | 50 | | | | | | |

| 1005163 | ondansetroon, 8mg | A04AA01 | ZOFRAN, õhukese polümeerikattega tablett, 10TK | GlaxoSmithKline Export Ltd | 100 | C00-D48 | | | | | suukaudsest keemiaravist põhjustatud iivelduse ja oksendamise profülaktikaks ja raviks juhul, kui metoklopramiid ei ole esmase valikuna soovitatud või see on osutunud ebaefektiivseks |

| | | | | | 50 | | | | | | |

| 1137372 | oomega-3-rasvhappe etüülestrid 90, 1000mg | C10AX80 | OMACOR, pehmekapsel, 28TK | Pronova BioPharma Norge AS | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1110643 | oseltamiviir, 75mg | J05AH02 | TAMIFLU, kõvakapsel, 10TK | Roche Registration Limited | 50 | | | | | | |

| 1043020 | pantoprasool, 20mg | A02BC02 | CONTROLOC 20 MG, gastroresistentne tablett, 14TK | Nycomed GmbH | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1043020 | pantoprasool, 20mg | A02BC02 | CONTROLOC 20 MG, gastroresistentne tablett, 14TK | Nycomed GmbH | 50 | | | | | | |

| | | | | | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| 1249758 | pantoprasool, 20mg | A02BC02 | NOLPAZA, gastroresistentne tablett, 14TK | KRKA d.d., Novo Mesto | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| | | | | | 50 | | | | | | |

| 1277232 | pantoprasool, 20mg | A02BC02 | PANTOPRAZOLE ACTAVIS, gastroresistentne tablett, 28TK | Actavis Group PTC ehf | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| | | | | | 50 | | | | | | |

| 1280337 | pantoprasool, 20mg | A02BC02 | PANTOPRAZOL - RATIOPHARM 20 MG, gastroresistentne tablett, 14TK | ratiopharm GmbH | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| | | | | | 50 | | | | | | |

| 1249770 | pantoprasool, 20mg | A02BC02 | NOLPAZA, gastroresistentne tablett, 28TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| 1277232 | pantoprasool, 20mg | A02BC02 | PANTOPRAZOLE ACTAVIS, gastroresistentne tablett, 28TK | Actavis Group PTC ehf | 50 | | | | | | |

| | | | | | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| 1043031 | pantoprasool, 40mg | A02BC02 | CONTROLOC 40 MG, gastroresistentne tablett, 14TK | Nycomed GmbH | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| | | | | | 50 | | | | | | |

| 1249646 | pantoprasool, 40mg | A02BC02 | NOLPAZA, gastroresistentne tablett, 14TK | KRKA d.d., Novo Mesto | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| | | | | | 50 | | | | | | |

| 1277344 | pantoprasool, 40mg | A02BC02 | PANTOPRAZOLE ACTAVIS, gastroresistentne tablett, 28TK | Actavis Group PTC ehf | 50 | | | | | | |

| 1249646 | pantoprasool, 40mg | A02BC02 | NOLPAZA, gastroresistentne tablett, 14TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1249668 | pantoprasool, 40mg | A02BC02 | NOLPAZA, gastroresistentne tablett, 28TK | KRKA d.d., Novo Mesto | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| | | | | | 50 | | | | | | |

| 1277344 | pantoprasool, 40mg | A02BC02 | PANTOPRAZOLE ACTAVIS, gastroresistentne tablett, 28TK | Actavis Group PTC ehf | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| | | | | | 50 | | | | | | |

| 1280449 | pantoprasool, 40mg | A02BC02 | PANTOPRAZOL - RATIOPHARM 40 MG, gastroresistentne tablett, 14TK | ratiopharm GmbH | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| | | | | | 50 | | | | | | |

| 1110799 | paroksetiin, 20mg | N06AB05 | PAROXETIN HEXAL 20 MG, õhukese polümeerikattega tablett, 30TK | HEXAL AG | 50 | | | | | | |

| 1351583 | paroksetiin, 20mg | N06AB05 | PAROXETINE ORION, õhukese polümeerikattega tablett, 30TK | Orion Corporation | 50 | | | | | | |

| 1060232 | paroksetiin, 20mg | N06AB05 | SEROXAT, õhukese polümeerikattega tablett, 30TK | SMITHKLINE BEECHAM plc | 50 | | | | | | |

| 1096837 | paroksetiin, 20mg | N06AB05 | REXETIN, õhukese polümeerikattega tablett, 30TK | Gedeon Richter Plc. | 50 | | | | | | |

| 1110799 | paroksetiin, 20mg | N06AB05 | PAROXETIN HEXAL 20 MG, õhukese polümeerikattega tablett, 30TK | HEXAL AG | 50 | | | | | | |

| 1185072 | paroksetiin, 20mg | N06AB05 | PAROXETIN ACTAVIS 20 MG, õhukese polümeerikattega tablett, 30TK | Actavis Nordic A/S | 50 | | | | | | |

| 1244900 | paroksetiin, 20mg | N06AB05 | ARKETIS 20 MG, tablett, 30TK | Medochemie Ltd | 50 | | | | | | |

| 1351583 | paroksetiin, 20mg | N06AB05 | PAROXETINE ORION, õhukese polümeerikattega tablett, 30TK | Orion Corporation | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1115514 | paroksetiin, 30mg | N06AB05 | SEROXAT, õhukese polümeerikattega tablett, 30TK | SMITHKLINE BEECHAM plc | 50 | | | | | | |

| 1110834 | paroksetiin, 40mg | N06AB05 | PAROXETIN HEXAL 40 MG, õhukese polümeerikattega tablett, 30TK | HEXAL AG | 50 | | | | | | |

| 1245103 | paroksetiin, 40mg | N06AB05 | ARKETIS 40 MG, tablett, 30TK | Medochemie Ltd | 50 | | | | | | |

| 1009404 | pentoksüfülliin, 400mg | C04AD03 | TRENTAL, toimeainet prolongeeritult vabastav tablett, 100TK | Nycomed GmbH | 50 | | | | | | |

| 1015018 | pentoksüfülliin, 400mg | C04AD03 | PENTILIN, toimeainet prolongeeritult vabastav tablett, 20TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1028854 | pentoksüfülliin, 600mg | C04AD03 | VASONIT RETARD, toimeainet prolongeeritult vabastav tablett, 20TK | G.L. Pharma GmbH | 50 | | | | | | |

| 1168422 | perindopriil, 10mg | C09AA04 | PRESTARIUM ARGININE 10MG, õhukese polümeerikattega tablett, 30TK | Les Laboratoires Servier | 50 | | | | | | |

| 1019393 | perindopriil, 4mg | C09AA04 | PRESTARIUM, tablett, 30TK | Les Laboratoires Servier | 50 | | | | | | |

| 1283970 | perindopriil, 4mg | C09AA04 | PERINDOBAX, tablett, 30TK | Ranbaxy (UK) Limited | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1283970 | perindopriil, 4mg | C09AA04 | PERINDOBAX, tablett, 30TK | Ranbaxy (UK) Limited | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1302860 | perindopriil, 4mg | C09AA04 | STOPRESS, tablett, 30TK | Pharmaceutical Works Polpharma S.A. | 50 | | | | | | |

| 1168310 | perindopriil, 5mg | C09AA04 | PRESTARIUM ARGININE 5MG, õhukese polümeerikattega tablett, 30TK | Les Laboratoires Servier | 50 | | | | | | |

| 1132782 | perindopriil, 8mg | C09AA04 | PRESTARIUM 8MG, tablett, 30TK | Les Laboratoires Servier | 50 | | | | | | |

| 1284016 | perindopriil, 8mg | C09AA04 | PERINDOBAX, tablett, 30TK | Ranbaxy (UK) Limited | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1284016 | perindopriil, 8mg | C09AA04 | PERINDOBAX, tablett, 30TK | Ranbaxy (UK) Limited | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1302871 | perindopriil, 8mg | C09AA04 | STOPRESS, tablett, 30TK | Pharmaceutical Works Polpharma S.A. | 50 | | | | | | |

| 1001855 | pilokarpiinvesinikkloriid +timolool, 20mg 1ml+5mg 1ml | S01EB80 | FOTIL, silmatilgad, lahus, 5ml 1TK | SANTEN OY | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1229587 | perindopriil+ indapamiid, 2,5mg+0,625mg | C09BA04 | NOLIPREL ARGININE, õhukese polümeerikattega tablett, 30TK | Les Laboratoires Servier | 50 | | | | | | |

| 1407068 | perindopriil+ indapamiid, 2mg+0,625mg | C09BA04 | CO-PRENESSA, tablett, 30TK | Krka, d.d., Novo mesto | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1042401 | perindopriil+ indapamiid, 2mg+0,625mg | C09BA04 | NOLIPREL, tablett, 30TK | Les Laboratoires Servier | 50 | | | | | | |

| 1407158 | perindopriil+ indapamiid, 4mg+1,25mg | C09BA04 | CO-PRENESSA, tablett, 30TK | Krka, d.d., Novo mesto | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1042412 | perindopriil+ indapamiid, 4mg+1,25mg | C09BA04 | NOLIPREL FORTE, tablett, 30TK | Les Laboratoires Servier | 50 | | | | | | |

| 1229879 | perindopriil+ indapamiid, 5mg+1,25mg | C09BA04 | NOLIPREL FORTE ARGININE, õhukese polümeerikattega tablett, 30TK | Les Laboratoires Servier | 50 | | | | | | |

| 1001855 | pilokarpiinvesinikkloriid +timolool, 20mg+5mg 1ml | S01EB80 | FOTIL, silmatilgad, lahus, 5ml 1TK | SANTEN OY | 50 | | | | | | |

| | | | | | 100 | H40-H42 | Oftalmoloog | esmane | | | |

| 1002025 | pilokarpiinvesinikkloriid +timolool, 40mg 1ml+5mg 1ml | S01EB80 | FOTIL FORTE, silmatilgad, lahus, 5ml 1TK | SANTEN OY | 100 | H40-H42 | Oftalmoloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1002025 | pilokarpiinvesinikkloriid +timolool, 40mg+5mg 1ml | S01EB80 | FOTIL FORTE, silmatilgad, lahus, 5ml 1TK | SANTEN OY | 50 | | | | | | |

| | | | | | 100 | H40-H42 | Oftalmoloog | esmane | | | |

| 1104680 | pimekroliimus, 10mg 1g | D11AH02 | ELIDEL, kreem, 15g 1TK | Novartis Finland OY | 50 | | | | | | |

| 1013566 | pioglitasoon, 15mg | A10BG03 | ACTOS, tablett, 28TK | Takeda Global Research and Development Centre (Europe) Ltd | 50 | | | | | | |

@@ -2881,8 +2860,8 @@

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1013577 | pioglitasoon, 30mg | A10BG03 | ACTOS, tablett, 28TK | Takeda Global Research and Development Centre (Europe) Ltd | 50 | | | | | | |

| | | | | | 75 | E14-E14, E11-E11 | | | | | suukaudseks kolmikraviks metformiini ja sulfonüüluurea preparaadiga vastavalt Eesti 2008. a II tüüpi diabeedi ravijuhisele |

| | | | | | 50 | | | | | | |

| 1013588 | pioglitasoon, 45mg | A10BG03 | ACTOS, tablett, 28TK | Takeda Global Research and Development Centre (Europe) Ltd | 50 | | | | | | |

| | | | | | 75 | E14-E14, E11-E11 | | | | | suukaudseks kolmikraviks metformiini ja sulfonüüluurea preparaadiga vastavalt Eesti 2008. a II tüüpi diabeedi ravijuhisele |

| 1023332 | piratsetaam, 1200mg | N06BX03 | NOOTROPIL, tablett, 20TK | UCB Pharma OY Finland | 50 | G25.3-G25.3 | | | | | |

| 1023365 | piratsetaam, 333mg 1ml | N06BX03 | NOOTROPIL, suukaudne lahus, 125ml 1TK | UCB Pharma OY Finland | 50 | G25.3-G25.3 | | | | | |

| 1023343 | piratsetaam, 800mg | N06BX03 | NOOTROPIL, tablett, 30TK | UCB Pharma OY Finland | 50 | G25.3-G25.3 | | | | | |

@@ -2892,55 +2871,55 @@

| 1033681 | podofüllotoksiin, 5mg 1ml | D06BB04 | WARTEC, nahalahus, 3ml 1TK | Stiefel Laboratories (Ireland) Ltd. | 50 | | | | | | |

| 1271775 | polüstüreensulfonaat, 949mg 1g | V03AE01 | SORBISTERIT, suukaudse /rektaalsuspensiooni pulber, 500g 1TK | Fresenius Medical Care Nephrologica Deutschland GmbH | 100 | N18-N18 | | | | | |

| | | | | | 50 | | | | | | |

| 1041242 | pramipeksool, 0,088mg | N04BC05 | MIRAPEXIN, tablett, 30TK | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | 50 | | | | | | |

| 1339332 | pramipeksool, 0,088mg | N04BC05 | PRAMIPEXOLE ORION, tablett, 30TK | Orion Corporation | 50 | | | | | | |

| | | | | | 100 | G20-G20 | Neuroloog | esmane | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1323256 | pramipeksool, 0,088mg | N04BC05 | EZAPREV 0,088 MG, tablett, 30TK | UAB Norameda | 100 | G20-G20 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1373611 | pramipeksool, 0,088mg | N04BC05 | OPRYMEA, tablett, 30TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| 1041242 | pramipeksool, 0,088mg | N04BC05 | MIRAPEXIN, tablett, 30TK | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | 100 | G20-G20 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1323256 | pramipeksool, 0,088mg | N04BC05 | EZAPREV 0,088 MG, tablett, 30TK | UAB Norameda | 50 | | | | | | |

| | | | | | 100 | G20-G20 | Neuroloog | esmane | | | |

| 1041253 | pramipeksool, 0,18mg | N04BC05 | MIRAPEXIN, tablett, 30TK | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | 50 | | | | | | |

| 1323728 | pramipeksool, 0,088mg | N04BC05 | PRAMIPEXOLE PORTFARMA, tablett, 30TK | Portfarma ehf | 50 | | | | | | |

| | | | | | 100 | G20-G20 | Neuroloog | esmane | | | |

| 1323267 | pramipeksool, 0,18mg | N04BC05 | EZAPREV 0,18 MG, tablett, 30TK | UAB Norameda | 50 | | | | | | |

| 1373611 | pramipeksool, 0,088mg | N04BC05 | OPRYMEA, tablett, 30TK | KRKA d.d., Novo Mesto | 100 | G20-G20 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1339354 | pramipeksool, 0,18mg | N04BC05 | PRAMIPEXOLE ORION, tablett, 30TK | Orion Corporation | 100 | G20-G20 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1041253 | pramipeksool, 0,18mg | N04BC05 | MIRAPEXIN, tablett, 30TK | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | 100 | G20-G20 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1323267 | pramipeksool, 0,18mg | N04BC05 | EZAPREV 0,18 MG, tablett, 30TK | UAB Norameda | 100 | G20-G20 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1323762 | pramipeksool, 0,18mg | N04BC05 | PRAMIPEXOLE PORTFARMA, tablett, 30TK | Portfarma ehf | 100 | G20-G20 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1373666 | pramipeksool, 0,18mg | N04BC05 | OPRYMEA, tablett, 30TK | KRKA d.d., Novo Mesto | 100 | G20-G20 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1450998 | pramipeksool, 0,26mg | N04BC05 | MIRAPEXIN, toimeainet prolongeeritult vabastav tablett, 30TK | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | 50 | | | | | | |

| | | | | | 100 | G20-G20 | Neuroloog | esmane | | | |

| 1323762 | pramipeksool, 0,18mg | N04BC05 | PRAMIPEXOLE PORTFARMA, tablett, 30TK | Portfarma ehf | 50 | | | | | | |

| 1451023 | pramipeksool, 0,52mg | N04BC05 | MIRAPEXIN, toimeainet prolongeeritult vabastav tablett, 30TK | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | 50 | | | | | | |

| | | | | | 100 | G20-G20 | Neuroloog | esmane | | | |

| 1339354 | pramipeksool, 0,18mg | N04BC05 | PRAMIPEXOLE ORION, tablett, 30TK | Orion Corporation | 50 | | | | | | |

| 1339400 | pramipeksool, 0,7mg | N04BC05 | PRAMIPEXOLE ORION, tablett, 30TK | Orion Corporation | 50 | | | | | | |

| | | | | | 100 | G20-G20 | Neuroloog | esmane | | | |

| 1373666 | pramipeksool, 0,18mg | N04BC05 | OPRYMEA, tablett, 30TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| 1041264 | pramipeksool, 0,7mg | N04BC05 | MIRAPEXIN, tablett, 30TK | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | 100 | G20-G20 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1323313 | pramipeksool, 0,7mg | N04BC05 | EZAPREV 0,7 MG, tablett, 100TK | UAB Norameda | 100 | G20-G20 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1323784 | pramipeksool, 0,7mg | N04BC05 | PRAMIPEXOLE PORTFARMA, tablett, 30TK | Portfarma ehf | 50 | | | | | | |

| | | | | | 100 | G20-G20 | Neuroloog | esmane | | | |

| 1450998 | pramipeksool, 0,26mg | N04BC05 | MIRAPEXIN, toimeainet prolongeeritult vabastav tablett, 30TK | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | 100 | G20-G20 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1451023 | pramipeksool, 0,52mg | N04BC05 | MIRAPEXIN, toimeainet prolongeeritult vabastav tablett, 30TK | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | 100 | G20-G20 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1041264 | pramipeksool, 0,7mg | N04BC05 | MIRAPEXIN, tablett, 30TK | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | 50 | | | | | | |

| | | | | | 100 | G20-G20 | Neuroloog | esmane | | | |

| 1323313 | pramipeksool, 0,7mg | N04BC05 | EZAPREV 0,7 MG, tablett, 100TK | UAB Norameda | 50 | | | | | | |

| | | | | | 100 | G20-G20 | Neuroloog | esmane | | | |

| 1323784 | pramipeksool, 0,7mg | N04BC05 | PRAMIPEXOLE PORTFARMA, tablett, 30TK | Portfarma ehf | 100 | G20-G20 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1339400 | pramipeksool, 0,7mg | N04BC05 | PRAMIPEXOLE ORION, tablett, 30TK | Orion Corporation | 100 | G20-G20 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1373824 | pramipeksool, 0,7mg | N04BC05 | OPRYMEA, tablett, 30TK | KRKA d.d., Novo Mesto | 100 | G20-G20 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1323728 | pramipeksool, 0.088mg | N04BC05 | PRAMIPEXOLE PORTFARMA, tablett, 30TK | Portfarma ehf | 50 | | | | | | |

| | | | | | 100 | G20-G20 | Neuroloog | esmane | | | |

| 1339332 | pramipeksool, 0.088mg | N04BC05 | PRAMIPEXOLE ORION, tablett, 30TK | Orion Corporation | 100 | G20-G20 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1451067 | pramipeksool, 1,05mg | N04BC05 | MIRAPEXIN, toimeainet prolongeeritult vabastav tablett, 30TK | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | 50 | | | | | | |

| | | | | | 100 | G20-G20 | Neuroloog | esmane | | | |

| 1451135 | pramipeksool, 2,1mg | N04BC05 | MIRAPEXIN, toimeainet prolongeeritult vabastav tablett, 30TK | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | 100 | G20-G20 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1451135 | pramipeksool, 2,1mg | N04BC05 | MIRAPEXIN, toimeainet prolongeeritult vabastav tablett, 30TK | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | 50 | | | | | | |

| | | | | | 100 | G20-G20 | Neuroloog | esmane | | | |

| 1451168 | pramipeksool, 3,15mg | N04BC05 | MIRAPEXIN, toimeainet prolongeeritult vabastav tablett, 30TK | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | 50 | | | | | | |

| | | | | | 100 | G20-G20 | Neuroloog | esmane | | | |

| 1026201 | pravastatiin, 20mg | C10AA03 | LIPOSTAT 20 MG, tablett, 30TK | Bristol-Myers Squibb Gyogyszerkereskedel mi Kft. | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| 1118034 | pravastatiin, 20mg | C10AA03 | PRAVAHEXAL 20 MG, tablett, 30TK | HEXAL AG | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

@@ -2950,24 +2929,23 @@

| 1118056 | pravastatiin, 40mg | C10AA03 | PRAVAHEXAL 40 MG, tablett, 30TK | HEXAL AG | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| 1065776 | prednisoloon, 5mg | H02AB06 | PREDNISOLON-RICHTER, tablett, 100TK | Gedeon Richter Plc. | 100 | G70-G70 | Neuroloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | G70-G70 | Pediaater, Neuroloog | esmane | | | |

| | | | | | 100 | C00-D48 | | | | | |

| | | | | | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | N00-N08 | Nefroloog, Pediaater | | | | |

| | | | | | 100 | C00-D48 | | | | | |

| | | | | | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1031702 | prednisoloon+salitsüül hape, 0,2%+0,4% | D07XA81 | ALPICORT, nahalahus, 100ml 1TK | Dr. August Wolff GmbH & Co. KG Arzneimittel | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1031735 | prednisoloon+östradio ol, 4mg 1g+0,05mg 1g | G03CA80 | LINOLADIOL-H N, kreem, 25g 1TK | Dr. August Wolff GmbH & Co. KG Arzneimittel | 50 | | | | | | |

| 1208652 | pregabaliin, 150mg | N03AX16 | LYRICA, kõvakapsel, 14TK | Pfizer Limited | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1208663 | pregabaliin, 150mg | N03AX16 | LYRICA, kõvakapsel, 56TK | Pfizer Limited | 50 | | | | | | |

| 1252617 | pregabaliin, 225mg | N03AX16 | LYRICA, kõvakapsel, 14TK | Pfizer Limited | 50 | | | | | | |

| 1208731 | pregabaliin, 300mg | N03AX16 | LYRICA, kõvakapsel, 14TK | Pfizer Limited | 50 | | | | | | |

@@ -2981,7 +2959,8 @@

| 1020137 | propafenoon, 300mg | C01BC03 | RYTMONORM, tablett, 50TK | Abbott GmbH & Co. KG | 50 | | | | | | |

| 1053223 | propranolool, 40mg | C07AA05 | PROPRA-RATIOPHARM 40 MG, õhukese polümeerikattega tablett, 50TK | ratiopharm GmbH | 50 | | | | | | |

| 1028696 | propüültiouratsiil, 50mg | H03BA02 | TIOTIL, tablett, 100TK | Nevadapharma AB | 50 | | | | | | |

| 1141311 | pseudoefedriin+tsetirisi in, 120mg+5mg | R01BA93 | CIRRUS, toimeainet prolongeeritult vabastav tablett, 14TK | UCB Pharma OY Finland | 50 | | | | | | |

| 1078310 | pseudoefedriin+ loratadiin, 240mg+10mg | R01BA89 | CLARINASE, toimeainet prolongeeritult vabastav tablett, 7TK | SCHERING-PLOUGH EUROPE | 50 | | | | | | |

| 1141311 | pseudoefedriin+ tsetirisiin, 120mg+5mg | R01BA93 | CIRRUS, toimeainet prolongeeritult vabastav tablett, 14TK | UCB Pharma OY Finland | 50 | | | | | | |

| 1074451 | püridostigmiinbromiid, 60mg | N07AA02 | KALYMIN 60 N, tablett, 100TK | AWD. pharma GmbH & Co.KG | 100 | G70-G70 | Pediaater, Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1059218 | ramipriil, 10mg | C09AA05 | CARDACE, tablett, 28TK | Sanofi-Aventis Estonia OÜ | 50 | | | | | | |

@@ -2997,14 +2976,14 @@

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1359121 | ramipriil, 10mg | C09AA05 | RAMIGAMMA, tablett, 30TK | WÖRWAG PHARMA GmbH & Co. KG | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1005826 | ramipriil, 2,5mg | C09AA05 | CARDACE 2,5 MG, tablett, 28TK | Sanofi-Aventis Estonia OÜ | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1005826 | ramipriil, 2,5mg | C09AA05 | CARDACE 2,5 MG, tablett, 28TK | Sanofi-Aventis Estonia OÜ | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1074743 | ramipriil, 2,5mg | C09AA05 | CARDACE 2,5 MG, tablett, 98TK | Sanofi-Aventis Estonia OÜ | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1153381 | ramipriil, 2,5mg | C09AA05 | RAMICOR 2,5 MG, tablett, 30TK | HEXAL AG | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1189953 | ramipriil, 2,5mg | C09AA05 | AMPRIL 2,5 MG, tablett, 30TK | KRKA d.d., Novo Mesto | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1153381 | ramipriil, 2,5mg | C09AA05 | RAMICOR 2,5 MG, tablett, 30TK | HEXAL AG | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1189953 | ramipriil, 2,5mg | C09AA05 | AMPRIL 2,5 MG, tablett, 30TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1358940 | ramipriil, 2,5mg | C09AA05 | RAMIGAMMA, tablett, 30TK | WÖRWAG PHARMA GmbH & Co. KG | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1005859 | ramipriil, 5mg | C09AA05 | CARDACE 5 MG, tablett, 28TK | Sanofi-Aventis Estonia OÜ | 50 | | | | | | |

@@ -3014,156 +2993,184 @@

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1153459 | ramipriil, 5mg | C09AA05 | RAMICOR 5 MG, tablett, 30TK | HEXAL AG | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1169849 | ramipriil, 5mg | C09AA05 | RAMIPRIL ACTAVIS 5MG, tablett, 28TK | Actavis Nordic A/S | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1169883 | ramipriil, 5mg | C09AA05 | RAMIPRIL ACTAVIS 5MG, tablett, 98TK | Actavis Nordic A/S | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1190034 | ramipriil, 5mg | C09AA05 | AMPRIL 5 MG, tablett, 30TK | KRKA d.d., Novo Mesto | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1153459 | ramipriil, 5mg | C09AA05 | RAMICOR 5 MG, tablett, 30TK | HEXAL AG | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1169849 | ramipriil, 5mg | C09AA05 | RAMIPRIL ACTAVIS 5MG, tablett, 28TK | Actavis Nordic A/S | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1169883 | ramipriil, 5mg | C09AA05 | RAMIPRIL ACTAVIS 5MG, tablett, 98TK | Actavis Nordic A/S | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1190034 | ramipriil, 5mg | C09AA05 | AMPRIL 5 MG, tablett, 30TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1359031 | ramipriil, 5mg | C09AA05 | RAMIGAMMA, tablett, 30TK | WÖRWAG PHARMA GmbH & Co. KG | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1141715 | ramipriil+ hüdroklorotiasiid, 5mg+25mg | C09BA05 | CARDACE PLUS, tablett, 28TK | Sanofi-Aventis Estonia OÜ | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1190179 | ramipriil+ hüdroklorotiasiid, 5mg+25mg | C09BA05 | AMPRIL HD 5MG/25MG, tablett, 30TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1021936 | ramipriil+hüdroklorotia siid, 2,5mg+12,5mg | C09BA05 | CARDACE COMP, tablett, 28TK | Sanofi-Aventis Estonia OÜ | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1113657 | ramipriil+hüdroklorotia siid, 2,5mg+12,5mg | C09BA05 | CO-RAMICOR 2,5 MG/12,5 MG, tablett, 30TK | HEXAL AG | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1190269 | ramipriil+hüdroklorotia siid, 2,5mg+12,5mg | C09BA05 | AMPRIL HL 2,5MG/12,5MG, tablett, 30TK | KRKA d.d., Novo Mesto | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1113680 | ramipriil+hüdroklorotia siid, 5mg+25mg | C09BA05 | CO-RAMICOR 5 MG/25 MG, tablett, 30TK | HEXAL AG | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1019922 | ranitidiin, 150mg | A02BA02 | RANISAN 150 MG, õhukese polümeerikattega tablett, 20TK | PRO. MED. CS. PRAHA a.s. | 50 | | | | | | |

| 1061525 | ranitidiin, 150mg | A02BA02 | ZANTAC, õhukese polümeerikattega tablett, 60TK | GlaxoSmithKline Export Ltd | 50 | | | | | | |

| 1061806 | ranitidiin, 150mg | A02BA02 | RANIBERL 150, õhukese polümeerikattega tablett, 50TK | Berlin-Chemie AG (Menarini Group) | 50 | | | | | | |

| 1134986 | ranitidiin, 150mg | A02BA02 | RANISAN 150 MG, õhukese polümeerikattega tablett, 60TK | PRO. MED. CS. PRAHA a.s. | 50 | | | | | | |

| 1026885 | ranitidiin, 300mg | A02BA02 | RANIBERL 300 MG, õhukese polümeerikattega tablett, 20TK | Berlin-Chemie AG (Menarini Group) | 50 | | | | | | |

| 1203422 | rasagiliin, 1mg | N04BD02 | AZILECT, tablett, 28TK | Teva Pharma GmbH | 100 | G20-G20 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1203422 | rasagiliin, 1mg | N04BD02 | AZILECT, tablett, 28TK | Teva Pharma GmbH | 50 | | | | | | |

| | | | | | 100 | G20-G20 | Neuroloog | esmane | | | |

| 1127797 | raud(II)glükonaat+vask glükonaat+mangaangl ükonaat, 5mg+0,07mg+0,133m g 1ml | B03AE81 | TOT'HEMA, suukaudne lahus, 10ml 20TK | LABORATOIRE INNOTECH INTERNATIONAL | 75 | D50-D50 | | | | | rasedatele |

| | | | | | 50 | D50-D50 | | | | 3,00 | |

| 1018202 | raud(II)sulfaat, 100mg | B03AA07 | RETAFER, toimeainet prolongeeritult vabastav tablett, 30TK | Orion Corporation | 75 | D50-D50 | | | | | rasedatele |

| | | | | | 50 | D50-D50 | | | | 3,00 | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1011036 | raud(III)hüdroksiid- polümaltoos kompleks, 100mg | B03AB80 | FERRUM LEK, närimistablett, 30TK | Lek Pharmaceuticals d.d. | 50 | D50-D50 | | | | 3,00 | |

| | | | | | 75 | D50-D50 | | | | | rasedatele |

| 1011036 | raud(III)hüdroksiid- polümaltoos kompleks, 100mg | B03AB80 | FERRUM LEK, närimistablett, 30TK | Lek Pharmaceuticals d.d. | 75 | D50-D50 | | | | | rasedatele |

| | | | | | 50 | D50-D50 | | | | 3,00 | |

| 1011025 | raud(III)hüdroksiid- polümaltoos kompleks, 10mg 1ml | B03AB02 | FERRUM LEK, siirup, 100ml 1TK | Lek Pharmaceuticals d.d. | 75 | D50-D50 | | | | | rasedatele |

| | | | | | 50 | D50-D50 | | | | 3,00 | |

| 1070930 | reboksetiin, 4mg | N06AX18 | EDRONAX, tablett, 60TK | Pfizer Enterprises SARL | 50 | | | | | | |

| 1073034 | ribaviriin, 200mg | J05AB04 | REBETOL, kõvakapsel, 140TK | SCHERING-PLOUGH EUROPE | 100 | B18.2-B18.2 | Gastroenteroloog, Infektsionist | | | | kroonilise progresseeruva C- viirushepatiidi näidustusel vastavalt Eesti Gastroenteroloogide Seltsi ja Eesti Infektsionistide Seltsi 2006. a ravijuhisele |

| | | | | | 50 | | | | | | |

| 1044380 | retinool+ dekspantenool, 20TÜ+20mg 1g | S01XA80 | OFTAN A-PANT, silmasalv, 3.5g 1TK | SANTEN OY | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1161447 | ribaviriin, 200mg | J05AB04 | COPEGUS, õhukese polümeerikattega tablett, 168TK | Roche Eesti OÜ | 100 | B18.2-B18.2 | Infektsionist, Gastroenteroloog | | | | kroonilise progresseeruva C- viirushepatiidi näidustusel vastavalt Eesti Gastroenteroloogide Seltsi ja Eesti Infektsionistide Seltsi 2006. a ravijuhisele |

| | | | | | 50 | | | | | | |

| 1073034 | ribaviriin, 200mg | J05AB04 | REBETOL, kõvakapsel, 140TK | SCHERING-PLOUGH EUROPE | 50 | | | | | | |

| 1035289 | rilusool, 50mg | N07XX02 | RILUTEK, õhukese polümeerikattega tablett, 56TK | Aventis Pharma SA | 50 | | | | | | |

| 1032804 | risatriptaan, 10mg | N02CC04 | MAXALT 10 MG, suukaudne lüofilisaat, 2TK | Merck Sharp & Dohme OÜ | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1032804 | risatriptaan, 10mg | N02CC04 | MAXALT, suukaudne lüofilisaat, 2TK | Merck Sharp & Dohme OÜ | 50 | | | | | | |

| 1107593 | risedroonhape, 35mg | M05BA07 | ACTONEL 35 MG OAW, õhukese polümeerikattega tablett, 4TK | Sanofi-Aventis Estonia OÜ | 75 | M80-M80 | | | | | patsientidele, kelle lülisamba või reieluukaela mineraalne tihedus on -2,5 SD või vähem DEXA meetodil määratuna |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1310757 | risedroonhape, 35mg | M05BA07 | RISONATE, õhukese polümeerikattega tablett, 4TK | Teva Pharma B.V. | 75 | M80-M80 | | | | | patsientidele, kelle lülisamba või reieluukaela mineraalne tihedus on -2,5 SD või vähem DEXA meetodil määratuna |

| | | | | | 50 | | | | | | |

| 1285680 | risedroonhape, 35mg | M05BA07 | RISENDROS 35MG, õhukese polümeerikattega tablett, 4TK | Zentiva, k.s. | 75 | M80-M80 | | | | | patsientidele, kelle lülisamba või reieluukaela mineraalne tihedus on -2,5 SD või vähem DEXA meetodil määratuna |

| | | | | | 50 | | | | | | |

| 1285703 | risedroonhape, 35mg | M05BA07 | RISENDROS 35MG, õhukese polümeerikattega tablett, 12TK | Zentiva, k.s. | 50 | | | | | | |

| 1285703 | risedroonhape, 35mg | M05BA07 | RISENDROS 35MG, õhukese polümeerikattega tablett, 12TK | Zentiva, k.s. | 75 | M80-M80 | | | | | patsientidele, kelle lülisamba või reieluukaela mineraalne tihedus on -2,5 SD või vähem DEXA meetodil määratuna |

| | | | | | 50 | | | | | | |

| 1298257 | risedroonhape, 35mg | M05BA07 | NORIFAZ, õhukese polümeerikattega tablett, 4TK | Zaklad Farmaceutyczny Adamed Pharma S.A. | 75 | M80-M80 | | | | | patsientidele, kelle lülisamba või reieluukaela mineraalne tihedus on -2,5 SD või vähem DEXA meetodil määratuna |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1298336 | risedroonhape, 35mg | M05BA07 | RISEDRONATE SODIUM ACTAVIS, õhukese polümeerikattega tablett, 4TK | Actavis Group PTC ehf | 50 | | | | | | |

| | | | | | 75 | M80-M80 | | | | | patsientidele, kelle lülisamba või reieluukaela mineraalne tihedus on -2,5 SD või vähem DEXA meetodil määratuna |

| 1298257 | risedroonhape, 35mg | M05BA07 | NORIFAZ, õhukese polümeerikattega tablett, 4TK | Zaklad Farmaceutyczny Adamed Pharma S.A. | 50 | | | | | | |

| | | | | | 75 | M80-M80 | | | | | patsientidele, kelle lülisamba või reieluukaela mineraalne tihedus on -2,5 SD või vähem DEXA meetodil määratuna |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1298336 | risedroonhape, 35mg | M05BA07 | RISEDRONATE SODIUM ACTAVIS, õhukese polümeerikattega tablett, 4TK | Actavis Group PTC ehf | 75 | M80-M80 | | | | | patsientidele, kelle lülisamba või reieluukaela mineraalne tihedus on -2,5 SD või vähem DEXA meetodil määratuna |

| | | | | | 50 | | | | | | |

| 1301229 | risedroonhape, 35mg | M05BA07 | RIBIDRON, õhukese polümeerikattega tablett, 4TK | ratiopharm GmbH | 75 | M80-M80 | | | | | patsientidele, kelle lülisamba või reieluukaela mineraalne tihedus on -2,5 SD või vähem DEXA meetodil määratuna |

| | | | | | 50 | | | | | | |

| 1060456 | risperidoon, 1mg | N05AX08 | RISPOLEPT 1 mg, õhukese polümeerikattega tablett, 60TK | Johnson & Johnson UAB | 50 | | | | | | |

| | | | | | 100 | F20-F29 | Psühhiaater | | | | vastavalt Eesti ravijuhisele ning arvestades Eesti Psühhiaatrite Seltsi poolt väljatöötatud kriteeriume üleminekuks konventsionaalselt atüüpilisele antipsühhootikumile |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1060456 | risperidoon, 1mg | N05AX08 | RISPOLEPT 1 mg, õhukese polümeerikattega tablett, 60TK | Johnson & Johnson UAB | 100 | F20-F29 | Psühhiaater | | | | vastavalt Eesti ravijuhisele ning arvestades Eesti Psühhiaatrite Seltsi poolt väljatöötatud kriteeriume üleminekuks konventsionaalselt atüüpilisele antipsühhootikumile |

| | | | | | 50 | | | | | | |

| 1119855 | risperidoon, 1mg | N05AX08 | RISPEN 1, õhukese polümeerikattega tablett, 20TK | Zentiva, k.s. | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1151952 | risperidoon, 1mg | N05AX08 | RISPERIDON ACTAVIS 1MG, õhukese polümeerikattega tablett, 60TK | Actavis Nordic A/S | 50 | | | | | | |

| 1041028 | risperidoon, 1mg 1ml | N05AX08 | RISPOLEPT, suukaudne lahus, 100ml 1TK | Johnson & Johnson UAB | 100 | F20-F29 | Psühhiaater | | | | vastavalt Eesti ravijuhisele ning arvestades Eesti Psühhiaatrite Seltsi poolt väljatöötatud kriteeriume üleminekuks konventsionaalselt atüüpilisele antipsühhootikumile |

| | | | | | 50 | | | | | | |

| 1122129 | risperidoon, 25mg | N05AX08 | RISPOLEPT CONSTA 25MG, toimeainet prolongeeritult vabastava süstesuspensiooni pulber ja lahusti, 1TK | Johnson & Johnson UAB | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1067509 | risperidoon, 2mg | N05AX08 | RISPOLEPT 2 mg, õhukese polümeerikattega tablett, 60TK | Johnson & Johnson UAB | 100 | F20-F29 | Psühhiaater | | | | vastavalt Eesti ravijuhisele ning arvestades Eesti Psühhiaatrite Seltsi poolt väljatöötatud kriteeriume üleminekuks konventsionaalselt atüüpilisele antipsühhootikumile |

| | | | | | 50 | | | | | | |

| 1067509 | risperidoon, 2mg | N05AX08 | RISPOLEPT 2 mg, õhukese polümeerikattega tablett, 60TK | Johnson & Johnson UAB | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1119888 | risperidoon, 2mg | N05AX08 | RISPEN 2, õhukese polümeerikattega tablett, 20TK | Zentiva, k.s. | 100 | F20-F29 | Psühhiaater | | | | vastavalt Eesti ravijuhisele ning arvestades Eesti Psühhiaatrite Seltsi poolt väljatöötatud kriteeriume üleminekuks konventsionaalselt atüüpilisele antipsühhootikumile |

| | | | | | 50 | | | | | | |

| 1151963 | risperidoon, 2mg | N05AX08 | RISPERIDON ACTAVIS 2MG, õhukese polümeerikattega tablett, 20TK | Actavis Nordic A/S | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1151974 | risperidoon, 2mg | N05AX08 | RISPERIDON ACTAVIS 2MG, õhukese polümeerikattega tablett, 60TK | Actavis Nordic A/S | 50 | | | | | | |

| 1122130 | risperidoon, 37,5mg | N05AX08 | RISPOLEPT CONSTA 37,5MG, toimeainet prolongeeritult vabastava süstesuspensiooni pulber ja lahusti, 1TK | Johnson & Johnson UAB | 50 | | | | | | |

| 1067521 | risperidoon, 3mg | N05AX08 | RISPOLEPT 3 mg, õhukese polümeerikattega tablett, 60TK | Johnson & Johnson UAB | 100 | F20-F29 | Psühhiaater | | | | vastavalt Eesti ravijuhisele ning arvestades Eesti Psühhiaatrite Seltsi poolt väljatöötatud kriteeriume üleminekuks konventsionaalselt atüüpilisele antipsühhootikumile |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1067521 | risperidoon, 3mg | N05AX08 | RISPOLEPT 3 mg, õhukese polümeerikattega tablett, 60TK | Johnson & Johnson UAB | 50 | | | | | | |

| 1119912 | risperidoon, 3mg | N05AX08 | RISPEN 3, õhukese polümeerikattega tablett, 20TK | Zentiva, k.s. | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1151985 | risperidoon, 3mg | N05AX08 | RISPERIDON ACTAVIS 3MG, õhukese polümeerikattega tablett, 20TK | Actavis Nordic A/S | 100 | F20-F29 | Psühhiaater | | | | vastavalt Eesti ravijuhisele ning arvestades Eesti Psühhiaatrite Seltsi poolt väljatöötatud kriteeriume üleminekuks konventsionaalselt atüüpilisele antipsühhootikumile |

| | | | | | 50 | | | | | | |

| 1151996 | risperidoon, 3mg | N05AX08 | RISPERIDON ACTAVIS 3MG, õhukese polümeerikattega tablett, 60TK | Actavis Nordic A/S | 100 | F20-F29 | Psühhiaater | | | | vastavalt Eesti ravijuhisele ning arvestades Eesti Psühhiaatrite Seltsi poolt väljatöötatud kriteeriume üleminekuks konventsionaalselt atüüpilisele antipsühhootikumile |

| | | | | | 50 | | | | | | |

| 1067532 | risperidoon, 4mg | N05AX08 | RISPOLEPT 4 mg, õhukese polümeerikattega tablett, 60TK | Johnson & Johnson UAB | 50 | | | | | | |

| 1151985 | risperidoon, 3mg | N05AX08 | RISPERIDON ACTAVIS 3MG, õhukese polümeerikattega tablett, 20TK | Actavis Nordic A/S | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1151996 | risperidoon, 3mg | N05AX08 | RISPERIDON ACTAVIS 3MG, õhukese polümeerikattega tablett, 60TK | Actavis Nordic A/S | 50 | | | | | | |

| 1067532 | risperidoon, 4mg | N05AX08 | RISPOLEPT 4 mg, õhukese polümeerikattega tablett, 60TK | Johnson & Johnson UAB | 100 | F20-F29 | Psühhiaater | | | | vastavalt Eesti ravijuhisele ning arvestades Eesti Psühhiaatrite Seltsi poolt väljatöötatud kriteeriume üleminekuks konventsionaalselt atüüpilisele antipsühhootikumile |

| | | | | | 50 | | | | | | |

| 1119967 | risperidoon, 4mg | N05AX08 | RISPEN 4, õhukese polümeerikattega tablett, 20TK | Zentiva, k.s. | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1152009 | risperidoon, 4mg | N05AX08 | RISPERIDON ACTAVIS 4MG, õhukese polümeerikattega tablett, 20TK | Actavis Nordic A/S | 100 | F20-F29 | Psühhiaater | | | | vastavalt Eesti ravijuhisele ning arvestades Eesti Psühhiaatrite Seltsi poolt väljatöötatud kriteeriume üleminekuks konventsionaalselt atüüpilisele antipsühhootikumile |

| | | | | | 50 | | | | | | |

| 1152010 | risperidoon, 4mg | N05AX08 | RISPERIDON ACTAVIS 4MG, õhukese polümeerikattega tablett, 60TK | Actavis Nordic A/S | 50 | | | | | | |

| 1122141 | risperidoon, 50mg | N05AX08 | RISPOLEPT CONSTA 50MG, toimeainet prolongeeritult vabastava süstesuspensiooni pulber ja lahusti, 1TK | Johnson & Johnson UAB | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1381665 | rivaroksabaan, 10mg | B01AX06 | XARELTO, õhukese polümeerikattega tablett, 10TK | Bayer Schering Pharma AG | 50 | | | | | | |

| 1381676 | rivaroksabaan, 10mg | B01AX06 | XARELTO, õhukese polümeerikattega tablett, 30TK | Bayer Schering Pharma AG | 50 | | | | | | |

| 1225741 | ropinirool, 2mg | N04BC04 | REQUIP-MODUTAB, toimeainet prolongeeritult vabastav tablett, 28TK | SMITHKLINE BEECHAM plc | 100 | G20-G20 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1225752 | ropinirool, 2mg | N04BC04 | REQUIP-MODUTAB, toimeainet prolongeeritult vabastav tablett, 42TK | SMITHKLINE BEECHAM plc | 100 | G20-G20 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1225752 | ropinirool, 2mg | N04BC04 | REQUIP-MODUTAB, toimeainet prolongeeritult vabastav tablett, 42TK | SMITHKLINE BEECHAM plc | 50 | | | | | | |

| | | | | | 100 | G20-G20 | Neuroloog | esmane | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1436598 | ropinirool, 2mg | N04BC04 | ROLPRYNA SR 2MG, toimeainet prolongeeritult vabastav tablett, 28TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 100 | G20-G20 | Neuroloog | esmane | | | |

| 1225796 | ropinirool, 4mg | N04BC04 | REQUIP-MODUTAB, toimeainet prolongeeritult vabastav tablett, 28TK | SMITHKLINE BEECHAM plc | 50 | | | | | | |

| | | | | | 100 | G20-G20 | Neuroloog | esmane | | | |

| 1436633 | ropinirool, 4mg | N04BC04 | ROLPRYNA SR 4MG, toimeainet prolongeeritult vabastav tablett, 28TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 100 | G20-G20 | Neuroloog | esmane | | | |

| 1225819 | ropinirool, 8mg | N04BC04 | REQUIP-MODUTAB, toimeainet prolongeeritult vabastav tablett, 28TK | SMITHKLINE BEECHAM plc | 100 | G20-G20 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1436677 | ropinirool, 8mg | N04BC04 | ROLPRYNA SR 8MG, toimeainet prolongeeritult vabastav tablett, 28TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 100 | G20-G20 | Neuroloog | esmane | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| 1385861 | rosuvastatiin, 10mg | C10AA07 | ZARANTA, õhukese polümeerikattega tablett, 30TK | Gedeon Richter Plc. | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| 1396874 | rosuvastatiin, 10mg | C10AA07 | ROSUCARD 10MG, õhukese polümeerikattega tablett, 30tabl | Zentiva, k.s. | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1384950 | rosuvastatiin, 20mg | C10AA07 | ROSUVASTATIN TEVA 20 MG, õhukese polümeerikattega tablett, 28TK | Teva Pharma B.V. | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1384758 | rosuvastatiin, 10mg | C10AA07 | ROXARDIO, õhukese polümeerikattega tablett, 30TK | Sandoz d.d. | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| 1384859 | rosuvastatiin, 10mg | C10AA07 | ROSUVASTATIN TEVA 10 MG, õhukese polümeerikattega tablett, 28TK | Teva Pharma B.V. | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| 1396874 | rosuvastatiin, 10mg | C10AA07 | ROSUCARD 10MG, õhukese polümeerikattega tablett, 30tabl | Zentiva, k.s. | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| 1385906 | rosuvastatiin, 20mg | C10AA07 | ZARANTA, õhukese polümeerikattega tablett, 30TK | Gedeon Richter Plc. | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1106132 | rosuvastatiin, 20mg | C10AA07 | CRESTOR, õhukese polümeerikattega tablett, 28TK | AstraZeneca UK Limited | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| 1384950 | rosuvastatiin, 20mg | C10AA07 | ROSUVASTATIN TEVA 20 MG, õhukese polümeerikattega tablett, 28TK | Teva Pharma B.V. | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| 1397099 | rosuvastatiin, 20mg | C10AA07 | ROSUCARD 20MG, õhukese polümeerikattega tablett, 30tabl | Zentiva, k.s. | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| 1473476 | rosuvastatiin, 20mg | C10AA07 | ROXARDIO, õhukese polümeerikattega tablett, 30TK | Sandoz d.d. | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

@@ -3173,132 +3180,165 @@

| | | | | | 50 | | | | | | |

| | | | | | 75 | J45-J45 | | | | | |

| 1045572 | salbutamool, 100mcg 1annust | R03AC02 | ECOSAL, inhalatsiooniaerosool, suspensioon, 200annust 1TK | TEVA Czech Industries s.r.o. | 75 | J45-J45 | | | | | |

| | | | | | 50 | | | | | | |

| 1031308 | salbutamool, 200mcg 1annust | R03AC02 | VENTOLIN DISKUS, inhalatsioonipulber, 60annust 1TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 75 | J45-J45 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | J45-J45 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | J45-J45 | | | | | |

| | | | | | 50 | | | | | | |

| 1004319 | salbutamool, 400mcg 1ml | R03CC02 | VENTOLIN SYRUP, siirup, 150ml 1TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 50 | | | | | | |

| | | | | | 75 | J45-J45 | | | | | |

| 1004948 | salbutamool, 5000mcg 1ml | R03AC02 | VENTOLIN, nebuliseeritav lahus, 20ml 1TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 50 | | | | | | |

| | | | | | 75 | J45-J45 | | | | | |

| 1004948 | salbutamool, 5000mcg 1ml | R03AC02 | VENTOLIN, nebuliseeritav lahus, 20ml 1TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 75 | J45-J45 | | | | | |

| 1000405 | salmeterool, 25mcg 1annust | R03AC12 | SEREVENT, inhalatsiooniaerosool, suspensioon, 120annust 1TK | GlaxoSmithKline Export Ltd | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1000405 | salmeterool, 25mcg 1annust | R03AC12 | SEREVENT, inhalatsiooniaerosool, suspensioon, 120annust 1TK | GlaxoSmithKline Export Ltd | 50 | | | | | | |

| | | | | | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1107346 | salmeterool+ flutikasoon, 25mcg+125mcg 1annust | R03AK82 | SERETIDE INHALER, inhalatsiooniaerosool, suspensioon, 120annust 1TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1107357 | salmeterool+ flutikasoon, 25mcg+250mcg 1annust | R03AK82 | SERETIDE INHALER, inhalatsiooniaerosool, suspensioon, 120annust 1TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| 1107335 | salmeterool+ flutikasoon, 25mcg+50mcg 1annust | R03AK82 | SERETIDE INHALER, inhalatsiooniaerosool, suspensioon, 120annust 1TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 50 | | | | | | |

| | | | | | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | | |

| 1037607 | salmeterool+ flutikasoon, 50mcg+100mcg 1annust | R03AK82 | SERETIDE DISKUS 100, inhalatsioonipulber, 60annust 1TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 50 | | | | | | |

| | | | | | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | | | |

| 1037595 | salmeterool+ flutikasoon, 50mcg+250mcg 1annust | R03AK82 | SERETIDE DISKUS 250, inhalatsioonipulber, 60annust 1TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 50 | | | | | | |

| | | | | | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | | | |

| 1153167 | salmeterool+flutikasoo n, 50mcg+500mcg 1annust | R03AK82 | SERETIDE DISKUS 500, inhalatsioonipulber, 60annust 1TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1391789 | sapropteriin, 100mg | A16AX07 | KUVAN, lahustuv tablett, 120TK | Merck Serono Europe Limited | 100 | E70.0-E70.1 | | | | 12,00 | konsiiliumi (vähemalt kahe pediaatri või meditsiinigeneetiku ühise) otsuse alusel järgmistel tingimustel: tegemist on biopteriinitundliku haigusvormiga ning dieedi järgimine ei ole taganud ravijuhendi kohase vere fenüülalaniini taseme eesmärkväärtuse saavutamist; ravi võib jätkata kuni 12. eluaastani patsiendil, kellel ravimi kasutamisega püsib fenüülalaniini tase eesmärkväärtuste piires |

| 1027066 | sertindool, 12mg | N05AE03 | SERDOLECT, õhukese polümeerikattega tablett, 28TK | H. LUNDBECK A/S | 50 | | | | | | |

| | | | | | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1027077 | sertindool, 16mg | N05AE03 | SERDOLECT, õhukese polümeerikattega tablett, 28TK | H. LUNDBECK A/S | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1027088 | sertindool, 20mg | N05AE03 | SERDOLECT, õhukese polümeerikattega tablett, 28TK | H. LUNDBECK A/S | 50 | | | | | | |

| | | | | | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1027055 | sertindool, 4mg | N05AE03 | SERDOLECT, õhukese polümeerikattega tablett, 30TK | H. LUNDBECK A/S | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1008638 | sertraliin, 50mg | N06AB06 | ZOLOFT, õhukese polümeerikattega tablett, 28TK | Pfizer Europe MA EEIG | 50 | | | | | | |

| 1125302 | sertraliin, 50mg | N06AB06 | SERLIFT, õhukese polümeerikattega tablett, 30TK | Ranbaxy (UK) Limited | 50 | | | | | | |

| 1239218 | sertraliin, 50mg | N06AB06 | SERTRALINE-TEVA 50 MG, õhukese polümeerikattega tablett, 30TK | Teva Pharma B.V. | 50 | | | | | | |

| 1110856 | sertraliin, 50mg | N06AB06 | SERTRAL 50 MG, õhukese polümeerikattega tablett, 28TK | Sandoz d.d. | 50 | | | | | | |

| 1125302 | sertraliin, 50mg | N06AB06 | SERLIFT, õhukese polümeerikattega tablett, 30TK | Ranbaxy (UK) Limited | 50 | | | | | | |

| 1143100 | sertraliin, 50mg | N06AB06 | ASENTRA, õhukese polümeerikattega tablett, 28TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| 1152391 | sertraliin, 50mg | N06AB06 | SERTRALIN "GENERICON" 50MG, õhukese polümeerikattega tablett, 30TK | Genericon Pharma GmbH | 50 | | | | | | |

| 1189841 | sertraliin, 50mg | N06AB06 | SERTRALIN ACTAVIS 50 MG, õhukese polümeerikattega tablett, 28TK | Actavis Nordic A/S | 50 | | | | | | |

| 1239218 | sertraliin, 50mg | N06AB06 | SERTRALINE-TEVA 50 MG, õhukese polümeerikattega tablett, 30TK | Teva Pharma B.V. | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1123074 | sevelameer, 800mg | V03AE02 | RENAGEL, õhukese polümeerikattega tablett, 180TK | Genzyme Europe B.V. | 50 | | | | | | |

| | | | | | 100 | N18-N18 | Nefroloog, Pediaater | | | | juhul, kui kaltsiumipõhine fosforisiduja on vastunäidustatud (seerumi kaltsiumisisaldus >2,54 mmol/l) |

| 1221039 | sildenafiil, 20mg | G04BE03 | REVATIO, õhukese polümeerikattega tablett, 90TK | Pfizer Limited | 100 | I27.0-I27.0 | Pediaater, Kardioloog, Reumatoloog, Pulmonoloog | | | | NYHA III-IV kl idiopaatilise või süsteemse sidekoehaigusega seotud pulmonaalse arteriaalse hüpertensiooniga patsientidele, kelle ravi alustamine ja jätkamine sildenafiiliga on hinnatud konsiiliumi (vähemalt 3 vastava eriala spetsialisti) poolt vastavaks Eesti Pulmonoloogide Seltsi, Eesti Kardioloogide Seltsi, Eesti Reumatoloogide Seltsi ja Eesti Lastearstide Seltsi 2007. a tunnustatud ravijuhisele |

| | | | | | 50 | I27.0-I27.0 | Pulmonoloog, Kardioloog, Pediaater, Reumatoloog | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1010271 | simvastatiin, 10mg | C10AA01 | VASILIP, õhukese polümeerikattega tablett, 28TK | KRKA d.d., Novo Mesto | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1221039 | sildenafiil, 20mg | G04BE03 | REVATIO, õhukese polümeerikattega tablett, 90TK | Pfizer Limited | 100 | I27.0-I27.0 | Pulmonoloog, Pediaater, Reumatoloog, Kardioloog | | | | NYHA III-IV kl idiopaatilise või süsteemse sidekoehaigusega seotud pulmonaalse arteriaalse hüpertensiooniga patsientidele, kelle ravi alustamine ja jätkamine sildenafiiliga on hinnatud konsiiliumi (vähemalt 3 vastava eriala spetsialisti) poolt vastavaks Eesti Pulmonoloogide Seltsi, Eesti Kardioloogide Seltsi, Eesti Reumatoloogide Seltsi ja Eesti Lastearstide Seltsi 2007. a tunnustatud ravijuhisele |

| | | | | | 50 | I27.0-I27.0 | Reumatoloog, Kardioloog, Pulmonoloog, Pediaater | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1080166 | simvastatiin, 10mg | C10AA01 | SIMVACOR, õhukese polümeerikattega tablett, 30TK | HEXAL AG | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| 1113534 | simvastatiin, 10mg | C10AA01 | SIMVOR, õhukese polümeerikattega tablett, 30TK | Ranbaxy (UK) Limited | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| 1163023 | simvastatiin, 10mg | C10AA01 | ZOCOR 10 MG, õhukese polümeerikattega tablett, 28TK | Merck Sharp & Dohme OÜ | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1010765 | simvastatiin, 10mg | C10AA01 | SIMGAL, õhukese polümeerikattega tablett, 28TK | TEVA Czech Industries s.r.o. | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| 1083934 | simvastatiin, 10mg | C10AA01 | SIMVASTATIN- RATIOPHARM, õhukese polümeerikattega tablett, 30TK | ratiopharm GmbH | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| 1147429 | simvastatiin, 10mg | C10AA01 | SIMVAGAMMA 10MG, õhukese polümeerikattega tablett, 30TK | WÖRWAG PHARMA GmbH & Co. KG | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| 1163023 | simvastatiin, 10mg | C10AA01 | ZOCOR 10 MG, õhukese polümeerikattega tablett, 28TK | Merck Sharp & Dohme OÜ | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| 1010260 | simvastatiin, 20mg | C10AA01 | VASILIP, õhukese polümeerikattega tablett, 28TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1436880 | simvastatiin, 10mg | C10AA01 | SIMVASTATIN PFIZER, õhukese polümeerikattega tablett, 30TK | Pfizer Europe MA EEIG | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1080177 | simvastatiin, 20mg | C10AA01 | SIMVACOR, õhukese polümeerikattega tablett, 30TK | HEXAL AG | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| 1080740 | simvastatiin, 20mg | C10AA01 | ZOCOR 20 MG, õhukese polümeerikattega tablett, 28TK | Merck Sharp & Dohme OÜ | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| 1113523 | simvastatiin, 20mg | C10AA01 | SIMVOR, õhukese polümeerikattega tablett, 30TK | Ranbaxy (UK) Limited | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| 1147463 | simvastatiin, 20mg | C10AA01 | SIMVAGAMMA 20MG, õhukese polümeerikattega tablett, 30TK | WÖRWAG PHARMA GmbH & Co. KG | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1083956 | simvastatiin, 20mg | C10AA01 | SIMVASTATIN- RATIOPHARM, õhukese polümeerikattega tablett, 30TK | ratiopharm GmbH | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1113523 | simvastatiin, 20mg | C10AA01 | SIMVOR, õhukese polümeerikattega tablett, 30TK | Ranbaxy (UK) Limited | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| 1121038 | simvastatiin, 20mg | C10AA01 | SIMVASTATIN NYCOMED 20MG, õhukese polümeerikattega tablett, 30TK | Nycomed Sefa AS | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| 1147463 | simvastatiin, 20mg | C10AA01 | SIMVAGAMMA 20MG, õhukese polümeerikattega tablett, 30TK | WÖRWAG PHARMA GmbH & Co. KG | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| 1436970 | simvastatiin, 20mg | C10AA01 | SIMVASTATIN PFIZER, õhukese polümeerikattega tablett, 30TK | Pfizer Europe MA EEIG | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1129698 | simvastatiin, 30mg | C10AA01 | SIMVACOR, õhukese polümeerikattega tablett, 30TK | HEXAL AG | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1060715 | simvastatiin, 40mg | C10AA01 | ZOCOR FORTE 40, õhukese polümeerikattega tablett, 28TK | Merck Sharp & Dohme OÜ | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| 1083978 | simvastatiin, 40mg | C10AA01 | SIMVASTATIN- RATIOPHARM, õhukese polümeerikattega tablett, 30TK | ratiopharm GmbH | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| 1086218 | simvastatiin, 40mg | C10AA01 | VASILIP, õhukese polümeerikattega tablett, 28TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| 1129700 | simvastatiin, 40mg | C10AA01 | SIMVACOR, õhukese polümeerikattega tablett, 30TK | HEXAL AG | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| 1154797 | simvastatiin, 40mg | C10AA01 | SIMVOR, õhukese polümeerikattega tablett, 30TK | Ranbaxy (UK) Limited | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| 1437061 | simvastatiin, 40mg | C10AA01 | SIMVASTATIN PFIZER, õhukese polümeerikattega tablett, 30TK | Pfizer Europe MA EEIG | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1107739 | siroliimus, 1mg | L04AA10 | RAPAMUNE, kaetud tablett, 30TK | Wyeth Europe Ltd. | 50 | | | | | | |

| | | | | | 100 | Z94-Z94, T86-T86 | | | | | |

| 1286568 | sitagliptiin, 100mg | A10BH01 | JANUVIA, õhukese polümeerikattega tablett, 28TK | Merck Sharp & Dohme | 50 | | | | | | |

@@ -3307,18 +3347,15 @@

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| Ravimi- kood | Toimeaine, toimeaine sisaldus | ATC kood | Ravim, pakendi suurus | Müügiloa hoidja | Soodus- tus % — 50 — 100 | Diagnoos — C64-C64 | Eriala — Onkoloog | Esmane | Vanus üle | Vanus alla | Märkused — patsientidele, kellel ravi alustamine ja jätkamine sorafeniibiga on hinnatud konsiiliumi (vähemalt kolme onkoloogi) poolt vastavaks järgmistele kriteeriumidele: diagnoositud IV staadiumis heledarakuline neeru kartsinoom, eelnev interferoonravi on osutunud ebaefektiivseks või talumatuks, patsiendi üldseisund ECOG kriteeriumide järgi on 0-1 ja haiguse prognoos MSKCC kriteeriumide järgi hea kuni keskmine ning mitte enam kui 3 ravikuu möödumisel on saavutatud täielik või osaline ravivastus või haigu |

| Ravimi- kood | Toimeaine, toimeaine sisaldus | ATC kood | Ravim, pakendi suurus | Müügiloa hoidja | Soodus- tus % — 100 — 50 | Diagnoos — C64-C64 | Eriala — Onkoloog | Esmane | Vanus üle | Vanus alla | Märkused — patsientidele, kellel ravi alustamine ja jätkamine sorafeniibiga on hinnatud konsiiliumi (vähemalt kolme onkoloogi) poolt vastavaks järgmistele kriteeriumidele: diagnoositud IV staadiumis heledarakuline neeru kartsinoom, eelnev interferoonravi on osutunud ebaefektiivseks või talumatuks, patsiendi üldseisund ECOG kriteeriumide järgi on 0-1 ja haiguse prognoos MSKCC kriteeriumide järgi hea kuni keskmine ning mitte enam kui 3 ravikuu möödumisel on saavutatud täielik või osaline ravivastus või haigu |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1034491 | sotalool, 160mg | C07AA07 | SOTAHEXAL 160 MG, tablett, 20TK | HEXAL AG | 75 | I47-I49 | Pediaater, Kardioloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1034480 | sotalool, 80mg | C07AA07 | SOTAHEXAL 80 MG, tablett, 20TK | HEXAL AG | 50 | | | | | | |

| | | | | | 75 | I47-I49 | Pediaater, Kardioloog | esmane | | | |

| 1034480 | sotalool, 80mg | C07AA07 | SOTAHEXAL 80 MG, tablett, 20TK | HEXAL AG | 75 | I47-I49 | Pediaater, Kardioloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1071863 | sotalool, 80mg | C07AA07 | SOTAHEXAL 80 MG, tablett, 50TK | HEXAL AG | 50 | | | | | | |

| | | | | | 75 | I47-I49 | Kardioloog, Pediaater | esmane | | | |

@@ -3329,66 +3366,66 @@

| | | | | | 50 | | | | | | |

| | | | | | 75 | I50-I50 | | | | | |

| 1120790 | spironolaktoon, 100mg | C03DA01 | SPIROGAMMA 100, tablett, 20TK | WÖRWAG PHARMA GmbH & Co. KG | 75 | I50-I50 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | I27.0-I27.0 | | | | | |

| | | | | | 50 | | | | | | |

| 1120813 | spironolaktoon, 100mg | C03DA01 | SPIROGAMMA 100, tablett, 100TK | WÖRWAG PHARMA GmbH & Co. KG | 75 | I50-I50 | | | | | |

| | | | | | 100 | I27.0-I27.0 | | | | | |

| | | | | | 50 | | | | | | |

| 1120824 | spironolaktoon, 100mg | C03DA01 | SPIROGAMMA 100, tablett, 50TK | WÖRWAG PHARMA GmbH & Co. KG | 100 | I27.0-I27.0 | | | | | |

| | | | | | 75 | I50-I50 | | | | | |

| | | | | | 50 | | | | | | |

| 1000944 | spironolaktoon, 25mg | C03DA01 | SPIRIX, tablett, 20TK | Nycomed Sefa AS | 50 | | | | | | |

| 1120813 | spironolaktoon, 100mg | C03DA01 | SPIROGAMMA 100, tablett, 100TK | WÖRWAG PHARMA GmbH & Co. KG | 50 | | | | | | |

| | | | | | 75 | I50-I50 | | | | | |

| | | | | | 100 | I27.0-I27.0 | | | | | |

| 1014848 | spironolaktoon, 25mg | C03DA01 | VEROSPIRON, tablett, 20TK | Gedeon Richter Plc. | 100 | I27.0-I27.0 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | I50-I50 | | | | | |

| 1001013 | spironolaktoon, 50mg | C03DA01 | SPIRIX, tablett, 20TK | Nycomed Sefa AS | 100 | I27.0-I27.0 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | I50-I50 | | | | | |

| 1004993 | spironolaktoon, 50mg | C03DA01 | SPIRONOLACTON- RATIOPHARM 50MG, tablett, 20TK | ratiopharm GmbH | 100 | I27.0-I27.0 | | | | | |

| | | | | | 75 | I50-I50 | | | | | |

| | | | | | 50 | | | | | | |

| 1042018 | spironolaktoon, 50mg | C03DA01 | VEROSPIRON, kõvakapsel, 30TK | Gedeon Richter Plc. | 75 | I50-I50 | | | | | |

| | | | | | 100 | I27.0-I27.0 | | | | | |

| | | | | | 50 | | | | | | |

| 1071650 | spironolaktoon, 50mg | C03DA01 | SPIRIX, tablett, 100TK | Nycomed Sefa AS | 50 | | | | | | |

| | | | | | 75 | I50-I50 | | | | | |

| | | | | | 100 | I27.0-I27.0 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1120712 | spironolaktoon, 50mg | C03DA01 | SPIROGAMMA 50, tablett, 20TK | WÖRWAG PHARMA GmbH & Co. KG | 75 | I50-I50 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | I27.0-I27.0 | | | | | |

| 1120723 | spironolaktoon, 50mg | C03DA01 | SPIROGAMMA 50, tablett, 50TK | WÖRWAG PHARMA GmbH & Co. KG | 50 | | | | | | |

| 1120824 | spironolaktoon, 100mg | C03DA01 | SPIROGAMMA 100, tablett, 50TK | WÖRWAG PHARMA GmbH & Co. KG | 50 | | | | | | |

| | | | | | 100 | I27.0-I27.0 | | | | | |

| | | | | | 75 | I50-I50 | | | | | |

| 1000944 | spironolaktoon, 25mg | C03DA01 | SPIRIX, tablett, 20TK | Nycomed Sefa AS | 75 | I50-I50 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | I27.0-I27.0 | | | | | |

| 1014848 | spironolaktoon, 25mg | C03DA01 | VEROSPIRON, tablett, 20TK | Gedeon Richter Plc. | 75 | I50-I50 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | I27.0-I27.0 | | | | | |

| 1001013 | spironolaktoon, 50mg | C03DA01 | SPIRIX, tablett, 20TK | Nycomed Sefa AS | 100 | I27.0-I27.0 | | | | | |

| | | | | | 75 | I50-I50 | | | | | |

| | | | | | 50 | | | | | | |

| 1042018 | spironolaktoon, 50mg | C03DA01 | VEROSPIRON, kõvakapsel, 30TK | Gedeon Richter Plc. | 100 | I27.0-I27.0 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | I50-I50 | | | | | |

| 1071650 | spironolaktoon, 50mg | C03DA01 | SPIRIX, tablett, 100TK | Nycomed Sefa AS | 100 | I27.0-I27.0 | | | | | |

| | | | | | 75 | I50-I50 | | | | | |

| | | | | | 50 | | | | | | |

| 1004993 | spironolaktoon, 50mg | C03DA01 | SPIRONOLACTON- RATIOPHARM 50MG, tablett, 20TK | ratiopharm GmbH | 75 | I50-I50 | | | | | |

| | | | | | 100 | I27.0-I27.0 | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1120712 | spironolaktoon, 50mg | C03DA01 | SPIROGAMMA 50, tablett, 20TK | WÖRWAG PHARMA GmbH & Co. KG | 75 | I50-I50 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | I27.0-I27.0 | | | | | |

| 1120723 | spironolaktoon, 50mg | C03DA01 | SPIROGAMMA 50, tablett, 50TK | WÖRWAG PHARMA GmbH & Co. KG | 75 | I50-I50 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | I27.0-I27.0 | | | | | |

| 1120734 | spironolaktoon, 50mg | C03DA01 | SPIROGAMMA 50, tablett, 100TK | WÖRWAG PHARMA GmbH & Co. KG | 50 | | | | | | |

| | | | | | 100 | I27.0-I27.0 | | | | | |

| | | | | | 75 | I50-I50 | | | | | |

| | | | | | 100 | I27.0-I27.0 | | | | | |

| 1186949 | strontsiumranelaat, 2g | M05BX03 | PROTELOS, suukaudse suspensiooni graanulid, 28TK | Les Laboratoires Servier | 50 | | | | | | |

| | | | | | 75 | M80-M80 | | | | | patsientidele, kelle lülisamba või reieluukaela mineraalne tihedus on -2,5 SD või vähem DEXA meetodil määratuna ja kellel esineb kaasuvalt raske neerupuudulikkus või söögitoru akalaasia, striktuur, düskineesia või põletik (N17-19; K22.0; K22.2; K22.4; K20) |

| 1008818 | sulfametoksasool+trim etoprim, 40mg 1ml+8mg 1ml | J01EE01 | BACTRIM, siirup, 100ml 1TK | Roche Eesti OÜ | 50 | | | | | | |

| 1186949 | strontsiumranelaat, 2g | M05BX03 | PROTELOS, suukaudse suspensiooni graanulid, 28TK | Les Laboratoires Servier | 75 | M80-M80 | | | | | patsientidele, kelle lülisamba või reieluukaela mineraalne tihedus on -2,5 SD või vähem DEXA meetodil määratuna ja kellel esineb kaasuvalt raske neerupuudulikkus või söögitoru akalaasia, striktuur, düskineesia või põletik (N17-19; K22.0; K22.2; K22.4; K20) |

| | | | | | 50 | | | | | | |

| 1008818 | sulfametoksasool+trim etoprim, 40mg+8mg 1ml | J01EE01 | BACTRIM, siirup, 100ml 1TK | Roche Eesti OÜ | 50 | | | | | | |

| 1016086 | sulfametoksasool+trim etoprim, 800mg+160mg | J01EE01 | BERLOCID, tablett, 20TK | Berlin-Chemie AG (Menarini Group) | 50 | | | | | | |

| 1023455 | sulfasalasiin, 500mg | A07EC01 | SALAZOPYRIN EN, gastroresistentne tablett, 100TK | Pfizer Enterprises SARL | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1040612 | sulpiriid, 100mg | N05AL01 | BETAMAKS, tablett, 30TK | Grindeks | 100 | F20-F29 | Psühhiaater | | | | vastavalt Eesti ravijuhisele ning arvestades Eesti Psühhiaatrite Seltsi poolt väljatöötatud kriteeriume üleminekuks konventsionaalselt atüüpilisele antipsühhootikumile |

| | | | | | 50 | | | | | | |

| 1040601 | sulpiriid, 200mg | N05AL01 | BETAMAKS, tablett, 30TK | Grindeks | 50 | | | | | | |

| 1040612 | sulpiriid, 100mg | N05AL01 | BETAMAKS, tablett, 30TK | Grindeks | 50 | | | | | | |

| 1040601 | sulpiriid, 200mg | N05AL01 | BETAMAKS, tablett, 30TK | Grindeks | 100 | F20-F29 | Psühhiaater | | | | vastavalt Eesti ravijuhisele ning arvestades Eesti Psühhiaatrite Seltsi poolt väljatöötatud kriteeriume üleminekuks konventsionaalselt atüüpilisele antipsühhootikumile |

| | | | | | 50 | | | | | | |

| 1040623 | sulpiriid, 50mg | N05AL01 | BETAMAKS, tablett, 30TK | Grindeks | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1018482 | sultamitsilliin, 375mg | J01CR04 | UNASYN, õhukese polümeerikattega tablett, 12TK | Pfizer Europe MA EEIG | 50 | | | | | | juhul, kui esmavaliku antibiootikum ei ole efektiivne või on vastunäidustatud |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1018493 | sultamitsilliin, 50mg 1ml | J01CR04 | UNASYN, suukaudse suspensiooni pulber, 30ml 1TK | Pfizer Europe MA EEIG | 50 | | | | | | juhul, kui esmavaliku antibiootikum ei ole efektiivne või on vastunäidustatud |

| 1139914 | sumatriptaan, 100mg | N02CC01 | IMIGRAN FDT, õhukese polümeerikattega tablett, 2TK | GlaxoSmithKline Export Ltd | 50 | | | | | | |

| 1192092 | sumatriptaan, 100mg | N02CC01 | SUMATRIPTAN SANDOZ 100MG, tablett, 2TK | Sandoz GmbH | 50 | | | | | | |

@@ -3405,13 +3442,13 @@

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1353305 | sunitiniib, 12,5mg | L01XE04 | SUTENT, kõvakapsel, 28TK | Pfizer Limited | 50 | | | | | | |

| | | | | | 100 | C64-C64 | Onkoloog | | | | patsientidele, kellel ravi alustamine ja jätkamine sunitiniibiga on hinnatud konsiiliumi (vähemalt kolme onkoloogi) poolt vastavaks järgmistele kriteeriumidele: diagnoositud IV staadiumis heledarakuline neeru kartsinoom, patsiendi üldseisund ECOG kriteeriumide järgi on 0-1 ja haiguse prognoos MSKCC kriteeriumide järgi hea kuni keskmine ning mitte enam kui 3 ravikuu möödumisel on saavutatud täielik või osaline ravivastus või haigus püsib stabiilsena |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1353293 | sunitiniib, 25mg | L01XE04 | SUTENT, kõvakapsel, 28TK | Pfizer Limited | 50 | | | | | | |

| 1353305 | sunitiniib, 12,5mg | L01XE04 | SUTENT, kõvakapsel, 28TK | Pfizer Limited | 100 | C64-C64 | Onkoloog | | | | patsientidele, kellel ravi alustamine ja jätkamine sunitiniibiga on hinnatud konsiiliumi (vähemalt kolme onkoloogi) poolt vastavaks järgmistele kriteeriumidele: diagnoositud IV staadiumis heledarakuline neeru kartsinoom, patsiendi üldseisund ECOG kriteeriumide järgi on 0-1 ja haiguse prognoos MSKCC kriteeriumide järgi hea kuni keskmine ning mitte enam kui 3 ravikuu möödumisel on saavutatud täielik või osaline ravivastus või haigus püsib stabiilsena |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1353293 | sunitiniib, 25mg | L01XE04 | SUTENT, kõvakapsel, 28TK | Pfizer Limited | 100 | C64-C64 | Onkoloog | | | | patsientidele, kellel ravi alustamine ja jätkamine sunitiniibiga on hinnatud konsiiliumi (vähemalt kolme onkoloogi) poolt vastavaks järgmistele kriteeriumidele: diagnoositud IV staadiumis heledarakuline neeru kartsinoom, patsiendi üldseisund ECOG kriteeriumide järgi on 0-1 ja haiguse prognoos MSKCC kriteeriumide järgi hea kuni keskmine ning mitte enam kui 3 ravikuu möödumisel on saavutatud täielik või osaline ravivastus või haigus püsib stabiilsena |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

@@ -3419,69 +3456,82 @@

| | | | | | 50 | | | | | | |

| 1040083 | zanamiviir, 5mg 1annust | J05AH01 | RELENZA, annustatud inhalatsioonipulber, 4annust 5TK | GlaxoSmithKline Eesti OÜ | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1119215 | ziprasidoon, 40mg | N05AE04 | ZELDOX, kõvakapsel, 56TK | Pfizer Europe MA EEIG | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1119215 | ziprasidoon, 40mg | N05AE04 | ZELDOX, kõvakapsel, 56TK | Pfizer Europe MA EEIG | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1119271 | ziprasidoon, 60mg | N05AE04 | ZELDOX, kõvakapsel, 56TK | Pfizer Europe MA EEIG | 50 | | | | | | |

| | | | | | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| 1119271 | ziprasidoon, 60mg | N05AE04 | ZELDOX, kõvakapsel, 56TK | Pfizer Europe MA EEIG | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1119316 | ziprasidoon, 80mg | N05AE04 | ZELDOX, kõvakapsel, 56TK | Pfizer Europe MA EEIG | 50 | | | | | | |

| | | | | | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| 1119316 | ziprasidoon, 80mg | N05AE04 | ZELDOX, kõvakapsel, 56TK | Pfizer Europe MA EEIG | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1110722 | zolmitriptaan, 2,5mg | N02CC03 | ZOMIG RAPIMELT, suus dispergeeruv tablett, 2TK | AstraZeneca UK Limited | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1006232 | zuklopentiksool, 200mg 1ml | N05AF05 | CISORDINOL DEPOT, süstelahus, 1ml 1TK | H. LUNDBECK A/S | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1005781 | zuklopentiksool, 25mg | N05AF05 | CISORDINOL, õhukese polümeerikattega tablett, 50TK | H. LUNDBECK A/S | 50 | | | | | | |

| 1065226 | zuklopentiksool, 200mg 1ml | N05AF05 | CISORDINOL DEPOT, süstelahus, 1ml 10TK | H. LUNDBECK A/S | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1006322 | zuklopentiksool, 50mg 1ml | N05AF05 | CISORDINOL-ACUTARD, süstelahus, 1ml 10TK | H. LUNDBECK A/S | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1294635 | takroliimus, 0,5mg | L04AD02 | ADVAGRAF, toimeainet prolongeeritult vabastav kõvakapsel, 30TK | Astellas Pharma Europe B.V. | 100 | Z94-Z94, T86-T86 | | | | | patsientidele, kellel esineb kõrge immunoloogiline risk (PRA >20%), korduvsiirdamise puhul, maksasiirdamise puhul,kopsusiirdamise puhul, steroidresistentse ägeda äratõukereaktsiooni ravi järgselt ning müokardiinfarkti või müokardi revaskulariseeriva protseduuri järgselt |

| 1294703 | takroliimus, 1mg | L04AD02 | ADVAGRAF, toimeainet prolongeeritult vabastav kõvakapsel, 100TK | Astellas Pharma Europe B.V. | 100 | Z94-Z94, T86-T86 | | | | | patsientidele, kellel esineb kõrge immunoloogiline risk (PRA >20%), korduvsiirdamise puhul, maksasiirdamise puhul,kopsusiirdamise puhul, steroidresistentse ägeda äratõukereaktsiooni ravi järgselt ning müokardiinfarkti või müokardi revaskulariseeriva protseduuri järgselt |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1294657 | takroliimus, 5mg | L04AD02 | ADVAGRAF, toimeainet prolongeeritult vabastav kõvakapsel, 30TK | Astellas Pharma Europe B.V. | 100 | Z94-Z94, T86-T86 | | | | | patsientidele, kellel esineb kõrge immunoloogiline risk (PRA >20%), korduvsiirdamise puhul, maksasiirdamise puhul,kopsusiirdamise puhul, steroidresistentse ägeda äratõukereaktsiooni ravi järgselt ning müokardiinfarkti või müokardi revaskulariseeriva protseduuri järgselt |

| 1002665 | tamoksifeen, 20mg | L02BA01 | NOLVADEX D, tablett, 30TK | AstraZeneca UK Limited | 100 | D18.1-D18.1 | Onkoloog, Pulmonoloog | | | | |

| 1294635 | takroliimus, 0,5mg | L04AD02 | ADVAGRAF, toimeainet prolongeeritult vabastav kõvakapsel, 30TK | Astellas Pharma Europe B.V. | 100 | Z94-Z94, T86-T86 | | | | | patsientidele, kellel esineb kõrge immunoloogiline risk (PRA>20%), korduvsiirdamise puhul, maksasiirdamise puhul, kopsusiirdamise puhul, steroidresistentse ägeda äratõukereaktsiooni ravi järgselt ning müokardiinfarkti või müokardi revaskulariseeriva protseduuri järgselt |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1294703 | takroliimus, 1mg | L04AD02 | ADVAGRAF, toimeainet prolongeeritult vabastav kõvakapsel, 100TK | Astellas Pharma Europe B.V. | 100 | Z94-Z94, T86-T86 | | | | | patsientidele, kellel esineb kõrge immunoloogiline risk (PRA>20%), korduvsiirdamise puhul, maksasiirdamise puhul, kopsusiirdamise puhul, steroidresistentse ägeda äratõukereaktsiooni ravi järgselt ning müokardiinfarkti või müokardi revaskulariseeriva protseduuri järgselt |

| 1294657 | takroliimus, 5mg | L04AD02 | ADVAGRAF, toimeainet prolongeeritult vabastav kõvakapsel, 30TK | Astellas Pharma Europe B.V. | 100 | Z94-Z94, T86-T86 | | | | | patsientidele, kellel esineb kõrge immunoloogiline risk (PRA>20%), korduvsiirdamise puhul, maksasiirdamise puhul, kopsusiirdamise puhul, steroidresistentse ägeda äratõukereaktsiooni ravi järgselt ning müokardiinfarkti või müokardi revaskulariseeriva protseduuri järgselt |

| 1002665 | tamoksifeen, 20mg | L02BA01 | NOLVADEX D, tablett, 30TK | AstraZeneca UK Limited | 100 | D18.1-D18.1 | Pulmonoloog, Onkoloog | | | | |

| | | | | | 100 | C00-D48 | Onkoloog | | | | |

| | | | | | 50 | | | | | | |

| 1015704 | tamoksifeen, 20mg | L02BA01 | TAMOXIFEN "EBEWE", tablett, 30TK | Ebewe Pharma Ges.m.b.H Nfg.KG | 100 | C00-D48 | Onkoloog | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1015704 | tamoksifeen, 20mg | L02BA01 | TAMOXIFEN "EBEWE", tablett, 30TK | Ebewe Pharma Ges.m.b.H Nfg.KG | 50 | | | | | | |

| | | | | | 100 | C00-D48 | Onkoloog | | | | |

| | | | | | 100 | D18.1-D18.1 | Pulmonoloog, Onkoloog | | | | |

| 1154528 | tamsulosiin, 0,4mg | G04CA02 | OMNIC TOCAS, toimeainet prolongeeritult vabastav tablett, 30TK | Astellas Pharma Europe B.V. | 50 | | | | | | |

| 1436015 | tamsulosiin, 0,4mg | G04CA02 | TANYZ ERAS 0.4MG, toimeainet prolongeeritult vabastav tablett, 30TK | Krka d.d. Novo Mesto | 50 | | | | | | |

| 1188143 | tamsulosiin, 0,4mg | G04CA02 | FLOSIN 0,4MG, toimeainet modifitseeritult vabastav kõvakapsel, 30TK | Menarini International Operations Luxembourg S.A. | 50 | | | | | | |

| 1188604 | tamsulosiin, 0,4mg | G04CA02 | UROSTAD, toimeainet modifitseeritult vabastav kõvakapsel, 30TK | STADA ARZNEIMITTEL AG | 50 | | | | | | |

| 1195826 | tamsulosiin, 0,4mg | G04CA02 | OMSAL, toimeainet prolongeeritult vabastav kõvakapsel, 30TK | Gedeon Richter Plc. | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1206773 | tamsulosiin, 0,4mg | G04CA02 | FOKUSIN, toimeainet modifitseeritult vabastav kõvakapsel, 30TK | Nycomed GmbH | 50 | | | | | | |

| 1390463 | tamsulosiin+dutasteriid , 0,4mg+0,5mg | G04CA52 | COMBODART, kõvakapsel, 30TK | GlaxoSmithKline Eesti OÜ | 50 | | | | | | |

| 1046292 | telmisartaan, 40mg | C09CA07 | MICARDIS, tablett, 28TK | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15 | | | | | |

| 1060524 | telmisartaan, 40mg | C09CA07 | PRITOR, tablett, 28TK | Bayer Schering Pharma AG | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 50 | | | | | | |

| 1046258 | telmisartaan, 80mg | C09CA07 | MICARDIS, tablett, 28TK | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15 | | | | | |

| 1183519 | telmisartaan, 80mg | C09CA07 | PRITOR, tablett, 28TK | Bayer Schering Pharma AG | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 50 | | | | | | |

| 1183519 | telmisartaan, 80mg | C09CA07 | PRITOR, tablett, 28TK | Bayer Schering Pharma AG | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1499452 | telmisartaan+amlodipii n, 80mg+10mg | C09DB04 | TWYNSTA, tablett, 28TK | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 50 | | | | | | |

| 1499384 | telmisartaan+amlodipii n, 80mg+5mg | C09DB04 | TWYNSTA, tablett, 28TK | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 50 | | | | | | |

| 1114793 | telmisartaan+hüdroklor otiasiid, 80mg+12,5mg | C09DA07 | MICARDISPLUS, tablett, 28TK | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 50 | | | | | | |

| 1121465 | telmisartaan+hüdroklor otiasiid, 80mg+12,5mg | C09DA07 | PRITORPLUS 80/12,5 MG, tablett, 28TK | Bayer Schering Pharma AG | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15 | | | | | |

| 1367524 | telmisartaan+hüdroklor otiasiid, 80mg+25mg | C09DA07 | MICARDISPLUS, tablett, 28TK | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 50 | | | | | | |

| 1368110 | telmisartaan+hüdroklor otiasiid, 80mg+25mg | C09DA07 | PRITORPLUS 80/25 MG, tablett, 28TK | Bayer Schering Pharma AG | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15 | | | | | |

| 1114995 | temosolomiid, 100mg | L01AX03 | TEMODAL, kõvakapsel, 5TK | SCHERING-PLOUGH EUROPE | 100 | C71-C71 | Onkoloog | | | | konsiiliumi (vähemalt 3 onkoloogi ühise) otsuse alusel heas üldseisundis patsiendile (WHO funktsionaalne klass 0...1) |

| | | | | | 50 | | | | | | |

| 1303232 | temosolomiid, 140mg | L01AX03 | TEMODAL, kõvakapsel, 5TK | SCHERING-PLOUGH EUROPE | 100 | C71-C71 | Onkoloog | | | | konsiiliumi (vähemalt 3 onkoloogi ühise) otsuse alusel heas üldseisundis patsiendile (WHO funktsionaalne klass 0...1) |

| | | | | | 50 | | | | | | |

| 1303232 | temosolomiid, 140mg | L01AX03 | TEMODAL, kõvakapsel, 5TK | SCHERING-PLOUGH EUROPE | 50 | | | | | | |

| | | | | | 100 | C71-C71 | Onkoloog | | | | konsiiliumi (vähemalt 3 onkoloogi ühise) otsuse alusel heas üldseisundis patsiendile (WHO funktsionaalne klass 0...1) |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

@@ -3491,131 +3541,146 @@

| | | | | | 100 | C71-C71 | Onkoloog | | | | konsiiliumi (vähemalt 3 onkoloogi ühise) otsuse alusel heas üldseisundis patsiendile (WHO funktsionaalne klass 0...1) |

| 1115019 | temosolomiid, 250mg | L01AX03 | TEMODAL, kõvakapsel, 5TK | SCHERING-PLOUGH EUROPE | 50 | | | | | | |

| | | | | | 100 | C71-C71 | Onkoloog | | | | konsiiliumi (vähemalt 3 onkoloogi ühise) otsuse alusel heas üldseisundis patsiendile (WHO funktsionaalne klass 0...1) |

| 1114951 | temosolomiid, 5mg | L01AX03 | TEMODAL, kõvakapsel, 5TK | SCHERING-PLOUGH EUROPE | 50 | | | | | | |

| | | | | | 100 | C71-C71 | Onkoloog | | | | konsiiliumi (vähemalt 3 onkoloogi ühise) otsuse alusel heas üldseisundis patsiendile (WHO funktsionaalne klass 0...1) |

| 1033861 | teofülliin, 200mg | R03DA04 | TEOTARD, toimeainet prolongeeritult vabastav kõvakapsel, 40TK | KRKA d.d., Novo Mesto | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | | |

| 1114951 | temosolomiid, 5mg | L01AX03 | TEMODAL, kõvakapsel, 5TK | SCHERING-PLOUGH EUROPE | 100 | C71-C71 | Onkoloog | | | | konsiiliumi (vähemalt 3 onkoloogi ühise) otsuse alusel heas üldseisundis patsiendile (WHO funktsionaalne klass 0...1) |

| | | | | | 50 | | | | | | |

| 1033861 | teofülliin, 200mg | R03DA04 | TEOTARD, toimeainet prolongeeritult vabastav kõvakapsel, 40TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1124031 | teofülliin, 200mg | R03DA04 | RETAFYLLIN, toimeainet prolongeeritult vabastav tablett, 100TK | Orion Corporation | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | | | |

| | | | | | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1124031 | teofülliin, 200mg | R03DA04 | RETAFYLLIN, toimeainet prolongeeritult vabastav tablett, 100TK | Orion Corporation | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | | |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1124042 | teofülliin, 300mg | R03DA04 | RETAFYLLIN, toimeainet prolongeeritult vabastav tablett, 100TK | Orion Corporation | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| 1124042 | teofülliin, 300mg | R03DA04 | RETAFYLLIN, toimeainet prolongeeritult vabastav tablett, 100TK | Orion Corporation | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | | |

| 1033850 | teofülliin, 350mg | R03DA04 | TEOTARD, toimeainet prolongeeritult vabastav kõvakapsel, 40TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | | | |

| 1034345 | terbinafiin, 10mg 1g | D01AE15 | LAMISIL, nahasprei, lahus, 30ml 1TK | Novartis Finland OY | 50 | | | | | | |

| 1158724 | terbinafiin, 250mg | D01BA02 | TERBINAFINE SANDOZ 250 MG, tablett, 14TK | Sandoz d.d. | 50 | | | | | | |

| 1002766 | terbinafiin, 250mg | D01BA02 | LAMISIL, tablett, 14TK | Novartis Finland OY | 50 | | | | | | |

| 1012969 | terbinafiin, 250mg | D01BA02 | TERBISIL, tablett, 14TK | Gedeon Richter Plc. | 50 | | | | | | |

| 1146552 | terbinafiin, 250mg | D01BA02 | TERBINAFIN NYCOMED, tablett, 14TK | Nycomed Sefa AS | 50 | | | | | | |

| 1158724 | terbinafiin, 250mg | D01BA02 | TERBINAFINE SANDOZ 250 MG, tablett, 14TK | Sandoz d.d. | 50 | | | | | | |

| 1176308 | terbinafiin, 250mg | D01BA02 | TERBINAFIN ACTAVIS, tablett, 14TK | Actavis Nordic A/S | 50 | | | | | | |

| 1176319 | terbinafiin, 250mg | D01BA02 | TERBINAFIN ACTAVIS, tablett, 28TK | Actavis Nordic A/S | 50 | | | | | | |

| 1213614 | terbinafiin, 250mg | D01BA02 | TERBINAFIN NYCOMED, tablett, 28TK | Nycomed Sefa AS | 50 | | | | | | |

| 1022623 | testosteroon, 250mg 1ml | G03BA03 | SUSTANON, süstelahus, 1ml 1TK | N.V. ORGANON | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | C00-D48 | Onkoloog, Hematoloog | | | | |

| 1169445 | testosteroon, 250mg 1ml | G03BA03 | NEBIDO, süstelahus, 4ml 1TK | Bayer Schering Pharma AG | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1022588 | testosteroon, 40mg | G03BA03 | ANDRIOL TESTOCAPS, pehmekapsel, 60TK | N.V. ORGANON | 100 | C00-D48 | Hematoloog, Onkoloog | | | | |

| | | | | | 50 | | | | | | |

| 1014163 | tetratsükliin, 250mg | J01AA07 | TETRACYCLIN NYCOMED, õhukese polümeerikattega tablett, 24TK | Nycomed Sefa AS | 50 | | | | | | |

| | | | | | 100 | A50-A53 | Dermatoveneroloog | | | | |

| 1022588 | testosteroon, 40mg | G03BA03 | ANDRIOL TESTOCAPS, pehmekapsel, 60TK | N.V. ORGANON | 50 | | | | | | |

| | | | | | 100 | C00-D48 | Hematoloog, Onkoloog | | | | |

| 1014163 | tetratsükliin, 250mg | J01AA07 | TETRACYCLIN NYCOMED, õhukese polümeerikattega tablett, 24TK | Nycomed Sefa AS | 100 | A50-A53 | Dermatoveneroloog | | | | |

| | | | | | 50 | | | | | | |

| 1017403 | tetratsükliin, 30mg 1g | D06AA04 | IMEX, salv, 20g 1TK | Merz Pharmaceuticals GmbH | 50 | | | | | | |

| 1019360 | tianeptiin, 12,5mg | N06AX14 | COAXIL, kaetud tablett, 30TK | Les Laboratoires Servier | 50 | | | | | | |

| 1034165 | tiboloon, 2,5mg | G03CX01 | LIVIAL, tablett, 28TK | N.V. ORGANON | 50 | | | | | | |

| 1018695 | timolool, 0,5% | S01ED01 | ARUTIMOL, silmatilgad, lahus, 5ml 1TK | Chauvin ankerpharm GmbH | 50 | | | | | | |

| 1018695 | timolool, 0,5% | S01ED01 | ARUTIMOL, silmatilgad, lahus, 5ml 1TK | Chauvin ankerpharm GmbH | 100 | H40-H42 | Oftalmoloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1038956 | timolool, 1mg 1g | S01ED01 | TIMOSAN, silmageel, 5g 1TK | SANTEN OY | 50 | | | | | | |

| | | | | | 100 | H40-H42 | Oftalmoloog | esmane | | | |

| 1038956 | timolool, 1mg 1g | S01ED01 | TIMOSAN, silmageel, 5g 1TK | SANTEN OY | 100 | H40-H42 | Oftalmoloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1112634 | timolool, 2,5mg 1ml | S01ED01 | OFTAN TIMOLOL, silmatilgad, lahus, 5ml 1TK | SANTEN OY | 50 | | | | | | |

| | | | | | 100 | H40-H42 | Oftalmoloog | esmane | | | |

| 1078062 | timolool, 5mg 1ml | S01ED01 | NYOLOL 0,5%, silmatilgad, lahus, 5ml 1TK | Novartis Finland OY | 50 | | | | | | |

| | | | | | 100 | H40-H42 | Oftalmoloog | esmane | | | |

| 1078062 | timolool, 5mg 1ml | S01ED01 | NYOLOL 0,5%, silmatilgad, lahus, 5ml 1TK | Novartis Finland OY | 100 | H40-H42 | Oftalmoloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1112645 | timolool, 5mg 1ml | S01ED01 | OFTAN TIMOLOL, silmatilgad, lahus, 5ml 1TK | SANTEN OY | 100 | H40-H42 | Oftalmoloog | esmane | | | |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1252976 | timolool+bimatoprost, 5mg+0,3mg 1ml | S01ED82 | GANFORT, silmatilgad, lahus, 3ml 1TK | Allergan Pharmaceuticals Ireland | 50 | | | | | | |

| 1392207 | timolool+brinsolamiid, 5mg+10mg 1ml | S01ED83 | AZARGA, silmatilgad, suspensioon, 5ml 1TK | Alcon Laboratories Ltd. (Ühendkuningriik) | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1088254 | timolool+latanoprost, 5mg+50mcg 1ml | S01ED51 | XALACOM, silmatilgad, lahus, 2.5ml 1TK | Pfizer Enterprises SARL | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| 1004375 | tioguaniin, 40mg | L01BB03 | LANVIS, tablett, 25TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1111341 | tiokthape (alfa- lipoehape), 600mg | A16AX01 | THIOCTACID HR, õhukese polümeerikattega tablett, 30TK | Meda Pharma GmbH & Co. KG | 50 | | | | | | |

| 1173822 | tisanidiin, 2mg | M03BX02 | SIRDALUD, tablett, 30TK | Novartis Finland OY | 75 | G82-G82, G81-G81 | | | | | |

| | | | | | 50 | | | | | | |

| 1290237 | tisanidiin, 2mg | M03BX02 | TIZANIDINE-TEVA, tablett, 30TK | Teva Pharma B.V. | 75 | G82-G82, G81-G81 | | | | | |

| | | | | | 50 | | | | | | |

| 1211599 | tisanidiin, 4mg | M03BX02 | SIRDALUD, tablett, 30TK | Novartis Finland OY | 75 | G82-G82, G81-G81 | | | | | |

| | | | | | 50 | | | | | | |

| 1290237 | tisanidiin, 2mg | M03BX02 | TIZANIDINE-TEVA, tablett, 30TK | Teva Pharma B.V. | 50 | | | | | | |

| | | | | | 75 | G82-G82, G81-G81 | | | | | |

| 1211599 | tisanidiin, 4mg | M03BX02 | SIRDALUD, tablett, 30TK | Novartis Finland OY | 50 | | | | | | |

| | | | | | 75 | G82-G82, G81-G81 | | | | | |

| 1290361 | tisanidiin, 4mg | M03BX02 | TIZANIDINE-TEVA, tablett, 30TK | Teva Pharma B.V. | 75 | G82-G82, G81-G81 | | | | | |

| | | | | | 50 | | | | | | |

| 1012543 | tobramütsiin, 3mg 1g | S01AA12 | TOBREX, silmasalv, 3.5g 1TK | s.a. ALCON- COUVREUR n.v. | 50 | | | | | | |

| 1150120 | tobramütsiin, 3mg 1ml | S01AA12 | TOBREX 2X, silmatilgad, lahus, 5ml 1TK | Alcon Cusi S.A. | 50 | | | | | | |

| 7002504 | toitained ilma fenüülalaniinita, | | PKU-EXPRESS, pulber, 25g N30 | Vitaflo International Ltd. | 100 | E70.0-E70.1 | | | | | |

| 7000153 | toitained ilma fenüülalaniinita, | | XP MAXAMUM (ORANGE FLAVOURED) pulber, pulber, 500g N4 | SHS International | 100 | E70.0-E70.1 | | | | | |

| | | | | | 50 | | | | | | |

| 7002515 | toitained ilma fenüülalaniinita, | | PKU-GEL, pulber, 20g N30 | Vitaflo International Ltd. | 100 | E70.0-E70.1 | | | | | |

| 7000186 | toitained ilma fenüülalaniinita, | | DUOCAL Supersoluble , pulber, 400 g | SHS | 100 | E70.0-E70.1 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | E70.0-E70.1 | | | | | |

| 7000131 | toitained ilma fenüülalaniinita, | | XP MAXAMAID (ORANGE FLAVOURED) pulber, pulber, 500g N4 | SHS International | 100 | E70.0-E70.1 | | | | | |

| | | | | | 50 | | | | | | |

| 7000142 | toitained ilma fenüülalaniinita, | | XP MAXAMAID (UNFLAVOURED) pulber, pulber, 500g N4 | SHS International | 100 | E70.0-E70.1 | | | | | |

| | | | | | 50 | | | | | | |

| 7000164 | toitained ilma fenüülalaniinita, | | XP MAXAMUM (UNFLAVOURED) pulber, pulber, 500g N4 | SHS International | 100 | E70.0-E70.1 | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 7000131 | toitained ilma fenüülalaniinita, | | XP MAXAMAID (ORANGE FLAVOURED) pulber, pulber, 500g N4 | SHS International | 100 | E70.0-E70.1 | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 7000153 | toitained ilma fenüülalaniinita, | | XP MAXAMUM (ORANGE FLAVOURED) pulber, pulber, 500g N4 | SHS International | 100 | E70.0-E70.1 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | E70.0-E70.1 | | | | | |

| 7000186 | toitained ilma fenüülalaniinita, | | DUOCAL Supersoluble , pulber, 400 g | SHS | 50 | | | | | | |

| | | | | | 100 | E70.0-E70.1 | | | | | |

| 7002504 | toitained ilma fenüülalaniinita, | | PKU-EXPRESS, pulber, 25g N30 | Vitaflo International Ltd. | 100 | E70.0-E70.1 | | | | | |

| 7002515 | toitained ilma fenüülalaniinita, | | PKU-GEL, pulber, 20g N30 | Vitaflo International Ltd. | 100 | E70.0-E70.1 | | | | | |

| 1196940 | tolkapoon, 100mg | N04BX01 | TASMAR, õhukese polümeerikattega tablett, 100TK | Meda AB | 50 | | | | | | |

| 1284465 | tolterodiin, 1mg | G04BD07 | UROFLOW 1, õhukese polümeerikattega tablett, 28TK | Zentiva, k.s. | 50 | | | | | | |

| 1043301 | tolterodiin, 1mg | G04BD07 | DETRUSITOL 1 MG, õhukese polümeerikattega tablett, 28TK | Pfizer Enterprises SARL | 50 | | | | | | |

| 1284465 | tolterodiin, 1mg | G04BD07 | UROFLOW 1, õhukese polümeerikattega tablett, 28TK | Zentiva, k.s. | 50 | | | | | | |

| 1284498 | tolterodiin, 2mg | G04BD07 | UROFLOW 2, õhukese polümeerikattega tablett, 28TK | Zentiva, k.s. | 50 | | | | | | |

| 1043312 | tolterodiin, 2mg | G04BD07 | DETRUSITOL 2 MG, õhukese polümeerikattega tablett, 28TK | Pfizer Enterprises SARL | 50 | | | | | | |

| 1284498 | tolterodiin, 2mg | G04BD07 | UROFLOW 2, õhukese polümeerikattega tablett, 28TK | Zentiva, k.s. | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1076778 | topiramaat, 100mg | N03AX11 | TOPAMAX, õhukese polümeerikattega tablett, 60TK | Johnson & Johnson UAB | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1309878 | topiramaat, 100mg | N03AX11 | TOPIRAMATE ORION, õhukese polümeerikattega tablett, 60TK | Orion Corporation | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1076846 | topiramaat, 200mg | N03AX11 | TOPAMAX, õhukese polümeerikattega tablett, 60TK | Johnson & Johnson UAB | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1076688 | topiramaat, 25mg | N03AX11 | TOPAMAX, õhukese polümeerikattega tablett, 60TK | Johnson & Johnson UAB | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| 1076734 | topiramaat, 50mg | N03AX11 | TOPAMAX, õhukese polümeerikattega tablett, 60TK | Johnson & Johnson UAB | 50 | | | | | | |

| 1309834 | topiramaat, 50mg | N03AX11 | TOPIRAMATE ORION, õhukese polümeerikattega tablett, 60TK | Orion Corporation | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1239757 | topiramaat, 50mg | N03AX11 | TOPIRAMATE SANDOZ 50 MG, õhukese polümeerikattega tablett, 60TK | Sandoz d.d. | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1158050 | torasemiid, 100mg | C03CA04 | TORASEMID HEXAL 100 MG TABLETID, tablett, 30TK | HEXAL AG | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1032332 | torasemiid, 10mg | C03CA04 | TRIFAS 10 MG, tablett, 30TK | Menarini International Operations Luxembourg S.A. | 50 | | | | | | |

| 1166015 | torasemiid, 10mg | C03CA04 | TORASEMIDE TEVA, tablett, 30TK | Teva Pharma B.V. | 50 | | | | | | |

| 1032321 | torasemiid, 200mg | C03CA04 | TRIFAS 200 MG, tablett, 30TK | Menarini International Operations Luxembourg S.A. | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1158106 | torasemiid, 200mg | C03CA04 | TORASEMID HEXAL 200 MG TABLETID, tablett, 30TK | HEXAL AG | 50 | | | | | | |

| 1165957 | torasemiid, 5mg | C03CA04 | TORASEMIDE TEVA, tablett, 30TK | Teva Pharma B.V. | 50 | | | | | | |

| 1015399 | tramadool, 100mg | N02AX02 | TRAMAL, rektaalsuposiit, 5TK | Grünenthal GmbH | 50 | | | | | | |

@@ -3627,12 +3692,12 @@

| 1085138 | tramadool, 100mg | N02AX02 | TRAMADOLOR ID 100MG, toimeainet modifitseeritult vabastav tablett, 30TK | Sandoz d.d. | 50 | | | | | | |

| 1085149 | tramadool, 100mg | N02AX02 | TRAMADOLOR ID 100MG, toimeainet modifitseeritult vabastav tablett, 50TK | Sandoz d.d. | 50 | | | | | | |

| 1174621 | tramadool, 100mg | N02AX02 | MABRON RETARD, toimeainet modifitseeritult vabastav tablett, 30TK | Medochemie Ltd | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1015401 | tramadool, 100mg 1ml | N02AX02 | TRAMAL, suukaudsed tilgad, lahus, 10ml 1TK | GRÜNENTHAL GmbH | 50 | | | | | | |

| 1032680 | tramadool, 100mg 1ml | N02AX02 | TRAMADOL LANNACHER, suukaudsed tilgad, lahus, 10ml 1TK | LANNACHER HEILMITTEL GmbH | 50 | | | | | | |

| 1041545 | tramadool, 150mg | N02AX02 | TRAMAL RETARD 150 MG, toimeainet prolongeeritult vabastav tablett, 10TK | Grünenthal GmbH | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1085857 | tramadool, 150mg | N02AX02 | TRAMADOL LANNACHER 150MG, toimeainet prolongeeritult vabastav tablett, 30TK | LANNACHER HEILMITTEL GmbH | 50 | | | | | | |

| 1096196 | tramadool, 150mg | N02AX02 | TRAMADOLOR ID 150MG, toimeainet modifitseeritult vabastav tablett, 10TK | Sandoz d.d. | 50 | | | | | | |

| 1096219 | tramadool, 150mg | N02AX02 | TRAMADOLOR ID 150MG, toimeainet modifitseeritult vabastav tablett, 50TK | Sandoz d.d. | 50 | | | | | | |

@@ -3642,35 +3707,36 @@

| 1015377 | tramadool, 50mg | N02AX02 | TRAMAL, kõvakapsel, 20TK | Grünenthal GmbH | 50 | | | | | | |

| 1015580 | tramadool, 50mg | N02AX02 | TRAMADOL KRKA, kõvakapsel, 20TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| 1032679 | tramadool, 50mg | N02AX02 | TRAMADOL LANNACHER, õhukese polümeerikattega tablett, 20TK | LANNACHER HEILMITTEL GmbH | 50 | | | | | | |

| 1074765 | trandolapriil, 2mg | C09AA10 | GOPTEN, kõvakapsel, 28TK | Abbott Laboratories Baltics SIA | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 50 | | | | | | |

| 1074765 | trandolapriil, 2mg | C09AA10 | GOPTEN, kõvakapsel, 28TK | Abbott Laboratories Baltics SIA | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1233290 | trandolapriil+verapamiil , 2mg+180mg | C09BB10 | TARKA, toimeainet modifitseeritult vabastav tablett, 28TK | Abbott Laboratories Baltics SIA | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15 | | | | | |

| 1051816 | traneksaamhape, 100mg 1ml | B02AA02 | CYKLOKAPRON, süstelahus, 5ml 10TK | Pfizer Enterprises SARL | 50 | | | | | | |

| 1083316 | traneksaamhape, 500mg | B02AA02 | CYKLOKAPRON, õhukese polümeerikattega tablett, 20TK | Meda AB | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1130454 | travoprost, 40mcg 1ml | S01EE04 | TRAVATAN, silmatilgad, lahus, 2.5ml 1TK | ALCON LABORATORIES (UK) Ltd. | 50 | | | | | | |

| | | | | | 100 | H40-H42 | Oftalmoloog | esmane | | | |

| 1130454 | travoprost, 40mcg 1ml | S01EE04 | TRAVATAN, silmatilgad, lahus, 2.5ml 1TK | ALCON LABORATORIES (UK) Ltd. | 100 | H40-H42 | Oftalmoloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1007200 | triamtsinoloon, 0,1% | D07AB09 | FTOROCORT, salv, 15g 1TK | Gedeon Richter Plc. | 50 | | | | | | |

| 1008425 | triamtsinoloon, 40mg 1ml | H02AB08 | KENALOG, süstesuspensioon, 1ml 5TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| 1014422 | triheksüfenidüül, 2mg | N04AA01 | CYCLODOL, tablett, 50TK | Grindeks | 50 | | | | | | |

| 1109641 | trimetasidiin, 35mg | C01EB15 | PREDUCTAL MR, toimeainet modifitseeritult vabastav tablett, 60TK | Les Laboratoires Servier | 50 | | | | | | |

| 1401411 | trimetasidiin, 35mg | C01EB15 | TRIMETAZIDINE ACTAVIS, toimeainet modifitseeritult vabastav tablett, 60TK | Actavis Group PTC ehf | 50 | | | | | | |

| 1016312 | trimetoprim, 100mg | J01EA01 | TRIMETOP 100MG, tablett, 30TK | VITABALANS OY | 50 | | | | | | |

| 1040397 | triptoreliin, 3,75mg | L02AE04 | DIPHERELINE 3,75 MG, toimeainet prolongeeritult vabastava süstesuspensiooni pulber ja lahusti, 1TK | Ipsen Pharma | 75 | N80-N80 | Günekoloog | | | | III-IV astme endometrioosi põdevatele patsientidele |

| | | | | | 50 | | | | | | |

| | | | | | 75 | E22.8-E22.8 | Pediaater, Endokrinoloog | | | | |

| 1040397 | triptoreliin, 3,75mg | L02AE04 | DIPHERELINE 3,75 MG, toimeainet prolongeeritult vabastava süstesuspensiooni pulber ja lahusti, 1TK | Ipsen Pharma | 50 | | | | | | |

| | | | | | 75 | E22.8-E22.8 | Endokrinoloog, Pediaater | | | | |

| | | | | | 75 | N80-N80 | Günekoloog | | | | III-IV astme endometrioosi põdevatele patsientidele |

| 1007963 | tromantadiin, 1% | D06BB02 | VIRU-MERZ SEROL GEEL, geel, 2g 1TK | Merz Pharmaceuticals GmbH | 50 | | | | | | |

| 1123850 | tropikamiid, 5mg 1ml | S01FA06 | MYDRIACYL, silmatilgad, lahus, 15ml 1TK | s.a. ALCON- COUVREUR n.v. | 50 | | | | | | |

| 1002698 | tropisetroon, 5mg | A04AA03 | NAVOBAN, kõvakapsel, 5TK | Novartis Finland OY | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1090189 | trospiumkloriid, 15mg | G04BD09 | SPASMED 15, õhukese polümeerikattega tablett, 30TK | PRO. MED. CS. PRAHA a.s. | 50 | | | | | | |

| 1090123 | trospiumkloriid, 5mg | G04BD09 | SPASMED 5, tablett, 30TK | PRO. MED. CS. PRAHA a.s. | 50 | | | | | | |

| 1025064 | tsefadroksiil, 1g | J01DB05 | DURACEF, lahustuv tablett, 10TK | Bristol-Myers Squibb Gyogyszerkereskedel mi Kft. | 50 | | | | | | |

| 1027123 | tsefadroksiil, 250mg | J01DB05 | DURACEF, kõvakapsel, 12TK | Bristol-Myers Squibb Gyogyszerkereskedel mi Kft. | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1027134 | tsefadroksiil, 500mg | J01DB05 | DURACEF, kõvakapsel, 12TK | Bristol-Myers Squibb Gyogyszerkereskedel mi Kft. | 50 | | | | | | |

| 1027101 | tsefadroksiil, 50mg 1ml | J01DB05 | DURACEF, suukaudse suspensiooni pulber, 60ml 1TK | Bristol-Myers Squibb Gyogyszerkereskedel mi Kft. | 50 | | | | | | |

| 1067318 | tsefadroksiil, 50mg 1ml | J01DB05 | DURACEF, suukaudse suspensiooni pulber, 100ml 1TK | Bristol-Myers Squibb Gyogyszerkereskedel mi Kft. | 50 | | | | | | |

@@ -3680,13 +3746,13 @@

| 1068319 | tsefprosiil, 50mg 1ml | J01DC10 | CEFZIL, suukaudse suspensiooni graanulid, 100ml 1TK | Bristol-Myers Squibb Gyogyszerkereskedel mi Kft. | 50 | | | | | | |

| 1007110 | tsefuroksiim, 250mg | J01DC02 | ZINNAT, õhukese polümeerikattega tablett, 10TK | Glaxo Group Ltd | 50 | | | | | | |

| 1219766 | tsefuroksiim, 250mg | J01DC02 | XORIMAX, kaetud tablett, 10TK | Sandoz GmbH | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1137350 | tsefuroksiim, 25mg 1ml | J01DC02 | ZINNAT, suukaudse suspensiooni graanulid, 100ml 1TK | Glaxo Group Ltd | 50 | | | | | | |

| 1007143 | tsefuroksiim, 500mg | J01DC02 | ZINNAT, õhukese polümeerikattega tablett, 10TK | Glaxo Group Ltd | 50 | | | | | | |

| 1287840 | tsefuroksiim, 500mg | J01DC02 | ZINNAT, õhukese polümeerikattega tablett, 14TK | Glaxo Group Ltd | 50 | | | | | | |

| 1219801 | tsefuroksiim, 500mg | J01DC02 | XORIMAX, kaetud tablett, 10TK | Sandoz GmbH | 50 | | | | | | |

| 1287840 | tsefuroksiim, 500mg | J01DC02 | ZINNAT, õhukese polümeerikattega tablett, 14TK | Glaxo Group Ltd | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1073641 | tselekoksiib, 100mg | M01AH01 | CELEBREX, kõvakapsel, 20TK | Pfizer Europe MA EEIG | 50 | | | | | | |

| 1073731 | tselekoksiib, 200mg | M01AH01 | CELEBREX, kõvakapsel, 10TK | Pfizer Europe MA EEIG | 50 | | | | | | |

| 1077836 | tsetirisiin, 10mg | R06AE07 | ZYRTEC, tablett, 30TK | UCB Pharma Oy Finland | 50 | | | | | | |

@@ -3695,227 +3761,222 @@

| 1022869 | tsetirisiin, 10mg 1ml | R06AE07 | ZYRTEC, suukaudsed tilgad, lahus, 20ml 1TK | UCB Pharma Oy Finland | 50 | | | | | | |

| 1043356 | tsetroreliks, 0,25mg | H01CC02 | CETROTIDE, süstelahuse pulber ja lahusti, 1TK | Merck Serono Europe Limited | 50 | | | | | | |

| 1205132 | tsinakaltseet, 30mg | H05BX01 | MIMPARA, õhukese polümeerikattega tablett, 28TK | Amgen Europe B.V. | 50 | | | | | | |

| | | | | | 100 | N18-N18 | Nefroloog, Pediaater | | | | vastavalt Eesti Nefroloogide Seltsi, Sotsiaalministeeriumi ja Eesti Haigekassa poolt tunnustatud ravijuhisele |

| 1205176 | tsinakaltseet, 60mg | H05BX01 | MIMPARA, õhukese polümeerikattega tablett, 28TK | Amgen Europe B.V. | 100 | N18-N18 | Pediaater, Nefroloog | | | | vastavalt Eesti Nefroloogide Seltsi, Sotsiaalministeeriumi ja Eesti Haigekassa poolt tunnustatud ravijuhisele |

| | | | | | 50 | | | | | | |

| 1205211 | tsinakaltseet, 90mg | H05BX01 | MIMPARA, õhukese polümeerikattega tablett, 28TK | Amgen Europe B.V. | 100 | N18-N18 | Nefroloog, Pediaater | | | | vastavalt Eesti Nefroloogide Seltsi, Sotsiaalministeeriumi ja Eesti Haigekassa poolt tunnustatud ravijuhisele |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 100 | N18-N18 | Pediaater, Nefroloog | | | | vastavalt Eesti Nefroloogide Seltsi, Sotsiaalministeeriumi ja Eesti Haigekassa poolt tunnustatud ravijuhisele |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1205176 | tsinakaltseet, 60mg | H05BX01 | MIMPARA, õhukese polümeerikattega tablett, 28TK | Amgen Europe B.V. | 100 | N18-N18 | Nefroloog, Pediaater | | | | vastavalt Eesti Nefroloogide Seltsi, Sotsiaalministeeriumi ja Eesti Haigekassa poolt tunnustatud ravijuhisele |

| | | | | | 50 | | | | | | |

| 1205211 | tsinakaltseet, 90mg | H05BX01 | MIMPARA, õhukese polümeerikattega tablett, 28TK | Amgen Europe B.V. | 100 | N18-N18 | Pediaater, Nefroloog | | | | vastavalt Eesti Nefroloogide Seltsi, Sotsiaalministeeriumi ja Eesti Haigekassa poolt tunnustatud ravijuhisele |

| | | | | | 50 | | | | | | |

| 1196388 | tsinkatsetaatdihüdraat, 25mg | A16AX05 | WILZIN, kõvakapsel, 250TK | Orphan Europe SARL | 100 | E83.0-E83.0 | Gastroenteroloog, Neuroloog | esmane | | | |

| 1196377 | tsinkatsetaatdihüdraat, 50mg | A16AX05 | WILZIN, kõvakapsel, 250TK | Orphan Europe SARL | 100 | E83.0-E83.0 | Gastroenteroloog, Neuroloog | esmane | | | |

| 1040768 | tsinkpüritioon+tõrvad, 1%+1% | D05AA82 | FONGITAR, šampoon, 150ml 1TK | Stiefel Laboratoires UK Ltd. | 75 | M07-M07, L40-L40 | | | | | |

| | | | | | 50 | | | | | | |

| 1008953 | tsinnarisiin, 25mg | N07CA02 | STUGERON, tablett, 50TK | Johnson & Johnson UAB | 50 | | | | | | |

| 1013353 | tsinnarisiin, 75mg | N07CA02 | CINNARON, kõvakapsel, 50TK | REMEDICA LTD. | 50 | | | | | | |

| 1019944 | tsiprofibraat, 100mg | C10AB08 | LIPANOR, kõvakapsel, 30TK | Sanofi-Aventis Estonia OÜ | 50 | | | | | | |

| 1005488 | tsiprofloksatsiin, 250mg | J01MA02 | CIPRINOL, õhukese polümeerikattega tablett, 10TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 100 | D60-D64 | Pediaater, Hematoloog | | | | |

| | | | | | 100 | E84-E84 | Pulmonoloog, Pediaater | | | | |

| | | | | | 100 | D60-D64 | Pediaater, Hematoloog | | | | |

| 1070895 | tsiprofloksatsiin, 250mg | J01MA02 | CIFLOXINAL, tablett, 20TK | PRO. MED. CS. PRAHA a.s. | 100 | D60-D64 | Pediaater, Hematoloog | | | | |

| | | | | | 100 | E84-E84 | Pulmonoloog, Pediaater | | | | |

| | | | | | 50 | | | | | | |

| 1223851 | tsiprofloksatsiin, 250mg | J01MA02 | CIPROFLOXACIN SANDOZ 250MG, õhukese polümeerikattega tablett, 10TK | Sandoz d.d. | 100 | E84-E84 | Pediaater, Pulmonoloog | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | D60-D64 | Hematoloog, Pediaater | | | | |

| 1042827 | tsiprofloksatsiin, 3mg 1ml | S01AX13 | CILOXAN, silmatilgad, 5ml 1TK | s.a. ALCON- COUVREUR n.v. | 50 | | | | | | |

| 1005545 | tsiprofloksatsiin, 500mg | J01MA02 | CIPRINOL, õhukese polümeerikattega tablett, 10TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 100 | E84-E84 | Pediaater, Pulmonoloog | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1223851 | tsiprofloksatsiin, 250mg | J01MA02 | CIPROFLOXACIN SANDOZ 250MG, õhukese polümeerikattega tablett, 10TK | Sandoz d.d. | 50 | | | | | | |

| | | | | | 100 | E84-E84 | Pulmonoloog, Pediaater | | | | |

| | | | | | 100 | D60-D64 | Hematoloog, Pediaater | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1041466 | tsiprofloksatsiin, 500mg | J01MA02 | BACTIFLOX LACTAB 500 MG, õhukese polümeerikattega tablett, 10TK | MEPHA Lda. | 100 | E84-E84 | Pulmonoloog, Pediaater | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | D60-D64 | Pediaater, Hematoloog | | | | |

| 1223929 | tsiprofloksatsiin, 500mg | J01MA02 | CIPROFLOXACIN SANDOZ 500MG, õhukese polümeerikattega tablett, 10TK | Sandoz d.d. | 100 | D60-D64 | Hematoloog, Pediaater | | | | |

| 1042827 | tsiprofloksatsiin, 3mg 1ml | S01AX13 | CILOXAN, silmatilgad, lahus, 5ml 1TK | s.a. ALCON- COUVREUR n.v. | 50 | | | | | | |

| 1005545 | tsiprofloksatsiin, 500mg | J01MA02 | CIPRINOL, õhukese polümeerikattega tablett, 10TK | KRKA d.d., Novo Mesto | 100 | E84-E84 | Pulmonoloog, Pediaater | | | | |

| | | | | | 100 | D60-D64 | Hematoloog, Pediaater | | | | |

| | | | | | 50 | | | | | | |

| 1223929 | tsiprofloksatsiin, 500mg | J01MA02 | CIPROFLOXACIN SANDOZ 500MG, õhukese polümeerikattega tablett, 10TK | Sandoz d.d. | 100 | D60-D64 | Pediaater, Hematoloog | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | E84-E84 | Pulmonoloog, Pediaater | | | | |

| 1083552 | tsitalopraam, 10mg | N06AB04 | CITALEC 10, õhukese polümeerikattega tablett, 30TK | Zentiva a.s. | 50 | | | | | | |

| 1176465 | tsitalopraam, 10mg | N06AB04 | CITALANORM GENERICON, õhukese polümeerikattega tablett, 30TK | Genericon Pharma GmbH | 50 | | | | | | |

| 1218361 | tsitalopraam, 10mg | N06AB04 | CITALOPRAM - TEVA 10MG, õhukese polümeerikattega tablett, 30TK | Teva Pharma B.V. | 50 | | | | | | |

| 1083563 | tsitalopraam, 20mg | N06AB04 | CITALEC 20, õhukese polümeerikattega tablett, 30TK | Zentiva a.s. | 50 | | | | | | |

| 1185409 | tsitalopraam, 20mg | N06AB04 | CITALOPRAM ACTAVIS 20 MG, õhukese polümeerikattega tablett, 28TK | Actavis Nordic A/S | 50 | | | | | | |

| 1070525 | tsitalopraam, 20mg | N06AB04 | CIPRAMIL 20 MG, õhukese polümeerikattega tablett, 28TK | H. LUNDBECK A/S | 50 | | | | | | |

| 1083563 | tsitalopraam, 20mg | N06AB04 | CITALEC 20, õhukese polümeerikattega tablett, 30TK | Zentiva a.s. | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1109517 | tsitalopraam, 20mg | N06AB04 | PRAM 20MG, õhukese polümeerikattega tablett, 28TK | LANNACHER HEILMITTEL GmbH | 50 | | | | | | |

| 1112937 | tsitalopraam, 20mg | N06AB04 | CIRAL 20 MG, kaetud tablett, 28TK | Sandoz d.d. | 50 | | | | | | |

| 1176634 | tsitalopraam, 20mg | N06AB04 | CITALANORM GENERICON, õhukese polümeerikattega tablett, 30TK | Genericon Pharma GmbH | 50 | | | | | | |

| 1185409 | tsitalopraam, 20mg | N06AB04 | CITALOPRAM ACTAVIS 20 MG, õhukese polümeerikattega tablett, 28TK | Actavis Nordic A/S | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1218462 | tsitalopraam, 20mg | N06AB04 | CITALOPRAM - TEVA 20MG, õhukese polümeerikattega tablett, 30TK | Teva Pharma B.V. | 50 | | | | | | |

| 1185533 | tsitalopraam, 40mg | N06AB04 | CITALOPRAM ACTAVIS 40 MG, õhukese polümeerikattega tablett, 28TK | Actavis Nordic A/S | 50 | | | | | | |

| 1106806 | tsitalopraam, 40mg | N06AB04 | CIRAL 40 MG, kaetud tablett, 28TK | Sandoz d.d. | 50 | | | | | | |

| 1176803 | tsitalopraam, 40mg | N06AB04 | CITALANORM GENERICON, õhukese polümeerikattega tablett, 30TK | Genericon Pharma GmbH | 50 | | | | | | |

| 1185533 | tsitalopraam, 40mg | N06AB04 | CITALOPRAM ACTAVIS 40 MG, õhukese polümeerikattega tablett, 28TK | Actavis Nordic A/S | 50 | | | | | | |

| 1218563 | tsitalopraam, 40mg | N06AB04 | CITALOPRAM - TEVA 40MG, õhukese polümeerikattega tablett, 30TK | Teva Pharma B.V. | 50 | | | | | | |

| 7000175 | tsitrulliin, | | L-CITRULLINE , pulber, 100 g | SHS | 50 | | | | | | |

| 1021790 | tsüklofosfamiid, 50mg | L01AA01 | ENDOXAN, kaetud tablett, 50TK | Baxter Oncology GmbH | 50 | | | | | | |

| | | | | | 100 | C00-D48 | Onkoloog, Hematoloog | | | | |

| 1021790 | tsüklofosfamiid, 50mg | L01AA01 | ENDOXAN, kaetud tablett, 50TK | Baxter Oncology GmbH | 100 | C00-D48 | Hematoloog, Onkoloog | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | N00-N08 | Nefroloog, Pediaater | | | | |

| 1123760 | tsüklopentolaat, 10mg 1ml | S01FA04 | CYCLOGYL, silmatilgad, lahus, 15ml 1TK | s.a. ALCON- COUVREUR n.v. | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 100 | D60-D64 | Hematoloog, Pediaater | | | | |

| | | | | | 75 | N00-N08 | Pediaater, Nefroloog | | | | |

| 1123760 | tsüklopentolaat, 10mg 1ml | S01FA04 | CYCLOGYL, silmatilgad, lahus, 15ml 1TK | s.a. ALCON- COUVREUR n.v. | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1008559 | tsüklosporiin, 100mg | L04AD01 | SANDIMMUN NEORAL, pehmekapsel, 50TK | Novartis Finland OY | 100 | Z94-Z94, T86-T86 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | Z94-Z94, T86-T86 | | | | | |

| | | | | | 75 | N00-N08 | Pediaater, Nefroloog | | | | |

| | | | | | 100 | D60-D64 | Hematoloog, Pediaater | | | | |

| 1098840 | tsüklosporiin, 100mg | L04AD01 | EQUORAL 100 MG, pehmekapsel, 50TK | TEVA Czech Industries s.r.o. | 50 | | | | | | |

| | | | | | 100 | Z94-Z94, T86-T86 | | | | | |

| | | | | | 100 | D60-D64 | Hematoloog, Pediaater | | | | |

| | | | | | 75 | N00-N08 | Nefroloog, Pediaater | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1113264 | tsüklosporiin, 100mg | L04AD01 | CICLOSPORIN SANDOZ 100 MG, pehmekapsel, 50TK | Sandoz d.d. | 75 | N00-N08 | Pediaater, Nefroloog | | | | |

| | | | | | 100 | Z94-Z94, T86-T86 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1113264 | tsüklosporiin, 100mg | L04AD01 | CICLOSPORIN SANDOZ 100 MG, pehmekapsel, 50TK | Sandoz d.d. | 50 | | | | | | |

| | | | | | 75 | N00-N08 | Nefroloog, Pediaater | | | | |

| | | | | | 100 | D60-D64 | Hematoloog, Pediaater | | | | |

| | | | | | 100 | Z94-Z94, T86-T86 | | | | | |

| 1008526 | tsüklosporiin, 25mg | L04AD01 | SANDIMMUN NEORAL, pehmekapsel, 50TK | Novartis Finland OY | 100 | Z94-Z94, T86-T86 | | | | | |

| | | | | | 75 | N00-N08 | Nefroloog, Pediaater | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | D60-D64 | Pediaater, Hematoloog | | | | |

| | | | | | 100 | D60-D64 | Hematoloog, Pediaater | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 100 | Z94-Z94, T86-T86 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | N00-N08 | Pediaater, Nefroloog | | | | |

| | | | | | 100 | D60-D64 | Hematoloog, Pediaater | | | | |

| | | | | | 100 | D60-D64 | Hematoloog, Pediaater | | | | |

| | | | | | 100 | Z94-Z94, T86-T86 | | | | | |

| | | | | | 75 | N00-N08 | Nefroloog, Pediaater | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1008548 | tsüklosporiin, 50mg | L04AD01 | SANDIMMUN NEORAL, pehmekapsel, 50TK | Novartis Finland OY | 75 | N00-N08 | Nefroloog, Pediaater | | | | |

| | | | | | 100 | Z94-Z94, T86-T86 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1098828 | tsüklosporiin, 25mg | L04AD01 | EQUORAL 25 MG, pehmekapsel, 50TK | TEVA Czech Industries s.r.o. | 100 | Z94-Z94, T86-T86 | | | | | |

| | | | | | 100 | D60-D64 | Hematoloog, Pediaater | | | | |

| | | | | | 50 | | | | | | |

| 1098839 | tsüklosporiin, 50mg | L04AD01 | EQUORAL 50 MG, pehmekapsel, 50TK | TEVA Czech Industries s.r.o. | 100 | D60-D64 | Pediaater, Hematoloog | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | Z94-Z94, T86-T86 | | | | | |

| | | | | | 75 | N00-N08 | Nefroloog, Pediaater | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 100 | Z94-Z94, T86-T86 | | | | | |

| | | | | | 75 | N00-N08 | Pediaater, Nefroloog | | | | |

| | | | | | 100 | D60-D64 | Pediaater, Hematoloog | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | N00-N08 | Nefroloog, Pediaater | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | Z94-Z94, T86-T86 | | | | | |

| | | | | | 100 | D60-D64 | Hematoloog, Pediaater | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1008548 | tsüklosporiin, 50mg | L04AD01 | SANDIMMUN NEORAL, pehmekapsel, 50TK | Novartis Finland OY | 100 | Z94-Z94, T86-T86 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | D60-D64 | Pediaater, Hematoloog | | | | |

| | | | | | 75 | N00-N08 | Nefroloog, Pediaater | | | | |

| 1098839 | tsüklosporiin, 50mg | L04AD01 | EQUORAL 50 MG, pehmekapsel, 50TK | TEVA Czech Industries s.r.o. | 100 | Z94-Z94, T86-T86 | | | | | |

| | | | | | 75 | N00-N08 | Pediaater, Nefroloog | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | D60-D64 | Pediaater, Hematoloog | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1113253 | tsüklosporiin, 50mg | L04AD01 | CICLOSPORIN SANDOZ 50 MG, pehmekapsel, 50TK | Sandoz d.d. | 75 | N00-N08 | Pediaater, Nefroloog | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | Z94-Z94, T86-T86 | | | | | |

| | | | | | 100 | D60-D64 | Pediaater, Hematoloog | | | | |

| 1064124 | tsüproteroon, 50mg | G03HA01 | ANDROCUR, tablett, 50TK | Bayer Schering Pharma AG | 50 | | | | | | |

| | | | | | 100 | C61-C61 | Onkoloog, Uroloog | | | | juhul, kui haigus on pärast kirurgilist või medikamentoosset kastratsiooni progresseerunud, metastaatilise haiguse korral lühiajaliselt ravi alustamisel LHRH analoogiga, kombinatsioonis kiiritusraviga või juhul, kui patsient keeldub eelistatud hormoonravist (kirurgilisest või medikamentoossest kastratsioonist) |

| 1341177 | tsüproteroon+ östrogeen, 2mg+0,035mg | G03HB01 | CYPRETIL, kaetud tablett, 21TK | ratiopharm GmbH | 50 | | | | | | |

| 1018370 | tsüproteroon+ östrogeen+ östrogeen, 1mg+2mg/0+2mg | G03HB01 | CLIMEN, kaetud tablett, 10TK / 11TK | Bayer Schering Pharma AG | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1014488 | tsüproteroon+östrogee n, 2mg+0,035mg | G03HB01 | DIANE, kaetud tablett, 21TK | Bayer Schering Pharma AG | 50 | | | | | | |

| 1341177 | tsüproteroon+östrogee n, 2mg+0,035mg | G03HB01 | CYPRETIL, kaetud tablett, 21TK | ratiopharm GmbH | 50 | | | | | | |

| 1122084 | tsüproteroon+östrogee n, 2mg+35mcg | G03HB01 | FEMINA-35, kaetud tablett, 21TK | Nycomed Sefa AS | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1018370 | tsüproteroon+östrogee n+östrogeen, 1mg+2mg+2mg | G03HB01 | CLIMEN, kaetud tablett, 10TK / 11TK | Bayer Schering Pharma AG | 50 | | | | | | |

| 1040779 | tõrvad, 1% | D05AA84 | POLYTAR LIQUID, šampoon, 150ml 1TK | Stiefel Laboratories (Ireland) Ltd. | 75 | M07-M07, L40-L40 | | | | | |

| | | | | | 50 | | | | | | |

| 1016985 | ursodeoksükoolhape, 250mg | A05AA02 | URSOSAN, kõvakapsel, 50TK | PRO. MED. CS. PRAHA a.s. | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1044818 | ursodeoksükoolhape, 250mg | A05AA02 | URSOFALK, kõvakapsel, 50TK | Dr. Falk Pharma GmbH | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1016301 | valatsikloviir, 500mg | J05AB11 | VALTREX, õhukese polümeerikattega tablett, 10TK | Glaxo Wellcome Operations | 50 | | | | | | |

| 1300936 | valatsikloviir, 500mg | J05AB11 | VALACICLOVIR ACTAVIS 500MG, õhukese polümeerikattega tablett, 10TK | Actavis Group PTC ehf | 50 | | | | | | |

| 1369593 | valatsikloviir, 500mg | J05AB11 | VALACICLOVIR PORTFARMA 500 MG, õhukese polümeerikattega tablett, 10TK | Portfarma ehf | 50 | | | | | | |

| 1078185 | valproehape, 1000mg | N03AG01 | ORFIRIL LONG 1000 MG, toimeainet prolongeeritult vabastavad graanulid, 100TK | Desitin Arzneimittel GmbH | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1043592 | valproehape, 150mg | N03AG01 | CONVULEX 150 MG, gastroresistentne pehmekapsel, 100TK | GEROT PHARMAZEUTIKA Ges.m.b.H. | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1076419 | valproehape, 150mg | N03AG01 | ORFIRIL LONG 150 MG, toimeainet prolongeeritult vabastav kõvakapsel, 100TK | Desitin Arzneimittel GmbH | 50 | | | | | | |

| 1078185 | valproehape, 1000mg | N03AG01 | ORFIRIL LONG 1000 MG, toimeainet prolongeeritult vabastavad graanulid, 100TK | Desitin Arzneimittel GmbH | 50 | | | | | | |

| | | | | | 100 | G40-G40 | Neuroloog | esmane | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1043604 | valproehape, 300mg | N03AG01 | CONVULEX 300 MG, gastroresistentne pehmekapsel, 100TK | GEROT PHARMAZEUTIKA Ges.m.b.H. | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1076419 | valproehape, 150mg | N03AG01 | ORFIRIL LONG 150 MG, toimeainet prolongeeritult vabastav kõvakapsel, 100TK | Desitin Arzneimittel GmbH | 100 | G40-G40 | Neuroloog | esmane | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1086555 | valproehape, 300mg | N03AG01 | DEPAKINE CHRONO 300 mg, toimeainet prolongeeritult vabastav tablett, 100TK | Sanofi-Aventis Estonia OÜ | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1108257 | valproehape, 300mg | N03AG01 | ORFIRIL 300, gastroresistentne tablett, 100TK | Desitin Arzneimittel GmbH | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1224605 | valproehape, 300mg | N03AG01 | VALPROATE SODIUM SANDOZ 300MG, toimeainet prolongeeritult vabastav tablett, 100TK | Sandoz d.d. | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1108246 | valproehape, 150mg | N03AG01 | ORFIRIL 150, gastroresistentne tablett, 100TK | Desitin Arzneimittel GmbH | 50 | | | | | | |

| | | | | | 100 | G40-G40 | Neuroloog | esmane | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1252190 | valproehape, 300mg | N03AG01 | ABSENOR, toimeainet prolongeeritult vabastav tablett, 100TK | Orion Corporation Orion Pharma | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1076341 | valproehape, 500mg | N03AG01 | ORFIRIL LONG 500 MG, toimeainet prolongeeritult vabastavad graanulid, 100TK | Desitin Arzneimittel GmbH | 50 | | | | | | |

| 1043604 | valproehape, 300mg | N03AG01 | CONVULEX 300 MG, gastroresistentne pehmekapsel, 100TK | G.L. Pharma GmbH | 50 | | | | | | |

| | | | | | 100 | G40-G40 | Neuroloog | esmane | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1224638 | valproehape, 500mg | N03AG01 | VALPROATE SODIUM SANDOZ 500MG, toimeainet prolongeeritult vabastav tablett, 30TK | Sandoz d.d. | 100 | G40-G40 | Neuroloog | esmane | | | |

| 1224605 | valproehape, 300mg | N03AG01 | VALPROATE SODIUM SANDOZ 300MG, toimeainet prolongeeritult vabastav tablett, 100TK | Sandoz d.d. | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| | | | | | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1252202 | valproehape, 500mg | N03AG01 | ABSENOR, toimeainet prolongeeritult vabastav tablett, 100TK | Orion Corporation Orion Pharma | 50 | | | | | | |

| 1108257 | valproehape, 300mg | N03AG01 | ORFIRIL 300, gastroresistentne tablett, 100TK | Desitin Arzneimittel GmbH | 50 | | | | | | |

| | | | | | 100 | G40-G40 | Neuroloog | esmane | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1252190 | valproehape, 300mg | N03AG01 | ABSENOR, toimeainet prolongeeritult vabastav tablett, 100TK | Orion Corporation Orion Pharma | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1076341 | valproehape, 500mg | N03AG01 | ORFIRIL LONG 500 MG, toimeainet prolongeeritult vabastavad graanulid, 100TK | Desitin Arzneimittel GmbH | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1086544 | valproehape, 500mg | N03AG01 | DEPAKINE CHRONO 500 MG, toimeainet prolongeeritult vabastav tablett, 30TK | Sanofi-Aventis Estonia OÜ | 50 | | | | | | |

| | | | | | 100 | G40-G40 | Neuroloog | esmane | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1043581 | valproehape, 50mg 1ml | N03AG01 | CONVULEX, siirup, 100ml 1TK | GEROT PHARMAZEUTIKA Ges.m.b.H. | 50 | | | | | | |

| | | | | | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1224672 | valproehape, 500mg | N03AG01 | VALPROATE SODIUM SANDOZ 500MG, toimeainet prolongeeritult vabastav tablett, 100TK | Sandoz d.d. | 50 | | | | | | |

| | | | | | 100 | G40-G40 | Neuroloog | esmane | | | |

| 1113017 | valproehape, 50mg 1ml | N03AG01 | DEPAKINE, siirup, 150ml 1TK | Sanofi-Aventis Estonia OÜ | 100 | G40-G40 | Neuroloog | esmane | | | |

| 1252202 | valproehape, 500mg | N03AG01 | ABSENOR, toimeainet prolongeeritult vabastav tablett, 100TK | Orion Corporation Orion Pharma | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1043581 | valproehape, 50mg 1ml | N03AG01 | CONVULEX, siirup, 100ml 1TK | G.L. Pharma GmbH | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

@@ -3923,64 +3984,91 @@

| 1108268 | valproehape, 600mg | N03AG01 | ORFIRIL 600, gastroresistentne tablett, 50TK | Desitin Arzneimittel GmbH | 50 | | | | | | |

| | | | | | 100 | G40-G40 | Neuroloog | esmane | | | |

| 1025536 | valproehape, 60mg 1ml | N03AG01 | ORFIRIL SAFT, suukaudne lahus, 250ml 1TK | Desitin Arzneimittel GmbH | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1025536 | valproehape, 60mg 1ml | N03AG01 | ORFIRIL SAFT, suukaudne lahus, 250ml 1TK | Desitin Arzneimittel GmbH | 50 | | | | | | |

| | | | | | 100 | G40-G40 | Neuroloog | esmane | | | |

| 1092844 | valsartaan, 160mg | C09CA03 | DIOVAN, õhukese polümeerikattega tablett, 28TK | Novartis Finland OY | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1250378 | valsartaan, 160mg | C09CA03 | VALSACOR, õhukese polümeerikattega tablett, 28TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1250389 | valsartaan, 160mg | C09CA03 | VALSACOR, õhukese polümeerikattega tablett, 56TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1434495 | valsartaan, 160mg | C09CA03 | VALZAP, õhukese polümeerikattega tablett, 28TK | Zentiva, k.s. | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1092877 | valsartaan, 80mg | C09CA03 | DIOVAN, õhukese polümeerikattega tablett, 28TK | Novartis Finland OY | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1092844 | valsartaan, 160mg | C09CA03 | DIOVAN, õhukese polümeerikattega tablett, 28TK | Novartis Finland OY | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1250378 | valsartaan, 160mg | C09CA03 | VALSACOR, õhukese polümeerikattega tablett, 28TK | KRKA d.d., Novo Mesto | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1250389 | valsartaan, 160mg | C09CA03 | VALSACOR, õhukese polümeerikattega tablett, 56TK | KRKA d.d., Novo Mesto | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1406809 | valsartaan, 160mg | C09CA03 | SUVARTAR 160MG, õhukese polümeerikattega tablett, 28TK | Sandoz d.d. | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1434495 | valsartaan, 160mg | C09CA03 | VALZAP, õhukese polümeerikattega tablett, 28TK | Zentiva, k.s. | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1421233 | valsartaan, 320mg | C09CA03 | VALSACOR, õhukese polümeerikattega tablett, 28TK | KRKA d.d., Novo Mesto | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1092877 | valsartaan, 80mg | C09CA03 | DIOVAN, õhukese polümeerikattega tablett, 28TK | Novartis Finland OY | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1250323 | valsartaan, 80mg | C09CA03 | VALSACOR, õhukese polümeerikattega tablett, 28TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1406663 | valsartaan, 80mg | C09CA03 | SUVARTAR 80MG, õhukese polümeerikattega tablett, 28TK | Sandoz d.d. | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1434473 | valsartaan, 80mg | C09CA03 | VALZAP, õhukese polümeerikattega tablett, 28TK | Zentiva, k.s. | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1434518 | valsartaan+ hüdroklorotiasiid, 160mg+12,5mg | C09DA03 | VALZAP H, õhukese polümeerikattega tablett, 28TK | Zentiva, k.s. | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15 | | | | | |

| 1434530 | valsartaan+ hüdroklorotiasiid, 80mg+12,5mg | C09DA03 | VALZAP H, õhukese polümeerikattega tablett, 28TK | Zentiva, k.s. | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15 | | | | | |

| 1402681 | valsartaan+hüdroklorot iasiid, 12,5mg+80mg | C09DA03 | SUVARTAR HCT 80 MG/12,5 MG, õhukese polümeerikattega tablett, 28TK | Sandoz d.d. | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 50 | | | | | | |

| 1086027 | valsartaan+hüdroklorot iasiid, 160mg+12,5mg | C09DA03 | CO-DIOVAN, õhukese polümeerikattega tablett, 28TK | Novartis Finland OY | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1324314 | valsartaan+hüdroklorot iasiid, 160mg+12,5mg | C09DA03 | VALSACOMBI, õhukese polümeerikattega tablett, 28TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15 | | | | | |

| 1405921 | valsartaan+hüdroklorot iasiid, 160mg+12,5mg | C09DA03 | SUVARTAR HCT 160 MG/12,5 MG, õhukese polümeerikattega tablett, 28TK | Sandoz d.d. | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 50 | | | | | | |

| 1086072 | valsartaan+hüdroklorot iasiid, 160mg+25mg | C09DA03 | CO-DIOVAN, õhukese polümeerikattega tablett, 28TK | Novartis Finland OY | 50 | | | | | | |

| 1324235 | valsartaan+hüdroklorot iasiid, 160mg+25mg | C09DA03 | VALSACOMBI, õhukese polümeerikattega tablett, 28TK | KRKA d.d., Novo Mesto | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 50 | | | | | | |

| 1457557 | valsartaan+hüdroklorot iasiid, 320mg+12,5mg | C09DA03 | VALSACOMBI, õhukese polümeerikattega tablett, 28TK | KRKA d.d., Novo Mesto | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 50 | | | | | | |

| 1324156 | valsartaan+hüdroklorot iasiid, 80mg+12,5mg | C09DA03 | VALSACOMBI, õhukese polümeerikattega tablett, 28TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| 1031342 | valsartaan+hüdroklorot iasiid, 80mg+12,5mg | C09DA03 | CO-DIOVAN, õhukese polümeerikattega tablett, 28TK | Novartis Finland OY | 50 | | | | | | |

| 1008335 | varfariin, 3mg | B01AA03 | MAREVAN, tablett, 100TK | Orion Corporation | 50 | | | | | | |

| | | | | | 75 | I47-I49 | | | | | |

| | | | | | 100 | Z95.2-Z95.2, T82- T82, I27.0-I27.0, I26-I26 | | | | | |

| 1008368 | varfariin, 5mg | B01AA03 | MAREVAN FORTE, tablett, 100TK | Orion Corporation | 100 | Z95.2-Z95.2, T82- T82, I27.0-I27.0, I26-I26 | | | | | |

| | | | | | 75 | I47-I49 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | I80-I82, Z95.2- Z95.2, I26-I26, T82- T82, I67.6-I67.6, I27.0-I27.0 | | | | | |

| 1008368 | varfariin, 5mg | B01AA03 | MAREVAN FORTE, tablett, 100TK | Orion Corporation | 75 | I47-I49 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | I80-I82, Z95.2- Z95.2, I26-I26, T82- T82, I67.6-I67.6, I27.0-I27.0 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1261741 | venlafaksiin, 150mg | N06AX16 | VENLAFAXIN MEDOCHEMIE XR 150 MG, toimeainet prolongeeritult vabastav kõvakapsel, 28TK | Medochemie Ltd | 50 | | | | | | |

| 1319419 | venlafaksiin, 150mg | N06AX16 | VENLAFAXINE ORION, toimeainet prolongeeritult vabastav kõvakapsel, 28TK | Orion Corporation | 50 | | | | | | |

| 1068791 | venlafaksiin, 150mg | N06AX16 | EFEXOR XR, toimeainet prolongeeritult vabastav kõvakapsel, 28TK | Pfizer Europe MA EEIG | 50 | | | | | | |

| 1232468 | venlafaksiin, 150mg | N06AX16 | ALVENTA, toimeainet prolongeeritult vabastav kõvakapsel, 28TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| 1261741 | venlafaksiin, 150mg | N06AX16 | VENLAFAXIN MEDOCHEMIE XR 150 MG, toimeainet prolongeeritult vabastav kõvakapsel, 28TK | Medochemie Ltd | 50 | | | | | | |

| 1306325 | venlafaksiin, 150mg | N06AX16 | VENLAGAMMA 150 MG, toimeainet prolongeeritult vabastav kõvakapsel, 30TK | WÖRWAG PHARMA GmbH & Co. KG | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1316405 | venlafaksiin, 150mg | N06AX16 | ARGOFAN 150 SR, toimeainet prolongeeritult vabastav tablett, 30TK | Zentiva a.s. | 50 | | | | | | |

| 1319419 | venlafaksiin, 150mg | N06AX16 | VENLAFAXINE ORION, toimeainet prolongeeritult vabastav kõvakapsel, 28TK | Orion Corporation | 50 | | | | | | |

| 1435205 | venlafaksiin, 150mg | N06AX16 | VENLAFAXINE PORTFARMA, toimeainet prolongeeritult vabastav kõvakapsel, 28TK | Portfarma ehf | 50 | | | | | | |

| 1232266 | venlafaksiin, 37,5mg | N06AX16 | ALVENTA, toimeainet prolongeeritult vabastav kõvakapsel, 28TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| 1261684 | venlafaksiin, 75mg | N06AX16 | VENLAFAXIN MEDOCHEMIE XR 75 MG, toimeainet prolongeeritult vabastav kõvakapsel, 28TK | Medochemie Ltd | 50 | | | | | | |

| 1319396 | venlafaksiin, 75mg | N06AX16 | VENLAFAXINE ORION, toimeainet prolongeeritult vabastav kõvakapsel, 28TK | Orion Corporation | 50 | | | | | | |

| 1068858 | venlafaksiin, 75mg | N06AX16 | EFEXOR XR, toimeainet prolongeeritult vabastav kõvakapsel, 28TK | Pfizer Europe MA EEIG | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1232367 | venlafaksiin, 75mg | N06AX16 | ALVENTA, toimeainet prolongeeritult vabastav kõvakapsel, 28TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| 1261684 | venlafaksiin, 75mg | N06AX16 | VENLAFAXIN MEDOCHEMIE XR 75 MG, toimeainet prolongeeritult vabastav kõvakapsel, 28TK | Medochemie Ltd | 50 | | | | | | |

| 1281709 | venlafaksiin, 75mg | N06AX16 | VENLAFAXIN-RATIOPHARM 75MG, toimeainet prolongeeritult vabastav kõvakapsel, 30TK | ratiopharm GmbH | 50 | | | | | | |

| 1306246 | venlafaksiin, 75mg | N06AX16 | VENLAGAMMA 75 MG, toimeainet prolongeeritult vabastav kõvakapsel, 30TK | WÖRWAG PHARMA GmbH & Co. KG | 50 | | | | | | |

| 1316371 | venlafaksiin, 75mg | N06AX16 | ARGOFAN 75 SR, toimeainet prolongeeritult vabastav tablett, 30TK | Zentiva a.s. | 50 | | | | | | |

| 1319396 | venlafaksiin, 75mg | N06AX16 | VENLAFAXINE ORION, toimeainet prolongeeritult vabastav kõvakapsel, 28TK | Orion Corporation | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1435182 | venlafaksiin, 75mg | N06AX16 | VENLAFAXINE PORTFARMA, toimeainet prolongeeritult vabastav kõvakapsel, 28TK | Portfarma ehf | 50 | | | | | | |

| 1017267 | verapamiil, 120mg | C08DA01 | ISOPTIN RETARD 120 MG, toimeainet prolongeeritult vabastav tablett, 20TK | Abbott GmbH & Co. KG | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 50 | | | | | | |

| 1017267 | verapamiil, 120mg | C08DA01 | ISOPTIN RETARD 120 MG, toimeainet prolongeeritult vabastav tablett, 20TK | Abbott GmbH & Co. KG | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 75 | I47-I49 | Pediaater, Kardioloog | esmane | | | |

| 1073157 | verapamiil, 120mg | C08DA01 | ISOPTIN RETARD 120 MG, toimeainet prolongeeritult vabastav tablett, 100TK | Abbott GmbH & Co. KG | 75 | I47-I49 | Kardioloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| 1073157 | verapamiil, 120mg | C08DA01 | ISOPTIN RETARD 120 MG, toimeainet prolongeeritult vabastav tablett, 100TK | Abbott GmbH & Co. KG | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | I47-I49 | Kardioloog, Pediaater | esmane | | | |

| 1073180 | verapamiil, 240mg | C08DA01 | ISOPTIN RETARD, toimeainet prolongeeritult vabastav tablett, 100TK | Abbott GmbH & Co. KG | 75 | I47-I49 | Kardioloog, Pediaater | esmane | | | |

| | | | | | 75 | I10-I13, I15-I15 | | | | | |

| 1073180 | verapamiil, 240mg | C08DA01 | ISOPTIN RETARD, toimeainet prolongeeritult vabastav tablett, 100TK | Abbott GmbH & Co. KG | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 75 | I47-I49 | Pediaater, Kardioloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1073405 | verapamiil, 80mg | C08DA01 | VERAPAMIL- RATIOPHARM 80 MG, õhukese polümeerikattega tablett, 50TK | ratiopharm GmbH | 75 | I47-I49 | Kardioloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| 1073405 | verapamiil, 80mg | C08DA01 | VERAPAMIL- RATIOPHARM 80 MG, õhukese polümeerikattega tablett, 50TK | ratiopharm GmbH | 75 | I47-I49 | Pediaater, Kardioloog | esmane | | | |

| | | | | | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 50 | | | | | | |

@@ -3999,8 +4087,10 @@

| 1035896 | östradiool, 25mcg | G03CA03 | VAGIFEM, vaginaaltablett, 15TK | Novo Nordisk A/S | 50 | | | | | | |

| 1030431 | östradiool, 2mg | G03CA03 | ESTROFEM, õhukese polümeerikattega tablett, 28TK | Novo Nordisk A/S | 50 | | | | | | |

| 1026672 | östradiool, 50mcg 24h | G03CA03 | CLIMARA, transdermaalne plaaster, 4TK | Bayer Schering Pharma AG | 50 | | | | | | |

| 1030453 | östradiool+ noretisteroon, 0+1mg/1mg+2mg/0+2 mg | G03FB05 | TRISEQUENS, õhukese polümeerikattega tablett, 6TK / 10TK / 12TK | Novo Nordisk A/S | 50 | | | | | | |

| 1031735 | östradiool+prednisoloo n, 0,05mg+4mg 1g | G03CA80 | LINOLADIOL-H N, kreem, 25g 1TK | Dr. August Wolff GmbH & Co. KG Arzneimittel | 50 | | | | | | |

| 1021161 | östramustiin, 140mg | L01XX11 | ESTRACYT, kõvakapsel, 100TK | Pfizer Enterprises SARL | 50 | | | | | | |

| 1022634 | östriool, 500mcg | G03CA04 | OVESTIN, vaginaalsuposiit, 15TK | N.V. ORGANON | 50 | | | | | | |

📎 [Original PDF: EHKloetelu_11.05.2011.pdf](https://www.riigiteataja.ee/aktilisa/EHKloetelu_11.05.2011.pdf)

📎 [Original PDF: EHKloetelu_juuni.pdf](https://www.riigiteataja.ee/aktilisa/EHKloetelu_juuni.pdf)

2011-05-15

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2011-03-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2010-12-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2010-09-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2010-06-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2010-03-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2009-12-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2009-09-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2009-08-08

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2009-06-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2009-03-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2008-12-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2008-10-25

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2008-09-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2008-06-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2008-03-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2007-12-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2007-09-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2007-06-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2007-03-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2006-12-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2006-09-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2006-06-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2006-03-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2005-12-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2005-09-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2005-06-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2005-03-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2004-12-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2004-09-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2004-06-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2004-03-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2003-12-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2003-09-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2003-06-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2003-02-28

Eesti Haigekassa ravimite loetelu

original version Text at this date